<SEC-DOCUMENT>0001079973-25-001567.txt : 20251007
<SEC-HEADER>0001079973-25-001567.hdr.sgml : 20251007
<ACCEPTANCE-DATETIME>20251007160541
ACCESSION NUMBER:		0001079973-25-001567
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		21
CONFORMED PERIOD OF REPORT:	20251120
FILED AS OF DATE:		20251007
DATE AS OF CHANGE:		20251007

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PRO DEX INC
		CENTRAL INDEX KEY:			0000788920
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				841261240
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-14942
		FILM NUMBER:		251379867

	BUSINESS ADDRESS:	
		STREET 1:		2361 MCGAW AVENUE
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614
		BUSINESS PHONE:		949-769-3231

	MAIL ADDRESS:	
		STREET 1:		2361 MCGAW AVENUE
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRO-DEX, INC.
		DATE OF NAME CHANGE:	20151110

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CONTEXT CAPITAL FUNDS
		DATE OF NAME CHANGE:	20151104

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRO DEX INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>pdex_def14a.htm
<DESCRIPTION>DEFINITIVE 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:pdex="http://pro-dex.com/20250630">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_ECD%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_039_pdex_pro%2Ddex.com_20250630 -->
<!-- Field: Set; Name: xdx; ID: xdx_044_20240701_20250630 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05B_edei%2D%2DEntityCentralIndexKey_0000788920 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000004" name="dei:EntityCentralIndexKey">0000788920</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="xdx2ixbrl0010" name="dei:DocumentType">DEF 14A</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="pdex-20250630.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2024-07-01to2025-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_ReportedValueOfEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_EquityAwardAdjustmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:EquityAwardAdjustmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_ReportedValueOfEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_EquityAwardAdjustmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:EquityAwardAdjustmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_ReportedValueOfEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_EquityAwardAdjustmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:EquityAwardAdjustmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_TotalEquityAwardAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:TotalEquityAwardAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_TotalEquityAwardAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:TotalEquityAwardAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_TotalEquityAwardAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:TotalEquityAwardAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ReportedValueOfEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_EquityAwardAdjustmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:EquityAwardAdjustmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ReportedValueOfEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_EquityAwardAdjustmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:EquityAwardAdjustmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ReportedValueOfEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_EquityAwardAdjustmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:EquityAwardAdjustmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_TotalEquityAwardAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:TotalEquityAwardAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_TotalEquityAwardAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:TotalEquityAwardAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_TotalEquityAwardAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788920</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:TotalEquityAwardAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_904_edei--DocumentType_dxL_c20240701__20250630_ztPK0DhDI1u8" title="::XDX::DEF 14A"><span style="-sec-ix-hidden: xdx2ixbrl0010">SCHEDULE 14A</span></span> INFORMATION</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Proxy Statement Pursuant to Section&#160;14(a)
of the</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Securities Exchange Act of 1934</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Filed by the Registrant&#160;&#160; <span style="font-family: Wingdings">x</span>
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Filed by a Party other than the Registrant&#160;&#160; <span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box:</p>

<p style="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font: 11pt Times New Roman, Times, Serif; width: 3%; padding-right: 0.8pt"><span style="font-family: Wingdings; font-size: 10pt">&#168;</span></td>
    <td style="font: 11pt Times New Roman, Times, Serif; width: 1%; padding-right: 0.8pt">&#160;</td>
    <td style="font: 11pt Times New Roman, Times, Serif; width: 96%; padding-right: 0.8pt"><span style="font-size: 10pt">Preliminary Proxy Statement</span></td></tr>
  </table>
<p style="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%; padding-right: 0.8pt"><span style="font-family: Wingdings; font-size: 10pt">&#168;</span></td>
    <td style="width: 1%; padding-right: 0.8pt">&#160;</td>
    <td style="width: 96%; padding-right: 0.8pt"><span style="font-size: 10pt"><b>Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</b></span></td></tr>
  </table>
<p style="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%; padding-right: 0.8pt"><span style="font-family: Wingdings; font-size: 10pt">x</span></td>
    <td style="width: 1%; padding-right: 0.8pt">&#160;</td>
    <td style="width: 96%; padding-right: 0.8pt"><span style="font-size: 10pt">Definitive Proxy Statement</span></td></tr>
  </table>
<p style="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%; padding-right: 0.8pt"><span style="font-family: Wingdings; font-size: 10pt">&#168;</span></td>
    <td style="width: 1%; padding-right: 0.8pt">&#160;</td>
    <td style="width: 96%; padding-right: 0.8pt"><span style="font-size: 10pt">Definitive Additional Materials</span></td></tr>
  </table>
<p style="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%; padding-right: 0.8pt"><span style="font-family: Wingdings; font-size: 10pt">&#168;</span></td>
    <td style="width: 1%; padding-right: 0.8pt">&#160;</td>
    <td style="width: 96%; padding-right: 0.8pt"><span style="font-size: 10pt">Soliciting Material Pursuant to 240.14a-11(c) or 240.14a-12</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;<b><span id="xdx_90D_edei--EntityRegistrantName_c20240701__20250630_zfB4XJHvQ4wd"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000011" name="dei:EntityRegistrantName">PRO-DEX, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Name of Registrant as Specified In Its Charter)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Name of Person(s) Filing Proxy Statement if
other than the Registrant)</b></p>

<p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Payment of Filing Fee (Check the appropriate box):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%; padding-right: 0.8pt"><span style="font-family: Wingdings; font-size: 10pt">x</span></td>
    <td style="width: 1%; padding-right: 0.8pt">&#160;</td>
    <td style="width: 96%; padding-right: 0.8pt"><span style="font-size: 10pt">No fee required</span></td></tr>
  </table>
<p style="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%; padding-right: 0.8pt"><span style="font-family: Wingdings; font-size: 10pt">&#168;</span></td>
    <td style="width: 1%; padding-right: 0.8pt">&#160;</td>
    <td style="width: 96%; padding-right: 0.8pt"><span style="font-size: 10pt">Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.</span></td></tr>
  </table>
<p style="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 4%; padding-right: 0.8pt">&#160;</td>
    <td style="vertical-align: top; width: 4%; padding-right: 0.8pt"><span style="font-size: 10pt">1.</span></td>
    <td style="vertical-align: top; width: 92%; padding-right: 0.8pt"><span style="font-size: 10pt">Title of each class of securities to which transaction applies:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;&#160;</b></p>

<!-- Field: Rule-Page --><div style="margin: 1pt 0in 1pt 40.5pt"><div style="border-top: black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 4%; padding-right: 0.8pt">&#160;</td>
    <td style="vertical-align: top; width: 4%; padding-right: 0.8pt"><span style="font-size: 10pt">2.</span></td>
    <td style="vertical-align: top; width: 92%; padding-right: 0.8pt"><span style="font-size: 10pt">Aggregate number of securities to which transaction applies:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;&#160;</b></p>

<!-- Field: Rule-Page --><div style="margin: 1pt 0in 1pt 40.5pt"><div style="border-top: black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 4%; padding-right: 0.8pt">&#160;</td>
    <td style="vertical-align: top; width: 4%; padding-right: 0.8pt"><span style="font-size: 10pt">3.</span></td>
    <td style="vertical-align: top; width: 92%; padding-right: 0.8pt"><span style="font-size: 10pt">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule&#160;0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;&#160;</b></p>

<!-- Field: Rule-Page --><div style="margin: 1pt 0in 1pt 40.5pt"><div style="border-top: black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 4%; padding-right: 0.8pt">&#160;</td>
    <td style="vertical-align: top; width: 4%; padding-right: 0.8pt"><span style="font-size: 10pt">4.</span></td>
    <td style="vertical-align: top; width: 92%; padding-right: 0.8pt"><span style="font-size: 10pt">Proposed maximum aggregate value of transaction:</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<!-- Field: Rule-Page --><div style="margin: 1pt 0in 1pt 40.5pt"><div style="border-top: black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 4%; padding-right: 0.8pt">&#160;</td>
    <td style="vertical-align: top; width: 4%; padding-right: 0.8pt"><span style="font-size: 10pt">5.</span></td>
    <td style="vertical-align: top; width: 92%; padding-right: 0.8pt"><span style="font-size: 10pt">Total fee paid:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;&#160;</b></p>

<!-- Field: Rule-Page --><div style="margin: 1pt 0in 1pt 40.5pt"><div style="border-top: black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%; padding-right: 0.8pt"><span style="font-family: Wingdings; font-size: 10pt">&#168;</span></td>
    <td style="width: 1%; padding-right: 0.8pt">&#160;</td>
    <td style="width: 96%; padding-right: 0.8pt"><span style="font-size: 10pt">Fees paid previously with preliminary materials.</span></td></tr>
  </table>
<p style="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%; padding-right: 0.8pt"><span style="font-family: Wingdings; font-size: 10pt">&#168;</span></td>
    <td style="width: 1%; padding-right: 0.8pt">&#160;</td>
    <td style="width: 96%; padding-right: 0.8pt"><span style="font-size: 10pt">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.</span></td></tr>
  </table>
<p style="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 4%; padding-right: 0.8pt">&#160;</td>
    <td style="vertical-align: top; width: 4%; padding-right: 0.8pt"><span style="font-size: 10pt">1.</span></td>
    <td style="vertical-align: top; width: 92%; padding-right: 0.8pt"><span style="font-size: 10pt">Amount Previously Paid:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;&#160;</b></p>

<!-- Field: Rule-Page --><div style="margin: 1pt 0in 1pt 40.5pt"><div style="border-top: black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 4%; padding-right: 0.8pt">&#160;</td>
    <td style="vertical-align: top; width: 4%; padding-right: 0.8pt"><span style="font-size: 10pt">2.</span></td>
    <td style="vertical-align: top; width: 92%; padding-right: 0.8pt"><span style="font-size: 10pt">Form, Schedule or Registration Statement No.:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;&#160;</b></p>

<!-- Field: Rule-Page --><div style="margin: 1pt 0in 1pt 40.5pt"><div style="border-top: black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 4%; padding-right: 0.8pt">&#160;</td>
    <td style="vertical-align: top; width: 4%; padding-right: 0.8pt"><span style="font-size: 10pt">3.</span></td>
    <td style="vertical-align: top; width: 92%; padding-right: 0.8pt"><span style="font-size: 10pt">Filing Party:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<!-- Field: Rule-Page --><div style="margin: 1pt 0in 1pt 40.5pt"><div style="border-top: black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 4%; padding-right: 0.8pt">&#160;</td>
    <td style="vertical-align: top; width: 4%; padding-right: 0.8pt"><span style="font-size: 10pt">4.</span></td>
    <td style="vertical-align: top; width: 92%; padding-right: 0.8pt"><span style="font-size: 10pt">Date Filed:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;&#160;</b></p>

<!-- Field: Rule-Page --><div style="margin: 1pt 0in 1pt 40.5pt"><div style="border-top: black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->


<p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 7pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><img src="logo.jpg" alt=""/>&#160;</p>

<p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0">To Our Shareholders,</p>

<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you for your continued support of Pro-Dex.
In Fiscal 2025, we continued our trend with our tenth consecutive years of sales growth, including 24% year-over-year growth finishing
at $65M in sales. Other highlights include assisting customers with major product launches, adding depth to our management team, and improving
our manufacturing systems.</p>

<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As always, Pro-Dex remains committed to its
plans for continued growth. Between a healthy backlog, new customers, and new products and technology in development, we believe Pro-Dex
is well positioned for another strong year in Fiscal 2026.</p>

<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We cannot discuss the past, and upcoming,
accomplishments without a word of thanks and appreciation for our Pro-Dex teammates, including our Board of Directors. Their efforts and
dedication make this all possible.</p>

<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also value our shareholders, and I look
forward to seeing some of you at our annual shareholder meeting on November 20, 2025.</p>

<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We look forward to hearing from you and answering
any questions you have. You can reach the Board or myself at (949) 769-3200 or investor.relations@pro-dex.com.</p>

<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0">Sincerely,</p>

<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">/s/ Rick Van Kirk</span></p>

<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0">Rick Van Kirk</p>

<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0">President and Chief Executive Officer</p>

<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 7pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;<img src="logo.jpg" alt=""/></p>

<p style="font: 7pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="margin: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTICE OF ANNUAL MEETING OF SHAREHOLDERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TO BE HELD <span style="text-transform: uppercase">NOVEMBER
20, 2025</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the Shareholders of Pro-Dex, Inc.:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">The Annual Meeting of Shareholders
(&#8220;Annual Meeting&#8221;) of Pro-Dex, Inc. (&#8220;Pro-Dex&#8221;, the &#8220;Company&#8221;, &#8220;we&#8221;, &#8220;us&#8221;
or &#8220;our&#8221;) will be held at our headquarters, 2361 McGaw Avenue, Irvine, California on November 20, 2025, at 9:30 a.m. Pacific
Standard Time, for the following purposes:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">1.</td><td style="text-align: justify; padding-right: 0.8pt">To elect seven directors to serve until our 2026 annual meeting of shareholders
or until their successors are duly elected and qualified. The nominees for election to our Board of Directors are named in the attached
Proxy Statement, which is part of this Notice.</td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">2.</td><td style="text-align: justify; padding-right: 0.8pt">To ratify the appointment of Baker Tilly US, LLP as our independent registered public
accounting firm for the fiscal year ending June&#160;30, 2026.</td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">3.</td><td style="text-align: justify; padding-right: 0.8pt">To hold an advisory vote to approve the compensation of our Named Executive Officers.</td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">4.</td><td style="text-align: justify; padding-right: 0.8pt">To hold an advisory vote on the frequency of future advisory votes to approve the
compensation of our Named Executive Officers.</td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">5.</td><td style="text-align: justify; padding-right: 0.8pt">To amend the 2016 Equity Incentive Compensation Plan in order to extend its term
for an additional ten years.</td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">6.</td><td style="text-align: justify; padding-right: 0.8pt">To transact such other business as may properly come before the Annual Meeting or
any adjournments or postponements thereof.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">Only shareholders of record
at the close of business on September 23, 2025, are entitled to notice of and to vote at the Annual Meeting and at any adjournments or
postponements of the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">All shareholders are cordially
invited to attend the Annual Meeting in person. Whether or not you plan to attend the Annual Meeting, your vote is important. In an effort
to facilitate the voting process, we are pleased to avail ourselves of Securities and Exchange Commission, or SEC, rules that allow proxy
materials to be furnished to shareholders on the Internet. You can vote by proxy over the Internet by following the instructions provided
in the Notice of Internet Availability of Proxy Materials that was mailed to you on or about October&#160;10, 2025, or, if you request
printed copies of the proxy materials by mail, you can also vote by mail or by telephone. Your promptness in voting by proxy will assist
in its expeditious and orderly processing and will assure that you are represented at the Annual Meeting. If you vote by proxy, you may
nevertheless attend the Annual Meeting and vote your shares in person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"><b>TO ENSURE YOUR REPRESENTATION
AT THE ANNUAL MEETING, YOU ARE URGED TO READ THIS PROXY STATEMENT AND SUBMIT YOUR PROXY OR VOTING INSTRUCTIONS AS SOON AS POSSIBLE BY
FOLLOWING THE INSTRUCTIONS IN THE NOTICE OF INTERNET AVAILABILITY OF PROXY MATERIALS, WHICH WAS MAILED TO YOU ON OR ABOUT OCTOBER 10,
2025, OR, IF YOU REQUEST PRINTED COPIES OF THE PROXY MATERIALS BY MAIL, YOU CAN ALSO VOTE BY MAIL OR BY TELEPHONE.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><b>OUR BOARD OF DIRECTORS
RECOMMENDS: A VOTE &#8220;FOR&#8221; EACH OF THE SEVEN DIRECTOR NOMINEES NAMED IN THE PROXY STATEMENT; A VOTE &#8220;FOR&#8221; EACH OF
PROPOSALS 2, 3 AND 5; AND A VOTE OF &#8220;1 YEAR&#8221; WITH RESPECT TO PROPOSAL 4.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 311pt; text-indent: -11.5pt">By Order of the Board of Directors,</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 311pt; text-indent: -11.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 311pt; text-indent: -11.5pt">PRO-DEX, INC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 311pt; text-indent: -11.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 311pt; text-indent: -11.5pt">/s/ Alisha K. Charlton</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 311pt; text-indent: -11.5pt">Corporate Secretary</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;<img src="logo.jpg" alt=""/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>
<!-- Field: Rule-Page --><div style="margin: 1pt 227.4pt"><div style="border-top: black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ANNUAL MEETING OF SHAREHOLDERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TO BE HELD NOVEMBER 20, 2025</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<!-- Field: Rule-Page --><div style="margin: 1pt 227.4pt"><div style="border-top: black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROXY STATEMENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<!-- Field: Rule-Page --><div style="margin: 1pt 227.4pt"><div style="border-top: black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SOLICITATION OF PROXIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">The Board of Directors (&#8220;Board&#8221;)
of Pro-Dex, Inc. (&#8220;Pro-Dex&#8221;, the &#8220;Company&#8221;, &#8220;we&#8221;, &#8220;us&#8221; or &#8220;our&#8221;) has made
these materials available to you on the Internet, or, upon your request, has delivered printed versions of these materials to you by mail,
in connection with the Board&#8217;s solicitation of proxies for use at our Annual Meeting of Shareholders (&#8220;Annual Meeting&#8221;)
to be held at Pro-Dex&#8217;s headquarters, 2361 McGaw Avenue, Irvine, California, on Thursday, November 20, 2025, at 9:30 a.m. Pacific
Standard Time, and at any and all adjournments or postponements thereof. Shareholders are requested to promptly vote by proxy over the
Internet by following the instructions provided in the Notice of Internet Availability of Proxy Materials, which was mailed to you on
or about October&#160;10, 2025. If you request printed copies of the proxy materials by mail, you can also vote by mail or by telephone.
All shares represented by each properly submitted and unrevoked proxy received on the Internet or by telephone prior to 11:59 p.m. Eastern
Standard Time on Wednesday, November 19, 2025, or by proxy card prior to or at the Annual Meeting, will be voted in the manner specified
therein, and if no direction is indicated (except in the case of broker non-votes), &#8220;for&#8221; each of the seven director nominees
named under Proposal No. 1; &#8220;for&#8221; each of Proposal Nos. 2, 3 and 5 and for &#8220;1 Year&#8221; with respect to Proposal No.
4.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">Any shareholder has the power
to revoke his or her proxy at any time before it is voted. A proxy may be revoked by delivering a written notice of revocation to our
Secretary prior to or at the Annual Meeting, by voting again on the Internet or by telephone (only your latest Internet or telephone proxy
submitted prior to 11:59 p.m. Eastern Standard Time on Wednesday, November 19, 2025, will be counted), by submitting prior to or at the
Annual Meeting a later dated proxy card executed by the person executing the prior proxy, or by attendance at the Annual Meeting and voting
in person by the person submitting the prior proxy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">Any shareholder who owns
shares in street name and would like to vote in person at the Annual Meeting should inform his or her broker of such plans and request
a legal proxy from the broker. Such shareholders will need to bring the legal proxy with them to the Annual Meeting and valid picture
identification, such as a driver&#8217;s license or passport, in addition to documentation indicating share ownership. Such shareholders
who do not receive the legal proxy in time should bring with them to the Annual Meeting their most recent brokerage account statement
showing that they owned our stock as of the record date. Upon submission of proper identification and ownership documentation, we will
be able to admit the shareholder to the Annual Meeting; however, such shareholder will not be able to vote his or her shares at the Annual
Meeting without a legal proxy. Shareholders are advised that if they own shares in street name and request a legal proxy, any previously
executed proxy will be revoked, and such shareholder&#8217;s vote will not be counted unless he or she appears at the Annual Meeting and
votes in person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">Our Board does not presently
intend to bring any business before the Annual Meeting other than the proposals referred to in this proxy statement and specified in the
accompanying Notice of Annual Meeting. So far as is known to our Board, no other matters are to be brought before the Annual Meeting.
However, if any other matters are presented properly for action at the Annual Meeting or at any adjournments or postponements thereof,
it is intended that the proxies will be voted with respect thereto by the proxy holders in accordance with the instructions and at the
discretion of our Board or a properly authorized committee thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"><b>This proxy statement, the
accompanying shareholder letter, the accompanying proxy card, and our Annual Report on Form 10-K are being made available to our shareholders
on the Internet at www.proxyvote.com through the notice and access process on or about October 10, 2025.</b> We will bear the cost of
soliciting proxies pursuant to this proxy statement. The solicitation will be made through the Internet and expenses will include reimbursement
paid to brokerage firms and others for their expenses in forwarding solicitation material regarding the Annual Meeting to beneficial owners
of our common stock, no par value per share (&#8220;Common Stock&#8221;). Further solicitation of proxies may be made by mail upon request,
and by telephone or oral communications with some shareholders. Our regular employees, who will not receive additional compensation for
the solicitation, or a compensated proxy solicitation firm, will make such further solicitations.</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 4; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OUTSTANDING SHARES AND VOTING RIGHTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">Only holders of record of the
3,280,004 shares of our Common Stock outstanding at the close of business on September 23, 2025, are entitled to notice of and to vote
at the Annual Meeting or any adjournment or postponement thereof. Under Colorado law, our Articles of Incorporation, and our Bylaws, the
holders of a majority of the total shares entitled to vote at the Annual Meeting, as of the record date, represented in person or by proxy,
will constitute a quorum for the transaction of business at the Annual Meeting. If a quorum is not present, the Annual Meeting may be
postponed or adjourned to allow additional time for obtaining additional proxies or votes. At any subsequent reconvening of the Annual
Meeting, all proxies will be voted in the same manner as the proxies would have been voted at the original convening of the Annual Meeting,
except for any proxies that have been effectively revoked or withdrawn prior to the reconvening of the Annual Meeting. Shares of our Common
Stock represented in person or by proxy (regardless of whether the proxy has authority to vote on all matters), as well as abstentions
and broker non-votes, will be counted for purposes of determining whether a quorum is present at the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">An &#8220;abstention&#8221;
is the voluntary act of not voting by a shareholder who is represented in person or by proxy at a meeting and entitled to vote. &#8220;Broker
non-votes&#8221; are shares of voting stock held in record name by brokers and nominees concerning which: (i)&#160;the broker or nominee
does not have discretionary voting power under applicable rules or the instruments under which it serves in such capacity and instructions
have not been received from the beneficial owners or persons entitled to vote; or (ii)&#160;the record holder has indicated on the proxy
or has executed a proxy and otherwise notified us that it does not have authority to vote such shares on that matter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">For Proposal No. 1 (the election
of directors), assuming that a quorum is present, the seven nominees for director receiving the highest number of affirmative votes will
be elected; votes withheld and broker non-votes have no practical effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">For Proposal No. 2 (to ratify
the appointment of Baker Tilly US, LLP as our independent registered public accounting firm for the fiscal year ending June&#160;30, 2026);
Proposal No. 3 (advisory vote to approve the compensation of our Named Executive Officers) and Proposal No. 5 (to approve the amendment
to the 2016 Equity Incentive Plan) assuming that a quorum is present, the matter will be approved if the votes cast in favor of the matter
exceed the votes cast opposing the matter. In such matters, abstentions and broker non-votes will not be included in the vote totals and,
therefore, will have no effect on the vote.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">For Proposal No. 4 (advisory
vote on the frequency of future advisory votes to approve the compensation of our Named Executive Officers), assuming that a quorum is
present, the voting frequency option that receives the highest number of votes will be deemed the frequency for the advisory vote on executive
compensation that has been selected by shareholders; abstentions and broker non-votes have no practical effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">Each shareholder will be entitled
to one vote, in person or by proxy, for each share of Common Stock held of record on the record date. Votes cast at the Annual Meeting
will be tabulated by the person or persons appointed by us to act as inspectors of election for the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Recommendations of our Board</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">Our Board recommends that our
shareholders vote &#8220;for&#8221; each of the seven director nominees named under Proposal No. 1; and &#8220;for&#8221; each of Proposal
Nos. 2, 3 and 5; and for &#8220;1 Year&#8221; with respect to Proposal No. 4.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"><b>THE PROPOSALS TO BE VOTED
UPON AT THE ANNUAL MEETING ARE DISCUSSED IN DETAIL IN THIS PROXY STATEMENT. YOU ARE STRONGLY URGED TO READ AND CONSIDER CAREFULLY THIS
PROXY STATEMENT IN ITS ENTIRETY.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"><b>&#160;<br/>
</b></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Value: 2; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
AND MANAGEMENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in">The following table sets forth
information concerning the beneficial ownership of our Common Stock as of September 23, 2025 by:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><b>&#8226;</b></td><td style="width: 5pt"/><td style="text-align: justify">each member of the Board;</td>
</tr></table>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><b>&#8226;</b></td><td style="width: 5pt"/><td style="text-align: justify">each of our Named Executive Officers listed in the &#8220;Summary Compensation Table&#8221;
included in the &#8220;Executive Compensation&#8221; section of this proxy statement;</td>
</tr></table>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><b>&#8226;</b></td><td style="width: 5pt"/><td style="text-align: justify">all of our directors and Named Executive Officers as a group; and</td>
</tr></table>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><b>&#8226;</b></td><td style="width: 5pt"/><td style="text-align: justify">each person or entity known to us that beneficially owns more than five percent of our Common
Stock.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in">Beneficial ownership is determined
in accordance with the rules of the SEC. Unless otherwise indicated below, the address of each beneficial owner is c/o Pro-Dex, Inc.,
2361 McGaw Avenue, Irvine, California, 92614. Unless otherwise indicated below, we believe that each of the persons listed in the table
(subject to applicable community property laws) has the sole power to vote and to dispose of the shares listed opposite the shareholder&#8217;s
name.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in">The percentages of Common
Stock beneficially owned are based on 3,280,004 shares of Common Stock outstanding at September 23, 2025.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: justify"><span style="font-size: 8pt"><b>Name and Address of Beneficial Owner</b></span></td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Number of<br/> Shares of Common<br/> Stock Beneficially<br/> Owned</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Percent of<br/> Common Stock<br/> Beneficially<br/> <span style="font-size: 8pt; line-height: 110%"><b>Owned</b></span><span style="font-size: 10pt; line-height: 110%"><sup>(1)</sup></span></td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.05pt; text-align: justify; text-indent: -5.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nicholas
                                    J. Swenson, AO Partners I, L.P.; and AO Partners, LLC; <sup>(2), (4)</sup></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.05pt; text-align: justify; text-indent: -5.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5000
                                            West 36<sup>th</sup> Street, Suite 200</span></p></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 66%; text-align: justify; text-indent: -5.05pt; padding-left: 5.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minneapolis,
    MN 55416	</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,024,017</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -5.05pt; padding-left: 5.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Raymond
    E. Cabillot; Farnam Street Partners, L.P.;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.05pt; text-align: justify; text-indent: -5.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Farnam
                                    Street Capital, Inc.; and Peter O. Haeg<sup>(3), (4)</sup></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.05pt; text-align: justify; text-indent: -5.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3033
                                            Excelsior Blvd., Suite 560</span></p></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -5.05pt; padding-left: 5.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minneapolis,
    MN 55416	</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">277,046</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -5.05pt; padding-left: 5.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 110%">Richard
    L. Van Kirk<sup>(4)</sup>	</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">125,979</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -5.05pt; padding-left: 5.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 110%">Alisha
    K. Charlton<sup>(4)</sup>	</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,414</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 110%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -5.05pt; padding-left: 5.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 110%">Katrina
    M.K. Philp<sup>(4), (5)</sup>	</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,896</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 110%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -5.05pt; padding-left: 5.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 110%">Angelita
    R. Domingo<sup>(4)</sup>	</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,844</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 110%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -5.05pt; padding-left: 5.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 110%">William
    J. Farrell III<sup>(4)</sup>	</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,300</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 110%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -5.05pt; padding-left: 5.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 110%">David
    C. Hovda<sup>(4)</sup>	</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,400</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 110%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.05pt; text-align: justify; text-indent: -5.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                    Directors, Director Nominees and Named Executive Officers as a group</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.05pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8
                                            persons)<sup>(4)</sup> 	</span></p></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,505,896</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45.9</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  </table>


<p style="font: 11pt/115% Times New Roman, Times, Serif; margin: 0pt 0">____________</p>

<p style="font: 11pt/115% Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt/115% Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.3in">*</td><td><span style="font-size: 10pt; line-height: 115%">Indicates less than 1 percent of outstanding shares of Common Stock.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.3in"><sup>(1)</sup></td><td style="text-align: justify">Applicable percentage ownership is based on 3,280,004 shares of Common Stock outstanding as of September
23, 2025. Any securities not outstanding but subject to options exercisable as of September 23, 2025, or exercisable within 60 days after
such date, are deemed to be outstanding for the purpose of computing the percentage of outstanding Common Stock beneficially owned by
the person holding such options, but are not deemed to be outstanding for the purpose of computing the percentage of Common Stock beneficially
owned by any other person.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.3in"><sup>(2)</sup></td><td style="text-align: justify">AO Partners, LLC is the General Partner of AO Partners I, L.P. Nicholas J.&#160;Swenson (&#8220;Nick&#8221;)
is the Managing Member of AO Partners, LLC, and, in such capacity, has the power to direct the affairs of AO Partners, LLC, including
the voting and disposition of shares of our Common Stock held by AO Partners I, L.P. As such, AO Partners I, L.P., AO Partners, LLC and
Nick may be deemed to share voting and dispositive power with regard to the 922,204 shares of our Common Stock held by AO Partners I,
L.P. Nick also owns 95,613 shares directly. AO Partners I, L.P.&#8217;s holdings of 922,204 shares of our Common Stock, plus additional
securities and collateral owned by AO Partners I, L.P., are pledged to secure a bank loan to AO Partners I, L.P.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.3in"><sup>(3)</sup></td><td style="text-align: justify; padding-right: 0.8pt">Farnam Street Partners, L.P., Farnam Street Capital, Inc., Raymond E. Cabillot (&#8220;Ray&#8221;),
and Peter O. Haeg claim shared voting power and shared dispositive power of 270,846 shares of our Common Stock held by Farnam Street Partners,
L.P.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0.3in; text-align: justify; text-indent: -0.3in">&#160;</p>

<p style="font: 1pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0.3in; text-align: justify; text-indent: -0.3in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><sup>(4)</sup></td><td style="text-align: justify; padding-right: 0.8pt">Includes shares of Common Stock issuable upon the exercise of options or vesting
of restricted shares that were exercisable as of September 23, 2024, or exercisable/vested within 60 days after September 23, 2025 as
follows: Nick, 6,200 shares; Ray, 6,200 shares; Richard L. Van Kirk (&#8220;Rick&#8221;), 27,200 shares; Alisha K. Charlton (&#8220;Alisha&#8221;),
7,075 shares; Katrina M.K. Philp (&#8220;Katrina&#8221;), 6,200 shares; Angelita R. Domingo (&#8220;Angel&#8221;), 2,325 shares; William
J. Farrell III (&#8220;Bill&#8221;), 6,200 shares; David C. Hovda (&#8220;David&#8221;), 6,200 shares; and all directors, director nominees
and Named Executive Officers as a group, 67,600 shares.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><sup>(5)</sup></td><td style="text-align: justify; padding-right: 0.8pt">14,696 are owned by Katrina&#8217;s spouse and both Katrina and her spouse claim
shared voting power and shared dispositive power with regard to such shares. Of these shares, 7,496 are pledged as collateral for a loan.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in"></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;<b>Proposal
No.&#160;1</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ELECTION OF DIRECTORS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Current Board Structure and Director Terms</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">Our Board is currently composed
of seven members. All directors or their successor nominees stand for election each year at our annual meeting of shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">Certain information with respect
to each of the nominees who will be presented at the Annual Meeting by our Board for election as a director is set forth below. Although
it is anticipated that each nominee will be available to serve as a director, should a nominee become unavailable to serve, proxies will
be voted for such other person as may be designated by our Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">Unless the authority to vote
for directors has been withheld in the proxy, the person named in the accompanying proxy intends to vote at the Annual Meeting for the
election of each of the nominees presented below. In the election of directors, assuming a quorum is present, the seven nominees for director
receiving the highest number of votes cast at the Annual Meeting will be elected as our directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>DIRECTORS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">Set forth below is certain
information with respect to our directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><b>Name</b></td><td style="font-size: 10pt; padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><b>Age</b></td><td style="padding-bottom: 1pt; font-size: 10pt"><b>&#160;</b></td><td style="font-size: 10pt; padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><b>Position With Company</b></td><td style="font-size: 10pt; padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><b>Audit</b></td><td style="padding-bottom: 1pt; font-size: 10pt"><b>&#160;</b></td><td style="font-size: 10pt; padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><b>Compensation</b></td><td style="padding-bottom: 1pt; font-size: 10pt"><b>&#160;</b></td><td style="font-size: 10pt; padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><b>Nominating and Governance</b></td><td style="font-size: 10pt; padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><b>Investment</b></td><td style="padding-bottom: 1pt; font-size: 10pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 24%; font-size: 10pt; text-align: left">Raymond E. Cabillot</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 9%; font-size: 10pt; text-align: center">62</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 17%; font-size: 10pt">Director</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 10%; font-size: 10pt; text-align: center"><span style="font-size: 10pt">X</span></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 10%; font-size: 10pt; text-align: center"><span style="font-size: 10pt">X</span></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 10%; font-size: 10pt; text-align: center">C</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 10%; font-size: 10pt; text-align: center"><span style="font-size: 10pt">X</span></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Angelita R. Domingo</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">53</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">Director</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">William J. Farrell III</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">52</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">Director</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt">X</span></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">X</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">David C. Hovda</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">63</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">Director</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt">C</span></td><td style="font-size: 10pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Katrina M.K. Philp</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">40</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">Director</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt">X</span></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt">X</span></td><td style="font-size: 10pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Nicholas J. Swenson</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">57</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">Director, Chairman of the Board</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt">C</span></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">X</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt">C</span></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Richard L. Van Kirk</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">65</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">Director, Chief Executive Officer, and President</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt">X</span></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">____________________________</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%; padding-right: 0.8pt"><span style="font-size: 10pt">(X)</span></td>
    <td style="width: 96%; padding-right: 0.8pt; text-align: justify"><span style="font-size: 10pt">Member of the Committee</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.8pt"><span style="font-size: 10pt">(C)</span></td>
    <td style="padding-right: 0.8pt; text-align: justify"><span style="font-size: 10pt">Chairman of the Committee</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">Ray, Bill, David, Nick and
Katrina currently each qualify as an &#8220;independent director&#8221; as such term is defined in Rule 5605(a)(2) of the Nasdaq Listing
Rules and we expect that each will continue to qualify as an &#8220;independent director&#8221; if elected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">Our Board is of the opinion
that the election to our Board of the director nominees identified herein, each of whom has consented to serve if elected, would be in
our shareholders&#8217; best interests.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OUR BOARD RECOMMENDS THAT YOU VOTE &#8220;FOR&#8221;
THE ELECTION OF THE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOMINEES NAMED BELOW.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt/11.25pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">Ray (62), current
director and nominee, has, from January 1998 until the present, served as Chief Executive Officer and a director of Farnam Street Capital,
Inc., the general partner of Farnam Street Partners L.P., a private investment partnership located in Minneapolis, MN.&#160;&#160;Ray
was a Senior Research Analyst at Piper Jaffray, Inc. from 1990 to 1998.&#160;&#160;Prior to that, Ray worked for Prudential Capital Corporation
from 1987 to 1990 as an Associate Investment Manager and as an Investment Manager.&#160;&#160;Ray has served on the board of directors
of Oxbridge Re Holdings Limited, a specialty and casualty reinsurer, from 2013 to 2023, and Air T, Inc. (Nasdaq: AIRT), a provider of
air cargo services and ground equipment sales and support services, since November 2016. Ray was a director of O.I. Corporation, a former
Nasdaq listed company, from 2006 to 2010. He served as chairman of the board of O.I. Corporation from 2007 through 2010 and during 2010
served as co-chairman of the board of O.I. Corporation. Ray has a B.A. degree with a double major in Economics and Chemistry from Saint
Olaf College and an M.B.A. from the University of Minnesota. Ray has been a director of ours since January 2013.</p>

<p style="font: 10pt/11.25pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ray
brings the following experience, qualifications, attributes, and skills to our Board:</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">More than 25 years
of experience as a financial analyst and investment manager;</span></td>
</tr></table>



<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">More than 10 years
of public company board experience, including three years as chairman and one year as co-chairman; and</span></td>
</tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent of
our management.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23.05pt">&#160;</p>

<!-- Field: Page; Sequence: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Angel (53), current director
and nominee, has served as our Director of Quality Systems and Regulatory Affairs since 2014. Angel joined the Company in February 2005.
Angel&#8217;s responsibilities include ensuring that the Company&#8217;s Quality Management System and products consistently meet industry
and regulatory standards and customer requirements. This encompasses compliance requirements of local, state, federal and OUS authorities.
Angel holds a B.S. in Biology/Human Physiology and a Chemistry minor from California State University, Long Beach. Angel has been a director
of ours since December 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Angel brings the following
experience, qualifications, attributes, and skills to our Board:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt">Multidisciplinary business experience within scientific industries;</span></td>
</tr></table>



<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt">Senior-level management experience in Regulatory Affairs and
Quality Management Systems;</span></td>
</tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt">Operational and customer project management, including customer
strategic alliance; and</span></td>
</tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt">Over 15 years of management in the areas of product design,
production and quality controls, risk assessment and risk mitigation, quality management and regulatory compliance.</span></td>
</tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23.05pt">Bill (52), current director
and nominee, currently serves as Chief Strategy &amp; Innovation Officer of Emplify Health. Bill has from October 2017 until the present,
served in various executive roles at Emplify Health, formerly Gundersen Health System, an integrated healthcare organization serving counties
in Wisconsin, Iowa, and Minnesota. Bill is currently the Managing Director of two venture capital funds, b3 ventures and ghsEdge ventures.
Bill serves as a director of several private companies as well. Bill is a co-founder of FreshRealm, LLC, a developer of new technologies
to streamline fresh food distribution and served as its Chief Operating Officer from January 2013 through September 2017. In addition,
from January 2011 to January 2013, he served as Chief Executive Officer of Viszy Inc., a company developing software and services for
the consumer market, until assets merged into FreshRealm. From 2010 to the present, Bill founded and has served as Chief Executive Officer
of b3 experience, LLC,&#160;an&#160;art, design and stay&#160;company that designs and manufactures modern furniture, creates and sells
contemporary art, and owns and operates a portfolio of art infused vacation rental and micro hotels internationally. From April 1998 to
January 2011, Bill held various senior management roles at Medtronic, Inc. (NYSE: MDT), a multi-national medical technology company. Bill&#8217;s
engineering career began with eight years in production support, process development and operations. Bill then worked 10 years in product
development for Medtronic, during which time Bill led management teams in program, product, and process development. At the end of his
tenure with Medtronic, Bill was Senior Director of Product Development and led corporate-wide initiatives to improve design, reliability,
and manufacturability practices. Bill has a B.S. degree in Mechanical Engineering from the University of Minnesota and a master&#8217;s
degree in science and technology management from the University of St. Thomas. Bill has been a director of ours since January 2013.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23.05pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23.05pt">Bill brings the following
experience, qualifications, attributes, and skills to our Board:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23.05pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt">Current senior-level management, operating and board experience;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 59.05pt; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt">More than 12 years of experience in engineering and management
roles in the medical device industry, our primary target market; and</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt">Independent of our management.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23.05pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23.05pt">David (63), current director
and nominee, is CEO and a member of the Board of Directors of Versa Vascular, a venture-backed, privately held structural heart company
treating patients with tricuspid disease. He also serves as an Advisor at Stanford Medicine Catalyst, a Stanford University School of
Medicine program that supports health innovations. Previously, David served as Chief executive Officer of Innovein, Inc., a vascular company
focused on treating deep venous reflux disease, a position he held from January 2022 to August 2023. Prior to Innovein, Inc., he served
as Chief Executive Officer and a member of the Board of Directors of Simplify Medical, Inc., a privately held medical device company that
developed a cervical artificial disc replacement, from 2013 to 2021. In February 2021, Simplify Medical was acquired by Nuvasive, the
largest spine-focused company in the world. Prior to Simplify Medical, David was President, Chief Executive Officer and a member of the
Board of Directors of SpinalMotion, Inc., a privately held medical device company that designed, developed and marketed artificial discs
for use in the spine, from 2004 to 2013. Prior to joining SpinalMotion, he held leadership positions with Arthrocare, Inc. (Nasdaq: ARTC),
a developer and manufacturer of surgical devices, instruments, serving as the Vice President/General Manager of its Spine Division from
1999 to 2004, and as the Managing Director of its ENT Division from 1997 to 1999. From 1992 to 1997, David served in financial analysis
and product management positions with Medtronic, Inc. (NYSE: MDT), a multi-national medical technology company. He is an inventor on more
than 50 U.S. patents. David served for five years in the United States Navy, achieving the rank of Lieutenant. He received a Bachelor
of Science degree in Civil Engineering from Northwestern University and an M.B.A. from the Harvard Graduate School of Business Administration.
David has been a director of ours since January 2013.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"></p>

<!-- Field: Page; Sequence: 8 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">David brings the following
experience, qualifications, attributes, and skills to our Board:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt/115% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify">Senior-level management, operating and board experience based on more than 20 years of participation
in the medical device industry, our primary target market, twelve years of which are specifically with medical devices to treat disorders
of the spine, a sector within the medical device industry that we believe represents potential for future revenue growth;</td>
</tr></table>



<table cellpadding="0" cellspacing="0" style="font: 10pt/115% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify">Core management and leadership skills gained through experience overseeing and managing operations
at the manager and chief executive officer levels, including experience in medical device intellectual property, product development,
clinical testing and marketing;</td>
</tr></table>


<table cellpadding="0" cellspacing="0" style="font: 10pt/115% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify">Experience in financial analysis, including operational restructuring, acquisition opportunities,
raising capital, budgeting and forecasting, and market entry feasibility; and</td>
</tr></table>


<table cellpadding="0" cellspacing="0" style="font: 10pt/115% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify">Independent of our management.</td>
</tr></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Katrina (40), current director
and nominee, has, from January 2014 until the present, served in various capacities at Air T, Inc. (Nasdaq: AIRT), and most recently
as its Chief of Staff from October 2017 to present. Katrina is co-founder of Fox Lake Capital, LLC, where Katrina worked full time from
November 2012 until January 2014, a consulting firm offering financial analysis and investment expertise. Katrina was a Senior Investment
Analyst at Whitebox Advisors, LLC, a multi-strategy hedge fund, from 2007 to 2012. Katrina has a B.A. degree in Business Administration,
Finance and Management from Northwestern College. Katrina has been a director of ours since December 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Katrina brings the following
experience, qualifications, attributes, and skills to our Board:</p>




<table cellpadding="0" cellspacing="0" style="font: 11pt/115% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt">Current senior-level management and operating experience;</span></td>
</tr></table>



<table cellpadding="0" cellspacing="0" style="font: 11pt/115% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt">Experience as a financial analyst; and</span></td>
</tr></table>


<p style="font: 11pt/115% Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt/115% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt">Independent of our management.</span></td>
</tr></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Nick (57), current Chairman
of the Board, director and nominee, is an executive, investor and research analyst. Since January 2012, Nick has served as the managing
partner of AO Partners, LLC, the general partner of <span style="background-color: white">AO Partners I, L.P., </span>a private investment
partnership located in Minneapolis, MN. Nick has served as President and Chief Executive Officer and Director of Air T, Inc. (Nasdaq:
AIRT), since October 2013. Nick currently serves as a director of Lendway Inc. (Nasdaq: LDWY) and serves as a director of several private
companies as well. Nick has a B.A. degree in History from Middlebury College and an M.B.A. from the University of Chicago. Nick has been
a director of ours since January 2013.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Nick brings the following
experience, qualifications, attributes and skills to our Board:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt">27 years of experience as a financial analyst and investment
manager;</span></td>
</tr></table>



<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt">Public company C-suite roles, including operating and board
experience; and</span></td>
</tr></table>


<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt">Independent of our management.</span></td>
</tr></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 9 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Rick (65), current director
and nominee, has served as our Chief Executive Officer and President since January 2015, and as our Chief Operating Officer since April
2013. Rick joined the Company as Director of Manufacturing in 2006 and was our Vice President of Operations from 2007 to 2013. Rick has
served on the board of directors of Monogram Technologies Inc., formerly Monogram Orthopaedics Inc. (Nasdaq: MGRM), a company working
to develop a product solution architecture with the long-term goal to enable patient-optimized orthopaedic implants economically at scale
by linking 3D printing and robotics with advanced pre-operative imaging, since April 2017. Prior to joining the Company, Rick served as
Manufacturing Manager and Manager of Product Development for the ChargeSource division of Comarco, Inc., a provider of power and charging
functionality for popular electronic devices and wireless accessories, and as General Manager at Dynacast, a leader in precision die casting.
Rick holds a B.A. in Business Administration from California State University, Fullerton and an M.B.A. from Claremont Graduate School.
Rick has been a director of ours since January 2015.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Rick brings the following
experience, qualifications, attributes, and skills to our Board:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt">Current senior-level management experience as our Chief Executive
Officer; and</span></td>
</tr></table>



<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt">Over 15 years of senior-level management in the areas of manufacturing,
operations, supply chain, distribution, and logistics, including over 10 years of experience in our operations management.</span></td>
</tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>BUSINESS EXPERIENCE OF KEY MANAGEMENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">Set forth below is information
concerning our other non-director key management personnel.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23.05pt">Alisha (56), was appointed
as our Chief Financial Officer in January 2015. Alisha joined the Company in January 2014 as Senior Director of Finance. Prior to joining
the Company, Alisha held various accounting positions at Comarco, Inc., a provider of wireless test solutions for the cellular industry,
emergency call boxes, and power adapters for rechargeable consumer electronic devices, from October 2000 to January 2014, culminating
in Alisha&#8217;s appointment as Chief Accounting Officer in April 2011. Prior to her 13-year tenure at Comarco, Alisha held various accounting
and finance positions with CKE Restaurants, Inc., an owner, operator, and franchisor of quick-service restaurants, from February 1995
to October 2000. Alisha began her career in July 1991 with KPMG Peat Marwick (now KPMG LLP) and was formerly a certified public accountant.
Alisha holds a B.A. in Business Economics from the University of California, Santa Barbara with high honors and a CPA license (inactive)
from the California State Board of Accountancy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23.05pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>BOARD MEETINGS AND RELATED MATTERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">During the fiscal year ended
June&#160;30, 2025, our Board held four meetings and acted once by unanimous written consent. The independent directors held three executive
sessions during the fiscal year ending June 30, 2025. The independent directors consist of all non-employee, &#8220;independent directors&#8221;
(as defined in Rule 5605(a)(2) of the Nasdaq Listing Rules). No director attended less than 75% of the aggregate of all meetings of our
Board and all meetings of committees of our Board upon which he or she served.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -4.5pt"><b>Audit Committee</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -4.5pt"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"><span style="font-size: 10pt">Our
Board has an Audit Committee that consists of three Board members, David (Chairman), Ray, and Katrina. The Audit Committee is comprised
entirely of non-employee, &#8220;independent directors&#8221; (as defined in Rule 5605(a)(2) of the Nasdaq Listing Rules) that satisfy
the additional Audit Committee requirements of Rule 5605(c)(2) of the Nasdaq Listing Rules and operates under a written charter adopted
by our Board. The duties of the Audit Committee include meeting with our independent registered public accounting firm to review the scope
of the annual audit and to review our quarterly and annual financial statements before the statements are released to our shareholders.
The Audit Committee also evaluates the independent public accounting firm&#8217;s performance and appoints or replaces the independent
public accounting firm subject, if applicable, to the consideration of shareholder ratification for the ensuing fiscal year. A copy of
the Audit Committee&#8217;s current charter may be found at https://www.pro-dex.com/investors/governance</span>. <span style="font-size: 10pt">The
Audit Committee and Board have confirmed that the Audit Committee does and will continue to include at least three independent directors
and has confirmed that all members meet applicable SEC regulations for designation as an &#8220;Audit Committee Financial Expert&#8221;
based upon their respective experience noted elsewhere in this proxy statement. The Audit Committee held six meetings and acted once by
unanimous written consent during the fiscal year ended June&#160;30, 2025.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23.05pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<!-- Field: Page; Sequence: 10 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Nominating/Corporate Governance Committee</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">	</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt; text-align: justify"><span style="font-size: 10pt">Our
Board has a Nominating/Corporate Governance Committee (&#8220;Nominating Committee&#8221;) that consists of three Board members, Ray (Chairman),
Bill, and Nick. The Nominating Committee is comprised entirely of non-employee, &#8220;independent directors&#8221; (as defined in Rule
5605(a)(2) of the Nasdaq Listing Rules) and operates under a written charter adopted by our Board, a copy of which may be found at https://www.pro-dex.com/investors/governance</span>.
<span style="font-size: 10pt">In such capacity, the Nominating Committee identifies and reviews the qualifications of candidate nominees
to our Board. During the fiscal year ended June&#160;30, 2025, the Nominating Committee held two meetings. </span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">The Nominating Committee works
with our Board to determine the appropriate characteristics, skills and experiences for our Board as a whole and its individual members
with the objective of having a Board with diverse experience. The Nominating Committee believes that it is desirable that directors possess
an understanding of our business environment and have the requisite ethical standards, knowledge, skills, expertise and diversity of experience
such that our Board&#8217;s ability to manage and direct our affairs and business is enhanced. Additional considerations may include an
individual&#8217;s capacity to enhance the ability of committees of our Board to fulfill their duties and/or satisfy any independence
requirements imposed by law, regulation or listing requirements. The Nominating Committee may receive candidate nomination suggestions
from current Board members, our executive officers, our shareholders or other sources, which may be either unsolicited or in response
to requests from our Board for such candidates. The Nominating Committee may also, from time to time, engage firms that specialize in
identifying director candidates. Once a person has been identified by the Nominating Committee as a potential candidate, the Nominating
Committee may collect and review publicly available information regarding the person to assess whether the person should be considered
further. If the Nominating Committee determines that the candidate warrants further consideration, a member of the Nominating Committee
may contact the person. Generally, if the person expresses a willingness to be considered and to serve on our Board, the Nominating Committee
may request information from the candidate, review the person&#8217;s accomplishments and qualifications and may conduct one or more interviews
with the candidate. The Nominating Committee may consider all such information in light of information regarding any other candidates
that it might be evaluating for nomination to our Board. The Nominating Committee or other Board members may also contact one or more
references provided by the candidate or may contact other members of the business community or other persons that may have greater first-hand
knowledge of the candidate&#8217;s qualifications and accomplishments. With the candidate&#8217;s consent, the Nominating Committee may
also engage an outside firm to conduct background checks on the candidate as part of the evaluation process. The Nominating Committee&#8217;s
evaluation process does not vary based on the source of the recommendation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">Shareholder nominations for
director should be sent to our Secretary and should include the candidate&#8217;s name and qualifications and a statement from the candidate
that he or she consents to being named in the proxy statement and will serve as a director if elected. In order for any such candidate
to be considered for nomination and, if nominated, to be included in our proxy statement, such recommendation must satisfy the requirements
discussed later in this proxy statement under the heading &#8220;Proposals of Shareholders.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">In compiling the list of our
Board nominees appearing in this proxy statement, nominee referrals as well as nominee recommendations were received from existing directors
and members of management&#8212;both solicited and unsolicited. No paid consultants were engaged by us, our Board or any of our Board&#8217;s
committees for the purposes of identifying qualified, interested Board candidates.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"></p>

<!-- Field: Page; Sequence: 11 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Compensation Committee</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt; text-align: justify"><span style="font-size: 10pt">Our
Board has a Compensation Committee that consists of four Board members, Nick (Chairman), Ray, Bill, and Katrina. The Compensation Committee
is comprised entirely of non-employee, &#8220;independent directors&#8221; (as defined in Rule 5605(a)(2) of the Nasdaq Listing Rules)
and operates under a written charter adopted by our Board. A copy of the Compensation Committee&#8217;s current charter may be found
at https://www.pro-dex.com/investors/governance</span>. <span style="font-size: 10pt">The Compensation Committee establishes compensation
policies applicable to our executive officers and directors. During the fiscal year ended June&#160;30, 2025, the Compensation Committee
held one meeting and acted three times by unanimous written consent.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">From time to time, various
members of management and other employees, as well as outside advisors or consultants, may be invited by the Compensation Committee to
make presentations, provide financial or other background information or advice, or otherwise participate in Compensation Committee meetings
or executive sessions of the Board. Among other things, the charter of the Compensation Committee grants the Compensation Committee authority
to obtain, at our expense, advice and assistance from internal and external legal, accounting or other advisors and consultants and other
external resources that the Compensation Committee considers necessary or appropriate in the performance of its duties. In particular,
the Compensation Committee has the sole authority to retain compensation consultants to assist in its evaluation of executive and director
compensation, including the authority to approve the consultant&#8217;s reasonable fees and other retention terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Investment Committee</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in">The Investment Committee was
formed in April 2013 and is currently comprised of one management director, Rick, and two non-management directors, Ray and Nick, who
chairs the committee. The purpose of the Investment Committee is to administer and invest surplus capital from time to time, in such amounts
as approved by our Board, in authorized investments. During the fiscal year ended June&#160;30, 2025, the Investment Committee held one
meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FAMILY RELATIONSHIPS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">There are no family relationships
among our executive officers and directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>BOARD LEADERSHIP STRUCTURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">Our Board has separated the
roles of Chairman of the Board and Chief Executive Officer. Nick, an independent director, serves as Chairman of our Board and presides
at all Board and shareholder meetings. Rick, our Chief Executive Officer, serves as our primary spokesperson and supervises our business,
subject to the direction of our Board. The independent Board members annually assess Rick&#8217;s performance as Chief Executive Officer.
We believe that an independent Chairman of the Board is better able to provide oversight and guidance to management, especially in relation
to the Board&#8217;s essential role in risk management oversight, and to ensure the efficient use and accountability of resources. Furthermore,
this separation provides for focused engagement between these two roles in their respective areas of responsibility, while still providing
for collaborative participation. The separation of the Chairman of the Board and Chief Executive Officer roles, together with our other
comprehensive corporate governance practices, are designed to establish and preserve management accountability, provide a structure that
allows the Board to set objectives and monitor performance, and enhance shareholder value.</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>BOARD&#8217;S ROLE IN RISK OVERSIGHT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">Our Board has an active role,
as a whole and also at the committee level, in overseeing management of our risks. Our Board regularly reviews information regarding our
credit, liquidity, and operations, as well as the risks associated with each. The Compensation Committee is responsible for overseeing
the management of risks relating to our executive compensation plans and arrangements. The Audit Committee oversees management of financial
and cyber risks. The Nominating Committee manages risks associated with the independence of our Board and potential conflicts of interest.
While each committee is responsible for evaluating certain risks and overseeing the management of such risks, the entire Board is regularly
informed through committee and management reports about such risks and their mitigation. Our Board believes the division of risk management
responsibilities described above is an effective approach for evaluating and addressing the risks we face and that the structure allows
our Board to exercise effective oversight of the actions of management.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"></p>

<!-- Field: Page; Sequence: 12 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>COMPENSATION OF EXECUTIVE OFFICERS AND MANAGEMENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Compensation Committee Procedures</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">The Compensation Committee
makes its most significant determinations with respect to annual compensation, bonus awards, and new financial and other corporate performance
objectives for executive compensation purposes, at one or more meetings held during the fiscal year for which the targets and compensation
levels are applicable. At various meetings throughout the year, the Compensation Committee also considers matters related to individual
compensation, such as compensation for new executive hires, as well as high-level strategic issues, such as the efficacy of, and any risks
relating to, our compensation strategies, policies and practices, potential modifications to those strategies, policies and practices,
and new trends, plans or approaches to compensation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">Generally, the Compensation
Committee&#8217;s process consists of three related elements: (i)&#160;the determination of compensation levels, (ii)&#160;the approval
of discretionary cash bonus awards based upon Company and personal performance, and (iii) the review and determination of equity incentive
awards. For executive officers other than our CEO, the Compensation Committee solicits and considers evaluations and recommendations submitted
to the Compensation Committee by our CEO. In the case of our CEO, the evaluation of his performance is conducted by the Compensation Committee,
which determines any adjustments to his compensation. Our CEO may not participate in, or be present during, any deliberations or determinations
of the Compensation Committee regarding his compensation. For all executive officers and directors, as part of its deliberations, the
Compensation Committee may review and consider, as appropriate, materials such as financial reports and projections, operational data,
tax and accounting information, tally sheets that set forth the total compensation that may become payable to executive officers in various
hypothetical scenarios, our stock performance data, and analyses of historical executive compensation levels and our current compensation
levels. Periodically, the Compensation Committee reviews all of our incentive compensation plans in order to evaluate the level of risk
that such plans may encourage and, along with management&#8217;s report concerning such matters and their mitigation, to ensure that each
plan is properly monitored and evaluated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Compensation Committee Philosophy</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23.05pt">Our compensation philosophy
is predicated upon the following concepts:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23.05pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 27.55pt"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-size: 10pt">We pay competitively. We are committed to providing a pay program that helps
attract and retain highly qualified people in the industry. To ensure that pay is competitive, we compare our pay practices with those
of other leading companies of similar size and location(s) and set our pay parameters based on this review.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 27.55pt"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-size: 10pt">We pay for sustained performance. Executive officers are rewarded based
upon Company performance and individual performance. Company performance is evaluated by the Compensation Committee by reviewing the extent
to which strategic and business plan goals are met, including such factors as revenues, operating profit, cash flow, and stock price.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 27.55pt"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-size: 10pt">We strive for fairness in the administration of pay and to achieve a balance
of the compensation paid to a particular individual as compared to the compensation paid to both our executives and executives at comparable
companies.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 27.55pt"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-size: 10pt">We believe that employees should understand the performance evaluation and
pay administration process.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">The Compensation Committee
believes that it is important that our executives be compensated in a manner that closely links compensation with performance and yet
does not incent excessive risk-taking. To that end, the Compensation Committee has developed a comprehensive and balanced compensation
plan that includes a base salary; discretionary bonuses upon evaluation of Company and personal performance; performance awards generally
payable in shares of Common Stock upon the satisfaction of various service periods and the market price of our Common Stock achieving
certain pre-determined prices; stock options; and, a package of benefits similar in scope and nature to those offered to all our other
employees. Additionally, all employees, including the Named Executive Officers, are eligible to participate in our 2014 Employee Stock
Purchase Plan (the &#8220;ESPP&#8221;), which allows employees to purchase shares of Common Stock from us at 15% discount from the applicable
market price as calculated under the terms of the ESPP.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">The Compensation Committee
believes that there are no risks related to our compensation plans that would result in a material adverse impact on us. This conclusion
is based upon management&#8217;s risk analysis and the Compensation Committee&#8217;s belief that the following mitigating factors also
serve to reduce such risks:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 27.5pt"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Incentives are capped at a maximum amount regardless of the degree to which
objectives may be exceeded.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 27.5pt"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Bonus payments are based upon audited year-end results and the company has
an effective compensation recovery policy in place.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 27.5pt"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Multiple objectives are used as performance targets.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 31.5pt"/><td style="width: 27.5pt"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Computations are reviewed at regular intervals during the year and are subject
to multiple levels of review at the management, committee, and full Board level.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Compensation of Executive Officers</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">The following table sets forth
certain compensation information for the fiscal years ended June&#160;30, 2025 and 2024, for our Chief Executive Officer and our Chief
Financial Officer, who were the only executive officers during the fiscal year ended June 30, 2025 (collectively, the &#8220;Named Executive
Officers&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><i>Summary Compensation Table (&#8220;SCT&#8221;)</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Name and</b></p></td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: center">&#160;</td><td style="font-size: 11pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Salary</b></p></td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Bonus<sup>(1)</sup></b></p></td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Stock Awards&#160;<sup>(2)</sup></b></p></td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>All Other</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Compensation<sup>(3)</sup></b></p></td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Total</b></p></td><td style="font-size: 8pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Principal Position</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Year</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">($)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">($)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">($)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">($)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">($)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 23%; text-align: left; text-indent: -5.05pt; padding-left: 5.05pt">Richard L. Van Kirk</td><td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: center">2025</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">350,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">210,116</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">47,630</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">45,205</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">652,951</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10.35pt">Director, CEO, President and COO</td><td>&#160;</td>
    <td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">327,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">70,114</td><td style="text-align: left">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">$</td><td style="font-size: 11pt; text-align: right">&#8212;</td><td style="font-size: 11pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">43,689</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">441,303</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -5.05pt; padding-left: 5.05pt">Alisha K. Charlton</td><td>&#160;</td>
    <td style="text-align: center">2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">247,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">50,116</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">47,630</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12,879</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">357,825</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 10.35pt">Chief Financial Officer</td><td>&#160;</td>
    <td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">242,685</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">50,114</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,070</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,631</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">320,500</td><td style="text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><sup>(1)</sup> The Bonus amount for fiscal 2025
includes bonuses awarded to Rick and Alisha in the amount of $140,000 and $50,000, respectively, which were accrued for during fiscal
2025 but paid during fiscal 2026. The Bonus amount for fiscal 2024 includes bonuses awarded to Rick and Alisha in the amount of $70,000
and $50,000 respectively, which were accrued for during fiscal 2024 but paid during fiscal 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><sup>(2) </sup> The amounts reported above under
the heading &#8220;Stock Awards&#8221; represent the aggregate grant date value of awards under Accounting Standards Codification Topic
718, <i>Compensation - Stock Compensation</i>. The assumptions used in calculating the fair value of these stock awards can be found under
Note&#160;11 (Share-Based Compensation) to the Financial Statements in the Company&#8217;s Annual Report on Form 10-K for the year ended
June 30, 2025 and have no relation to amounts or periods in which earnings may be reported in the Named Executive Officer&#8217;s W-2.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 13 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><sup>(3) </sup> The amounts reported above under
the heading &#8220;All Other Compensation&#8221; consist of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 9%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 5%; text-align: center">&#160;</td>
    <td style="width: 24%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 61%; text-align: center"><span style="font-size: 8pt"><b>All Other Compensation ($)</b></span></td></tr>
  </table>
<p style="font: 11pt/115% Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: center"><span style="font-size: 8pt"><b>Name and<br/> Principal Position</b></span></td><td style="padding-bottom: 1pt; text-align: center; font-size: 11pt"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: center"><span style="font-size: 8pt"><b>Year</b></span></td><td style="padding-bottom: 1pt; text-align: center; font-size: 11pt"><span style="font-size: 8pt"><b>&#160;</b></span></td><td style="padding-bottom: 1pt; text-align: center; font-size: 8pt; font-weight: bold"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>Insurance<br/> Premiums<br/>
    ($)</b></span></td><td style="padding-bottom: 1pt; text-align: center; font-size: 8pt; font-weight: bold"><span style="font-size: 8pt"><b>&#160;</b></span></td><td style="padding-bottom: 1pt; text-align: center; font-size: 8pt; font-weight: bold"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>Car<br/> Allowance<br/>
    ($)</b></span></td><td style="padding-bottom: 1pt; text-align: center; font-size: 8pt; font-weight: bold"><span style="font-size: 8pt"><b>&#160;</b></span></td><td style="padding-bottom: 1pt; text-align: center; font-size: 8pt; font-weight: bold"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>401K Matching<br/> Contributions<br/>
    ($)</b></span></td><td style="padding-bottom: 1pt; text-align: center; font-size: 8pt; font-weight: bold"><span style="font-size: 8pt"><b>&#160;</b></span></td><td style="padding-bottom: 1pt; text-align: center; font-size: 8pt; font-weight: bold"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>Imputed<br/> Earnings<br/>
    ($)</b></span></td><td style="padding-bottom: 1pt; text-align: center; font-size: 8pt; font-weight: bold"><span style="font-size: 8pt"><b>&#160;</b></span></td><td style="padding-bottom: 1pt; text-align: center; font-size: 11pt"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: center"><span style="font-size: 8pt"><b>Total<br/> ($)</b></span></td><td style="padding-bottom: 1pt; text-align: center; font-size: 11pt"><span style="font-size: 8pt"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 23%; text-align: justify; text-indent: -5.05pt; padding-left: 5.05pt">Richard L. Van Kirk</td><td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: center">2024</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">23,016</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">10,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">8,625</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">3,564</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">45,205</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10.35pt">Director, CEO, President, and COO</td><td>&#160;</td>
    <td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">25,562</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,563</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,564</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">43,689</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -5.05pt; padding-left: 5.05pt">Alisha K. Charlton</td><td>&#160;</td>
    <td style="text-align: center">2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,158</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,430</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,291</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12,879</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify; padding-left: 10.35pt">Chief Financial Officer</td><td>&#160;</td>
    <td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,872</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,013</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,746</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,631</td><td style="text-align: left">&#160;</td></tr>
  </table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b>Employment Agreements with Named
Executive Officers</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><b>Employment
Arrangement with Richard L. Van Kirk</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">On January 12, 2015, Rick began
service as our Chief Executive Officer, President and Director, in addition to continuing to serve as our Chief Operating Officer, a position
Rick has held since April 23, 2013. In connection with that appointment, Rick continues his at-will employment arrangement with the Company.
Rick&#8217;s compensation consists of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">&#8226;</span></td><td><span style="font-size: 10pt">A base annual salary of $350,000 (previously $305,000 through December 28, 2023).</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">&#8226;</span></td><td><span style="font-size: 10pt">An annual car allowance of $10,000.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">&#8226;</span></td><td><span style="font-size: 10pt">Rick is eligible to participate in any program of stock options or other equity grants that we provide
key employees from time to time, including our 2016 Equity Incentive Plan and ESPP.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">&#8226;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Health, dental, disability and life insurance, qualified retirement plans,
and optional employee benefits on the same terms as other employees.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Employment Arrangement with Alisha K. Charlton</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">On January 12, 2015, Alisha
began service as our Chief Financial Officer. In connection with that appointment, Alisha continued her at-will employment arrangement
with the Company. Alisha&#8217;s compensation consists of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">&#8226;</span></td><td><span style="font-size: 10pt">A base annual salary of $247,200 (previously $240,000 through October 14, 2023).</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">&#8226;</span></td><td><span style="font-size: 10pt">Alisha is eligible to participate in any program of stock options or other equity grants that we provide
key employees from time to time, including our 2016 Equity Incentive Plan and ESPP.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">&#8226;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Health, dental, disability and life insurance, qualified retirement plans,
and optional employee benefits on the same terms as other employees.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p id="xdx_988_eecd--AwardTmgMnpiDiscTextBlock_iB_c20240701__20250630_gBFATMDTB-GNC_zT9XNHOtLkkf" class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" continuedAt="ConU000016-01" escape="true" id="Fact000016" name="ecd:AwardTmgMnpiDiscTextBlock"><b>Equity Award Timing Policies and Procedures</b></ix:nonNumeric></p>

<div id="xdx_C06_gBFATMDTB-GNC_zAK7CjAYSOVe"><ix:continuation continuedAt="ConU000016-02" id="ConU000016-01"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p></ix:continuation></div>

<div id="xdx_C0B_gBFATMDTB-GNC_z3i9i5MgfMc7"><ix:continuation continuedAt="ConU000016-03" id="ConU000016-02"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">In accordance with Item 402(x)
of Regulation S-K, we are providing information regarding our policies and procedures related to the granting of certain equity awards
in relation to the disclosure of material nonpublic information (&#8220;MNPI&#8221;). <span id="xdx_902_eecd--AwardTmgMethodTextBlock_c20240701__20250630_zdKfyT7OxJ1e" class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000017" name="ecd:AwardTmgMethodTextBlock">We <span id="xdx_90A_eecd--MnpiDiscTimedForCompValFlag_dbF_c20240701__20250630_zYUCdsJ02dNl" class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleanfalse" id="Fact000018" name="ecd:MnpiDiscTimedForCompValFlag">do not</ix:nonNumeric></span> have a formal policy, program, or plan
that requires us to award equity or equity-based compensation. Our Policy on Insider Trading prohibits directors, officers, and employees
from trading in our securities while in possession of or on the basis of MNPI</ix:nonNumeric></span>. <span id="xdx_90C_eecd--AwardTmgHowMnpiCnsdrdTextBlock_c20240701__20250630_zhMA9YjzH045" class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000019" name="ecd:AwardTmgHowMnpiCnsdrdTextBlock">We have <span id="xdx_904_eecd--AwardTmgMnpiCnsdrdFlag_dbF_c20240701__20250630_zSM96kySZlm7" class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleanfalse" id="Fact000020" name="ecd:AwardTmgMnpiCnsdrdFlag">not timed</ix:nonNumeric></span>, and do not plan to time, the disclosure
of MNPI for the purpose of affecting the value of executive compensation.</ix:nonNumeric></span></p></ix:continuation></div>

<div id="xdx_C0E_gBFATMDTB-GNC_zezNcIr24O5f"><ix:continuation continuedAt="ConU000016-04" id="ConU000016-03"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:continuation></div>

<div id="xdx_C07_gBFATMDTB-GNC_z23ZFT47zQmj"><ix:continuation id="ConU000016-04"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the year ended June 30,
2025, no equity awards were granted to our named executive officers within four business days prior to, or one business day following,
the filing or furnishing of a periodic or current report by us that disclosed MNPI.</p></ix:continuation></div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 14 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Outstanding Equity Awards at Fiscal Year End</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">The following table sets forth
information about outstanding equity awards held by our Named Executive Officers as of June&#160;30, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt; text-align: center">&#160;</td><td style="text-align: center; font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="13" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Option Awards</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt; text-align: center">&#160;</td><td style="text-align: center; font-size: 8pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>	Number
                                            of Securities Underlying</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>	Unexercised
                                            Options	</b></p></td><td style="text-align: center; font-size: 8pt">&#160;</td><td style="text-align: center; font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Option</b></p></td><td style="text-align: center; font-size: 8pt">&#160;</td><td style="text-align: center; font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Option</b></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-size: 11pt; font-weight: bold; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Name&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b></p></td><td style="padding-bottom: 1pt; text-align: center; font-size: 8pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>	Exercisable</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>	(#)	</b></p></td><td style="padding-bottom: 1pt; text-align: center; font-size: 8pt">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-size: 8pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Unexercisable</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>	(#)<span style="font-family: Times New Roman, Times, Serif"><sup>(1)</sup></span>	</b></p></td><td style="padding-bottom: 1pt; text-align: center; font-size: 8pt">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-size: 8pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Exercise
                                            Price</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>($)</b></p></td><td style="padding-bottom: 1pt; text-align: center; font-size: 8pt">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-size: 8pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Expiration</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Date</b></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 20%; text-align: justify; text-indent: -5.05pt; padding-left: 5.05pt">Richard L. Van Kirk</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 17%; text-align: right">18,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 17%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 17%; text-align: right">27.50</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 19%; text-align: center">07/01/2031</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 11pt; text-align: justify; text-indent: -5.05pt; padding-left: 5.05pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">42.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">07/01/2034</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 11pt; text-align: justify; text-indent: -5.05pt; padding-left: 5.05pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">45.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">07/01/2036</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 11pt; text-align: justify; text-indent: -5.05pt; padding-left: 5.05pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">47.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">07/01/2038</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 11pt; text-align: justify; text-indent: -5.05pt; padding-left: 5.05pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">50.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">07/01/2040</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -5.05pt; padding-left: 5.05pt">Alisha K. Charlton</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">27.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">07/01/2031</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 11pt; text-align: justify; text-indent: -5.05pt; padding-left: 5.05pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,625</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">42.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">07/01/2034</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 11pt; text-align: justify; text-indent: -5.05pt; padding-left: 5.05pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">45.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">07/01/2036</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 11pt; text-align: justify; text-indent: -5.05pt; padding-left: 5.05pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">47.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">07/01/2038</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 11pt; text-align: justify; text-indent: -5.05pt; padding-left: 5.05pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="font-size: 11pt; text-align: left">&#160;</td><td style="font-size: 11pt; text-align: right">&#160;</td><td style="font-size: 11pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">50.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">07/01/2040</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -22.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><sup>(1)</sup></td><td style="width: 5pt"/><td style="text-align: justify">Whether any of the unexercisable options vest, and the amount that does vest, is tied to
various service periods corresponding to future testing dates and the achievement of our Common Stock trading at or above the exercise
price. In the event that the market price of our Common Stock does not reach or exceed the exercise price during the 60 days immediately
preceding the three testing dates of the unexercisable options, a fraction, either 50%, 75% or 100%, of the above-mentioned unexercisable
stock options will expire. Accordingly, the number of exercisable options with a strike price of $42.00 represents 50% of the original
award.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt; text-align: justify; padding-bottom: 1pt; padding-left: 2.35pt">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: left">&#160;</td><td colspan="5" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>Stock Awards</b></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-size: 11pt; text-align: justify; padding-left: 2.35pt"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"><b>Name</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td>
    <td style="padding-bottom: 1pt; font-size: 8pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Equity Incentive Plan Awards: Number of Unearned Shares That Have Not Vested</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(#)<sup>(1)</sup></b></p></td><td style="padding-bottom: 1pt; font-size: 8pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td>
    <td style="padding-bottom: 1pt; font-size: 8pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Equity Incentive Plan Awards: Market Value of Unearned Shares That Have Not Vested</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>($)<span style="font-family: Times New Roman, Times, Serif"><sup>(2)</sup></span></b></p></td><td style="padding-bottom: 1pt; font-size: 8pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 66%; text-align: justify; text-indent: -5.05pt; padding-left: 5.05pt">Richard L. Van Kirk</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">15,800</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">689,512</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -5.05pt; padding-left: 5.05pt">Alisha K. Charlton</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">471,312</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -22.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><sup>(1)</sup></td><td style="width: 5pt"/><td style="text-align: justify">Represents both performance awards and restricted shares which, upon vesting, will generally
be paid in shares of our Common Stock. The performance awards, which includes 14,800 issued to Rick and 9,800 issued to Alisha vest on
July 1, 2026. The restricted shares which account for 1,000 shares issued to both Rick and Alisha vest ratably, 200 shares per year over
a five-year period beginning November 20, 2025.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -22.5pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><sup>(2)</sup></td><td style="width: 5pt"/><td style="text-align: justify">The payout value of unearned shares is based upon the closing market price of our Common
Stock on June 30, 2025, on the Nasdaq Capital Market of $43.64 per share.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>


<!-- Field: Page; Sequence: 15 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Pay Versus Performance</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">As required by the SEC&#8217;s
pay versus performance (&#8220;PvP&#8221;) disclosure rules as set forth in Item 402(v) of Regulation S-K, we are providing the following
information regarding the relationship between executive compensation actually paid and certain financial performance of the Company for
the last three fiscal years. Under the PvP rules, the SEC has developed a new definition of executive &#8220;compensation actually paid&#8221;
(&#8220;CAP&#8221;), which requires us to make various adjustments to amounts reported in the Summary Compensation Table (&#8220;SCT&#8221;).
As required by SEC rules, the table presented below discloses CAP for (i) the Company&#8217;s principal executive officer (&#8220;PEO&#8221;),
Rick, and (ii) the Company&#8217;s Named Executive Officers other than Rick (collectively, &#8220;Non-PEO NEOs&#8221;), on an average
basis. Note that as a smaller reporting company we only have one Non-PEO NEO, Alisha, and as a result, the CAP for Non-PEO NEOs just reflects
CAP for Alisha. Due to the valuation component of CAP, the dollar amounts do not reflect the actual amount of compensation earned or paid
during the year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">The PvP table below provides
compensation values reported in our current and prior SCTs, as well as the CAP amounts required in this section for the fiscal years ending
June 30, 2023, 2024, and 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><i>Pay Versus Performance Table (&#8220;PvP&#8221;)</i></b></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000022" name="ecd:PvpTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_881_eecd--PvpTableTextBlock_ze253odgCMPf" summary="xdx: Disclosure - Pay vs Performance Disclosure" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt; text-align: center">&#160;</td><td style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td colspan="2" style="font-size: 11pt; text-align: center">&#160;</td><td style="font-size: 11pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td colspan="2" style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td colspan="2" style="font-size: 11pt; text-align: center">&#160;</td><td style="font-size: 11pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Year</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SCT for PEO<sup>(1)</sup></b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CAP for PEO<sup>(2)</sup></b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt; line-height: 110%"><b>SCT for Non-PEO NEO<sup>(3)</sup></b></span></td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt; line-height: 110%"><b>CAP for Non-PEO NEO<sup>(4)</sup></b></span></td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt; line-height: 110%"><b>Fixed $100 Investment Based on TSR<sup>(5)</sup></b></span></td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Net Income</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(in 000&#8217;s)<sup>(6)</sup></b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">(a)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">(b)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">(c)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">(d)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">(e)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">(f)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">(g)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 13%; text-align: center">2025</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eecd--PeoTotalCompAmt_c20240701__20250630_zwMt8KkZJDUf" title="Summary Compensation Table Total for PEO" style="width: 12%; text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2024-07-01to2025-06-30" id="Fact000024" format="ixt:numdotdecimal" decimals="0" unitRef="USD">652,951</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eecd--PeoActuallyPaidCompAmt_c20240701__20250630_zmg2KSXtQog1" title="Compensation Actually Paid to PEO" style="width: 12%; text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2024-07-01to2025-06-30" id="Fact000026" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,948,805</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eecd--NonPeoNeoAvgTotalCompAmt_c20240701__20250630_z4xpL4y1mZW7" title="Average Summary Compensation Table Total for Non-PEO Named Executive Officers" style="width: 11%; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2024-07-01to2025-06-30" id="Fact000028" format="ixt:numdotdecimal" decimals="0" unitRef="USD">357,825</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20240701__20250630_zYIGFuynhJrc" title="Average Compensation Actually Paid to Non-PEO Named Executive Officers" style="width: 11%; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2024-07-01to2025-06-30" id="Fact000030" format="ixt:numdotdecimal" decimals="0" unitRef="USD">773,236</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eecd--TotalShareholderRtnAmt_pp2p0_c20240701__20250630_zN1OPEnZUxFg" title="Total Shareholder Return Amount" style="width: 11%; text-align: right"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2024-07-01to2025-06-30" id="Fact000032" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">271.22</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--NetIncomeLoss_pn3n3_c20240701__20250630_zOD2AyQ3VmWg" title="Net Income" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-01to2025-06-30" id="Fact000034" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,978</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eecd--PeoTotalCompAmt_c20230701__20240630_z1UGiiLBvQoj" title="Summary Compensation Table Total for PEO" style="text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2023-07-012024-06-30" id="Fact000036" format="ixt:numdotdecimal" decimals="0" unitRef="USD">441,303</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eecd--PeoActuallyPaidCompAmt_c20230701__20240630_znuBrc9DECOh" title="Compensation Actually Paid to PEO" style="text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2023-07-012024-06-30" id="Fact000038" format="ixt:numdotdecimal" decimals="0" unitRef="USD">397,475</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eecd--NonPeoNeoAvgTotalCompAmt_c20230701__20240630_z176qpMTP4z9" title="Average Summary Compensation Table Total for Non-PEO Named Executive Officers" style="text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2023-07-012024-06-30" id="Fact000040" format="ixt:numdotdecimal" decimals="0" unitRef="USD">320,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230701__20240630_z2Os5pA6i2E3" title="Average Compensation Actually Paid to Non-PEO Named Executive Officers" style="text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2023-07-012024-06-30" id="Fact000042" format="ixt:numdotdecimal" decimals="0" unitRef="USD">328,349</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eecd--TotalShareholderRtnAmt_pp2p0_c20230701__20240630_zS42dq0lUIsb" title="Total Shareholder Return Amount" style="text-align: right"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2023-07-012024-06-30" id="Fact000044" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">122.06</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--NetIncomeLoss_pn3n3_c20230701__20240630_zAHHVAMuNmAb" title="Net Income" style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012024-06-30" id="Fact000046" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,127</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eecd--PeoTotalCompAmt_c20220701__20230630_z6H1gmeCvDE" title="Summary Compensation Table Total for PEO" style="text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2022-07-012023-06-30" id="Fact000048" format="ixt:numdotdecimal" decimals="0" unitRef="USD">418,605</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eecd--PeoActuallyPaidCompAmt_c20220701__20230630_zOjvKe8HK2I7" title="Compensation Actually Paid to PEO" style="text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2022-07-012023-06-30" id="Fact000050" format="ixt:numdotdecimal" decimals="0" unitRef="USD">632,137</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eecd--NonPeoNeoAvgTotalCompAmt_c20220701__20230630_z66lvtcVFD4d" title="Average Summary Compensation Table Total for Non-PEO Named Executive Officers" style="text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2022-07-012023-06-30" id="Fact000052" format="ixt:numdotdecimal" decimals="0" unitRef="USD">297,613</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220701__20230630_zsC3ZhgwTopf" title="Average Compensation Actually Paid to Non-PEO Named Executive Officers" style="text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2022-07-012023-06-30" id="Fact000054" format="ixt:numdotdecimal" decimals="0" unitRef="USD">424,446</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eecd--TotalShareholderRtnAmt_pp2p0_c20220701__20230630_zzaOxUMWNJN4" title="Total Shareholder Return Amount" style="text-align: right"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2022-07-012023-06-30" id="Fact000056" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">118.71</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20230630_zT4mABQcwgP7" title="Net Income" style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012023-06-30" id="Fact000058" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,074</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000060" name="ecd:NamedExecutiveOfficersFnTextBlock"><p id="xdx_840_eecd--NamedExecutiveOfficersFnTextBlock_dU_zcaiXkienLz3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-size: 10pt">The dollar amounts reported in column (b) are the amounts of total compensation
reported for <span id="xdx_90C_eecd--PeoName_c20240701__20250630_zAN8gjvi5Y98"><span id="xdx_904_eecd--PeoName_c20230701__20240630_zxilWoxAXaNk"><span id="xdx_901_eecd--PeoName_c20220701__20230630_zkUBKoB3upPf"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000061" name="ecd:PeoName"><ix:nonNumeric contextRef="From2023-07-012024-06-30" id="Fact000062" name="ecd:PeoName"><ix:nonNumeric contextRef="From2022-07-012023-06-30" id="Fact000063" name="ecd:PeoName">Rick</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></span></span>, our Chief Executive Officer, for each corresponding year in the &#8220;Total&#8221; column of the SCT. Refer to &#8220;Executive
Compensation &#8211; Summary Compensation Table.&#8221;</span></td></tr></table>

</ix:nonNumeric><p id="xdx_857_zHQTteA8tRVa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000065" name="ecd:AdjToPeoCompFnTextBlock"><p id="xdx_84B_eecd--AdjToPeoCompFnTextBlock_dU_zolMlgYU6bwl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-size: 10pt">The dollar amounts reported in column (c) represent the amount of CAP to
Rick, as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual amount of compensation
earned by or paid to Rick during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following
adjustments were made to Rick&#8217;s total compensation as reported in the SCT for each year to determine the CAP:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Year</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt"/>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SCT Total for PEO</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SCT Reported Equity Award Value for</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PEO</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Equity Award</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Adjustments</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>for PEO<span style="font-family: Times New Roman, Times, Serif"><sup>(A)</sup></span></b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CAP to</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PEO</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 19%; text-align: center">2025</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eecd--PeoTotalCompAmt_c20240701__20250630_zpRSp3cQXMYi" style="width: 17%; text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2024-07-01to2025-06-30" id="Fact000066" format="ixt:numdotdecimal" decimals="0" unitRef="USD">652,951</ix:nonFraction></td><td style="width: 1%; text-align: left"/><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_zTw5jM2Vw0c4" style="width: 17%; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_ReportedValueOfEquityAwardsMember" id="Fact000067" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">47,630</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--EquityAwardAdjustmentsMember_zTiQ8JbIWwm9" style="width: 17%; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_EquityAwardAdjustmentsMember" id="Fact000068" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,343,484</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eecd--PeoActuallyPaidCompAmt_c20240701__20250630_zzefrWkVfYui" style="width: 17%; text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2024-07-01to2025-06-30" id="Fact000069" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,948,805</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eecd--PeoTotalCompAmt_c20230701__20240630_zUYzdqHPDcy2" style="text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2023-07-012024-06-30" id="Fact000070" format="ixt:numdotdecimal" decimals="0" unitRef="USD">441,303</ix:nonFraction></td><td style="text-align: left"/><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eecd--AdjToCompAmt_d0_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_zHklvaBdenjc" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_ReportedValueOfEquityAwardsMember" id="Fact000071" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--EquityAwardAdjustmentsMember_zNlUVtT4AAN2" style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_EquityAwardAdjustmentsMember" id="Fact000072" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">43,828</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eecd--PeoActuallyPaidCompAmt_c20230701__20240630_zp2ZFoXZ8itk" style="text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2023-07-012024-06-30" id="Fact000073" format="ixt:numdotdecimal" decimals="0" unitRef="USD">397,475</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eecd--PeoTotalCompAmt_c20220701__20230630_zSE6qoVo3he1" style="text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2022-07-012023-06-30" id="Fact000074" format="ixt:numdotdecimal" decimals="0" unitRef="USD">418,605</ix:nonFraction></td><td style="text-align: left"/><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eecd--AdjToCompAmt_d0_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_zvZSPwn63Oe1" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_ReportedValueOfEquityAwardsMember" id="Fact000075" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--EquityAwardAdjustmentsMember_zFPxrxplvvx6" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_EquityAwardAdjustmentsMember" id="Fact000076" format="ixt:numdotdecimal" decimals="0" unitRef="USD">213,532</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eecd--PeoActuallyPaidCompAmt_c20220701__20230630_zyHHj8bRySOk" style="text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2022-07-012023-06-30" id="Fact000077" format="ixt:numdotdecimal" decimals="0" unitRef="USD">632,137</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 10pt">(A)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt">Represents the year-over-year change in the fair value of equity
awards to Rick as summarized below:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Year</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Add: fair value of awards granted during FY at end of year</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Change in fair value of awards granted in any PY unvested at end of FY</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Add for awards granted and vested in the same FY the fair value as of vesting date</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Change in fair value as of vesting date of any awards from a PY vested in CY</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Subtract: Awards granted in any PY fail to meet vesting conditions during the year; value at end of PY</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Total Equity Award Adjustments</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 13%; text-align: center">2025</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember_zClFSVskUwu7" style="width: 12%; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember" id="Fact000078" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43,640</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember_zWFURhYOa1Xh" style="width: 12%; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember" id="Fact000079" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,394,524</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eecd--AdjToCompAmt_d0_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember_z0mrZSSwXjV2" style="width: 11%; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember" id="Fact000080" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember_zgbGR4z40JO7" style="width: 11%; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember" id="Fact000081" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,300</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember_zuoRFfcLC2nk" style="width: 11%; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember" id="Fact000082" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">88,380</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--TotalEquityAwardAdjustmentMember_zYPy6nv3d353" style="width: 11%; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_TotalEquityAwardAdjustmentMember" id="Fact000083" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,343,484</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eecd--AdjToCompAmt_d0_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember_zl1lYr0pZoZa" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember" id="Fact000084" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember_z2vHmvd5EAob" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember" id="Fact000085" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,122</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eecd--AdjToCompAmt_d0_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember_z7PrM2ho2Xo4" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember" id="Fact000086" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eecd--AdjToCompAmt_d0_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember_zd2I33lU6xYl" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember" id="Fact000087" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember_z5A6I3LdqDP3" style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember" id="Fact000088" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">85,950</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--TotalEquityAwardAdjustmentMember_z2eKOjwS8Cl9" style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_TotalEquityAwardAdjustmentMember" id="Fact000089" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">43,828</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eecd--AdjToCompAmt_d0_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember_zj5bnUFLYmFf" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember" id="Fact000090" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember_z7upVd4a8axg" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember" id="Fact000091" format="ixt:numdotdecimal" decimals="0" unitRef="USD">288,017</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_d0_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember_zBbwBLA45Tkf" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember" id="Fact000092" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember_zYCHsPDgjQwh" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember" id="Fact000093" format="ixt:numdotdecimal" decimals="0" unitRef="USD">140,840</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember_zSojkcSVIGU7" style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember" id="Fact000094" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">215,325</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--TotalEquityAwardAdjustmentMember_zYFEqZeSO3W2" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_TotalEquityAwardAdjustmentMember" id="Fact000095" format="ixt:numdotdecimal" decimals="0" unitRef="USD">213,532</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_858_zjkMnJu4zcV" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000097" name="ecd:AdjToNonPeoNeoCompFnTextBlock"><p id="xdx_84A_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zktdUgWMofm1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-size: 10pt">(3)</span></td><td style="text-align: justify"><span style="font-size: 10pt">The dollar amounts reported in column (d) of the PvP table represent the
amounts reported for Alisha, who is the Company&#8217;s only Non-PEO NEOs in the &#8220;Total&#8221; column of the SCT in each applicable
year. </span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-size: 10pt">(4)</span></td><td style="text-align: justify"><span style="font-size: 10pt">The dollar amounts reported in column (e) represent the amount of CAP to
Alisha, as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual amount of compensation
earned by or paid to Alisha during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following
adjustments were made to Alisha&#8217;s total compensation as reported in the SCT for each year to determine the CAP:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 16 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Year</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SCT for Alisha Charlton</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SCT Reported Equity Award Value for</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Alisha Charlton</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Equity Award</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Adjustments</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>for Alisha </b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Charlton<span style="font-family: Times New Roman, Times, Serif"><sup>(A)</sup></span></b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Compensation </b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Actually</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Paid to </b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Alisha Charlton</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 19%; text-align: center">2025</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eecd--NonPeoNeoAvgTotalCompAmt_c20240701__20250630_z7FG8h1L9MQ4" style="width: 17%; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2024-07-01to2025-06-30" id="Fact000098" format="ixt:numdotdecimal" decimals="0" unitRef="USD">357,825</ix:nonFraction></td><td style="width: 1%; text-align: left"/><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$&#160;</td><td id="xdx_986_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_zrsDXu00CPXh" style="width: 17%; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ReportedValueOfEquityAwardsMember" id="Fact000099" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">47,630</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--EquityAwardAdjustmentsMember_zbAW8QviX7E2" style="width: 17%; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_EquityAwardAdjustmentsMember" id="Fact000100" format="ixt:numdotdecimal" decimals="0" unitRef="USD">463,041</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20240701__20250630_zCeAvIA0ACy2" style="width: 17%; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2024-07-01to2025-06-30" id="Fact000101" format="ixt:numdotdecimal" decimals="0" unitRef="USD">773,236</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eecd--NonPeoNeoAvgTotalCompAmt_c20230701__20240630_zoxojl9KaX2f" style="text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2023-07-012024-06-30" id="Fact000102" format="ixt:numdotdecimal" decimals="0" unitRef="USD">320,500</ix:nonFraction></td><td style="text-align: left"/><td>&#160;</td>
    <td style="text-align: left">$&#160;</td><td id="xdx_98B_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_zF7qpWmHjm8l" style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ReportedValueOfEquityAwardsMember" id="Fact000103" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,070</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--EquityAwardAdjustmentsMember_zjejMypa3lck" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_EquityAwardAdjustmentsMember" id="Fact000104" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,919</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230701__20240630_zxbyk2Xi9Irf" style="text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2023-07-012024-06-30" id="Fact000105" format="ixt:numdotdecimal" decimals="0" unitRef="USD">328,349</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eecd--NonPeoNeoAvgTotalCompAmt_c20220701__20230630_zM80TEHQ22L3" style="text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2022-07-012023-06-30" id="Fact000106" format="ixt:numdotdecimal" decimals="0" unitRef="USD">297,613</ix:nonFraction></td><td style="text-align: left"/><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eecd--AdjToCompAmt_d0_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_zDPZWrdlsbmh" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ReportedValueOfEquityAwardsMember" id="Fact000107" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--EquityAwardAdjustmentsMember_zsCNqaqWGcnb" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_EquityAwardAdjustmentsMember" id="Fact000108" format="ixt:numdotdecimal" decimals="0" unitRef="USD">126,833</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220701__20230630_zq2Y9Nopn9Xh" style="text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2022-07-012023-06-30" id="Fact000109" format="ixt:numdotdecimal" decimals="0" unitRef="USD">424,446</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 10pt">(A)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt">Represents the year-over-year change in the fair value of Alisha&#8217;s
equity awards as summarized below:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Year</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Add: fair value of awards granted during FY at end of year</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Change in fair value of awards granted in any PY unvested at end of FY</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Add for awards granted and vested in the same FY the fair value as of vesting date</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Change in fair value as of vesting date of any awards from a PY vested in CY</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Subtract: Awards granted in any PY fail to meet vesting conditions during the year; value at end of PY</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Total Equity Award Adjustments</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 13%; text-align: center">2025</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember_zIrHLIVMiiP1" style="width: 12%; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember" id="Fact000110" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43,640</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember_zLqb5hXxSehl" style="width: 12%; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember" id="Fact000111" format="ixt:numdotdecimal" decimals="0" unitRef="USD">451,867</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eecd--AdjToCompAmt_d0_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember_zhpmCIqB6IYa" style="width: 11%; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember" id="Fact000112" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember_zj87kFcV1D99" style="width: 11%; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember" id="Fact000113" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,688</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember_zkQi4zwUOOL9" style="width: 11%; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember" id="Fact000114" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">25,778</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--TotalEquityAwardAdjustmentMember_zNqPPjGGo9sg" style="width: 11%; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_TotalEquityAwardAdjustmentMember" id="Fact000115" format="ixt:numdotdecimal" decimals="0" unitRef="USD">463,041</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember_zlFJxgqFd596" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember" id="Fact000116" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,280</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember_z1TXHyJ01dUg" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember" id="Fact000117" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,708</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eecd--AdjToCompAmt_d0_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember_zIw5REBYHfib" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember" id="Fact000118" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_d0_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember_zn8LVY2hrUPh" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember" id="Fact000119" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember_zqTBVY0DUw7k" style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember" id="Fact000120" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">25,069</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--TotalEquityAwardAdjustmentMember_zObPM8wpGlMk" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_TotalEquityAwardAdjustmentMember" id="Fact000121" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,919</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eecd--AdjToCompAmt_d0_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember_zME93pInFV92" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember" id="Fact000122" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember_zO48jcKhvGPk" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember" id="Fact000123" format="ixt:numdotdecimal" decimals="0" unitRef="USD">92,897</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_d0_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember_z2HzoBHj22Va" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember" id="Fact000124" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember_zOz5NLguxGA8" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember" id="Fact000125" format="ixt:numdotdecimal" decimals="0" unitRef="USD">88,184</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember_zeT9raLZWJSb" style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember" id="Fact000126" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">54,248</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--TotalEquityAwardAdjustmentMember_zYdtV9a0gCjc" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_TotalEquityAwardAdjustmentMember" id="Fact000127" format="ixt:numdotdecimal" decimals="0" unitRef="USD">126,833</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-size: 10pt">(5)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Cumulative total shareholder return (&#8220;TSR&#8221;) assumes $100 is
invested in Pro-Dex, Inc. common stock as of July 1, 2022. The TSR represents the cumulative value of the $100 investment as of the end
of each fiscal year presented (each, a measurement period). Pursuant to SEC rules, TSR is calculated by dividing the sum of the cumulative
amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between the Company&#8217;s share price
at the end and the beginning of the measurement period by the Company&#8217;s share price at the beginning of the measurement period.
However, as the Company does not pay dividends, TSR in this proxy statement is calculated by dividing the difference between the Company&#8217;s
share price at the end and the beginning of the measurement periods by the Company&#8217;s share price at the beginning of the measurement
period. </span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-size: 10pt">(6)</span></td><td style="text-align: justify"><span style="font-size: 10pt">The dollar amounts reported represent the amount of net income reflected
in the Company&#8217;s audited financial statements for the applicable year.</span></td></tr></table>

</ix:nonNumeric><p id="xdx_85B_zzgJklD9Nv4k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><i>Analysis of the Information Presented in
the Pay versus Performance Table</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Our executive compensation
program reflects a variable&#160;pay-for-performance&#160;philosophy, utilizing several performance measures to align executive compensation
with our performance. Moreover, we generally seek to incentivize long-term performance, and therefore do not specifically align our performance
measures with compensation that is actually paid (as computed in accordance with Item 402(v) of Regulation&#160;S-K)&#160;for a particular
year. In accordance with Item 402(v) of Regulation&#160;S-K,&#160;we are providing the following descriptions of the relationships between
information presented in the Pay versus Performance table.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><i><span style="text-decoration: underline"></span></i></p>

<!-- Field: Page; Sequence: 17 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000129" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock"><p id="xdx_84E_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_zEcOxd3Ukh3f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><i><span style="text-decoration: underline">CAP and TSR</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As demonstrated by the
following graph, the amount of CAP for 2023, 2024 and 2025 and the CAP is generally aligned with our TSR over the three years presented
in the table. The alignment of CAP with our TSR over the period presented is because a significant portion of the CAP is comprised of
equity awards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 10pt"><i><img src="image_001.jpg" alt="" style="height: 337px; width: 577px"/></i></span></p>

</ix:nonNumeric><p id="xdx_85C_znq9X2wDdUL2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000131" name="ecd:CompActuallyPaidVsNetIncomeTextBlock"><p id="xdx_847_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zEgAWXTq5DEh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">CAP and Net Income</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As demonstrated by the following graph, the amount
of CAP for 2023, 2024 and 2025 and is generally aligned with our net income over the three years presented in the table. However, as noted
above, a significant portion of the CAP is comprised of equity awards, and therefore this may not always be the case.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img src="image_001.gif" alt="" style="height: 319px; width: 570px"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

</ix:nonNumeric><p id="xdx_854_zYqtN2hLP0wg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: Page; Sequence: 18 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Compensation of Directors</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify">In
May 2016, our Board approved the following compensation plan for our non-employee directors:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 22.5pt"/><td style="width: 13.5pt"><span style="font-family: Symbol; font-size: 6pt">&#183;</span></td><td style="text-align: justify"><span style="font-size: 10pt">A cash fee of $18,000 per fiscal year, paid quarterly in arrears; and</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 22.5pt"/><td style="width: 13.5pt"><span style="font-family: Symbol; font-size: 6pt">&#183;</span></td><td style="text-align: justify"><span style="font-size: 10pt">An additional cash fee of $7,000 per fiscal year for the Audit Committee
Chair, paid quarterly in arrears.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify">The
following table details the fees earned by our non-employee directors during fiscal 2025.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Name</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 0.5pt solid; font-size: 8pt; font-weight: bold; text-align: center"><p style="border-bottom: Black 0.5pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Fees Earned or<br/> Paid in Cash<span style="font-family: Times New Roman, Times, Serif"><sup>(1)</sup></span> ($)</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 0.5pt solid; font-size: 8pt; font-weight: bold; text-align: center">Total<br/> ($)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 66%; text-align: justify; padding-left: 5.4pt">David C. Hovda</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">25,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">25,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 5.4pt">Raymond E. Cabillot</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">18,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">18,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 5.4pt">William J. Farrell III</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">18,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">18,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 5.4pt">Katrina M.K. Philp</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">18,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">18,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 5.4pt">Nicholas J. Swenson</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">18,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">18,000</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-size: 10pt">The cash amount reported in this column represents amounts earned during
fiscal 2025. All amounts were paid in fiscal 2025 except for the 4<sup>th</sup> quarter accrual, which was paid in fiscal 2026. </span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify">The
Compensation Committee granted each non-employee director 1,000 restricted shares which vest ratably 200 shares per year over a five-year
period beginning November 20, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>EQUITY COMPENSATION PLAN INFORMATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify">The
following table provides information as of June 30, 2025 with respect to shares of Common Stock that may be issued under the Company&#8217;s
equity compensation plans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">Plan
    Category</span></td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Weighted-Average Exercise Price of Outstanding Options, Warrants and Rights</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (excluding securities reflected in the first column)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    compensation plans approved by Stockholders:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 49%; font-size: 10pt; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2016
    Equity Incentive Plan</span></td><td style="width: 1%; font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 8pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 14%; font-size: 8pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">295,250</span></td><td style="width: 1%; font-size: 8pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42.38</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="width: 1%; font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 8pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 14%; font-size: 8pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">993,000</span></td><td style="width: 1%; font-size: 8pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2014
    Employee Stock Purchase Plan</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">666,659</span></td><td style="font-size: 8pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(1)</sup></span></td><td style="text-align: justify"><span style="font-size: 10pt">Represents performance awards issued to employees (including the Named Executive
Officers) for 40,000 shares, restricted share awards issued to employees (including the Named Executive Officers) and directors for 18,000
shares, as well as nonqualified stock options issued to employees (including the Named Executive Officers) and directors to purchase 237,250
shares (of which 79,750 options are vested and exercisable). Whether any performance awards or unvested options vest, and the amount that
does vest, is tied to the completion of various service periods that range from July&#160;1, 2026 to July 1, 2031 and the achievement
of our Common Stock trading at certain pre-determined prices. Whether any restricted share awards vest, and the amount that does vest
is tied to the completion of various service periods that range from November 20, 2025 to November 20, 2030.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(2)</sup></span></td><td style="text-align: justify"><span style="font-size: 10pt">Represents the weighted average exercise price of the 237,250 non-qualified
stock options included in the &#8220;Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights&#8221;
column.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 19 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Options and Equity Awards Generally</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>2016 Equity Incentive Plan</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify">In
the event of a change in control (as such term is defined in the 2016 Equity Incentive Plan, which definition includes, among other items,
(a)&#160;conditions under which a person or group becomes a beneficial owner of 50% or more of the voting power of our outstanding stock,
or (b)&#160;a majority change in the composition of our Board occurring within a one-year period, or (c) a change in the ownership of
more than 40% of the Company&#8217;s assets, or (d) a complete liquidation or dissolution of the Company):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 43.5pt"/><td style="width: 18pt"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-size: 10pt">the Board has the discretion to accelerate the vesting of any outstanding
options or stock appreciation rights;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 43.5pt"/><td style="width: 18pt"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-size: 10pt">unless otherwise set forth in the applicable award agreement, all restrictions
applicable to restricted shares and restricted stock unit awards shall terminate fully and the underlying shares will be delivered; and</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 43.5pt"/><td style="width: 18pt"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-size: 10pt">unless otherwise set forth in the applicable award agreement, all performance
awards shall immediately become vested and payable within 30 days after a change of control. </span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>AUDIT COMMITTEE REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">The Audit Committee reports
to and acts on behalf of our Board in providing oversight to our financial management, independent registered public accounting firm,
and financial reporting procedures. Our management is responsible for preparing our financial statements and the independent registered
public accounting firm is responsible for auditing those statements. In this context, the Audit Committee has reviewed and discussed the
audited financial statements contained in our 2025 Annual Report on Form 10-K with management and Baker Tilly US, LLP, the independent
registered public accounting firm engaged to audit such financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">The Audit Committee has discussed
with Baker Tilly US, LLP the matters required to be discussed by Auditing Standard No.&#160;16 (&#8220;Communications with Audit Committees&#8221;).
The Audit Committee has received the written disclosures and the letter from Baker Tilly US, LLP required by applicable requirements of
the Public Company Accounting Oversight Board regarding the independent registered public accounting firm&#8217;s communications with
the audit committee concerning independence and has discussed with Baker Tilly US, LLP its independence. In concluding that Baker Tilly
US, LLP is independent, the Audit Committee considered, among other factors, whether any non-audit services provided by Baker Tilly US,
LLP were compatible with maintaining its independence.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">In reliance on the reviews
and discussions referred to above, the Audit Committee recommended to our Board that the audited financial statements be included in our
Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2025, and be filed with the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">The Audit Committee has appointed
Baker Tilly US, LLP to serve as our independent auditors for the fiscal year ending June&#160;30, 2026.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>AUDIT COMMITTEE</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 35%; line-height: 0.05pt">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; line-height: 0.05pt">&#160;</td>
    <td style="width: 32%; line-height: 0.05pt">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; line-height: 0.05pt">&#160;</td>
    <td style="width: 31%; line-height: 0.05pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 0.75pt; text-align: center"><span style="font-size: 10pt">David C. Hovda</span></td>
    <td style="padding-right: 0.8pt">&#160;</td>
    <td style="padding-right: 0.8pt; text-align: center"><span style="font-size: 10pt">Raymond E. Cabillot</span></td>
    <td style="padding-right: 0.8pt">&#160;</td>
    <td style="padding-right: 0.8pt; text-align: center"><span style="font-size: 10pt">Katrina M.K. Philp</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CODE OF ETHICS AND BUSINESS CONDUCT </b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Our code of ethics and business conduct (&#8220;code
of ethics&#8221;), as approved by our Board, can be obtained from https://www.pro-dex.com/investors/governance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt; text-align: justify">We intend to satisfy the
disclosure requirement under Item&#160;5.05 of Form 8-K relating to amendments to or waivers from provisions of the code of ethics that
relate to one of more of the items set forth in Item&#160;406(b) of Regulation S-K and its successor regulation, by describing on our
Internet website, within four business days following the date of a waiver or a substantive amendment, the date of the waiver or amendment,
the nature of the amendment or waiver, and the name of the person to whom the waiver was granted. There have been no waivers of the code
of ethics granted during the fiscal year ended June 30, 2025, and through the date of this proxy statement, nor have there been any requests
for such waivers during that period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">Information on our Internet
site is not, and shall not be deemed to be, a part of this proxy statement or incorporated into any other filings we make with the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<!-- Field: Page; Sequence: 20 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INSIDER TRADING POLICY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have <span id="xdx_909_eecd--InsiderTrdPoliciesProcAdoptedFlag_dbT_c20240701__20250630_zZJJ0nLPUts8" class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBQb2xpY2llcyBhbmQgUHJvY2VkdXJlcwA_"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleantrue" id="Fact000132" name="ecd:InsiderTrdPoliciesProcAdoptedFlag">adopted</ix:nonNumeric></span> a Policy on
Insider Trading governing the purchase, sale, and other dispositions of our securities by our directors, officers, employees, and any
other individual determined to be subject to such policy. We believe our Policy on Insider Trading is reasonably designed to promote compliance
with insider trading laws, rules and regulations, and applicable listing standards. Our Policy on Insider Trading is filed as Exhibit
19 to our Annual Report on Form 10-K for the year ended June 30,&#160;2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>POLICY ON HEDGING, SHORT-SELLING AND PLEDGING</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">Under our Policy on Insider
Trading, unless advance approval is obtained from our Chief Financial Officer (who has been appointed as the compliance officer under
our Policy on Insider Trading), our directors, executive officers, including our Named Executive Officers, and certain other employees
are prohibited from: (i) purchasing financial instruments that are designed to hedge our securities or offset any fluctuations in the
market value of our Common Stock; (ii) purchasing shares of our Common Stock on margin; (iii) short-selling shares of our Common Stock;
and (iv) pledging, whether directly or indirectly, shares of our Common Stock as collateral for a loan, unless the aggregate fair market
value of all collateral for the loan (inclusive of the fair market value of our Common Stock pledged as collateral for the loan) equals
or exceeds 200% of the total obligations under the loan from time to time outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>POLICIES AND PROCEDURES FOR APPROVAL OF RELATED
PARTY TRANSACTIONS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">Our Board has the responsibility
to review and discuss with management and approve, and has adopted written policies and procedures relating to approval or ratification
of, interested transactions with related parties.&#160;During this process, the material facts as to the related party&#8217;s interest
in a transaction are disclosed to all Board members or an applicable committee.&#160;Under the policies and procedures, the Board is to
review each interested transaction with a related party that requires approval and either approve or disapprove of the entry into the
interested transaction.&#160;An &#8220;interested transaction&#8221; is any transaction in which we are a participant and any related
party has or will have a direct or indirect interest.&#160;Transactions that are in the ordinary course of business and would not require
either disclosure pursuant to Item&#160;404(a) of Regulation S-K under the Securities Act or approval of the Board or an independent committee
of the Board pursuant to applicable Nasdaq rules would not be deemed interested transactions.&#160;No director may participate in any
approval of an interested transaction with respect to which such director is a related party.&#160;Our Board intends to approve only those
related party transactions that are in the best interests of the Company and our shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">We invest surplus cash from
time to time through our Investment Committee, which is comprised of one management director, Rick, and two non-management directors,
Ray and Nick, who chairs the committee. &#160;Both Ray and Nick are active investors with extensive portfolio management expertise. &#160;We
leverage the experience of these committee members to make investment decisions for the investment of our surplus operating capital or
borrowed funds. &#160;Additionally, many of our securities holdings include stocks of public companies that either Nick or Ray or both
may own from time to time either individually or through the investment funds that they manage, or other companies whose boards they sit
on, such as Air T, Inc. (described below).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Certain Relationships and Related Transactions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt/11.2pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">We have invested in
marketable equity securities at June 30, 2025 in the amount of $1.0 million in the common stock of Air T, Inc. (Nasdaq: AIRT). Two of
our Board members, Nick and Ray, are also board members of Air T, Inc. and both either individually or through affiliates own an equity
interest in Air T, Inc. Nick also serves as the Chief Executive Officer and Chairman of Air T, Inc. Another of our Board members, Katrina,
is employed by Air T, Inc. as its Chief of Staff. The shares have been purchased through 10b5-1 Plans, which in accordance with our internal
policies regarding the approval of related party transactions, was approved by our then three Board members that are not affiliated with
Air T, Inc.</p>

<p style="font: 10pt/11.2pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt/11.2pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">We own 2,126,673 shares
of Monogram Technologies Inc., (Nasdaq: MGRM), formerly Monogram Orthopaedics Inc. (&#8220;Monogram&#8221;), common stock, which we purchased
through the exercise of warrants. As of June 30, 2025, our investment in Monogram had an estimated fair value of $5.7 million. Rick, our
Chief Executive Officer, has been a member of Monogram&#8217;s board of directors since 2017.</p>

<p style="font: 10pt/11.2pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">We have entered into indemnification
agreements with each of our directors and executive officers.&#160;The indemnification agreements and our certificate of incorporation
and bylaws require us to indemnify our directors and officers to the fullest extent permitted by Colorado law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 21 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Director Independence</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">Our corporate governance guidelines
provide that a majority of the Board and all members of the Audit, Compensation, and Nominating Committees of the Board will be independent.&#160;On
an annual basis, each director and executive officer is obligated to complete a Director and Officer Questionnaire that requires disclosure
of any transactions with us in which a director or executive officer, or any member of his or her immediate family, have a direct or indirect
material interest. Following completion of these questionnaires, the Board, with the assistance of the Nominating Committee, makes an
annual determination as to the independence of each director using the current standards for &#8220;independence&#8221; established by
the SEC and Nasdaq, additional criteria set forth in our corporate governance guidelines, and consideration of any other material relationship
a director may have with us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">The Board has determined that
all of its directors are independent under these standards, except for&#160;Rick, our Chief Executive Officer and President, and Angel,
our Director of Quality Systems and Regulatory Affairs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>COMMUNICATIONS WITH DIRECTORS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">Our Board has established a
process to receive communications from shareholders. Shareholders and other interested parties may contact any member (or all members)
of our Board, or the independent directors as a group, any Board committee or any Chair of any such committee by mail or electronically.
To communicate with our Board, any individual directors, or any group or committee of directors, correspondence should be addressed to
our Board or any such individual directors or group or committee of directors by either name or title. All such correspondence should
be sent &#8220;c/o Corporate Secretary&#8221; at 2361 McGaw Avenue, Irvine, California 92614. To communicate with any of our directors
electronically, a shareholder should send an email to our Secretary: alisha.charlton@pro-dex.com.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">All communications received
as set forth in the preceding paragraph will be opened by the Company&#8217;s Secretary for the sole purpose of determining whether the
contents represent a message to one or more of the directors. Any contents that are not in the nature of advertising, promotions of a
product or service, or patently offensive material will be forwarded promptly to the addressee. In the case of communications to the Board
or any group or committee of directors, the Company&#8217;s Secretary will make sufficient copies (or forward such information in the
case of e-mail) of the contents to send to each director who is a member of the group or committee to which the envelope or e-mail is
addressed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23.05pt">It is our policy that our
directors are invited and encouraged to attend all of our annual meetings of shareholders either in person or telephonically. All of our
directors except for Katrina Philp were in attendance at the 2024 Annual Meeting in person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23.05pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 22 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Proposal No.&#160;2</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>RATIFICATION OF APPOINTMENT OF INDEPENDENT PUBLIC
ACCOUNTANTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">The Audit Committee has appointed
the firm of Baker Tilly US, LLP as our independent registered public accounting firm for the fiscal year ending June&#160;30, 2026, and
requests our shareholders to ratify this appointment. Our prior independent registered public accounting firm, Moss Adams LLP, merged
with Baker Tilly US, LLP on June 3, 2025 with the combined firms continuing to operate under Baker Tilly US, LLP. In the event that our
shareholders do not ratify the selection of Baker Tilly US, LLP as our independent public accountants, our Board will consider the selection
of another independent public accounting firm. Even if the appointment is ratified, the Audit Committee in its discretion may direct the
appointment of a different independent registered public accounting firm at any time during the year if it determines that such a change
would be in our best interest and the best interest of our shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">A representative of Baker Tilly
US, LLP is expected to be present at the Annual Meeting. He or she will have the opportunity to make a statement if such representative
desires to do so and will be available to respond to appropriate questions.</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ACCOUNTING FEES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">The Audit Committee&#8217;s
policy is to pre-approve all auditing services and permitted non-audit services (including the fees and terms thereof) to be performed
for us by our independent registered public accounting firm, subject to the de minimis exceptions for non-audit services described in
Section&#160;10A(i)(1)(B) of the Exchange Act, which are approved by the Audit Committee prior to the completion of the audit. The Audit
Committee considers whether the performance of any service by our independent registered public accounting firm is compatible with maintaining
such firm&#8217;s independence.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">The following table sets forth
the aggregate fees billed during the fiscal years ended June 30, 2025 and 2024 to our independent registered public accounting firm, Baker
Tilly US, LLP (formerly Moss Adams, LLP), all of which were preapproved by the Audit Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="vertical-align: middle; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Years
    ended June 30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="vertical-align: middle; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: middle; width: 1%; text-align: left">&#160;</td><td style="vertical-align: middle; width: 64%; text-align: left"><span style="font-size: 10pt">	Audit Fees</span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><sup>(1)</sup></b></span><span style="font-size: 10pt">	</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">312,375</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">439,950</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: middle; text-align: left">&#160;</td><td style="vertical-align: middle; text-align: left">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 15.95pt"/><td style="width: 20.05pt"><sup>(1)</sup></td><td style="text-align: justify"><i>Audit Fees</i> consist of fees billed for professional services rendered for the audit of our consolidated
annual financial statements and review of the interim consolidated financial statements included in quarterly reports and services that
are normally provided in connection with statutory and regulatory filings or engagements. The amounts above reflect amounts paid during
the fiscal year which may include a combination of pre-billings and billings in arrears.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -20.05pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Required Vote and Board Recommendation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">Although shareholder ratification
is not required for the appointment of Baker Tilly US, LLP as our independent registered public accounting firm for the fiscal year ending
June&#160;30, 2026, our Board has directed that this appointment be submitted to our shareholders for ratification at the Annual Meeting.
Assuming a quorum is present at the Annual Meeting, this proposal will be ratified and approved if the votes cast in favor of this proposal
exceed the votes cast opposing this proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"><b>OUR BOARD RECOMMENDS THAT
OUR SHAREHOLDERS VOTE &#8220;FOR&#8221; THE RATIFICATION OF THE APPOINTMENT OF BAKER TILLY US, LLP TO SERVE AS OUR INDEPENDENT PUBLIC
ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING JUNE&#160;30,&#160;2026.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 23 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Proposal No.&#160;3</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ADVISORY VOTE TO APPROVE THE COMPENSATION OF
OUR NAMED EXECUTIVE OFFICERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">Pursuant to Section 14A of
the Exchange Act, we are asking our shareholders to vote to approve, on a nonbinding, advisory basis, the compensation of our Named Executive
Officers, commonly referred to as the &#8220;say-on-pay&#8221; vote. In accordance with the Exchange Act requirements, we are providing
our shareholders with an opportunity to express their views on our Named Executive Officers&#8217; compensation. Although this advisory
vote is nonbinding, our Board and the Compensation Committee will review and consider the voting results when making future decisions
regarding our Named Executive Officer compensation and related executive compensation programs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">We encourage shareholders
to read the &#8220;Compensation of Executive Officers and Management&#8221; section in this proxy statement, including the compensation
tables and the related narrative disclosure, which describes the structure and amounts of the compensation of our Named Executive Officers
for the fiscal year ended June&#160;30, 2025. The compensation of our Named Executive Officers is designed to enable us to attract and
retain talented and experienced executives to lead us successfully in a competitive environment. The Compensation Committee and our Board
believe that our executive compensation strikes the appropriate balance between utilizing responsible, measured pay practices and effectively
incentivizing our Named Executive Officers to dedicate themselves fully to value creation for our shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Accordingly, we ask our shareholders to vote &#8220;FOR&#8221;
the following resolution at the Annual Meeting:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: justify">&#8220;RESOLVED, that the shareholders approve,
on an advisory basis, the compensation of our Named Executive Officers, as disclosed pursuant to Item 402 of Regulation S-K, including
the compensation tables and any other related disclosure in the proxy statement.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Required Vote and Board Recommendation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">Assuming a quorum is present
at the Annual Meeting, this proposal to approve, on an advisory basis, the compensation of our Named Executive Officers will be approved
if the votes cast in favor of this proposal exceed the votes cast opposing this proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"><b>OUR BOARD RECOMMENDS THAT
OUR SHAREHOLDERS VOTE &#8220;FOR&#8221;, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 24 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Proposal No.&#160;4</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY
VOTES TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">As described in Proposal
No. 3 above, in accordance with the requirements of Section 14A of the Exchange Act and the related rules of the SEC, our shareholders
have the opportunity to cast an advisory vote to approve the compensation of our Named Executive Officers. This Proposal No. 4 affords
our shareholders the opportunity to cast an advisory vote on how often we should include an advisory vote on executive compensation in
our proxy materials for future annual shareholder meetings or any special shareholder meeting for which we must include executive compensation
information in the proxy materials for that meeting. Shareholders may vote to have the advisory vote on executive compensation occur every
year, every two years, or every three years. Shareholders also may abstain from casting a vote on this proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">Our shareholders voted on
a similar proposal at our 2019 Annual Meeting, with the majority voting to hold the advisory vote on executive compensation every year.
We continue to believe that advisory votes on executive compensation should be conducted every year so that our shareholders may annually
express their views on our executive compensation program.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">Shareholders will be able
to specify one of four choices for this proposal: one year, two years, three years, or abstain. The voting frequency option that receives
the highest number of votes cast by shareholders will be deemed the frequency for the advisory vote on executive compensation that has
been selected by shareholders. Although this advisory vote on the frequency of future advisory votes to approve the compensation of our
Named Executive Officers is nonbinding, our Board and the Compensation Committee will carefully review and consider the voting results
when determining the frequency of future advisory votes to approve the compensation of our Named Executive Officers. It is expected that
the next advisory vote on the frequency of advisory votes on executive compensation will occur at our 2031 Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Required Vote and Board Recommendation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">Assuming a quorum is present
at the Annual Meeting, the voting frequency option that receives the highest number of votes will be deemed the frequency for the advisory
vote on executive compensation that has been selected by our shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"><b>OUR BOARD RECOMMENDS THAT
OUR SHAREHOLDERS VOTE FOR &#8220;1 YEAR&#8221; WITH RESPECT THE FREQUENCY OF FUTURE ADVISORY VOTES TO APPROVE THE COMPENSATION OF OUR
NAMED EXECUTIVE OFFICERS.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<!-- Field: Page; Sequence: 25 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Proposal No.&#160;5</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>AMEND THE 2016 EQUITY INCENTIVE PLAN</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">The Board unanimously adopted
the 2016 Equity Incentive Plan (the &#8220;2016 Plan&#8221;) in September 2016 and it was approved by shareholders at the 2016 Annual
Meeting, allowing for the issuance of 1,500,000 shares. In October 2025, the Board approved an amendment to the 2016 Plan for it to continue
un-interrupted for an additional ten (10) years. The text of the amendment is attached to this proxy statement as Exhibit A. The below
summary is qualified in its entirety by the full text of the 2016 Plan, which is set forth as Exhibit B to this proxy statement. Capitalized
terms used in this proposal are defined in the 2016 Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Reasons for the Amendment</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">The Company believes its
employees are valuable assets. Offering various equity incentives, such as non-qualified stock options, incentive stock options, restricted
shares, restricted stock units, performance awards and other stock-based awards (collectively, &#8220;Awards&#8221;) can assist us in
attracting and retaining our valuable employees. In addition, the Company believes that employees who have a stake in the future success
of its business become highly motivated to achieve the Company&#8217;s long-term business goals and to expend maximum effort in the creation
of shareholder value, thereby linking the interests of such individuals with those of shareholders generally.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">The Company has granted
performance awards for 200,000 shares of common stock, non-qualified stock options for 372,000 shares of common stock, and 18,000 restricted
shares of common stock under the 2016 Plan. The Board believes that increased time provided by the amendment is essential to the Company&#8217;s
continued growth, and therefore in the best interest of its shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Administration</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">The Compensation Committee
of the Board of Directors will administer the 2016 Plan. All Awards are approved by the Compensation Committee. With respect to the participation
of individuals whose transactions in the Company's equity securities are subject to Section&#160;16 of the Exchange Act, the Plan must
be administered in compliance with the requirements, if any, of Rule&#160;16b-3 under the Exchange Act. Subject to the provisions of the
Plan, the Compensation Committee determines the persons to whom awards are to be granted, the number of shares to be covered by each award,
whether an option is to be an incentive stock option or a non-qualified stock option, the terms of vesting and exercisability of each
option or other award, including the effect thereon of an optionee's termination of service, the type of consideration to be paid to the
Company upon exercise of an option, the duration of each award, and all other terms and conditions of the awards, subject to the policy
that neither the Board of Directors nor the Compensation Committee may reprice stock options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Eligibility</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">Generally,
all employees, directors and consultants of the Company or of any present or future parent or subsidiary corporations of the Company are
eligible to participate in the 2016 Plan. Any person eligible under the Plan may be granted a non-qualified stock option. However, only
employees may be granted incentive stock options.</p>

<p style="font: 1pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 1pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>New Plan Benefits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt; text-align: justify">Because Awards under the
2016 Plan are discretionary, no future Awards under the 2016 Plan are determinable at this time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 26 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Merger and Change in Control</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt; text-align: justify"><b><i>Merger.</i></b>&#160;&#160;&#160;&#160;Effective
upon a merger, as defined in the Plan, all outstanding awards shall terminate unless they are assumed or continued in connection with
the merger. The Compensation Committee has the authority to provide for full or partial vesting of unvested Awards and the release from
restrictions on transfer and repurchase or forfeiture rights of Awards in connection with a merger. The Compensation Committee may condition
any such Award vesting and exercisability or release from restrictions on the termination of service of the participant to the Company
within a specified period following the effective date of the merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt; text-align: justify"><b><i>Change in control.</i></b>&#160;&#160;&#160;&#160;Unless
otherwise provided in the applicable award agreement, effective upon a change in control, as defined in the Plan, all options and SARs
outstanding on the date of such change in control will be assumed by, or replaced with comparable awards, by the surviving corporation,
the options and SARs will be converted into options and SARs of the surviving corporation, except as to options or SARs granted to a participant
where a change in control resulted from such participant's beneficial ownership of the Company's securities.&#160; The Board of Directors
will have the discretion to accelerate or vest outstanding options and SARs, or determine that any restrictions on any options or SARs
shall lapse, or that the options and SARs will terminate as provided in the Plan. Unless otherwise provided in the applicable award agreement,
effective upon a change in control, all restrictions applicable to Restricted Share and RSU awards will terminate fully and the full number
of shares subject to each Restricted Share award or the number of shares subject to settlement under each RSU will immediately be delivered
as provided in the Plan, except as to Restricted Share and RSU awards granted to a participant where a change in control resulted from
such participant's beneficial ownership of the Company's securities. Unless otherwise provided in the applicable award agreement, in the
event of a change in control, all Performance Awards shall immediately become vested and payable to all participants as provided in the
Plan, within 30&#160;days after such change in control, except as to Performance Awards granted to a participant where a change in control
resulted from such participant's beneficial ownership of the Company's securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 1pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Amendment and Termination</b></p>

<p style="font: 1pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white">The
Board and/or the Compensation Committee may amend or terminate the 2016 Plan at any time. The termination of the 2016 Plan shall not have
any effect on any Award outstanding at the time of the termination of the 2016 Plan and may be exercised after termination of the 2016
Plan at any time prior to the expiration date of such Award to the same extent such Award would have been exercisable had the Plan not
terminated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 1pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Accordingly, we ask our shareholders to vote &#8220;FOR&#8221;
the following resolution at the Annual Meeting:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8220;RESOLVED, that the shareholders amend the
2016 Equity Incentive Plan.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Required Vote and Board Recommendation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">Assuming a quorum is present
at the Annual Meeting, this proposal to approve the amendment to the 2016 Plan will be approved if the votes cast in favor of this proposal
exceed the votes cast opposing this proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"><b>OUR BOARD RECOMMENDS THAT
OUR SHAREHOLDERS VOTE &#8220;FOR&#8221; THE AMENDMENT TO THE 2016 EQUITY INCENTIVE PLAN.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"><b></b></p>

<!-- Field: Page; Sequence: 27 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ANNUAL REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">Our Annual Report on Form 10-K
containing audited financial statements for the fiscal year ended June&#160;30, 2025 accompanies this proxy statement. Such report is
not incorporated herein and is not deemed to be a part of this proxy solicitation material.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROPOSALS OF SHAREHOLDERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">Proposals by shareholders and
submissions by shareholders of director nominees that are intended for inclusion in our proxy statement and proxy card and to be presented
at our next annual meeting must be received by us by June 12, 2026 (120 days prior to the anniversary of the mailing date of this proxy
statement), in order to be considered for inclusion in our proxy materials. Such proposals should be addressed to our Secretary and must
be received at our principal executive offices and may be included in next year&#8217;s proxy materials if they comply with certain rules
and regulations of the SEC governing shareholder proposals.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">Proposals by shareholders,
as well as shareholder nominees for director, for possible consideration at our next annual meeting that are not intended for inclusion
in our proxy materials must also be received by our Secretary no later than June&#160;12, 2026 (120 days prior to the anniversary of the
mailing date of this proxy statement). Every shareholder notice must also comply with certain other requirements set forth in our Bylaws,
a copy of which may be obtained by written request delivered to our Secretary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">In addition to complying with
our Bylaws, shareholders who intend to solicit proxies in support of a director nominee other than our nominees for consideration by shareholders
at our next annual meeting must also comply with the additional requirements of the SEC&#8217;s &#8220;universal proxy card&#8221; rules
under Rule 14a-19 of the Exchange Act. Rule 14a-19 requires proponents to provide a timely notice to the Secretary (as described above),
setting forth all of the information and disclosures required by Rule 14a-19.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OTHER MATTERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">Our Board knows of no other
matters which will be acted upon at the Annual Meeting. If any other matters are presented properly for action at the Annual Meeting or
at any adjournment or postponement thereof, it is intended that the proxy will be voted with respect thereto in accordance with the best
judgment and in the discretion of the proxy holder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"><b>OUR SHAREHOLDERS ARE URGED
TO PROMPTLY SUBMIT THEIR PROXY OR VOTING INSTRUCTIONS AS SOON AS POSSIBLE BY FOLLOWING THE INSTRUCTIONS IN THE NOTICE OF INTERNET AVAILABILITY
OF PROXY MATERIALS, WHICH WAS MAILED TO YOU ON OR ABOUT OCTOBER 10, 2025. IF YOU REQUEST PRINTED COPIES OF THE PROXY MATERIALS BY MAIL,
YOU CAN ALSO VOTE BY MAIL OR BY TELEPHONE.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 311pt; text-indent: -11.5pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 50%">&#160;</td>
  <td style="width: 50%"><p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0">By Order of the Board of Directors,</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0">PRO-DEX, INC.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0">/s/ Alisha K. Charlton</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0">Corporate Secretary</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0">Irvine, California</p>
</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 311pt; text-indent: -11.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">SHAREHOLDERS MAY OBTAIN, FREE OF CHARGE, A PAPER
COPY OF OUR ANNUAL REPORT ON FORM 10-K FOR THE FISCAL YEAR ENDED JUNE 30, 2025 (WITHOUT EXHIBITS) AS FILED WITH THE SECURITIES AND EXCHANGE
COMMISSION BY WRITING TO: INVESTOR RELATIONS, PRO-DEX, INC., 2361 MCGAW AVENUE, IRVINE, CALIFORNI A 92614 OR CALLING (949)&#160;769-3200.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 28 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; margin-left: 40pt; text-indent: 0pt; text-align: right"><i>Exhibit
A</i></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PRO-DEX, INC.</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FIRST AMENDMENT TO 2016 EQUITY INCENTIVE PLAN</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This First Amendment (this &#8220;Amendment&#8221;)
to the 2016 Equity Incentive Plan (the &#8220;Plan&#8221;) is made as of October 1, 2025. Capitalized terms used herein without definition
shall have the meanings ascribed to those terms in the Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, in September 2016, the Board of Pro-Dex,
Inc. a Colorado corporation (the &#8220;Company&#8221;) established, adopted and approved the Plan, which was ratified and approved by
the shareholders of the Company at the Company&#8217;s 2016 Annual Meeting of Shareholders;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, Article 10 of the Plan permits the Board
to amend the Plan, provided that to the extent necessary it obtain the requisite affirmative approval of shareholders of the Company as
required under the Code or under any other applicable law or rule of any stock exchange which lists Common Stock or Company Voting Securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the Board desires to amend the Plan to
extend its term through September 30, 2036,</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, this Amendment shall be submitted to the
Company&#8217;s shareholders for approval, and shall become effective as of the date on which the Company&#8217;s shareholders approve
this Amendment (the &#8220;Amendment Effective Date&#8221;)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the Board has approved and authorized
this Amendment to the Plan and has recommended that the shareholders of the Company approve this Amendment;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, if the Company&#8217;s shareholders fail
to approve this Amendment, the existing Plan shall continue in full force and effect;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">NOW, THEREFORE, pursuant to Article 10 of the Plan,
the Plan is hereby amended as follows, effective as of the Amendment Effective Date:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">1.Article I section 1.2 of the Plan is hereby amended
and restated in its entirety to read as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.55in">1.2 <span style="text-decoration: underline">Adoption
and Term</span>.&#160; The Plan has been approved by the Board to be effective as of September 29, 2016, subject to the approval of shareholders
of the Company. The Plan as amended on October 1, 2025, shall remain in effect until terminated by action of the Board; provided, however,
that no Awards may be granted hereunder after September 30, 2036.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. Except as expressly
amended by this Amendment, all terms and conditions of the Plan shall remain in full force and effect.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS HEREOF, the
Company, by its duly authorized officer, has executed this Amendment to the 2016 Equity Incentive Plan, on the date as first set forth
above, to be effective as of the Amendment Effective Date.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 50%">&#160;</td>
  <td style="width: 50%"><p style="margin-top: 0; margin-bottom: 0">PRO-DEX, INC.</p>
                         <p style="margin-top: 0; margin-bottom: 0">&#160;</p>
                         <p style="margin-top: 0; margin-bottom: 0">&#160;</p></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td><p style="margin-top: 0; margin-bottom: 0"><span style="text-decoration: underline">/s/ Richard
Van Kirk	</span></p>
      <p style="margin-top: 0; margin-bottom: 0">By: Richard Van
Kirk</p>
      <p style="margin-top: 0; margin-bottom: 0">Title: Chief Executive Officer</p></td></tr>
</table>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center">A-1</p>


<!-- Field: Page; Sequence: 29; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->




<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; margin-left: 40pt; text-indent: 0pt; text-align: right"><i>Exhibit
B</i></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PRO-DEX, INC.</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2016 EQUITY INCENTIVE PLAN</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARTICLE I</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>PURPOSE AND ADOPTION OF THE PLAN</b> 	1.1&#160;&#160;&#160;<span style="text-decoration: underline">Purpose</span>.&#160;
The purpose of the Pro-Dex, Inc. 2016 Equity Incentive Plan (as amended from time to time, the "Plan") is to assist in attracting
and retaining highly competent employees, directors and consultants, to act as an incentive in motivating selected employees, directors
and consultants of the Company and its subsidiaries to achieve long-term corporate objectives and to enable stock-based incentive awards
to qualify as performance-based compensation for purposes of the tax deduction limitations under Section&#160;162(m)&#160;of the Code.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">1.2&#160;<span style="text-decoration: underline">Adoption
and Term</span>.&#160; The Plan has been approved by the Board to be effective as of September 29, 2016, subject to the approval of shareholders
of the Company. The Plan shall remain in effect until terminated by action of the Board; provided, however, that no Awards may be granted
hereunder after the tenth anniversary of its initial effective date.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARTICLE II</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DEFINITIONS</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">For the purpose of the
Plan, capitalized terms shall have the following meanings:</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.1&#160;<span style="text-decoration: underline">Award</span>
means any one or a combination of Non-Qualified Stock Options or Incentive Stock Options described in Article&#160;VI, Stock Appreciation
Rights described in Article&#160;VI, Restricted Shares and Restricted Stock Units described in Article&#160;VII, Performance Awards described
in Article&#160;VIII, other stock-based Awards described in Article&#160;IX, or any other Award made under the terms of the Plan.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.2&#160;<span style="text-decoration: underline">Award Agreement</span>
means a written agreement between the Company and a Participant or a written acknowledgment from the Company to a Participant specifically
setting forth the terms and conditions of an Award granted under the Plan.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.3&#160;<span style="text-decoration: underline">Assumed</span>
means that pursuant to a Merger either (i) the Award is expressly affirmed by the Company, (ii) the contractual obligations represented
by the Award are expressly assumed (and not simply by operation of law) by the successor entity or its parent in connection with the Merger
with appropriate adjustments to the number and type of securities of the successor entity or its parent subject to the Award and the exercise
or purchase price thereof which at least preserves the compensation element of the Award existing at the time of the Merger as determined
in accordance with the instruments evidencing the agreement to assume the Award, or (iii) the Award is otherwise to continue in effect
following the Merger.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.4&#160;<span style="text-decoration: underline">Award Period</span>
means, with respect to an Award, the period of time, if any, set forth in the Award Agreement during which specified target performance
goals must be achieved or other conditions set forth in the Award Agreement must be satisfied.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.5&#160;<span style="text-decoration: underline">Beneficiary</span>
means an individual, trust or estate who or which, by a written designation of the Participant filed with the Company, or if no such written
designation is filed, by operation of law, succeeds to the rights and obligations of the Participant under the Plan and the Award Agreement
upon the Participant's death.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.6&#160;<span style="text-decoration: underline">Board</span>
means the Board of Directors of the Company.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in"></p>

<!-- Field: Page; Sequence: 30 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.7&#160;<span style="text-decoration: underline">Change in
Control</span> means the occurrence of subparagraph (a), (b), (c), or (d) below or any combination of said event(s). Notwithstanding the
foregoing, the term "Change of Control" shall also have such additional meanings as are permitted or required under Section
409A:</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a)&#160;<span style="text-decoration: underline">Change of
Ownership of the Company</span>.&#160; A change of ownership of the Company occurs on the date that any one person or persons acting as a
Group (as that term is defined in Subparagraph (2) below) acquires ownership of the stock of the Company, that, together with stock held
by such person or Group, constitutes more than fifty percent (50%) of the total fair market value or total voting power of the stock of
the Company or of any corporation that owns at least fifty percent (50%) of the total fair market value and total voting power of Company.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.65in">(1)&#160; &#160; &#160;&#160;
However, if any person or Group is considered to own more than fifty percent (50%) of the total fair market value or total voting power
of the stock of the Company, the acquisition of additional stock by the same person or Group of persons is not considered to cause a Change
of Control. In addition, the term Change of Control shall apply if there is an increase in the percentage of stock owned by any one person
or persons, acting as a Group, as a result of a transaction in which the Company acquires its stock in exchange for property. The rule
set forth in the immediately preceding sentence applies only when there is a transfer of stock of Company (or issuance of stock of Company)
and the stock of Company remains outstanding after the transaction.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.65in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.65in">(2)&#160; &#160; &#160;&#160;
Persons will not be considered to be acting as a Group solely because they purchase or own stock of the Company at the same time, or as
a result of the same public offering. However, persons will be considered to be acting as a Group if they are shareholders of the Company
and it enters into a merger, consolidation, purchase or acquisition of stock or similar business transaction with another corporation.
If a person owns stock in Company and another corporation is involved in a business transaction, then the stockholder of Company is deemed
to be acting as a Group with other shareholders in the Company prior to the transaction</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.65in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b)&#160; <span style="text-decoration: underline">Change in
Board of Directors</span>. The date a majority of the members of the Company&#8217;s Board of Directors are replaced during any 12-month
period by directors whose appointment or election is not endorsed by a majority of the members of the Company's Board of Directors before
the date of the appointment or election.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c)&#160;<span style="text-decoration: underline">Change in
Ownership of Company's Assets</span>.&#160; A change in the ownership of a substantial portion of Company's assets occurs on the date that
any person, or more than one person acting as a Group, acquires or has acquired during the 12-month period ending on the date of the most
recent acquisition by such person or persons) assets from the Company that have a total fair market value equal to more than forty percent
(40%) of the total gross fair market value of all of the assets of the Company immediately before such acquisition or acquisitions. For
this purpose, gross fair market value means the value of the assets of the Company, or the value of the assets being disposed of, determined
without regard to any liabilities associated with such assets. Notwithstanding the foregoing, there will be no Change in Control pursuant
to this Subparagraph (c) if the assets are transferred to:</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.65in">(i)&#160; &#160; &#160;
&#160; A shareholder of Company (immediately before the asset transfer) in exchange for or with respect to its stock;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.65in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.65in">(ii)&#160; &#160; &#160;&#160;
An entity, fifty percent (50%) or more of the total value or voting power of which is owned directly or indirectly, by the Company;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.65in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.65in">(iii)&#160; &#160; &#160;
A person, or more than one person, acting as a Group, that owns, directly or indirectly, fifty percent (50%) or more of the total value
or voting power of all the outstanding stock of the Company; or</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.65in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.65in">(iv)&#160; &#160; &#160;&#160;
An entity, at least fifty percent (50%) of the total value or voting power of which is owned, directly or indirectly, by a person described
in Subparagraph (iii) immediately above.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.65in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(d)&#160;a complete liquidation
or dissolution of the Company.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in"></p>

<!-- Field: Page; Sequence: 31 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.8&#160;<span style="text-decoration: underline">Code</span>
means the Internal Revenue Code of 1986, as amended.&#160; References to a section of the Code shall include that section and any comparable
section or sections of any future legislation that amends, supplements or supersedes said section.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.9&#160;<span style="text-decoration: underline">Committee</span>
means the Compensation Committee of the Board.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.10&#160;<span style="text-decoration: underline">Company</span>
means Pro-Dex, Inc. and its successors.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.11&#160;<span style="text-decoration: underline">Common
Stock</span> means the common stock of the Company, no par value per share.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.12&#160;<span style="text-decoration: underline">Company
Voting Securities</span> means the combined voting power of all outstanding voting securities of the Company entitled to vote generally in
the election of directors to the Board.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.13&#160;<span style="text-decoration: underline">Date of
Grant</span> means the date designated by the Committee as the date as of which it grants an Award, which shall not be earlier than the date
on which the Committee approves the granting of such Award.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.14&#160;<span style="text-decoration: underline">Dividend
Equivalent Account</span> means a bookkeeping account in accordance with under Section&#160;10.17 and related to an Award that is credited
with the amount of any cash dividends or stock distributions that would be payable with respect to the shares of Common Stock subject
to such Awards had such shares been outstanding shares of Common Stock.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.15&#160;<span style="text-decoration: underline">Exchange
Act</span> means the Securities Exchange Act of 1934, as amended.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.16&#160;<span style="text-decoration: underline">Exercise
Price</span> means, with respect to a Stock Appreciation Right, the amount established by the Committee in the Award Agreement which is to
be subtracted from the Fair Market Value on the date of exercise in order to determine the amount of the payment to be made to the Participant,
as further described in Section&#160;6.2(b).</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.17&#160;<span style="text-decoration: underline">Fair Market
Value</span> means, on any date, (i)&#160;the closing sale price of a share of Common Stock, as reported on the Nasdaq Capital Market (&#8220;NASDAQ&#8221;)
(or other established stock exchange on which the Common Stock is regularly traded) on such date or, if there were no sales on such date,
on the last date preceding such date on which a sale was reported; or (ii)&#160;if shares of Common Stock are not listed for trading on
an established stock exchange, Fair Market Value shall be determined by the Committee in good faith.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.18&#160;<span style="text-decoration: underline">Incentive
Stock Option</span> means a stock option within the meaning of Section&#160;422 of the Code.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.19&#160;<span style="text-decoration: underline">Merger</span>
means any merger, reorganization, consolidation, exchange, transfer of assets or other transaction having similar effect involving the
Company.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.20&#160;<span style="text-decoration: underline">Non-Qualified
Stock Option</span> means a stock option which is not an Incentive Stock Option.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.21&#160;<span style="text-decoration: underline">Options</span>
means all Non-Qualified Stock Options and Incentive Stock Options granted at any time under the Plan.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.22&#160;<span style="text-decoration: underline">Outstanding
Common Stock</span> means, at any time, the issued and outstanding shares of Common Stock.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.23&#160;<span style="text-decoration: underline">Participant</span>
means a person designated to receive an Award under the Plan in accordance with Section&#160;5.1.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.24&#160;<span style="text-decoration: underline">Performance
Awards</span> means Awards granted in accordance with Article&#160;VIII.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in"></p>

<!-- Field: Page; Sequence: 32 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.25&#160;<span style="text-decoration: underline">Performance
Goals</span> are based on one or more of the following measures and intended to comply with the performance-based compensation exception
under Code Section&#160;162(m):</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: right"><span style="font-size: 10pt; line-height: 115%">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt; line-height: 115%">Net earnings or net income (before or after
taxes)</span></td>
</tr></table>
<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: right"><span style="font-size: 10pt; line-height: 115%">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt; line-height: 115%">Earnings per share or earnings per share
growth, total units, or unit growth</span></td>
</tr></table>


<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: right"><span style="font-size: 10pt; line-height: 115%">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt; line-height: 115%">Net sales, sales growth, total revenue,
or revenue growth</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: right"><span style="font-size: 10pt; line-height: 115%">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt; line-height: 115%">Net operating profit</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: right"><span style="font-size: 10pt; line-height: 115%">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt; line-height: 115%">Return measures (including, but not limited
to, return on assets, capital, invested capital, equity, sales, or revenue)</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: right"><span style="font-size: 10pt; line-height: 115%">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt; line-height: 115%">Cash flow (including, but not limited to,
operating cash flow, free cash flow, cash flow return on equity, and cash flow return on investment)</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: right"><span style="font-size: 10pt; line-height: 115%">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt; line-height: 115%">Earnings before or after taxes, interest,
depreciation, and/or amortization</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: right"><span style="font-size: 10pt; line-height: 115%">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt; line-height: 115%">Gross or operating margins</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: right"><span style="font-size: 10pt; line-height: 115%">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt; line-height: 115%">Productivity ratios</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: right"><span style="font-size: 10pt; line-height: 115%">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt; line-height: 115%">Share price or relative share price (including,
but not limited to, growth measures and total stockholder return)</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: right"><span style="font-size: 10pt; line-height: 115%">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt; line-height: 115%">Expense targets</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: right"><span style="font-size: 10pt; line-height: 115%">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt; line-height: 115%">Margins</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: right"><span style="font-size: 10pt; line-height: 115%">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt; line-height: 115%">Operating efficiency</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: right"><span style="font-size: 10pt; line-height: 115%">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt; line-height: 115%">Customer retention or satisfaction</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: right"><span style="font-size: 10pt; line-height: 115%">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt; line-height: 115%">Working capital targets</span></td>
</tr></table>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Without limiting the
generality of the foregoing (and to the degree consistent with Code Section&#160;162(m)), the Committee shall have the authority, at the
time it establishes the performance objectives for any given performance period, to make equitable adjustments in the business criteria
in recognition of unusual or non-recurring events affecting the Company or its operating divisions, in response to changes in applicable
laws or regulations, or to account for items of gain, loss or expense determined to be extraordinary or unusual in nature or infrequent
in occurrence or related to the disposal of a segment of a business or related to a change in generally accepted accounting principles,
or as the Committee determines to be appropriate to reflect a true measurement of the profitability of the Company or its operating divisions,
as applicable and to otherwise satisfy the objectives of the Plan.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.26&#160;<span style="text-decoration: underline">Plan</span>
has the meaning given to such term in Section&#160;1.1.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.27&#160;<span style="text-decoration: underline">Purchase
Price</span>, with respect to Options, shall have the meaning set forth in Section&#160;6.1(b).</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.28&#160;<span style="text-decoration: underline">Restricted
Shares</span> means Common Stock subject to restrictions imposed in connection with Awards granted under Article&#160;VII.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in"></p>

<!-- Field: Page; Sequence: 33 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.29&#160;<span style="text-decoration: underline">Restricted
Stock Unit</span><b><i>&#160;</i></b>means a unit representing the right to receive Common Stock or the value thereof in the future subject
to restrictions imposed in connection with Awards granted under Article&#160;VII.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.30&#160;<span style="text-decoration: underline">Rule&#160;16b-3</span>
means Rule&#160;16b-3 promulgated by the Securities and Exchange Commission under Section&#160;16 of the Exchange Act, as the same may
be amended from time to time, and any successor rule.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.31&#160;<span style="text-decoration: underline">Stock Appreciation
Rights</span> means awards granted in accordance with Article&#160;VI.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.32&#160;<span style="text-decoration: underline">Subsidiary</span>
means a subsidiary of the Company within the meaning of Section&#160;424(f) of the Code.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">2.33&#160;<span style="text-decoration: underline">Termination
of Service</span> means the voluntary or involuntary termination of a Participant's service as an employee, director or consultant with the
Company or a Subsidiary for any reason, including death, disability, retirement or as the result of the divestiture of the Participant's
employer or any similar transaction in which the Participant's employer ceases to be the Company or one of its Subsidiaries. Whether entering
military or other government service shall constitute Termination of Service, or whether and when a Termination of Service shall occur
as a result of disability, shall be determined in each case by the Committee in its sole discretion.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARTICLE III</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ADMINISTRATION</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">3.1&#160;<span style="text-decoration: underline">Committee</span>.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a)&#160;<span style="text-decoration: underline">Duties and
Authority</span>.&#160; The Plan shall be administered by the Committee and the Committee shall have exclusive and final authority in each
determination, interpretation or other action affecting the Plan and its Participants. The Committee shall have the sole discretionary
authority to interpret the Plan, to establish and modify administrative rules for the Plan, to impose such conditions and restrictions
on Awards as it determines appropriate, and to make all factual determinations with respect to and take such steps in connection with
the Plan and Awards granted hereunder as it may deem necessary or advisable. The Committee shall not, however, have or exercise any discretion
that would disqualify amounts payable under Article&#160;X as performance-based compensation for purposes of Section&#160;162(m)&#160;of
the Code. The Committee may delegate such of its powers and authority under the Plan as it deems appropriate to a subcommittee of the
Committee or designated officers or employees of the Company. In addition, the full Board may exercise any of the powers and authority
of the Committee under the Plan. In the event of such delegation of authority or exercise of authority by the Board, references in the
Plan to the Committee shall be deemed to refer, as appropriate, to the delegate of the Committee or the Board.&#160; Actions taken by
the Committee or any subcommittee thereof, and any delegation by the Committee to designated officers or employees, under this Section&#160;3.1
shall comply with Section&#160;16(b) of the Exchange Act, the performance-based provisions of Section&#160;162(m) of the Code, and the
regulations promulgated under each of such statutory provisions, or the respective successors to such statutory provisions or regulations,
as in effect from time to time, to the extent applicable.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b)&#160;<span style="text-decoration: underline">Indemnification</span>.&#160;
Each person who is or shall have been a member of the Board or the Committee, or an officer or employee of the Company to whom authority
was delegated in accordance with the Plan shall be indemnified and held harmless by the Company against and from any loss, cost, liability,
or expense that may be imposed upon or reasonably incurred by such individual in connection with or resulting from any claim, action,
suit, or proceeding to which he or she may be a party or in which he or she may be involved by reason of any action taken or failure to
act under the Plan and against and from any and all amounts paid by him or her in settlement thereof, with the Company's approval, or
paid by him or her in satisfaction of any judgment in any such action, suit, or proceeding against him or her, provided he or she shall
give the Company an opportunity, at its own expense, to handle and defend the same before he or she undertakes to handle and defend it
on his or her own behalf; provided, however, that the foregoing indemnification shall not apply to any loss, cost, liability, or expense
that is a result of his or her own willful misconduct. The foregoing right of indemnification shall not be exclusive of any other rights
of indemnification to which such persons may be entitled under the Company's Articles of Incorporation or Bylaws, conferred in a separate
agreement with the Company, as a matter of law, or otherwise, or any power that the Company may have to indemnify them or hold them harmless.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 34 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARTICLE IV</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SHARES</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;&#160;&#160;4.1&#160;<span style="text-decoration: underline">Number
of Shares Issuable</span>.&#160; The maximum aggregate number of shares of Common Stock that may be issued pursuant to Awards shall be 1,500,000
shares of Common Stock, all of which shares of Common Stock may be issued under the Plan as Incentive Stock Options. The foregoing share
limits shall be subject to adjustment in accordance with Section 10.7. The shares to be offered under the Plan shall be authorized and
unissued Common Stock, or issued Common Stock that shall have been reacquired by the Company.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">4.2&#160;<span style="text-decoration: underline">Shares Subject
to Terminated Awards</span>.&#160; Common Stock covered by any unexercised portions of terminated or forfeited Options (including canceled
Options) granted under Article&#160;VI, Common Stock forfeited as provided in Section&#160;7.2(a), Stock Units and other stock-based Awards
terminated or forfeited as provided in Article&#160;IX, and Common Stock subject to any Awards that are otherwise surrendered by the Participant
may again be subject to new Awards under the Plan.&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARTICLE V</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>PARTICIPATION</b> &#160;&#160;&#160;&#160;5.1&#160;<span style="text-decoration: underline">Eligible
Participants</span>.&#160; Participants in the Plan shall be such employees, directors and consultants of the Company and its Subsidiaries
as the Committee, in its sole discretion, may designate from time to time. The Committee's designation of a Participant in any year shall
not require the Committee to designate such person to receive Awards or grants in any other year. The designation of a Participant to
receive Awards or grants under one portion of the Plan does not require the Committee to include such Participant under other portions
of the Plan.&#160; The Committee shall consider such factors as it deems pertinent in selecting Participants and in determining the type
and amount of their respective Awards.&#160; Incentive Stock Options may only be granted to employees of the Company or its Subsidiaries.
Subject to adjustment in accordance with Section&#160;10.7, in any calendar year, no Participant shall be granted Awards in respect of
more than 100,000 shares of Common Stock (whether through grants of Options or Stock Appreciation Rights or other Awards of Common Stock
or rights with respect thereto). Furthermore, subject to adjustment in accordance with Section 10.7, in any calendar year, no more than
a total of 75,000 shares of Common Stock may be granted as Awards under the Plan to the Company's non-employee directors.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARTICLE VI</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>STOCK OPTIONS AND STOCK APPRECIATION RIGHTS</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">6.1&#160;<span style="text-decoration: underline">Option Awards</span>.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a)&#160;<span style="text-decoration: underline">Grant of
Options</span>.&#160; The Committee may grant, to such Participants as the Committee may select, Options entitling the Participant to purchase
shares of Common Stock from the Company in such number, at such price, and on such terms and subject to such conditions, not inconsistent
with the terms of the Plan, as may be established by the Committee.&#160; The terms of any Option granted under the Plan shall be set
forth in an Award Agreement.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b)&#160;<span style="text-decoration: underline">Purchase
Price of Options</span>.&#160; The &#8220;Purchase Price&#8221; of each share of Common Stock which may be purchased upon exercise of any
Option granted under the Plan shall be determined by the Committee; provided, however, that in no event shall the Purchase Price be less
than the Fair Market Value on the Date of Grant. In the case of an Incentive Stock Option granted to a Participant who, on the Date of
Grant owns stock representing more than ten percent (10%) of the voting power of all classes of stock of the Company or its Subsidiaries,
the per share exercise price shall be not less than one hundred ten percent (110%) of the Fair Market Value per share of Common Stock
on the Date of Grant.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c)&#160;<span style="text-decoration: underline">Designation
of Options</span>.&#160; The Committee shall designate, at the time of the grant of each Option, the Option as an Incentive Stock Option
or a Non-Qualified Stock Option.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in"></p>

<!-- Field: Page; Sequence: 35 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(d)&#160;<span style="text-decoration: underline">Incentive
Stock Option Share Limitation</span>.&#160; Notwithstanding an Option's designation as an Incentive Stock Option, an Option will qualify
as an Incentive Stock Option under the Code only to the extent the $100,000 limitation of Section 422(d) of the Code is not exceeded.&#160;
The $100,000 limitation of Section 422(d) of the Code is calculated based on the aggregate Fair Market Value (measured on the Date of
Grant) of the shares of Common Stock subject to Options designated as Incentive Stock Options which first become exercisable in any one
calendar year (under the Plan or any other plans of the Company and its Subsidiaries).&#160; For purposes of this calculation, Incentive
Stock Options shall be taken into account in the order in which they were granted.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(e)&#160;<span style="text-decoration: underline">Rights As
a Stockholder</span>.&#160; A Participant or a transferee of an Option pursuant to Section&#160;10.4 shall have no rights as a stockholder
with respect to Common Stock covered by an Option until the Participant or transferee shall have become the holder of record of any such
shares, and no adjustment shall be made for dividends in cash or other property or distributions or other rights with respect to any such
Common Stock for which the record date is prior to the date on which the Participant or a transferee of the Option shall have become the
holder of record of any such shares covered by the Option; provided, however, that Participants are entitled to share adjustments to reflect
capital changes under Section&#160;10.7.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">6.2&#160;<span style="text-decoration: underline">Stock Appreciation
Rights</span>.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a)&#160;<span style="text-decoration: underline">Stock Appreciation
Right Awards</span>.&#160; The Committee is authorized to grant to any Participant one or more Stock Appreciation Rights.&#160; Such Stock
Appreciation Rights may be granted either independent of or in tandem with Options granted to the same Participant.&#160; Stock Appreciation
Rights granted in tandem with Options may be granted simultaneously with, or, in the case of Non-Qualified Stock Options, subsequent to,
the grant to such Participant of the related Option; provided however, that: (i)&#160;any Option covering any share of Common Stock shall
expire and not be exercisable upon the exercise of any Stock Appreciation Right with respect to the same share, (ii)&#160;any Stock Appreciation
Right covering any share of Common Stock shall expire and not be exercisable upon the exercise of any related Option with respect to the
same share, and (iii)&#160;an Option and Stock Appreciation Right covering the same share of Common Stock may not be exercised simultaneously.
Upon exercise of a Stock Appreciation Right with respect to a share of Common Stock, the Participant shall be entitled to receive an amount
equal to the excess, if any, of (A)&#160;the Fair Market Value of a share of Common Stock on the date of exercise over (B)&#160;the Exercise
Price of such Stock Appreciation Right established in the Award Agreement, which amount shall be payable as provided in Section&#160;6.2(c).</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b)&#160;<span style="text-decoration: underline">Exercise
Price</span>.&#160; The Exercise Price established under any Stock Appreciation Right granted under the Plan shall be determined by the Committee,
but in the case of Stock Appreciation Rights granted in tandem with Options shall not be less than the Purchase Price of the related Option;
provided, however, that in no event shall the Exercise Price be less than the Fair Market Value on the Date of Grant. Upon exercise of
Stock Appreciation Rights granted in tandem with options, the number of shares subject to exercise under any related Option shall automatically
be reduced by the number of shares of Common Stock represented by the Option or portion thereof which are surrendered as a result of the
exercise of such Stock Appreciation Rights.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c)&#160;<span style="text-decoration: underline">Payment of
Incremental Value</span>.&#160; Any payment which may become due from the Company by reason of a Participant's exercise of a Stock Appreciation
Right may be paid to the Participant as determined by the Committee (i)&#160;all in cash, (ii)&#160;all in Common Stock, or (iii)&#160;in
any combination of cash and Common Stock. In the event that all or a portion of the payment is made in Common Stock, the number of shares
of Common Stock delivered in satisfaction of such payment shall be determined by dividing the amount of such payment or portion thereof
by the Fair Market Value on the Exercise Date. No fractional share of Common Stock shall be issued to make any payment in respect of Stock
Appreciation Rights; if any fractional share would be issuable, the combination of cash and Common Stock payable to the Participant shall
be adjusted as directed by the Committee to avoid the issuance of any fractional share.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">6.3&#160;<span style="text-decoration: underline">Terms of
Stock Options and Stock Appreciation Rights</span>.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a)&#160;<span style="text-decoration: underline">Conditions
on Exercise</span>.&#160; An Award Agreement with respect to Options or Stock Appreciation Rights may contain such waiting periods, exercise
dates and restrictions on exercise (including, but not limited to, periodic installments) as may be determined by the Committee at the
time of grant.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in"></p>

<!-- Field: Page; Sequence: 36 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b)&#160;<span style="text-decoration: underline">Duration
of Options and Stock Appreciation Rights</span>.&#160; Options and Stock Appreciation Rights shall terminate upon the first to occur of the
following events:</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.65in">(i)&#160;&#160; Expiration
of the Option or Stock Appreciation Right as provided in the Award Agreement;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.65in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.65in">(ii)&#160;&#160;Termination
of the Award on, or within a specified period after, a Participant's disability, retirement, death or other Termination of Service as
provided in the Award Agreement;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.65in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.65in">(iii)&#160;Ten years
from the Date of Grant;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.65in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.65in">(iv)&#160;In the case
of an Incentive Stock Option granted to a Participant&#160; who, at the time the Incentive Stock Option is granted, owns stock representing
more than ten percent (10%) of the voting power of all classes of stock of the Company or any of its Subsidiaries, five years from the
Date of Grant; or</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.65in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.65in">(v)&#160;Solely in the
case of a Stock Appreciation Right granted in tandem with an Option, upon the expiration of the related Option.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.65in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c)&#160;<span style="text-decoration: underline">Acceleration
or Extension of Exercise Time</span>.&#160; The Committee, in its sole discretion, shall have the right (but shall not be obligated), exercisable
on or at any time after the Date of Grant, to permit the exercise of an Option or Stock Appreciation Right (i)&#160;prior to the time
such Option or Stock Appreciation Right would become exercisable under the terms of the Award Agreement, (ii)&#160;after the termination
of the Option or Stock Appreciation Right under the terms of the Award Agreement, or (iii)&#160;after the expiration of the Option or
Stock Appreciation Right; provided, however, that in no event shall the period to exercise an Option or Stock Appreciation Rights be extended
beyond the ten-year anniversary of the Sate of Grant or, in the case of an Incentive Stock Option granted to a Participant who, at the
time the Incentive Stock Option is granted, owns stock representing more than ten percent (10%) of the voting power of all classes of
stock of the Company or any of its Subsidiaries, five years from the Date of Grant.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">6.4&#160;<span style="text-decoration: underline">Exercise
Procedures</span>.&#160; Each Option and Stock Appreciation Right granted under the Plan shall be exercised prior to the close of business
on the expiration date of the Option or Stock Appreciation Right by notice to the Company or by such other method as provided in the Award
Agreement or as the Committee may establish or approve from time to time. The Purchase Price of shares purchased upon exercise of an Option
granted under the Plan shall be paid in full in cash by the Participant pursuant to the Award Agreement; provided, however, that the Committee
may (but shall not be required to) permit payment to be made by delivery to the Company of either (a)&#160;Common Stock (which may include
Restricted Shares or shares otherwise issuable in connection with the exercise of the Option, subject to such rules&#160;as the Committee
deems appropriate) or (b)&#160;any combination of cash and Common Stock, or (c)&#160;such other consideration as the Committee deems appropriate
and in compliance with applicable law (including payment under an arrangement constituting a brokerage transaction as permitted under
the provisions of Regulation T applicable to cashless exercises promulgated by the Federal Reserve Board, unless prohibited by Section&#160;402
of the Sarbanes-Oxley Act of 2002). In the event that any Common Stock shall be transferred to the Company to satisfy all or any part
of the Purchase Price, the part of the Purchase Price deemed to have been satisfied by such transfer of Common Stock shall be equal to
the product derived by multiplying the Fair Market Value as of the date of exercise times the number of shares of Common Stock transferred
to the Company. The Participant may not transfer to the Company in satisfaction of the Purchase Price any fractional share of Common Stock.
Any part of the Purchase Price paid in cash upon the exercise of any Option shall be added to the general funds of the Company and may
be used for any proper corporate purpose. Unless the Committee shall otherwise determine, any Common Stock transferred to the Company
as payment of all or part of the Purchase Price upon the exercise of any Option may again be used for awards under the Plan.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in"></p>

<!-- Field: Page; Sequence: 37 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">6.5&#160;<span style="text-decoration: underline">Assumption
of Grants Upon a&#160;Change in Control</span>. Upon a Change in Control where the Company is not the surviving corporation (or survives
only as a subsidiary of another corporation), unless the Board determines otherwise, all outstanding Options and Stock Appreciation Rights
that are not exercised shall be Assumed by, or replaced with comparable options by the surviving corporation (or a parent or subsidiary
of the surviving corporation), and outstanding Stock Awards shall be converted to Stock Awards of the surviving corporation (or a parent
or subsidiary of the surviving corporation); provided, that, this sentence shall not be applicable to any Options or Stock Appreciation
Rights granted to a Participant if any Change in Control results from such Participant's beneficial ownership (within the meaning of Rule&#160;13d-3
under the Exchange Act) of Common Stock or Company Voting Securities. Notwithstanding the foregoing, in the event of a Change of Control,
the Board, in its discretion, may take any of the following actions with respect to any or all outstanding Grants: the Board may (i) determine
that outstanding Options and/or Stock Appreciation Rights shall accelerate and become exercisable, in whole or in part, upon the Change
of Control or upon such other event as the Board determines, (ii) determine that the restrictions and conditions on outstanding Stock
Awards shall lapse, in whole or in part, upon the Change of Control or upon such other event as the Board determines, (iii) require that
Grantees surrender their outstanding Options and/or Stock Appreciation Rights in exchange for a payment by the Company, in cash or stock
as determined by the Board, in an amount equal to the amount by which the then Fair Market Value of the shares of Company Stock subject
to the Grantee's unexercised Options and/or Stock Appreciation Rights exceeds the Exercise Price of the Options or (iv) after giving Grantees
an opportunity to exercise their outstanding Options and/or Stock Appreciation Rights, terminate any or all unexercised Options and/or
Stock Appreciation Rights at such time as the Board deems appropriate.&#160; Such surrender or termination shall take place as of the
date of the Change of Control or such other date as the Board may specify. The Board shall have no obligation to take any of the foregoing
actions, and, in the absence of any such actions, outstanding Options, Stock Appreciation Rights and Stock Awards shall continue in effect
according to their terms (subject to any assumption discussed above).</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARTICLE VII</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>RESTRICTED SHARES AND RESTRICTED STOCK
UNITS</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">7.1&#160;<span style="text-decoration: underline">Award of
Restricted Stock and Restricted Stock Units</span>. The Committee may grant to any Participant an Award of Restricted Shares consisting of
a specified number of shares of Common Stock issued to the Participant subject to such terms, conditions and forfeiture and transfer restrictions,
whether based on performance standards, periods of service, retention by the Participant of ownership of specified shares of Common Stock
or other criteria, as the Committee shall establish. The Committee may also grant Restricted Stock Units representing the right to receive
shares of Common Stock in the future subject to such terms, conditions and restrictions, whether based on performance standards, periods
of service, retention by the Participant of ownership of specified shares of Common Stock or other criteria, as the Committee shall establish.
With respect to performance-based Awards of Restricted Shares or Restricted Stock Units intended to qualify as "performance-based"
compensation for purposes of Section&#160;162(m) of the Code, performance targets will consist of specified levels of one or more of the
Performance Goals. The terms of any Restricted Share and Restricted Stock Unit Awards granted under the Plan shall be set forth in an
Award Agreement which shall contain provisions determined by the Committee and not inconsistent with the Plan.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">7.2&#160;<span style="text-decoration: underline">Restricted
Shares</span>.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a)&#160;<span style="text-decoration: underline">Issuance
of Restricted Shares</span>.&#160; As soon as practicable after the Date of Grant of a Restricted Share Award by the Committee, the Company
shall cause to be transferred on the books of the Company, or its agent, Common Stock, registered on behalf of the Participant, evidencing
the Restricted Shares covered by the Award, but subject to forfeiture to the Company as of the Date of Grant if an Award Agreement with
respect to the Restricted Shares covered by the Award is not duly executed by the Participant and timely returned to the Company. All
Common Stock covered by Awards under this Article&#160;VII shall be subject to the restrictions, terms and conditions contained in the
Plan and the Award Agreement entered into by the Participant. Until the lapse or release of all restrictions applicable to an Award of
Restricted Shares, the share certificates representing such Restricted Shares may be held in custody by the Company, its designee, or,
if the certificates bear a restrictive legend, by the Participant. Upon the lapse or release of all restrictions with respect to an Award
as described in Section&#160;7.2(d), one or more share certificates, registered in the name of the Participant, for an appropriate number
of shares as provided in Section&#160;7.2(d), free of any restrictions set forth in the Plan and the Award Agreement shall be delivered
to the Participant.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b)&#160;<span style="text-decoration: underline">Stockholder
Rights</span>.&#160; Beginning on the Date of Grant of the Restricted Share Award and subject to execution of the Award Agreement as provided
in Section&#160;7.2(a), the Participant shall become a stockholder of the Company with respect to all shares subject to the Award Agreement
and shall have all of the rights of a stockholder, including, but not limited to, the right to vote such shares and the right to receive
dividends; provided, however, that any Common Stock distributed as a dividend or otherwise with respect to any Restricted Shares as to
which the restrictions have not yet lapsed, shall be subject to the same restrictions as such Restricted Shares and held or restricted
as provided in Section&#160;7.2(a).</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in"></p>

<!-- Field: Page; Sequence: 38 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c)&#160;<span style="text-decoration: underline">Restriction
on Transferability</span>.&#160; None of the Restricted Shares may be assigned or transferred (other than by will or the laws of descent
and distribution, or to an inter vivos trust with respect to which the Participant is treated as the owner under Sections&#160;671 through
677 of the Code, except to the extent that Section&#160;16 of the Exchange Act limits a Participant's right to make such transfers), pledged
or sold prior to lapse of the restrictions applicable thereto.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(d)&#160;<span style="text-decoration: underline">Delivery
of Shares upon Vesting</span>.&#160; Upon expiration or earlier termination of the forfeiture period without a forfeiture and the satisfaction
of or release from any other conditions prescribed by the Committee, or at such earlier time as provided under the provisions of Section&#160;7.4,
the restrictions applicable to the Restricted Shares shall lapse.&#160; As promptly as administratively feasible thereafter, subject to
the requirements of Section&#160;10.5, the Company shall deliver to the Participant or, in case of the Participant's death, to the Participant's
Beneficiary, one or more share certificates for the appropriate number of shares of Common Stock, free of all such restrictions, except
for any restrictions that may be imposed by law.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(e)&#160;<span style="text-decoration: underline">Forfeiture
of Restricted Shares</span>.&#160; Subject to Sections&#160;7.2(f) and 7.4, all Restricted Shares shall be forfeited and returned to the
Company and all rights of the Participant with respect to such Restricted Shares shall terminate unless the Participant continues in the
service of the Company or a Subsidiary as an employee until the expiration of the forfeiture period for such Restricted Shares and satisfies
any and all other conditions set forth in the Award Agreement. The Committee shall determine the forfeiture period (which may, but need
not, lapse in installments) and any other terms and conditions applicable with respect to any Restricted Share Award.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(f)&#160;<span style="text-decoration: underline">Waiver of
Forfeiture Period</span>.&#160; Notwithstanding anything contained in this Article&#160;VII to the contrary, the Committee may, in its sole
discretion, waive the forfeiture period and any other conditions set forth in any Award Agreement under appropriate circumstances (including
the death, disability or retirement of the Participant or a material change in circumstances arising after the date of an Award) and subject
to such terms and conditions (including forfeiture of a proportionate number of the Restricted Shares) as the Committee shall deem appropriate.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">7.3&#160;<span style="text-decoration: underline">Restricted
Stock Units</span>.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a)&#160;<span style="text-decoration: underline">Settlement
of Restricted Stock Units</span>.&#160; Payments shall be made to Participants with respect to their Restricted Stock Units as soon as practicable
after the Committee has determined that the terms and conditions applicable to such Award have been satisfied or at a later date if distribution
has been deferred. Payments to Participants with respect to Restricted Stock Units shall be made in the form of Common Stock, or cash
or a combination of both, as the Committee may determine. The amount of any cash to be paid in lieu of Common Stock shall be determined
on the basis of the Fair Market Value of the Common Stock on the date any such payment is processed. As to shares of Common Stock which
constitute all or any part of such payment, the Committee may impose such restrictions concerning their transferability and/or their forfeiture
as may be provided in the applicable Award Agreement or as the Committee may otherwise determine, provided such determination is made
on or before the date certificates for such shares are first delivered to the applicable Participant.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b)&#160;<span style="text-decoration: underline">Shareholder
Rights</span>.&#160; Until the lapse or release of all restrictions applicable to an Award of Restricted Stock Units, no shares of Common
Stock shall be issued in respect of such Awards and no Participant shall have any rights as a stockholder of the Company with respect
to the shares of Common Stock covered by such Award of Restricted Stock Units.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c)&#160;<span style="text-decoration: underline">Waiver of
Forfeiture Period</span>.&#160; Notwithstanding anything contained in this Section&#160;7.3 to the contrary, the Committee may, in its sole
discretion, waive the forfeiture period and any other conditions set forth in any Award Agreement under appropriate circumstances (including
the death, disability or retirement of the Participant or a material change in circumstances arising after the date of an Award) and subject
to such terms and conditions (including forfeiture of a proportionate number of shares issuable upon settlement of the Restricted Stock
Units constituting an Award) as the Committee shall deem appropriate.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(d)&#160;<span style="text-decoration: underline">Deferral
of Payment</span>.&#160; If approved by the Committee and set forth in the applicable Award Agreement, a Participant may elect to defer the
amount payable with respect to the Participant's Restricted Stock Units in accordance with such terms as may be established by the Committee.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in"></p>

<!-- Field: Page; Sequence: 39 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">7.4&#160;<span style="text-decoration: underline">Change in
Control</span>.&#160; Unless otherwise provided by the Committee in the applicable Award Agreement, in the event of a Change in Control,
all restrictions applicable to Restricted Shares and Restricted Stock Unit Awards shall terminate fully and the Participant shall immediately
have the right to the delivery in accordance with Section&#160;7.2(d) of a share certificate or certificates evidencing a number of shares
of Common Stock equal to the full number of shares subject to each such Award (in the case of Restricted Stock) or payment in accordance
with Section&#160;7.3(a) of a number of shares of Common Stock determined by the Committee, in its discretion, but, in the case of a performance-based
or other contingent Award, in no event less than the number of shares payable at the "target" level for each such Award (in
the case of Restricted Stock Units). The provisions of this Section&#160;7.4 shall not be applicable to any Restricted Share or Restricted
Stock Unit Award granted to a Participant if any Change in Control results from such Participant's beneficial ownership (within the meaning
of Rule&#160;13d-3 under the Exchange Act) of Common Stock or Company Voting Securities.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARTICLE VIII</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PERFORMANCE AWARDS</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">8.1&#160;<span style="text-decoration: underline">Performance
Awards</span>.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a)&#160;<span style="text-decoration: underline">Award Periods
and Calculations of Potential Incentive Amounts</span>.&#160; The Committee may grant Performance Awards to Participants.&#160; A Performance
Award shall consist of the right to receive a payment (measured by the Fair Market Value of a specified number of shares of Common Stock,
increases in such Fair Market Value during the Award Period and/or a fixed cash amount) contingent upon the extent to which certain predetermined
performance targets have been met during an Award Period. The Committee, in its discretion and under such terms as it deems appropriate,
may permit newly eligible Participants, such as those who are promoted or newly hired, to receive Performance Awards after an Award Period
has commenced.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b)&#160;<span style="text-decoration: underline">Performance
Targets</span>.&#160; Subject to Section&#160;10.18, the performance targets applicable to a Performance Award may include such goals related
to the performance of the Company or, where relevant, any one or more of its Subsidiaries or divisions and/or the performance of a Participant
in each case as may be established by the Committee in its discretion. In the case of Performance Awards to "covered employees"
(as defined in Section&#160;162(m) of the Code), the targets will be limited to specified levels of one or more of the Performance Goals.
The performance targets established by the Committee may vary for different Award Periods and need not be the same for each Participant
receiving a Performance Award in an Award Period.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c)&#160;<span style="text-decoration: underline">Earning Performance
Awards</span>.&#160; A Participant's Performance Award shall be determined based on the attainment of written Performance Goals approved
by the Committee for a performance period established by the Committee (i)&#160;while the outcome for that performance period is substantially
uncertain and (ii)&#160;no more than 90&#160;days after the commencement of the performance period to which the performance goal relates
or, if less, the number of days which is equal to 25&#160;percent of the relevant performance period.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(d)&#160;<span style="text-decoration: underline">Payment of
Earned Performance Awards</span>.&#160; Subject to the requirements of Section&#160;10.5, payments of earned Performance Awards shall be
made in cash or Common Stock, or a combination of cash and Common Stock, in the discretion of the Committee. The Committee, in its sole
discretion, may define, and set forth in the applicable Award Agreement, such terms and conditions with respect to the payment of earned
Performance Awards as it may deem desirable. The Committee shall determine whether, with respect to a performance period, the applicable
Performance Goals have been met with respect to a given Participant and, if they have, shall so certify and ascertain the amount of the
applicable Performance Award. No Performance Awards will be paid for such performance period until such certification is made by the Committee.
The amount of the Performance Award determined by the Committee for a performance period shall be paid to the Participant at such time
as determined by the Committee in its sole discretion after the end of such performance period; provided, however, that a Participant
may, if and to the extent permitted by the Committee and consistent with the provisions of Section&#160;409A of the Code, elect to defer
payment of a Performance Award.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in"></p>

<!-- Field: Page; Sequence: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">8.2&#160;<span style="text-decoration: underline">Termination
of Service</span>.&#160; In the event of a Participant's Termination of Service during an Award Period, the Participant's Performance Awards
shall be forfeited except as may otherwise be provided in the applicable Award Agreement.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">8.3&#160;<span style="text-decoration: underline">Change in
Control</span>.&#160; Unless otherwise provided by the Committee in the applicable Award Agreement, in the event of a Change in Control,
all Performance Awards for all Award Periods shall immediately become fully vested and payable to all Participants and shall be paid to
Participants in accordance with Section&#160;8.1(d), within 30 days after such Change in Control. The provisions of this Section&#160;8.3
shall not be applicable to any Performance Award granted to a Participant if any Change in Control results from such Participant's beneficial
ownership (within the meaning of Rule&#160;13d-3 under the Exchange Act) of Common Stock or Company Voting Securities.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARTICLE IX</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OTHER STOCK-BASED AWARDS</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">9.1&#160;<span style="text-decoration: underline">Grant of
Other Stock-Based Awards</span>.&#160; Other stock-based awards, consisting of stock purchase rights (with or without loans to Participants
by the Company containing such terms as the Committee shall determine), Awards of Common Stock, or Awards valued in whole or in part by
reference to, or otherwise based on, Common Stock or dividends on Common Stock, may be granted either alone or in addition to or in conjunction
with other Awards under the Plan. Subject to the provisions of the Plan, the Committee shall have sole and complete authority to determine
the persons to whom and the time or times at which such Awards shall be made, the number of shares of Common Stock to be granted pursuant
to such Awards, and all other conditions of the Awards. Any such Award shall be confirmed by an Award Agreement executed by the Committee
and the Participant, which Award Agreement shall contain such provisions as the Committee determines to be necessary or appropriate to
carry out the intent of the Plan with respect to such Award.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">9.2&#160;<span style="text-decoration: underline">Terms of
Other Stock-Based Awards</span>.&#160; In addition to the terms and conditions specified in the Award Agreement, Awards made pursuant to
this Article&#160;IX shall be subject to the following:</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a)&#160;Any Common Stock
subject to Awards made under this Article&#160;IX may not be sold, assigned, transferred, pledged or otherwise encumbered prior to the
date on which the shares are issued, or, if later, the date on which any applicable restriction, performance or deferral period lapses;
and</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b)&#160;If specified
by the Committee in the Award Agreement, the recipient of an Award under this Article&#160;IX shall be entitled to receive, currently
or on a deferred basis, interest or dividends or dividend equivalents with respect to the Common Stock or other securities covered by
the Award; and</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c)&#160;The Award Agreement
with respect to any Award shall contain provisions dealing with the disposition of such Award in the event of a Termination of Service
prior to the exercise, payment or other settlement of such Award, whether such termination occurs because of retirement, disability, death
or other reason, with such provisions to take account of the specific nature and purpose of the Award.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARTICLE X</b></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TERMS APPLICABLE GENERALLY TO AWARDS GRANTED
UNDER THE PLAN</b> &#160;&#160;&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;10.1&#160;<span style="text-decoration: underline">Plan
Provisions Control Award Terms</span>.&#160; Except as provided in Section&#160;10.16, the terms of the Plan shall govern all Awards granted
under the Plan, and in no event shall the Committee have the power to grant any Award under the Plan which is contrary to any of the provisions
of the Plan, except to the extent such authority is expressly granted to the Committee pursuant to another provision of the Plan. In the
event any provision of any Award granted under the Plan shall conflict with any term in the Plan as constituted on the Date of Grant of
such Award, the term in the Plan as constituted on the Date of Grant of such Award shall control. Except as provided in Section&#160;10.3
and Section&#160;10.7, the terms of any Award granted under the Plan may not be changed after the Date of Grant of such Award so as to
materially decrease the value of the Award without the express written approval of the holder.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in"></p>

<!-- Field: Page; Sequence: 41 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">10.2&#160;<span style="text-decoration: underline">Award Agreement</span>.&#160;
No person shall have any rights under any Award granted under the Plan unless and until the Company and the Participant to whom such Award
shall have been granted shall have executed and delivered an Award Agreement or received any other written Award acknowledgment authorized
by the Committee and signed by an authorized representative of the Company expressly granting the Award to such person and containing
provisions setting forth the terms of the Award.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">10.3&#160;<span style="text-decoration: underline">Modification
of Award After Grant</span>.&#160; No Award granted under the Plan to a Participant may be modified (unless such modification does not materially
decrease the value of the Award) after the Date of Grant except by express written agreement between the Company and the Participant,
provided that any such change (a)&#160;shall not be inconsistent with the terms of the Plan, and (b)&#160;shall be approved by the Committee.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">10.4&#160;<span style="text-decoration: underline">Limitation
on Transfer</span>.&#160; Except as provided in Section&#160;7.1(c) in the case of Restricted Shares, a Participant's rights and interest
under the Plan may not be assigned or transferred other than by will or the laws of descent and distribution, and during the lifetime
of a Participant, only the Participant personally (or the Participant's personal representative) may exercise rights under the Plan. The
Participant's Beneficiary may exercise the Participant's rights to the extent they are exercisable under the Plan following the death
of the Participant.&#160; Notwithstanding the foregoing, to the extent permitted under Section&#160;16(b) of the Exchange Act with respect
to Participants subject to such Section, the Committee may grant Non-Qualified Stock Options that are transferable, without payment of
consideration, to immediate family members of the Participant or to trusts or partnerships for such family members, and the Committee
may also amend outstanding Non-Qualified Stock Options to provide for such transferability.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">10.5&#160;<span style="text-decoration: underline">Taxes</span>.&#160;
The Company shall be entitled, if the Committee deems it necessary or desirable, to withhold (or secure payment from the Participant in
lieu of withholding) the amount of any withholding or other tax required by law to be withheld or paid by the Company with respect to
any amount payable and/or shares issuable under such Participant's Award, or with respect to any income recognized upon a disqualifying
disposition of shares received pursuant to the exercise of an Incentive Stock Option, and the Company may defer payment or issuance of
the cash or shares upon exercise or vesting of an Award unless indemnified to its satisfaction against any liability for any such tax.
The amount of such withholding or tax payment shall be determined by the Committee and shall be payable by the Participant at such time
as the Committee determines in accordance with the following rules:</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a)&#160;The Participant
shall have the right to elect to meet his or her withholding requirement (i)&#160;by having withheld from such Award at the appropriate
time that number of shares of Common Stock, rounded up to the next whole share, whose Fair Market Value is equal to the amount of withholding
taxes due, (ii)&#160;by direct payment to the Company in cash of the amount of any taxes required to be withheld with respect to such
Award or (iii)&#160;by a combination of shares and cash.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b)&#160;In the case
of Participants who are subject to Section&#160;16 of the Exchange Act, the Committee may impose such limitations and restrictions as
it deems necessary or appropriate with respect to the delivery or withholding of shares of Common Stock to meet tax withholding obligations.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">10.6&#160;<span style="text-decoration: underline">Surrender
of Awards</span>.&#160; Any Award granted under the Plan may be surrendered to the Company for cancellation on such terms as the Committee
and the holder approve.&#160; With the consent of the Participant, the Committee may substitute a new Award under the Plan in connection
with the surrender by the Participant of an equity compensation award previously granted under the Plan or any other plan sponsored by
the Company; provided, however, that no such substitution shall be permitted without the approval of the Company's shareholders if such
approval is required by the rules of any applicable stock exchange.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in"></p>

<!-- Field: Page; Sequence: 42 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">10.7&#160;<span style="text-decoration: underline">Adjustments
to Reflect Capital Changes</span>.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a)&#160;<span style="text-decoration: underline">Recapitalization</span>.&#160;
In the event of any corporate event or transaction (including, but not limited to, a change in the Common Stock or the capitalization
of the Company) such as a merger, consolidation, reorganization, recapitalization, separation, partial or complete liquidation, stock
dividend, stock split, reverse stock split, split up, spin-off, or other distribution of stock or property of the Company, a combination
or exchange of Common Stock, dividend in kind, or other like change in capital structure, number of outstanding shares of Common Stock,
distribution (other than normal cash dividends) to shareholders of the Company, or any similar corporate event or transaction, the Committee,
in order to prevent dilution or enlargement of Participants' rights under the Plan, shall make equitable and appropriate adjustments and
substitutions, as applicable, to or of the number and kind of shares subject to outstanding Awards, the Purchase Price or Exercise Price
for such shares, the number and kind of shares available for future issuance under the Plan and the maximum number of shares in respect
of which Awards can be made to any Participant in any calendar year, and other determinations applicable to outstanding Awards. The Committee
shall have the power and sole discretion to determine the amount of the adjustment to be made in each case.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b)&#160;<span style="text-decoration: underline">Merger</span>.&#160;
Effective upon the consummation of a Merger, all outstanding Awards under the Plan shall terminate. However, all such Awards shall not
terminate to the extent they are assumed in connection with the Merger. The Committee shall have the authority, exercisable either in
advance of any actual or anticipated Merger or at the time of an actual Merger and exercisable at the Date of Grant of an Award under
the Plan or any time while an Award remains outstanding, to provide for the full or partial automatic vesting and exercisability of one
or more outstanding unvested Awards under the Plan and the release from restrictions on transfer and repurchase or forfeiture rights of
such Awards in connection with a Merger, on such terms and conditions as the Committee may specify. The Committee also shall have the
authority to condition any such Award vesting and exercisability or release from such limitations upon the subsequent Termination of Service
of the Participant within a specified period following the effective date of the Merger. The Committee may provide that any Awards so
vested or released from such limitations in connection with a Merger shall remain fully exercisable until the expiration or sooner termination
of the Award. Any Incentive Stock Option accelerated under this Section 11.7(b) in connection with a Merger shall remain exercisable as
an Incentive Stock Option under the Code only to the extent the $100,000 dollar limitation of Section 422(d) is not exceeded.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(c)&#160;<span style="text-decoration: underline">Options to
Purchase Shares or Stock of Acquired Companies</span>.&#160; After any Merger in which the Company or a Subsidiary shall be a surviving corporation,
the Committee may grant substituted options under the provisions of the Plan, pursuant to Section 424 of the Code, replacing old options
granted under a plan of another party to the Merger whose shares or stock subject to the old options may no longer be issued following
the Merger. The foregoing adjustments and manner of application of the foregoing provisions shall be determined by the Committee in its
sole discretion.&#160; Any such adjustments may provide for the elimination of any fractional shares which might otherwise become subject
to any Options.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">10.8&#160;<span style="text-decoration: underline">No Right
to Continued Service</span>.&#160; No person shall have any claim of right to be granted an Award under the Plan.&#160; Neither the Plan
nor any action taken hereunder shall be construed as giving any Participant any right to be retained in the service of the Company or
any of its Subsidiaries.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">10.9&#160;<span style="text-decoration: underline">Awards
Not Includable for Benefit Purposes</span>.&#160; Payments received by a Participant pursuant to the provisions of the Plan shall not be
included in the determination of benefits under any pension, group insurance or other benefit plan applicable to the Participant which
is maintained by the Company or any of its Subsidiaries, except as may be provided under the terms of such plans or determined by the
Board.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">10.10&#160;<span style="text-decoration: underline">Governing
Law</span>.&#160; All determinations made and actions taken pursuant to the Plan shall be governed by the laws of the State of Colorado and
construed in accordance therewith.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">10.11&#160;<span style="text-decoration: underline">No Strict
Construction</span>.&#160; No rule of strict construction shall be implied against the Company, the Committee, or any other person in the
interpretation of any of the terms of the Plan, any Award granted under the Plan or any rule&#160;or procedure established by the Committee.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in"></p>

<!-- Field: Page; Sequence: 43 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">10.12&#160;<span style="text-decoration: underline">Compliance
with Rule&#160;16b-3</span>.&#160; It is intended that, unless the Committee determines otherwise, Awards under the Plan be eligible for
exemption under Rule&#160;16b-3. The Board is authorized to amend the Plan and to make any such modifications to Award Agreements to comply
with Rule&#160;16b-3, as it may be amended from time to time, and to make any other such amendments or modifications as it deems necessary
or appropriate to better accomplish the purposes of the Plan in light of any amendments made to Rule&#160;16b-3.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">10.13&#160;<span style="text-decoration: underline">Captions</span>.&#160;
The captions (i.e., all Section headings) used in the Plan are for convenience only, do not constitute a part of the Plan, and shall not
be deemed to limit, characterize or affect in any way any provisions of the Plan, and all provisions of the Plan shall be construed as
if no captions have been used in the Plan.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">10.14&#160;<span style="text-decoration: underline">Severability</span>.&#160;
Whenever possible, each provision in the Plan and every Award at any time granted under the Plan shall be interpreted in such manner as
to be effective and valid under applicable law, but if any provision of the Plan or any Award at any time granted under the Plan shall
be held to be prohibited by or invalid under applicable law, then (a)&#160;such provision shall be deemed amended to accomplish the objectives
of the provision as originally written to the fullest extent permitted by law and (b)&#160;all other provisions of the Plan and every
other Award at any time granted under the Plan shall remain in full force and effect.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">10.15&#160;<span style="text-decoration: underline">Amendment
and Termination</span>.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a)&#160;<span style="text-decoration: underline">Amendment</span>.&#160;
The Board shall have complete power and authority to amend the Plan at any time; provided, however, that the Board shall not, without
the requisite affirmative approval of shareholders of the Company, make any amendment which requires shareholder approval under the Code
or under any other applicable law or rule of any stock exchange which lists Common Stock or Company Voting Securities. No termination
or amendment of the Plan may, without the consent of the Participant to whom any Award shall theretofore have been granted under the Plan,
adversely affect the right of such individual under such Award.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b)&#160;<span style="text-decoration: underline">Termination</span>.&#160;
The Board shall have the right and the power to terminate the Plan at any time.&#160; No Award shall be granted under the Plan after the
termination of the Plan, but the termination of the Plan shall not have any other effect and any Award outstanding at the time of the
termination of the Plan may be exercised after termination of the Plan at any time prior to the expiration date of such Award to the same
extent such Award would have been exercisable had the Plan not terminated.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">10.16&#160;<span style="text-decoration: underline">Foreign
Qualified Awards</span>.&#160; Awards under the Plan may be granted to such employees of the Company and its Subsidiaries who are residing
in foreign jurisdictions as the Committee in its sole discretion may determine from time to time. The Committee may adopt such supplements
to the Plan as may be necessary or appropriate to comply with the applicable laws of such foreign jurisdictions and to afford Participants
favorable treatment under such laws; provided, however, that no Award shall be granted under any such supplement with terms or conditions
inconsistent with the provision set forth in the Plan.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">10.17&#160;<span style="text-decoration: underline">Dividend
Equivalents</span>.&#160; For any Award granted under the Plan, the Committee shall have the discretion, upon the Date of Grant or thereafter,
to establish a Dividend Equivalent Account with respect to the Award, and the applicable Award Agreement or an amendment thereto shall
confirm such establishment. If a Dividend Equivalent Account is established, the following terms shall apply:</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(a)&#160;<span style="text-decoration: underline">Terms and
Conditions</span>.&#160; Dividend Equivalent Accounts shall be subject to such terms and conditions as the Committee shall determine and
as shall be set forth in the applicable Award Agreement. Such terms and conditions may include, without limitation, for the Participant's
Account to be credited as of the record date of each cash dividend on the Common Stock with an amount equal to the cash dividends which
would be paid with respect to the number of shares of Common Stock then covered by the related Award if such shares of Common Stock had
been owned of record by the Participant on such record date.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">(b)&#160;<span style="text-decoration: underline">Unfunded
Obligation</span>.&#160; Dividend Equivalent Accounts shall be established and maintained only on the books and records of the Company and
no assets or funds of the Company shall be set aside, placed in trust, removed from the claims of the Company's general creditors, or
otherwise made available until such amounts are actually payable as provided hereunder.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.1in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in"></p>

<!-- Field: Page; Sequence: 44 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">10.18&#160;<span style="text-decoration: underline">Adjustment
of Performance Goals and Targets.</span>&#160; Notwithstanding any provision of the Plan to the contrary, the Committee shall have the authority
to adjust any Performance Goal, performance target or other performance-based criteria established with respect to any Award under the
Plan if circumstances occur (including, but not limited to, unusual or nonrecurring events, changes in tax laws or accounting principles
or practices or changed business or economic conditions) that cause any such Performance Goal, performance target or performance-based
criteria to be inappropriate in the judgment of the Committee; provided, that with respect to any Award that is intended to qualify for
the "performance-based compensation" exception under Section&#160;162(m) of the Code and the regulations thereunder, any adjustment
by the Committee shall be consistent with the requirements of Section&#160;162(m) and the regulations thereunder.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">10.19&#160;<span style="text-decoration: underline">Legality
of Issuance.</span>&#160; Notwithstanding any provision of the Plan or any applicable Award Agreement to the contrary, the Committee shall
have the sole discretion to impose such conditions, restrictions and limitations (including suspending exercises of Options or Stock Appreciation
Rights and the tolling of any applicable exercise period during such suspension) on the issuance of Common Stock with respect to any Award
unless and until the Committee determines that such issuance complies with (i)&#160;any applicable registration requirements under the
Securities Act of 1933 or the Committee has determined that an exemption there from is available, (ii)&#160;any applicable listing requirement
of any stock exchange on which the Common Stock is listed, and (iii)&#160;any other applicable provision of state, federal or foreign
law, including foreign securities laws where applicable.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">10.20&#160;<span style="text-decoration: underline">Restrictions
on Transfer.</span>&#160; Regardless of whether the offering and sale of Common Stock under the Plan have been registered under the Securities
Act of 1933 or have been registered or qualified under the securities laws of any state, the Company may impose restrictions upon the
sale, pledge, or other transfer of such Common Stock (including the placement of appropriate legends on stock certificates) if, in the
judgment of the Company and its counsel, such restrictions are necessary or desirable to achieve compliance with the provisions of the
Securities Act of 1933, the securities laws of any state, the United States or any other applicable foreign law.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">10.21&#160;<span style="text-decoration: underline">Further
Assurances.</span>&#160; As a condition to receipt of any Award under the Plan, a Participant shall agree, upon demand of the Company, to
do all acts and execute, deliver and perform all additional documents, instruments and agreements which may be reasonably required by
the Company, to implement the provisions and purposes of the Plan.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">10.22&#160;<span style="text-decoration: underline">Clawback/Repayment</span>.
All Awards shall be subject to reduction, cancellation, forfeiture or recoupment to the extent necessary to comply with (i) any clawback,
forfeiture or other similar policy adopted by the Board or Committee and as in effect from time to time; and (ii) applicable law. Further,
to the extent that the Participant receives any amount in excess of the amount that the Participant should otherwise have received under
the terms of the Award for any reason (including, without limitation, by reason of a financial restatement, mistake in calculations or
other administrative error), the Participant shall be required to repay any such excess amount to the Company.</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">&#160;</p>

<p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<!-- Field: Page; Sequence: 45 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font-size: 9pt; width: 100%"><tr><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0"><img src="image_002.jpg" alt="" style="height: 1005px; width: 777px"/></p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 46 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->



<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0"></p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0"><img src="image_003.jpg" alt="" style="height: 1005px; width: 777px"/></p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- 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 -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !" 1 # 2(  A$! Q$!_\0
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M[?\ 12=9_P"_@_PKZ#_8/^/'QN^/7[2_A;P]J7CS6;[087>\U.,N-I@12<'
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MCA^@'-?O/X"\)VG@7P5H?AZQB6&TTRSBM8XUZ *H'\\T ?SC_M,? J]_9O\
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MW*&/'I72?!WQIH/P[TO6=,\2RR:5XGDU>\ENEGMY'EG5IG,+AE4[E\LKC!X
MQ0!Z%XJ^,&@^";KPC9ZQ]HM;_P 3WBV-E:>7F17*DEI/[JKQENV16_IOBW3]
M5\2ZOH5NTC7VE+$UUE,(OF+N09[DCFOG+XD^%/%?Q?;QAXJT-X;:SLXEL=)%
M[ 6FQ$ZR2SVY(RGF [?4[*ZOX6_$_P .R>._%NKWUZVGW7B*6P-O:302!L+
M(U_AZDT >H>/OB-I_@"*P6XM;W4M0U"4PV>G:="9IYB!EB%'\*C!)[9K)U[X
MTZ7H:Z/;C2M8O=;U2 W,.BVUFS7<48QEY4_Y9@$@9/<UF?';_A'6L=.EU#7I
MO#/B"R=KG2=4MX7DDCDP RX4$,CC 9#U%<9X!\=6_A?XA^)]?\=PR:!J6MZ=
MILMOYL,CH46)Q)&A4'!#;25]2/2@#T[P_P#&3P_XBM-/DA-U;7-Y=M8?8;J
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,@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %1 D$# 2(  A$! Q$!_\0
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M(8Q&@QT^4>W^ _(4^B@!@AB&,1H,=/E'M_@/R% AB&,1H,=/E'M_@/R%/HH
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M"G8B]R21ECG'8< >V #,\/:B]QXCLH=*U>\U" VQDU&.Z=F6(D#85+*#DG/
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MQ_/V&)J* *_V0'.9Y^2"?WA'_P"KOT]?I@^R YS//R03^\(__5WZ>OTQ8HH
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MA(F;Y(]_WMH[9Y^F>,<5/8Z9#8%F62:61E5-\S[B%4< >@ZGZFKM% !1110
M@ 50J@  8 ':@ *H50  , #M2T4 ( %4*H  & !VH "J%4  #  [4M% " !5
M"J  !@ =J  JA5   P .U+10 @ 50J@  8 ':@ *H50  , #M2T4 ( %4*H
M & !VH "J%4  #  [4M% " !5"J  !@ =J  JA5   P .U+10 @ 50J@  8
M':@ *H50  , #M2T4 ( %4*H  & !VH "J%4  #  [4M% " !5"J  !@ =J
M JA5   P .U+10 @ 50J@  8 ':@ *H50  , #M2T4 ( %4*H  & !VH "J%
M4  #  [4M% " !5"J  !@ =J  JA5   P .U+10 @ 50J@  8 ':@ *H50
M, #M2T4 ( %4*H  & !VH "J%4  #  [4M% " !5"J  !@ =J  JA5   P .
MU+10 @ 50J@  8 ':@ *H50  , #M2U0U36+3282]Q(-Y4E(Q]YOI0 _4-0M
M=)LS-.P5%&%1<9;V45YUJ&NO<ZI'/<P;DB :.V#;5C7@K@CJ3WX_+MU-AIEU
MK-S_ &CJK2"/@PV^2H7[IZ>G'Z?ER7BY0OBF\"X 41X XP-B?Y_SQUX2G&I4
MM(Y<54E3A>/<UH_B!,B(B:7"D:KC:)3A>F /EZ<_I^0GQ!N %"Z9"JA>@E/'
M3&/E]_T_+C1Z@8P!_3_/^> >H&, ?T_S_GCU/JM'^7^OO/-^M5NYZ+X?\6RZ
MOJ<=D;&.!/++960G&,8 X'^1^75@!5"J  !@ =J\P\#C_BIXFP!B!Q^B_P"'
M_P!;T]0KR\7",*EHKH>EA9RG3O)ZB !5"J  !@ =J  JA5   P .U+17(=0@
M 50J@  8 ':@ *H50  , #M2T4 ( %4*H  & !VH "J%4  #  [4M% " !5"
MJ  !@ =J6BB@ HHHH **** "BBB@ HHHH PO%WEG1%62..0-<1#9+)LB;YAP
MY_N_GSCZU'X8L$LDGV:?I%H&(!&G2EP<#'.57TQ^'Y2^)I+H6EO%#IMG?12S
MHDJ74@51E@!@%3DG)Y[?RK^%MADO1%8Z-9I&RQ^3ITBN4('(8A5&/08XP?H
M#I**** .,HHHH ZVS_X\K?\ ZYK_ "J:H;/_ (\K?_KFO\JFH CGEBBB+32K
M&F,%F;;^M<EITNMK>^787:/:E-RP:M<*\S=.04RRC@_>R>?P&_K>GMJ-F(E%
MD &W,UY;B90.^%) S[Y[>^1RN@M8'Q!$L;Z89 NT"WT.2!LX!XE/&#U]P#C_
M &0#ND+%%+@*^!N"G(!]CQFG444 %%%% !1110 4444 %%%% !1110 4444
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M\_YX!Z@8P!_3_/\ G@'J!C ']/\ /^>/9N>.CH? X_XJ>)L 8@<?HO\ A_\
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MYQ8E@ -F#D$XYXQUR,9K+\'V\UK9S0MH\.GP J8V1/+,I*C)*')7'3&>WX
MZ6BBB@#C**** .ML_P#CRM_^N:_RJ:H;/_CRM_\ KFO\JFH ;(H>)U92P*D%
M1W]JXVRCOK?6=*2]TNY@B)\I,WL<D9D2/ =E5 2VU6QT'<C@;>LOIGM[*66.
MWDN' XBB.&;MP:YCP[9+!<6LUOX5%AN3,D[S*P3*@_(,D\\=AZ'V .OIL<D<
MR!XW5U)(W*<C@X-5-657TFY5[O[(I0@S]H_<^WKR.,\CK7/2M;MX1U6*5+2T
M2/<JR6;E89&V @KC'LI'3@\]< '745A7<]E>Z*MF;R&,B."1RXRNW>O7V)!'
M7UY&*R([BUFGD^VPV\%E%!*()(01%)(#RZ#@;O3G/!QGL =I17$01M]GC>ZB
M/]N+/:^2K*0^S;'NQQ]WA]W;.<XQQ;U*\M;F2]GDF5@;:-M.D4Y)8Y.4XZ[M
MN2.??T .LHK@I9+S^SX9+<,=<$=P;TH2''RG.<GIG;M'TQCMO:*UN=4D&G%3
M9&UC+^63L$N3VP!NVXST/ R/0 WZ**B?S]QV>6%[9R3_ )_P]^ "6BH?]*_Z
M8C\SC_/]/?@_TK_IB/S./\_T]^ ":BH?]*_Z8C\SC_/]/?@_TK_IB/S./\_T
M]^ ":BH?]*_Z8C\SC_/]/?@_TK_IB/S./\_T]^ ":BH?]*_Z8C\SC_/]/?@_
MTK_IB/S./\_T]^ ":BH?]*_Z8C\SC_/]/?@_TK_IB/S./\_T]^ ":BH?]*_Z
M8C\SC_/]/?@_TK_IB/S./\_T]^ ":BH?]*_Z8C\SC_/]/?@_TK_IB/S./\_T
M]^ ":BH?]*_Z8C\SC_/]/?@_TK_IB/S./\_T]^ ":BH?]*_Z8C\SC_/]/?@_
MTK_IB/S./\_T]^ ":BH?]*_Z8C\SC_/]/?@_TK_IB/S./\_T]^ ":BH?]*_Z
M8C\SC_/]/?@_TK_IB/S./\_T]^ ":BH?]*_Z8C\SC_/]/?@_TK_IB/S./\_T
M]^ ":BH?]*_Z8C\SC_/]/?@_TK_IB/S./\_T]^ ":BH?]*_Z8C\SC_/]/?C!
MU37+H79TRPC6:[) <QY/ECCUQD\^HQC/T +.LZX+5EM+/][>.<!5Y*\CL>O?
MCV^N#1M!6R"W-VWFWC?,W.54\=/R_P X%&CZ)+I:F1GCEN7&&D)8XX&0,GU&
M??';/RZO^E?],1^9Q_G^GOP 345#_I7_ $Q'YG'^?Z>_!_I7_3$?F<?Y_I[\
M $U>5^,,_P#"5WN#T$?_ *"O^?\ /'IW^E?],1^9Q_G^GOQY?XMW_P#"47FX
MKN 0D+V^5?S_ /K?EWX#^(_0XL;_  UZF(/4#& /Z?Y_SP#U Q@#^G^?\\ ]
M0,8 _I_G_/ /4#& /Z?Y_P \>S<\='0^!Q_Q4\38 Q X_1?\/_K>GJ%>6^"@
M_P#PDL9C50?(<<]!POMSTZ?Y'IG^E?\ 3$?F<?Y_I[\>+C_XOR/8P7\(FHJ'
M_2O^F(_,X_S_ $]^#_2O^F(_,X_S_3WXX3M)J*A_TK_IB/S./\_T]^#_ $K_
M *8C\SC_ #_3WX )J*A_TK_IB/S./\_T]^#_ $K_ *8C\SC_ #_3WX )J*B3
MS]_[SR]F.BYSG_.?R]\"6@"%;2W2[>[6%!<2*$:0#D@?Y_0>@I([*TA),5K"
MA*[3MC R../IP/R%3T4 0FUMS"L)MXO*0@JFP;1CI@4HMH ' AC ?&X;!\V.
M!GUQ@5+10!"UG:OY.ZVA/D_ZK*#]WT^[Z=!T]*FHHH P-9@O[K5$ATV[BAE:
MU9'9]V8E9E^=,<%OEZ'&>.>#5G2-%31[BZ6U"16<@3RX4_O 89S[GCIZ?DW4
MO#]CJ>I)>7\:2QQ0E%5B1M.X-G(/L/R'7C%C3-#TW1_,_L^T2#S,;MI)SCZF
M@"MXF$DFE;(<,1+&TB&Y\C<@;+?/GC@'\JI^%(XE^T-%IZ6N0O(U$W6X<CCD
M[1P?K@>F!;UJ>U\];0Z.-4N98PYAV1D",,!EBY QEN!]>G)I=#^QJTT,6CQZ
M7=(JM-"L:#ALX(9.&'RGGV]J -FBBB@#C**** .ML_\ CRM_^N:_RJ:H;/\
MX\K?_KFO\JFH CG:-()&EE$2;3ERVW;[Y[5QFC77VG4[*SCO8K^WL %BDLK1
ME*+MVJ7D)VX.""%SDCT''6ZCIMIJUD]G?0B:W<@LA8@'!R.GH0#^%4+/2+NP
MU,3QWQN+8Q+$T=P@WHJY(VN .Y/4'M0!L$!E*L 01@@]Z1$6-%1%"HH 55&
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M_"5WN#T$?_H*_P"?\\=^ _B/T.+&_P ->IA#U Q@#^G^?\\ ]0,8 _I_G_/
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M>NK&;6=/AA_L:*:$'=<63L9;KY.A78,#G<<D_=X[D 'H-%%% !1110 4444
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M4"TM;6&8E]W#X<9.#@]>,$_2+PLW[R^B+7H=75W2ZM(H#EAC<-@&[(7J?_K
M EU+5-2L-3D3[+YEN\#"T$*,YEFX^5^/EQR>N,9.>.'Z/)J4-_<V%[,]Z$5)
M#<^6$",P.4 XR.,CKC."?1VMR7UI_I4>J0VMH %97LVG;>3@;0K G.>F#^71
MOAS4I-3BFD>_2ZP$PJV,EL5R,YPYRP/K@#@_0 &W1110!QE%%% '6V?_ !Y6
M_P#US7^535#9_P#'E;_]<U_E4U $%[]H^QRFTDACGV_(\ZED7W(!!(_$5RFA
MZ[=:CJ=K;3ZY93,B[I8K:UD#.VT<;C\I').1UP<>W73E!;RF0$H$.X#N,<UQ
MFF$7&K:6\$MQ)8)''%)M92OVI8L@XVY.$!5B",' (XX .OOKV'3K&:[N"1%$
MNYL#)JF^K2VFD37U_8S1-"27BCPYQUR#G&,=2<=#5Z[61[258HXY'*D!)?NM
M['ZUBV^C75OI&H00+!"UX#LM_,8Q6^4VD+QTSS@ #Z4 :TM_'!91W,BL?,**
MJ)R2S$  =.Y_K5#_ (2&(O- +.Y:[@4M/  ,QJ #G.<$$'C!YP?0XBFL]0NX
M%M4CA@%EY+PMD[7D4Y(Z#*8P.G4^HX9_8NH1:I=:G!-;"YO(S'*C9VQ\ (5(
M&3C;STSZC P 7%UZV=BT<4SVRLB-<@ (K/MVCDY/WADXX[]\/OM9CLI94\B6
M58(Q).ZX B7U.>O )X]*S5\/S6D#V<30G3C)%,X"$RDQB/Y0.GS>7UZCMVP]
M],U.ZC:97MH9+^V1+Q&4_NSC!V^O!(YQT_( LCQ%:\R-'(MKMD9;@XVN(QEL
M<Y_O?E^5FQU1;R9X'MY;>X6-9?*EQG8W0\>X(]>*R7\,R26D&FM+&MA:JWD.
M,M)D@A=P/&!D]^<#IVT=.L+F.[:\OFA,_DK JPCY0HY)Y ZGM[?D :E%%1F"
M)I/,*#=G.?\ /X?D/04 245$+>%=N(P-IR/\_@/R'H*!;PKMQ&!M.1_G\!^0
M]!0!+140MX5VXC VG(_S^ _(>@H%O"NW$8&TY'^?P'Y#T% $M%1"WA7;B,#:
M<C_/X#\AZ"@6\*[<1@;3D?Y_ ?D/04 2T50U#28+^S-ONDA&[<&B."#V^HX'
M'L/05DKX-ME93]LN" H&,]QC!_0?EQCC !JKK%J^IO8J7+(I+2[#Y88=5W8Q
MN Y(SQ_)UOK&G74-S-#>PM#;.4FDW85" "<D\8YZ]*Y"+PJO]O\ DV<5_;V\
M4@-R99%$<@(X=".=Q*KG@=\\@8-)\*PPW.HR26.I0QM(C6Z@QJ64+&/X2><C
MOCCTQA0#JAXATEK&VO%O$>&Z ,&Q2S2 ]PH&[USQQCFI?[9TXV(O%NXW@*AP
MR'<<'V'/^%<);^#9'TW2_-M-0B>)V$XCF031D@;2ASC;V/.?88XTM/\ !ZVF
MF1I)92FYAM=RB*=0AD'"H.AR,#)X&6X]@#?'BK1#9R79U"-(8Y/*8R!D8/@'
M;M(!SSZ>OH:O/J-C']^\@'_;0?Y['\C7'W?@J&#PH84M9KG49(QO\MUP)FQN
M;!*C&1^6/3(W+7PSIC6\3FUGA8@,8VF;*G@\X/M_GC !?_MO2\*3?VX##(RX
M&>G^/\_0T@UW2CC_ (F%MS_TT'M_C_/T-54\*Z4@ 6*4 '/$S#T]_P#9_P \
M8=%X8TJ)-JP/U!SYC9[>_?'^<# !-_;^DC/_ !,(. #][_/K0?$&D@X-_#TS
MPV:1/#VE1_=M$X;<O)^4^WY4H\/Z2K!EL8@0<@C/% $9\2Z.&Q]NCSG'0^WM
M[_S]#0/$^C''^G)S_LM[>WO_ #]#4@\/Z2K!EL8@0<@C/%*NA:8@PMG&H!SQ
MD>G^ _*@"(>)]&./].3G_9;V]O?^?H:C/BO2 I/VDD 9X4\_YX_/V.+O]D:?
MVLX1]%QC_/'Y#T%*-*T]6!%G#D'(^0?Y]/R'H* .?07/BF\#G=#IT39!!Y8\
M'@CZ=^GUZ6Y=0?3]9M]*MQ:6MLBHS/<$IYX/&U"!C< "3Z\#IDC;2UMXU18X
M8T5#E0JX _ ?0?D/2LK4] ;4YEADN NFLN9(5C&_>&4C:_4#C'M@8QV )H]4
MN&\2R:8]J(X1;><DI?)?Y@.@& .3U.>.E1VFHZC-=7EC)#:"[@C1PZ.YC&_/
M!RO48)]P1TR</;13_;G]II<A?W0A$7DJ0%X/7KU53^GIBG'X6>+3+JR74Y=U
MPO-QY2B7=D9.X>P QQCMC P 7-/U@SZ5=7MY&L*VLDJNR-N1EC)RRGN./S!K
M/?Q3+9PK)?6T*F:V2X@6.4D'<ZKM)('(+KSCUK0M]#2*S@LWE0VT:M&8HX5C
M5T*A0..F,#ICG'H*J?\ ")6SQ*DUS)(8HTBMV"JIB5""O &"?E7/KCMQ@ U-
M+O#>VGG&>UF.XC=;-N4>QSW'^0*NUF:9HL6GF>5Y#/<3R"665E"Y(55  '
M"KQ[>PQ>%O"NW$8&TY'^?P'Y#T% $M%1"WA7;B,#:<C_ #^ _(>@H%O"NW$8
M&TY'^?P'Y#T% $M>5^,,_P#"5WN#T$?_ *"O^?\ /'IXMX5VXC VG(_S^ _(
M>@KR[Q:@3Q1>*G"J$X]/E7_./\COP'\1^AQ8W^&O4Q!Z@8P!_3_/^> >H&,
M?T_S_G@'J!C ']/\_P"> >H&, ?T_P _YX]FYXZ.A\#C_BIXFP!B!Q^B_P"'
M_P!;T]0KR[P2BOXGB)08$+=N^%]O;_ZWIZ8+>%=N(P-IR/\ /X#\AZ"O%Q_\
M7Y'L8+^$2T5$+>%=N(P-IR/\_@/R'H*!;PKMQ&!M.1_G\!^0]!7"=I+140MX
M5VXC VG(_P _@/R'H*!;PKMQ&!M.1_G\!^0]!0!+140MX5VXC VG(_S^ _(>
M@H%O"NW$8&TY'^?P'Y#T% $M%,2&./[B ?A_GT'Y"GT %%%% !1110 4444
M9/B%L:6%5;EI'FC1%MK@PL6+ ?>'0>M5O#=C<VC7#W=E-#(X7][<7WVEVP.F
M<< '/Y_@'>+4\S0F4FV\LRQF1;FX\F-E# D,WOZ=ZK>$4L\73VECIMMDC?\
M8;[[2"??Y1M[_D/P -'6?M+)&(+-YC%)'*C+<+%E@WW><YX[$<YXYY%/PW97
M5K-<F[M986*(L8ENUFV(,X1<*,*#NZY)_  'BFR>[@BF,(:.T99@[7[6RY#
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M5*\K\89_X2N]P>@C_P#05_S_ )X[\!_$?H<6-_AKU,(>H&, ?T_S_G@'J!C
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M=\KC8NW/&3DD_P!U<=> #=ILGF>4_E%1)M.TL,C/;/M3J:Z+(C(PRK @CVH
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M68ER,HK-D]]N2?;') Z17%Q/!K,>F07EQ+;3/ 9)#)ETR') ;L'"#ITYQC/
M!U5%9>ARR/;7,3S23"WN9(5DD8%F"^I'4CD?AVZ5J4 %%%% &7X@;9I+G.H
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MM  P.GW?\_YX[?X=( U^54* L8P!TX/M[?Y[<2/4#& /Z?Y_SQV_P\&6OSC
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M%9P) S!S&L8 +#&#CU&!CTP,=!5NB@!D,,5O"D,,:1Q(,*B* %'H .E/HHH
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M/C[(O-/.>/+D^@Y7G_/I^(XY3C;ROW<]/IS]./T[8^3\TQ_^\2_KHC]-R_\
MW:']=6"G&WE?NYZ?3GZ<?IVQ\FEX=_Y#^GC(_P!8. /ISTZ<?IVQ\N:IQMY7
M[N>GTY^G'Z=L?)I>'?\ D/Z>,C_6#@#Z<].G'Z=L?+S45^\CZK\T=-?^%+T?
MY,]8HHHK[4^&"BBB@ HHHH *\K\89_X2N]P>@C_]!7_/^>/5*\K\89_X2N]P
M>@C_ /05_P _YX[\!_$?H<6-_AKU,(>H&, ?T_S_ )X!Z@8P!_3_ #_G@'J!
MC ']/\_YX!Z@8P!_3_/^>/9N>.CH? X_XJ>)L 8@<?HO^'_UO3HO'@_T*S;
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M/_B1_G&-NWU*SNKA[>"=7E0$E1GH#@D>HSQQ4D%W;W,D\<$R2- _ERA3G:V
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M7.<*<<'!YQCJ<?GZ&K=<_P!6H_R+[CJ^N8C^=_><T/ ^DK]TS# &,R'@\?\
MQ(_SC&Z(9UVA;@! , >6/P_E^IZ<8L45<*4(? DC*I6J5+<\F[$'E7&X8N1C
M'0QC\/Y?J>G&#RKC<,7(QCH8Q^'\OU/3C$]%:&1$B2J^6FWKC&-H!SZY_P ]
M3[ 2T44 <Z1+%XAF2Q>8M-*KW5O/ 6C'RJ!*K]!PH &3G!&!C*UM/,\;:0?L
M5VGV&V>*YS$P)9M@PO0,"1NR.!@<#MU=% '$ZAIE_-I$FG6MD_VU+QYF?:%5
MD)).U^!R"%QGCV XW-,1IM:N[^.VD@MG@BC42Q&-F89)X(!  ('3MWP,;5%
M!1110 4444 %%%% !1110!QE%%% '6V?_'E;_P#7-?Y5-4-G_P >5O\ ]<U_
ME4U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8WB 7-Q#'91V
MD\EM-S<2P[=P0$?*H)'+=,]AD]>FS10!S=Q8WFV[MH;>1EN;R*Y28%5"(OE<
M8/(8;, ?3D=GVLEXPN[V[LKQ+N9$ CC"_NHP>$4YP6^8L3[X[#'0T4 9>B6]
MQ;P7'GB0+),7C\X+YI! R7*\9SG\ /H-2BB@ HHHH **** "BBB@ HHHH **
M** ,W6I[V*T$=C!*\DAP9(P"8AD9."1DXSCGK[9(Q[C3;B.&\MK6QE,-U9QP
M0,2H\G:"N&YR!R#QS],<=510!SMO'?W-[*QMYK5TMS;VSR*&1%.W+$A@2Q('
M QT&>>DWA_3[O3I;V.=(A$73RV3/("*._;K^.?H-RB@ HHHH **** "BBB@
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MP#_VC1#_ ,LO^ ?^T:** "'_ )9?\ _]HT0_\LO^ ?\ M&BB@ A_Y9?\ _\
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M7_ /_:-$/_++_@'_ +1HHH (?^67_ /_ &C1#_RR_P" ?^T:** "'_EE_P
M_P#:-$/_ "R_X!_[1HHH (?^67_ /_:-$/\ RR_X!_[1HHH (?\ EE_P#_VC
31#_RR_X!_P"T:** ,6BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.gif
M1TE&.#EA.@(_ 7< ,2'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "'Y
M! $     +      Z C\!AP          ,P  9@  F0  S   _P S   S,P S
M9@ SF0 SS  S_P!F  !F,P!F9@!FF0!FS !F_P"9  "9,P"99@"9F0"9S "9
M_P#,  #,,P#,9@#,F0#,S #,_P#_  #_,P#_9@#_F0#_S #__S,  #, ,S,
M9C, F3, S#, _S,S #,S,S,S9C,SF3,SS#,S_S-F #-F,S-F9C-FF3-FS#-F
M_S.9 #.9,S.99C.9F3.9S#.9_S/, #/,,S/,9C/,F3/,S#/,_S/_ #/_,S/_
M9C/_F3/_S#/__V8  &8 ,V8 9F8 F68 S&8 _V8S &8S,V8S9F8SF68SS&8S
M_V9F &9F,V9F9F9FF69FS&9F_V:9 &:9,V:99F:9F6:9S&:9_V;, &;,,V;,
M9F;,F6;,S&;,_V;_ &;_,V;_9F;_F6;_S&;__YD  )D ,YD 9ID F9D S)D
M_YDS )DS,YDS9IDSF9DSS)DS_YEF )EF,YEF9IEFF9EFS)EF_YF9 )F9,YF9
M9IF9F9F9S)F9_YG, )G,,YG,9IG,F9G,S)G,_YG_ )G_,YG_9IG_F9G_S)G_
M_\P  ,P ,\P 9LP F<P S,P _\PS ,PS,\PS9LPSF<PSS,PS_\QF ,QF,\QF
M9LQFF<QFS,QF_\R9 ,R9,\R99LR9F<R9S,R9_\S, ,S,,\S,9LS,F<S,S,S,
M_\S_ ,S_,\S_9LS_F<S_S,S___\  /\ ,_\ 9O\ F?\ S/\ __\S /\S,_\S
M9O\SF?\SS/\S__]F /]F,_]F9O]FF?]FS/]F__^9 /^9,_^99O^9F?^9S/^9
M___, /_,,__,9O_,F?_,S/_,____ /__,___9O__F?__S/___P$" P$" P$"
M P$" P$" P$" P$" P$" P$" P$" P$" P$" P$" P$" P$" P$" P$" P$"
M P$" P$" P$" P$" P$" P$" P$" P$" P$" P$" P$" P$" P$" P$" P$"
M P$" P$" P$" P$" P$" P$" PC_ +&U$MAJH$&"!PT6%,BP8$*$#2$F7#CQ
MH<.(%RMBI-B0HT*+'B5V!$ER8TF-*$>:7)GR(TN5+46ZC)D1ILV9-V7JK(FS
MY\Z0/'^>S!FT*-"C0WT:32KTI5*D3INV'(BMJM6K6+-JW<JUJ]>O8,.*'4NV
MK-FS:-.J7<NVK=NW<./*G4L7*\>Z>//JW<NWK]^_@ ,+'CQX(>'#B!,K7LRX
ML>/'BR]"GDRYLN7+F#-K)FMXL^?/H$.+'DVZZ\'2J%.K7LVZM=O.KF/+GDV[
M=N;3MG/KWLV[]UO8OH,+'TY<-^[BR),K7WZ;*O/GT*-+]RMYNO7KV+.+!:Z]
MN_?OT(^#_Q]/OKQQY^;3JU^/6CS[]VD%7;%Z!?W>5H($P;_.?3Q^^?:-AI]<
M5^BGEWQ5M5+?=O(5&&!6@CR(S8)Q 7C5@/$9N-]?[GTG" OY?:BA9[!=0:%;
M\K$ 5G5F(5@5"Q)J)6*!(,:HX'Q9*3BB6R;B6)6+INUX58$; M:?=Q\ZA^%G
M0-)5()%>M0)CA@F>^%5^5B5YEI4HFJAADUN!.:201>;%(G@@<O7?B M%2!5^
MZ.GW7XYN6D51A!?"Z5R$>!+D)9ZP%51G@@X-NI6"V.1GGZ!5FCA@=7T*Q.=5
M0"ZXY(\0^J@C09,2JJ2>4-K9649P?E6?A8GZ^..2#5Y*GX%NEO^*E:(7AIAG
MHH;)2BF6Z1VIG8(2-MCCJST6V&": AG;XY[%PEHLLC?*9V"/TO[HY8) "NNH
MM<*2F:6<5FI;T!4L; MLECAJZZ.+YZ(ZH:H_:BCE0-IJ".6-Q2XZY8\J1LME
M5D1""22^)EIK;( "/_MEO@8/6U6Q?YJ(;++"]LH0>5(>NN^-DN[K<,8O6NIB
MMM@6+-"4(%^<JXH/CT@KQP^7;."\AQ*)W[KW@JODB??:F;!5^VX<*KH,.7AQ
MJ@;Q^B%]0R?KH\V:>D7DTJG2QZRU7"4\,\O8( NHT.EZ;'+*0GO[:XS9N3LF
MI3B&.K"E)Y[KH$-3O@TNF8)2V.3(JK;_JVK3/J-+E9CG5GEUG@+/K#>.B&;*
ML*B%4SCTOQ:>NRE84.O'MT,W8[W5SX8CC=70%KJM:<F<FXSQT>#1;-?0(/,J
M^LE67P4C?N4^B6VDBQM-L<2O[CH0[%/S[NV?^7DL9.').I>S[L[6+CK@2!N:
M'XUPW^TSF2CC7!_:$SH[;H*Y5USUY]..6#>\EY/O^>RQ@PBQ>;YFU_[:@H<?
M>.C,RTVFW1<JF)04-SA5\2V ]/H;WI#7H/?9:5_-(]J[J (ZYCGH7XE:WKTD
ME[XA/0A!L*M65T*E+&M]$%[X>UL" <:F!86J<1%4F\7 =YUM>8IJDIK/G$SH
MOA<MS($,H=6+__0%/[$)+U4+2Z#S'I0R'KI+9]L+7M?>!+HIHDM,0$Q6_G9(
MLO\]*4 I>] +<P<T]!0P:["*%,HV1B^N=2Z#^1OBR6C8G?II!WE04Q8')1A!
M?"5/<:=2F@(S&*',78]" XQ>S$)41?VQ\'734A8%A1@Q*#DJ18KL'[F"A4(=
MW6R/3KL>!$<W,45=CGJD*]<5^51 (:;P=*VL5K2N-TD^%DY:@J+C=,XTGNO)
M[I,N^Q+OK-:J6GTQ7DN,E^]T5!]->3*#>\+EMY)IETA]BVEQ\Q(VX9C#$,W,
M7J/#H*2T<K,0)4U>N)3=Z]#SQ7-JQ4H[]),T#?;.P8W(F=I,4(.".?]-^HBJ
MG?3399E,(\[U8'&@"+T0ZQ)*EE'"QW4,C:BH)%H6YNU'AA1%:(<RJB:-<E2B
M=ORH2$=:IHV2]*0H74](4\K2EMIOI2Z-J4R5 ].9VO2FO3$I3G?*4]O4M*=
M#2II="K4HAKU,S\]JE*7VABB,O6I4$5,4J-*U:KBA9=T$:A5MRH:K;;'JVEQ
M%5?'JAJQSL:I;*&E,D<E+<7)[GK5--J:%.([LMIU+>-Z:Y]TM"-:)DVNYJR5
M7LTVEZFV:&8)>EB<E)1&7&DQ2TDK%9:P9-:[6E8LO+*GR.)E)UC1BUZLY.9C
M)VL0%-8%K6J!X:Q<MB=[EDI73\OL?)X&ULO_7E:=^OPL9W<[H-@J#K*Y[9,U
MKUK;%@$N7+:2+:O>M+!OLHJP$J&(=&<RW>A2][K6S2ZIL+M=[5:WN^#]KGBY
M.U[ODO>\YDUO>-&[7O66M[WP?:]\V5M>4S5M=U4"KJ18E;-K[G==Q34+:O%:
MUW\-3U9KRJT^7V4O& [7+AB)L$4D3.$)6[C"&+ZPAC/,X0U[N,,@_K"(0TSB
M$9NXQ"@^L8I)?*6!X6FOPB6@O60'8'T*$;>G#?"6[*DF6_U7>L]U[I=T;%O+
M\@RT"UY5<+_U3?_"B;9\P6I<(@O-+$7$37C"KRD//$X=8@EN10YS6)S762HC
M$E&EVJR7-9?+"2'9_Y5F(O*8I;FF+(-6:4),L)OC]<W!BOG/43)69XT66,?J
MF9 V;NQ_F MG,RVTL/UA5$4C!3XY ]JJE;53F3MZ&<-6Z"R>OK2HT1)JQ@QX
MU*A^:JE3S>J>GKK5L ;JJF--:Y=*N=:XEK6E<\UKCKZZU\ >Z:R#36R/[KK8
MR'[/L)/-;$COYM?-CG9=ZFJH37.J5@&RWK))?6QI>QO46$:F-16UN\;!:=RA
MQ7*W*[KM;[L;L_P4[80,U^2G;5K/..Y+N]_-[T#O++^[A5^G'#O.F%&Q,(_N
M-U>KO9EH2:J0Z&0PO:67653IBD/K5KA,"QV:PA7*R18?.(PE_MC 0%OC/?_E
MTX,Q0TTE QQ8C;4WE?$-7>*B?*QS[;C*"<6K=+%RT4(>%V@ERW$C)?SF2Q74
MRIMS9A@S5U1LDA=D6YMQSE0=Z2+-N8!BM/2M7QWK%%5ZS8?JFGV#W=?>9"JT
M+WQVD)Y;U<4E%\3*]?6V,T?K23]ZE/;K)[LS]-!JU_&ENNYW]>!=[7K_"M /
M6GB#ZBFJJR98X\M4=+C7??+I,>?EPUY<-T',M)C'6.55G7BNR.G<F2ZYXC6=
M(W)"6*&AQXSF98-C)KZ>];>/S.;YW.<=Y5S/AT?TPX5)^-@G)OBK*?3A@>]C
MX7?V9<TW>>D#W=:::9K*"E:4G>'H2C#[G."@-_[_\;5/>\02?4BY7?.>84AT
MR>Y>342&F+?R3?"""__MBDWR_4-;?_%'9O2KX2KXE62+)F[ZM22"9G]&%V#2
M-6_HXWN14G&(Y&,(YEM64V-[EU@:>#1*@GL=N($?R($>.((@2((B6((H>((J
M&((L:((MF((ON((N.(,P2(,R6(,PB'\WN(,QV(,V&()!DDU-@H#*U6 !%W+O
M1TZ"QV;]%U>[4BM,PUP(^'0\M%_"9!J<DX5:N(5<V(5>^(5@&(9B.(9D6(9F
M>(9HF(9JN(9@J'EL^(9LN"*)XTH2R&A#IG\BI%H8QX!9ICJFUV1/F$.N!2C#
MU#*_!64=M6**F&*,N(B._]B(D/B(DAB)E&AA.CB)F,B(8?$]S@5PX5-O_D2
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J]$%OUY U=.Y&]$-7]$1G]$5W]$:']$>7]$BG]$FW]$K']$O7=-4("  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" /M PD# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX]T*Q>0K'=0[-Z\XRS<BL+Q-J^HVOAJ7PMKJLUY:3(\$_42Q 'DG\L'\#R*
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M=2 * -7P]\1X1X4%_P"(I%2<3-"@B3YI\ '(4?7GM4L?Q;T&65(T@U L[!5
MA7DDX'\5<)XITK^P_#_A_39H5ANIU>>YE8<@DC"YZX&XY KL_!-]%#<_9)O$
MFGZA;PVW[J""V">6%QEF;'8>I[T ;5KX_P!)N;^_M'6XMY;%6:7SD !VMM(&
M"<G)JGH.HZ_XDU![I9OL>EA^ (U)8#^$$C\S7%7*:=JGC]A#(T<>IW(V.R=C
MP2!Z$@_G7LD,*6\*11*J(@"JJC  ^E $E%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<;\4O\
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M[>%>BH,9]SZGW-6Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH J:I"ESIL\,MNMPDB[3$W1\G&#[5D
M:8(=&C:'3](C@C=MSK I&&Z$'CDXQ6Y<7"6T8>3."< "H4U."1"Z;F )S@=
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M?>Q3=(MKB!;AKSF:60,3G(/R*#CT&0: -&BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"[6.1CW7%:,;B6-77HP!% #Z*** "BBB@ HHHH **** "BBB@ HHHH ****
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M.X<8 QCUX6G76EI<&';)Y8B39@+D8W*P_5!^&:2324>T,/FLK&4REP.A).X
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI!!QUSFL^+P9J20QX$0WN=J%E'V3F+$B[0 6Q&>F/O?6NG U*:WN$DW*S0.
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[-.6ZU9DC!B"[E5F=HS\K% <8&>-V14=WJM[-92+''Y<A7*L W&T@/\ ^/8
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M V!GI@D+SSUJ?2/M#7%W)<B0;_+QN3:,[!D >QS6I10 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 E%8.MZ]<Z5J26B1PLUW$HLRV?FFWA2I]@&#?
M0-5:V\0W]U/;[?L82\GFMXH]K&6$INPSC/(^7D#&-PY- '3T8KD++Q-JEQ_9
M =;<F_661_*MV;8J,JXQO]SSVXXJS?\ B2]MO%0TV-(!;9B0R.C<-('Q\V<9
MRHP,<Y/(H Z; HK!TG6K^^L[ZXN;>&'[&&A902=TR9WD'/W,XQWZUCZ;XWO+
MN72HIH;9&E.+XC.(PREXRO/&54GG/% '9RPQSILE0,IP2#T/.:?BN,L?'4M[
M$"L=OO:Z15 S_J71V4]?O93![5T^CWK:CHUE>.$#SP)(P3H"R@D#\Z +E%+1
M0 F**6B@!,48I:* $QS12T4 )BBEHH 2EHHH 2BEHH 3%&*6B@!*6BB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#*O+N%-56.Z@B9((A-'*P!9'.X8'ID \_A56WU&QMXDU"XL8H;R=
M&,C1(I;*@DJ3U/"GKZ5;N9;8ZJ8;FW5ALA82%<_-O;:#]&''N:A,FD-(\;6Z
M[DR"NWUX_/Y_R)H +5+&]OI;273[<M8N#&#$N(055ACT).>GI3[R73H=0>XE
MM(A=0;/W[1*6VD@?*>N!GJ.E(T^F7,4U\@(,2B5Y$!#%>#VY((4<>U.FO-.D
MN#YT3-*.#N0G:0RX'U)*?7B@!BZO9QI(J6<JASO90BC>&0N6Z\Y .>^:=<C2
M;>*+S+. QRA<8B7IMVKD?0D#T!Q5>-M,MEN&*[I.=RM'@+A6&,#T"MG_ /53
MY[S3VNHA+ IB"%0Y4XRKJH4>O+'Z4 ,N-1L9+=YTL0US%"SQK)$I*J$##G/3
MYAP#WJ<3VVEK';Z?:10[I(C((HPJ+O;;GC'. ?TJ,RZ==200PVJ2)-)Y+DJ<
M+^[/&?7"@8]*GN;G36D5YHM[*VU#LSN*L%P/7#'^?O0 DNOPQ2D>6QC3?YC
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MIFJR75G'<W,)L (R_P!G=D&[/(V@C'0ESC\:F672P,+""7)VC8<RG<,X]?F
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<KN&X<D9YH =13/.CPQ\Q,+]X[AQ]:7<OJ.* '44TNJD L 3P 3UH#*>A'-
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MEVQ[%E_[XKIJ* ,:TMC:ZE.L,$BV[ 9<H P8$8"MU*XSP>F/P&S110 4444
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M"LXE!"DG !/;)Z4 ,UCQ!IV@K$VI3F%920A$;/DCK]T&LO\ X6)X;_Y_V_\
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MCFB89#QL&4_B*KQZSILRS-%?6SK I:4K*IV*.I..@]Z ,;_A8GAO_H(-_P"
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M&: 0QA8C)\BG_=8?Q=ZV;W4;33H5EO;F*"-FVJTC  GT'OP::^IV,=@;Y[N
M68&XS^8-@'3.[I0!SMIXY\+6-N(HK]PHR2?LTF2>YX6MV]URPT[2TU&ZF*6C
M[2KA&.=W3@#-)/X@TJVN!!/J%M',<$(T@!.1D8'T(I/^$ATC]]_Q,;7$&?-/
MF#"8.TY].>* ,O\ X6)X;_Z"#?\ @/+_ /$UK:9KECK%B]Y83&6!&*LQ1EY
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M.,EA_%P,=A6\^K7=IJ26TQAECC),\BH5(4A<'&3@@GGVYIT.KW3:?)>,BLL
M221%7ED,89L<]1G(^F* +'AVZM;S189+&X:X@!91(49<X)XPW( Z#V%:E069
MF:W5[D*)&^8JO10>@]\#O4] !1110 4444 %%%<AJGQ.\/:7>/;&6:YD0X<V
M\>Y0?3)(!_"@#KZ*X3_A;_A__GAJ'_?E?_BJ/^%O^'_^>&H?]^5_^*H [NBN
M$_X6_P"'_P#GAJ'_ 'Y7_P"*H_X6_P"'_P#GAJ'_ 'Y7_P"*H [NBN$_X6_X
M?_YX:A_WY7_XJC_A;_A__GAJ'_?E?_BJ .[HKA/^%O\ A_\ YX:A_P!^5_\
MBJ/^%O\ A_\ YX:A_P!^5_\ BJ .[HKA/^%O^'_^>&H?]^5_^*H_X6_X?_YX
M:A_WY7_XJ@#NZ*X3_A;_ (?_ .>&H?\ ?E?_ (JC_A;_ (?_ .>&H?\ ?E?_
M (J@#NZ*X3_A;_A__GAJ'_?E?_BJ/^%O^'_^>&H?]^5_^*H [NBN$_X6_P"'
M_P#GAJ'_ 'Y7_P"*H_X6_P"'_P#GAJ'_ 'Y7_P"*H [NBN$_X6_X?_YX:A_W
MY7_XJC_A;_A__GAJ'_?E?_BJ .[HKA/^%O\ A_\ YX:A_P!^5_\ BJ/^%O\
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MBT:DLX<\=6&,'Z\#\JXK_A;_ (?_ .>&H?\ ?E?_ (JC_A;_ (?_ .>&H?\
M?E?_ (J@#LHM/M8)A-%"BR!0@8=E'&!Z=!3GL[>2W:!X4:)B24(XR3G/USS7
M%_\ "W_#_P#SPU#_ +\K_P#%4?\ "W_#_P#SPU#_ +\K_P#%4 =BNFVBQ>4M
MO&$"E,8[$Y/YD U)]DAW[_+7=NWYQ_%C;G\N*XK_ (6_X?\ ^>&H?]^5_P#B
MJ/\ A;_A_P#YX:A_WY7_ .*H ["#2[*V.8;:-/F#<#H1G'Y9/YT];&V6W>W6
M",0R%F9-HVL6.3D>Y-<9_P +?\/_ //#4/\ ORO_ ,51_P +?\/_ //#4/\
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M )Y)_P!\BI** (_(B_YY)_WR*/(B_P">2?\ ?(J2B@"/R(O^>2?]\BCR(O\
MGDG_ 'R*DHH C\B+_GDG_?(H\B+_ )Y)_P!\BI** (_(B_YY)_WR*/(B_P">
M2?\ ?(J2B@"/R(O^>2?]\BCR(O\ GDG_ 'R*DHH C\B+_GDG_?(H\B+_ )Y)
M_P!\BI** (_(B_YY)_WR*R=0UFUT_5[>PDMH\RQF5I7=$5%! /WCR>>@K:KG
M?$\&C0'[=K1<QS1&QVA=P <Y+=,@C!.>P!H MV^N:)=310P75L\LQ(1 /F..
MO&/<?G2:OJ]IH\JI/:E@\$LRE5'S%,90>YSQ]*S-/MM.L/%[.T][<:FX^QM+
M*%VL/+$HZ =%7KCJ3FMK5]$MM9^R_:6D7[-,)EV$#=C^$^Q[T 8[>,=,2.*6
M6U\N$VXGD9@-R95FV!1RS#8<@=*E_P"$KTK-ZHCCWP1^9$AP#./*$G QP<9'
M/H:>/!>GA9E,MP5EFFE8;AQYB%"HXZ ,<5F7UGHR3WNGW=[>2W,,7VV9@JY8
M+"8\ X SM.<>X- &S%XBT.2Q2Z>YMD1B%(."58KNQ^1SGICFJEWXMTNSM+V6
M6.+S+>1TCBR,S[0IROL=P%16.B:?JDMQ=65S>P31E;=I!M!V^2@( ((P5*\]
M<CBI&\!Z>(IHX+BZ@29#$X1EY3Y<+R#TVCGKR: -N^D@L-.N+R2!66")I655
M&2%!.!^59]GK^F7$5N;@VUO+<']W&9$?/.!RN0,GCZ\5;U^6VAT&\^VF46\D
M9B?RAE_G^3@>OS5E'1-+N5C9I)K)9(HDGM6*1F54?Y-PQD?,>H(SG% &DNJZ
M5+I<^H020RVL"L7=%R/E&2/K65-XLM(M-AN_[.?+Q3N\+;5>)HA\R-[YJT=,
MTF308]':^5K6.58G'FKND(;=Y;$=SW P:SKS0_#MM!?-)J7D6ZK*TL8F5O*W
MJ$<\Y.25'7O0!U8AB(!\I.?]D4OD1?\ /)/^^13HW62)7C8,C %6!R".QIU
M&7<7J6NH>1+9H(=AD,Y9< # Z=<Y(&*LI+9/;"X7RO*) W%<<YQ@^ASQ4=Y:
M6]U=+OF*3A,(%89&&# X/H5%-2WM!I\D!N0ZSLVZ7>N6<GDCMG/:@ FO]/AC
MWYA8988 Y^4X;''.#Q55-<TZ192L:Y6$3(&3!<%-WIP>#U]*<NG6,;"0W#;
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M (_(B_YY)_WR*/(B_P">2?\ ?(J2B@"/R(O^>2?]\BCR(O\ GDG_ 'R*DHH
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M_,[L<5:T72O[*MFB+*S$C+ MS@  X).#QVK2HH **** "BBB@ HHHH ****
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M@ J*:Y@M\>=-''GIO8#/YU+7.1Z=9ZEXOU7[?:P77E06XC\Z,/L!\PG&>F:
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M/[5\2_\ 0N6__@Q7_P"(KH:* .>_M7Q+_P!"Y;_^#%?_ (BC^U?$O_0N6_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7_E3? W_ ")&D?\ 7LM.\;?\B5K'_7J_\J;X&_Y$C2/^O9: -ZBBB@ HHHH
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MH.0O/ '8TU;K52H!%P64D(WD<3/G@,"H*)COQWY/&77-_/#=ZAYLC+%$6-N
M2 ["(':3V[D#OSZ4O]IW?]IQ%]BPLTT><':@5U 9N>2>0.@&: +>GM??:_\
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MFB\MXU*[2@ &,*>H^E "V\HN+:*8 @2(& /;(S5'4)KD7R107*6ZB!Y69T#
MD%0,^@Y-:0&!@=*AN+*VNV1KBWBE9/NET!V_3/TH R1XE020K)!A9$5G<-Q&
M<*6#<8X# ]<TR?7Y?LERT%NWFI$\H$C*-BA%.?<_../KS6NVG6CR/(]M"SR
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M0"EHH 3%%+10 F*,#TI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JMJ/_(-N
MO^N+_P C5FJVH_\ (-NO^N+_ ,C0!RWPI_Y$*U_ZZ2?^A&NRKC?A3_R(5K_U
MTD_]"-=E0 4444 %%%% &'XV_P"1*UC_ *]7_E3? W_(D:1_U[+3O&W_ ")6
ML?\ 7J_\J;X&_P"1(TC_ *]EH WJ*** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(@1<<G(SW_EZBI6\+Z6US'.T&66(0D%B0ZA=H##O@&D'A?3S'$DGVB58HWA
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M[JPT73#=F-9,2)'AI-@&Y@N2V#@#.:T:JW]A%J,"13[MJRI*-IQ\R,&'Z@4
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M!E7&5[BI: "BF+*CR/&K NF-P'49Z4^@ HHHH **CDGBB=5D=59\[03UQ_\
MKJ2@ HIK2*A4,P!<X4$]3C.!^ -.H **0D*"2< 55&J6)B27[7#L=MBMO&"?
M2@"W144]Q%;0F6>18XQU9C@"F?;K43)%]HB\R1=R+N&6'J* +%%51J5F;8W
MN8O)!V[]PQGTJR#D9'2@!:**J:I?II6EW-](K.EO&TA5>K8'04 6Z*P&UK5K
M-[9M2TNVBMYYDA+0W9D9&<X7@H 1DC.#6_0 4444 %%<^NMZM>?:)=.TJVEM
MH99(E:6[*.Y0E6. A Y!QDUK:;?)J>F6U[$K*EQ$LJJW4 C.#0!:HHHH **Q
M[_5KV/5AI^FV,5Q,(1/(TT_E*JEBH PI).0:ET?5)K][N"[MEM[JTD$<B))Y
MBG*A@0V!V/I0!IU6U'_D&W7_ %Q?^1JS5;4?^0;=?]<7_D: .6^%/_(A6O\
MUTD_]"-=E7&_"G_D0K7_ *Z2?^A&NRH **** "BBB@##\;?\B5K'_7J_\J;X
M&_Y$C2/^O9:=XV_Y$K6/^O5_Y4WP-_R)&D?]>RT ;U07K3I9R-:1K).!\BLV
M 3[FIZ* *FG1/;VL<31LF!EBS DL22<X[D\_C5NBB@"KJ,#W-FT<>-Q=#R<<
M!@3^@K.MK"]C6Z#$JSPLF[S2WFR'HX_N_3W]JVZ* .7NM$OK@M  /L_D-%S,
MQWY3C=DYSOYSZ5-/ITZ,U[(KJ\22>4%D9BF?+*KQUY4@_6NBHH P+S2;BYMK
M1R@>Y5)=^Z0C8TBG./4 G'TJ*XT6^79';32+;J^=JRG<#M4;@6]&!./>NDHH
M Y[6K34I)YIK?Y8TA<!HW(9AY;<8]=Q&,5!+I]]YL4:PRA&$A2,73XC.$ 8M
MWYR<?6NHHH P8M.U%9T9I"65U,LOF']^-X/W?X< $8]ZC71;B/[(Q5I3#Y;L
M&G8GS-KJ[9)]U/OBNBHH YH:)J$=OBWN'CGV*H=IV8 ^60YY]6VG\,T^/1[W
MR%)DE#HC&,--]QRP(Z<$8!ZYZUT5% &&FF30:7]FC@^1+AW:)9B/-0EB/F[=
M0<>U+'I$XCNWD(>>:S$&XN3EOGX/TRHSWK;HH Y=M*U46NV(!79]^]YLR(P5
M0,MT(X/8]J=+H^H_9O+21O\ 7,[>7)M)0EMJCMP2#[_A7344 9D%A-':7RN[
M/-.6VLSD\8POL/PJK>:5>3K&J%2JVWE[2_ ?RY%/ZLO-;M% &%#8SW5I?QEV
MVDF*W,A/*@YR<^YVY]%%%Q9WL_G7*P>7=.ZF("49B(4C<3C!!R<CTK=HH S+
MP7-Q!$T=N6D@N%8J2%W@=2/;GC-5387LR/"T9@!NQ<"59%)QNR0!CJ*W:* ,
M/4--NP+2#3@J0P!<-YA# AAG/J"N?QIO]EW$FG1QRQ;F@NEF16E.XJ"#DMTS
MU]NE;U% ',MHE]#9K%;N1D*94$I^<ACD#/3@CT'&*TFMKF!;.9%^TR01&-ED
M<!B3CY@<8SQ^IK4HH Y^YT[4+B68J61I#DR"<C*'H@ Z8]?;WJ.YTRZM[=_)
M\U@S[2HG?)7SD*C/8!-PS[UTE% ',MIFK-)%LQ&B;BI\XEE4[OD)[XRN/Y\"
MI/[/NK>:&"-Y=DS!6_>L=J;07;)Z'( '^\:Z*B@#-BM9H=9:2- MLT6TY;@'
ML%4=.^:SSI&H>0&6=ENL*N_SFQM$6T_F_.>O>NBHH YB+1K\7BR)OM[<S;_*
M2?>R<(-Q)Z_=88YZ^]0Q:9J<]FKIYL:DYE1IR6FY.#S]W'''^ KK:* .?DTF
M^VN\4\AF9L%FF(W)L QQP"6!Y [YJ"'1M06:)E+P0^<S^6DVXIDK@DGKP",<
M]:Z>B@#GO[%G6.VW*93$T$K*T[',@W!SDGW7ZXI=2TF]N)I98)9 KS9*K+@[
M-@ QG@8;)_6N@HH YE+>[EU8I$TK&-V,LQE8!AYB%1C&!A0PX_K37T;4"H:(
M>7,(Y(DD,Q+@$JWS'H2<,,CU!KJ** .:.CWYM7VS2AR$"JTO.T,2Z<<#@@9]
ML9J6UTN\COK1YM\HB?<9GGR0OEE=FT<$ACUKH** .;BLM0:>2>)77;/(QWSM
M^^42Y50#POR@^W/O0=+U&2X$K(%E=0/,%P?W7[QV((_B^5@*Z2B@# M--O('
MMA.AFCC( 19B!&<* WN.#Q_C3;K3]4FU&>5=JPL""B2E?-7*X'L2 PSQC/XU
MT-% & =.NR9-L+ ,%V_Z0>$&,Q=>"<'YO>EBLM3B=%',;/&W,Q_<JKDE?]K@
M@>^*WJ* .=71;B,VC%6E,/EN=T[$^9L=7;)/^TI]\4UM,O8+5Y6GD67:PD<3
M,?EV  #KCD'D#/.:Z2B@#GK.Q>^TIEDB98S>)+$CRL=J*RGJ>>S<4J:/=2/&
M;J1V&4#@3L,J V1Q[E?KBN@HH Q(M*N/[+N[69B_GVRI\TK',FTACGMDXJ&;
M2;UO,CB+)D8$@G893& F.Q'7=[>]=#10!A:KHS7-TK01@J;?R2QD(*@.K?R!
MYZTR/2KZ/5(G\Z3[+&Y\M5DSL7<3SGJ""!Z\5T%% &'<Z3-]JNY(-ZK.[,VR
M4JS#RPHZ\ Y!J+[#J(CDWP1R3.BJ&$[!43@% N>O!.?>NAHH Y^"SO++2[E[
MEB9]B%"C%B67.!Q^ J+^S-56=YA(79H\A&E^4$K\R'OU)(Q[5TM% &)I.FW=
MO(SW<C$JA6+]X6"99CTZ="H_"JMMHM_]G1+J:5F!8O\ OB S;,!ACG!;GFNE
MHH YM=*U WL,LG,B9+S&<G>"R' 7M@ C_P#6:9-87%A#$\[R21$+YT8F<F1_
MF[C)'53Z<8KIZ* ,(6=]/I6GP$%94B)DE:0DJYC90/4G+9S[4QM.O[J2:6<-
M%\C>2@N#\K[4"DX]U8_C[UT%% &-I5E?6D]U)=2/*S$[<N-K\D@CN.,"JHTJ
M_P#W\OE*[7*21%99060,%&2<<@;3P.V*Z.B@#.GDO!ISI:0L9E/E*78*2!P7
M&?Q(SUJD-,N(G1(;=!"6AD!:3YH_+ ^3WSCK[G\=ZB@#G9--U">%+EHVCO-[
MLZI.%^9E !! Z* !CN/RK=@\SRP)L;P "1T8XZ^U2T4 %9GB.SFU#PYJ%K;*
M&FE@=44G&21P,UIT4 <M>W]QK8L;6'2=1@9;N&9WN(@B(J.&;)S[8&*ZFBB@
M HHHH Y2ROKG1K>\LIM(U*9S<SR(\$0='5W9EP<^C=^E;7A^TEL/#VGVMPH6
M:&W1' .<,%&16C10 4444 <]?RSZ;XH-]]@N[JWFLUA!MD#E75V;D9'&&Z^Q
MJ;P^D\MYJM_-:S6T=W.C11S !\+&JDD G'(-;=% !5;4?^0;=?\ 7%_Y&K-5
MM1_Y!MU_UQ?^1H Y;X4_\B%:_P#723_T(UV5<;\*?^1"M?\ KI)_Z$:[*@ H
MHHH **** ,/QM_R)6L?]>K_RIO@;_D2-(_Z]EIWC;_D2M8_Z]7_E3? W_(D:
M1_U[+0!O4451U@SII5S);3F"6.-I X4-T&<8/% %ZBN*MO$>H6,UL]V_VV&6
MQMIY3\D9C:60KD #GJ./;K6SH/B5==N;B-+2:%(LE7;HP#%>>.#QTYZ]: -R
MBN"T7QC?")#>E;A[B.(Q*^R,!G=E)W+D*G ^\-V>U:?_  G$.;3_ $9?WL@B
ME ER8V+L@(XPRDJ<'(R.U '545Q%[XUNYM+B>"U2TEEBM[C>UPK%4DD"C (^
M8D Y],CO6SJOB8:7J#6WV;S%C6-Y&,@5L.Y1=BX^<Y'/3\30!O45R*ZSJ:>#
M-5U.:5$NHYIA%@ADC"R% !P.F#USGKWP(W\275AJ,UK+=B]BMY 1-&%3=^YE
MD,;X!&1L!^7'4?B =E17*)XXQ<113Z9.I,"SR>6WF% REEQQ@\+SSU/&<&D/
MB^YCEAEGM+86CV$MX1%<>8YV;2 . "<-R/QSQR =917,1^+Y9+N*T6PC>X:4
MHVRZ#1@>7YF0^.>.,>N.QS4J>*RWAN?5/L@,L,HB:V$O*L65=I8@ 'YAZCWH
M Z*BN4D\<"&>\BDTZ4&URA8-\OF J""Q  7+?>] 20.*FN/%QM+HPRVD9\OR
MA*4G!.Z3[NP8RX'<\=^.#0!TM%<K8>,Y+N>UCETX1+<&(;A<!MOFQLZ<8&?N
MD'\.M,M?'#S&W:;3?+CF$+;DG#D+*K,G&!D_(01].M '6T5R,'CF2[MX'M]+
M;?.QV"278I41F3.=OH"",=>YJ.3QG->7-C]BA$<+3HKAI5\R3,!EVA3T'*_-
MGJ/2@#LJ*Y^/Q2K>'AJKP*L:3".Y02']P-P5B25&=N<D8]>:KQ^,]TL0:QV(
MWD[MTP#XE8B,JN/FXP3TQGO@T =116%HGB9-:G2&.%48VBW+8D#;269=IX_V
M:IQ^-#,%2.Q42F1;=Q).$6.8[RR,V.,!,YQSN48YH ZFBN.'CF4&6=K-/LOV
M>&2)1(3(6>1DYP/N@J>1GC!YS@6]4UV[D\.V-Y91RVTUU=1PE-JEP"Q4@;N,
M\<$XH Z:BN0GUR_AN+AC<JCVMQ!;BRD1?,N X3+$@]3N.-O'RGKV?X:UO4+_
M %B:"[FW1[)G0.BKNVS% 4*]0 ,-NYR1V- '645Q+>+=27R+A[> [&O?.MXY
M>"L)&"21D$<\=\@\=M;3?%::GK+V,5G,J*#B8],A5;D8X&&X.3T[<4 =!17'
MVOBB^@:Y-U%%)+)>SQ1(TXCBC2(<C=MZ_7.>3P!58^,9TO&NRTAL07D\@H ^
MS[-'(%]OF8G/]* .YHKE9O&C6Z2>;8!I$D, $4X='F*JT:*V!G=NQ[$57E\<
M!D%Y# [01Q3-L$BXE9%C+ G&1M9RO7J#F@#LJ*Y*[\<-:)<*]@GVBV\\RHUR
M%7$84G:Q'S$[UXP._P"-W6_%!T?R,6J2B2UDNFWSB/"IMR!D<D[N![4 =!17
M+_\ "8R.[+'8(,W#P1--<"-6V+N8L<?+Q@ <Y.>PS42^/8VE5OL+BW)C&?,'
MF_/%Y@Q'C)]#S[T =;17)GQP4MS(]D@QY3NZW >...0$AF8 G(VX( /4'..:
M9>>,3+?BSM-J'[3$%F1MPD3SUC<$$#!Y(XS]: .OHK U?4[FQUW3HX9QY,\G
MER1L$V_=8_[X8X&#C:,'-;-K,UQ:12NJ*SH&(1]Z@D=F[CWH FHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BL7Q8UR-"86;2+,TT*@QLRG!E4'E>0,$Y([5F7.
MM:IIMXMDELK>6L86+;)*TX(^=Q*>R_[7)Q[B@#K:*S]#N+N[T6TN=0\L7$T2
MR,L:%0N1G&"2<BN<FU?5(_$TE]';WDFG"1K)4X\MB%X;&<Y,@V[L8P>M '9T
M5P:^,M4,$Z[(WG6.)UV6<@"LRNS(P+9ZJ%![GMZ/3Q!K CGEM;5(V<37#++'
M(_W(8F"CD8R68<>G3.: .YHKB+CQ%J\Q=E86\<%Y )&CMF=1$Q(())R2.-W
MQGKS76:G>C3],N+O8TGE1EPB@DL>P 'J>* +=%>=I>ZU96T%KJ#W<5Q'>PSF
M:93*/+=&W@["<JK@\9X&W.*GF\2Z_=:==".,07"V9G0Q6S,001DG<?E+#E1@
M\>XH [VBN'U/Q+?323VL,#SV[1'#B"2,[EV'<"#G#9..G3ZUK:%K&IWNHB*^
MBC$,L4LB%(F4H4EV $DG.1SVH Z*JVH_\@VZ_P"N+_R-6:K:C_R#;K_KB_\
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M'&,X^A-5AHE@LJR+!M*N) %=@NX'(. <'!S^= $,NOVR,"H=T(X*KU/R=R0
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MB54XX!SD=!],4 6()1/ DJC =0PY!_ED5)4-M:Q6D0C@4JBC 7<3COW^M34
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M#Z'VH EHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBJ?\ :UG_ &N-,$P-X8S+
MY8!X4$#)/0=: +E%9T&O6%S.D,<^96:1-A4@J8SA]V1P!D<GU'K5WSXL@>8F
M2-P^8<CU^E $E%-5U<91@P]0<U4&K6IU+[ 6=;@@E0T;!7QR=K$8.,CH: +M
M%9UIKVGWKQK!/EGC>3!4@HJMM;=G[N&XY]#Z5=,T0;:9$! W8+#IZ_2@"2BH
MTFCD8JDB,P&<!@3BH-0U*WTRW\^Z\P1#)9DB9P@ R6; . /4T 6Z*S[O7=/L
M'9;FX$>(#< E3AD! )![G)' YY'K5O[1$$+-(JA<;MQQMSZ^E $M%1-<0H?G
MEC7'JP%2T %%90\2::T4TD<^]8+E;63:I^60L% ^F3UZ5>FO;:WA,TUQ$D84
MON9P!@<DT 3U6U'_ )!MU_UQ?^1H:_MQ;&=)!*HB\T"/YBRXSD#O4=Y/'+IM
MR%<;C QVYY'R]Q0!S7PI_P"1"M?^NDG_ *$:[*N-^%/_ "(5K_UTD_\ 0C79
M4 %%%% !1110!A^-O^1*UC_KU?\ E3? W_(D:1_U[+3O&W_(E:Q_UZO_ "IO
M@;_D2-(_Z]EH WJ2EHH Y6?PY<S.X*JB/K NR8Y-K>5Y87@CD'/:H=.TCQ%#
MJ6G27=[(T,4:+(!+G&-VX-G[V[*\X)X[8Y["B@#C;SP]JTWB.ZN;8I$CW'G1
M2NZLB'R/+W;,;MX/OC':F/H_B$Z?+%&602,N$>^=G1@C9</QP6*G;[9QSBNU
MHH XTZ)KCL)YYIYF,D7F0I>-&'00A6P1P/WOS'U _ W(=$OT\-Z'IYD:)[9X
M_M7E3%<H%8$!AUYQ7344 <7;Z+XCCL94NKJ6X;SD:2-;DIYZC=NVOU3.5../
MNXXI;K1O$$K7GD3NCNDVV3[6V&##]V@7^ K_ 'AUQWSQV=% '&7&@:XHNQ:7
M<X5Q<)%NNV.%.PQ]3P00_/49I9=!UU#<"ROI8]XN$0R7+/A"R&(<YP<!QGJ,
MUV5% '%C0M?:)&-W/YD<(\L&Y(VOYV[#8.&PG&3GTJ*3P]KC74\SM,9?)EC$
MR7GS2%I59=H/W%VK@@8Z?C7<T4 <IK<6J)IVD16TK1ZD_P#H\BPLY3:R[7;/
M/W.&!8]O>F76B:V][<K;W3HC"01SFY;'EF(JD>SLP;#;^O&>^*ZZB@#G;#3M
M4N;/5(]0D>V>Y1%@*3ES$1&%+ C&#N!/%9TVC^(IK9)9)B;F99"\<=VR+;RG
M:$<$?>50OW?4G@YKLZ* .)N/#NM0K?)8RL@FO1<,Z3D-,ICQ@9/RD-SC.#QZ
M8K9UC1I=1T:SB=8Y[VWE@D$DF 05=2[#T) :MVB@#F_$$-Y/KFGP6,TRK< Q
MW2JS )$"&W@C@-\I3KGY_:J$>C^(TCO$GN6N/-E7/[\H"NXG<F#E3C:,<# [
M]^SHH YWP]I>J07'GZO<222"TAB $Y9-X#;VV]"3\O-9T6AZ^P"37,J@O$)W
M%VQ,Y$H+.O\ SS&S(VCUQVS79T4 <M>:%?77A,64I>:YANO-C5KA@6C6;<JE
M^N=F!ST./3-56\/ZW')=26%R;:2YDNF/[XE5W[3&=O0'(/(Y&:[.B@#E)M!U
M"]\'26%T\DERTRN@>8@JH<';N!YP <9)[56U+0-;N_[1B24LDR3J&>Y)25&&
M(TV'A2O&6[X/7/':44 <;=Z%K/GWC6K$)//-)&L=R8MCL$V2DC[P&UOE]^])
M?:)XD-W-]DO28E.(B9RNX2C$I([;#R@_"NSHH XVYT'6W-P8KF9=HG-OMNF7
MYC(IBSZX4'K2Z0-1_P"$P9)FN9$C-P9Y/-<Q'<R^4-I 52%R,#/0FNQHH X)
M-,U^_6]:VFN80TES'O>Z8%QYWR;5/W-J@X(Z@]\\6M1TO6;4WTL$\YBCCE:.
M47+L3%Y1"Q"/^^&P=W7WYQ79T4 <1;Z1K[VJR,T[6[,K&T-^XD8^7C=YG4#=
MSM__ %5,NE>(HFN-\OVDO;Q1N[W#+N8;0WEA2 HP&//.>^#78T4 <OH.D:Q:
M?;)+R9!=26BPQ3,WF897E*D^N R?6D\-Z#?:-))'<)$\;7?FJ\,K+_RR"L[
MGYLL.A[DGTKJ:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *H3:<TNN6E^'4+
M!#+$4QRV\H<Y]MGZU?HH YS4?"27UQJ\R3+"^H)"H94Y4H<G/J&X!]A6;/X$
MNIH88UOXD6(?+^Z)*9W[@&SG:=_0],8'%=K10!4TNPCTO3+:SB5%6&-4^1<
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MQ[U5&H:G(P\B17B7;B0VY_>@N%SC/&,G_OG/2@#HJ*YQ]6U".X\H8>1%&(A
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M:KYJH&,9)"E@ ^/0C)Z\<>] '1T5G:5>R7 E2X.9%E*A@A52.O&>N.^>]:-
M!1110 4444 %%%% !1110 4444 %4=2U>TTE8C=,^Z9BL<<<;2.Y R<*H)X%
M7JY_7+F&S\3:'/=2I#"%N$,DC!5!*K@9/&3@_E0!H:;K=GJLLL5NTJRQ %XY
MH7B< ]#A@#C@\^U:%<]97EO?^-;B6SGBN(TT^-6>)PZJ?,8X)'?':NAH *BN
M+B*TMI+BXD6.&)2[NW10.2:EK&\7*6\(ZJ%4L?LS\ 9[4 $'BK3;B>&+_2HC
M.P2-IK26-&8]!N90,GM6S7,:YJ^GWUMIT-I?6UQ*]_;%4BE5V($BDG /8 G\
M*Z>@ HHHH Q9_%>FP331YNI/(8I(\-I+(BD=1N52..]:T$\5U;QSP.LD4BAT
M=3D,#R"*YK0]7T^QTR_AN[ZVMY8[RZ+1RRJK+F5B."<]"#^-:7A12GA/2592
MI%I'D$8(^44 :]%%% &;J.O66F7"6\YF>=UWB."!Y6"YQDA0<#/'-2Z;JMKJ
MT+R6CL?+?8Z.C(Z-C."K $<$'\:RI[ZUL/&\K7EQ%;K)IT81I7"!B)'R 3UQ
MD?G3_#\\5WK.O7%M(DT+W,861#N5L0H#@C@X- &_5;4?^0;=?]<7_D:LU6U'
M_D&W7_7%_P"1H Y;X4_\B%:_]=)/_0C795QOPI_Y$*U_ZZ2?^A&NRH ****
M"BBB@##\;?\ (E:Q_P!>K_RIO@;_ )$C2/\ KV6G>-O^1*UC_KU?^5-\#?\
M(D:1_P!>RT ;U%%% !1110 4444 %%%% #(XHX0PC0+N8L<#J3U-/HHH ***
M* "BBB@ HHHH 8L:+(SJH#OC<0.3CI3Z** &2Q)-$T<JAD8893T(IP  P. *
M6B@ HHHH **** "BBB@ IABC,RRE 9%!4-CD ]?Y4^B@ HHHH **** &NBR(
MR. RL,$'H131#&&1@BYC!53C[H]!^0J2B@ HHHH **** "BBB@!HC42-(%&]
M@ 6QR0,X'ZG\Z=110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)>WEF6X<QQ!6<B"3A6R5;&WH0I.>F*C/BS383*;FX145V"&)7DW*J*Q8X7C
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M_7LM &]5>^MQ=64L)B27</N2,54_4CD58K/US5/[&T>XOA UP8@,1(<%R6
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M#D9'&/SI/[<L-ZHTQ5V;;M9&4KTZ@C@<CD^M &A167::Y#<9\Q7B)D9%!1N
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M]=L)-4T*^LH659)X612W0$CC-:%% ',W(UG6#9V\^DI9QQW,4TDQNE< (P;
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MK7HH S5T.!7+&68EV#398?OB#D;N.WMCTJ>VTZ&U96C+Y6,1#)SP"3_6K=%
M&4WA^W:-E\^X4N6WLK %@V,C@8 ^4=,?J:F32(4(_>3%%W;$)&U P(('&<<]
M\U?HH IR:;&\$$:R2Q- -L<B$;@,8[CN*CCT6VB?*&15'W4!^5?DV<=^@'Y5
MH44 9<'A^TMF8Q[P"RMCY>JD'.<9Y*C(SBK%]IL=^Z,\LT9563]VV-RMC(/'
ML*N44 9;Z#;NSD2SJK!E" J57<06P"#UQWS[4]=#M51D!EPR[3E\G&[=_,5H
MT4 92>'K2.W,"-(L>\/A0H/'09QG\<Y]ZG7285L;BU+RE+@L7;(!R>N,  ?E
M_.KU% &9;:%;6DL3QO+F-VD ^4#<W7H!Q[#CVJ>73()I'=R^78N<'N4V?RJY
M10!B3>&H!'+]G=Q)*ACW,W**2I)! R2-HQD\?2KMYIQN3:"*5X%MV)S&<-C8
M5 ';O5ZB@#-71+>*)4@>:$HQ971OF7( (Y!X( JNGAJW9)8YWD:$R%XX@?EC
MX ! /<8^GM6U10!072((HL)DL/+]%!*,67@ #J><"DL]+CATHV4WSA]WF<]<
MG/'L.@]@*T** ,XZ-$Y!EGGES@2;BO[W!RN[ [>V/?-(VA6CQ>6X=DPJD%NH
M"%/Y$UI44 48])@CTR6Q#.8I5*L0%5L$8_A Y]ZA&@6WVI+EWDDN%.3))M8L
M., Y&.,#I@^]:E% &?\ V-;B3<'E +;G3(Q(=Q8;N.Q)Z8]\TD6AVL-U#.F[
M?$BQC(4[@H(&21D$9[$5HT4 4Y=,AEO1<LT@8%#M!^4E<X/_ (\:BM-#M;*[
M^T0[M^.=P4Y/3.<9''H<5HT4 49=)MYGD9B^9"S'#?WD"']!59_#5B_F<,-[
M!_NJ=K9SD$CGZ'(]JUZ* ,R30K:4$,TH4H%*J0!PI7. .#AC[>U1ZGHS71<V
MTAC:?<LK[R#M*JI X/91Z<]ZUZ* *=UIL5V$W/(A5#&2A +(<94\=#@>].6P
MA6SFMEWB.7?G#8(W9S@]NM6J* ,J'P]:0Q2HID(E5E?D#(8*#P  /NC]:FM-
M.\J&Z$K9:YD9WVD_*#Q@'J/\2:OT4 8R>&+2.&1(Y;A/,4H[(RJ64J%(X&/X
M1TYS4D&AIY8\]VW,Q:5$/R2?.64'(SP3[9K5HH S[;1H;:5)!+.YCV[ [ A0
MH8 #CIAS0NC6RF(@R?NHQ&OS=@&'\G-:%% &7)X>LY#&3OW1[=I.UN H7&""
M.@%/?1;=XP@:5<!@I5N5RX?(_$"M&B@"G=Z='>,K.\BD*48H0-ZGJIXZ<=N:
MFM;:.T@$,60@)(!]R3_6IJ* "BBB@ HHHH **** "BBB@ HHHH **** "JVH
M_P#(-NO^N+_R-6:K:C_R#;K_ *XO_(T <M\*?^1"M?\ KI)_Z$:[*N-^%/\
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MN9E18;9-\@\LY<!V#$'/]U<]^M7;G49HM%%P'A6?>B.=I98RS@$$ YR ?TH
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M&!@8'04BP1*V5C0').0H'7K0!C6>M7)M;:.:&(W,L<;*S2X0[E8Y8[>#\AX
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M$1OG)60(20%X&3GC-:XL[=8FC$$0C8890@P1Z$4YK6!D*-%&4((VE1C!ZC%
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M988.<O#GGMPY&*GDU>422+'#$0)?(3?+M._U88^5>..I/''-7X[.WB $4$2
M= J 8_S@?E0]E;2,[26\3M(NURR EAZ'U% &2WB&5F416L7S,D>YY]HW,6'I
MT^4\]\BE_P"$C/DF86Z^6@PX\WYBQ!QM&.5XZ_X5ISZ?;7"HLL2%48,%P,'
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M44 %%%% !1110 56U'_D&W7_ %Q?^1JS5;4?^0;=?]<7_D: .6^%/_(A6O\
MUTD_]"-=E7&_"G_D0K7_ *Z2?^A&NRH **** "BBB@##\;?\B5K'_7J_\J;X
M&_Y$C2/^O9:=XV_Y$K6/^O5_Y4WP-_R)&D?]>RT ;U%%07+N@C$9"L[A<D9Q
MU_PH GHJOY=S_P ]T_[]?_7H\NY_Y[I_WZ_^O0!8HJOY=S_SW3_OU_\ 7H\N
MY_Y[I_WZ_P#KT 6**K^7<_\ /=/^_7_UZ/+N?^>Z?]^O_KT 6**K^7<_\]T_
M[]?_ %Z/+N?^>Z?]^O\ Z] %BBJ_EW/_ #W3_OU_]>CR[G_GNG_?K_Z] %BB
MJ_EW/_/=/^_7_P!>CR[G_GNG_?K_ .O0!8HJOY=S_P ]T_[]?_7H\NY_Y[I_
MWZ_^O0!8HJOY=S_SW3_OU_\ 7H\NY_Y[I_WZ_P#KT 6**K^7<_\ /=/^_7_U
MZ/+N?^>Z?]^O_KT 6**K^7<_\]T_[]?_ %Z/+N?^>Z?]^O\ Z] %BBJ_EW/_
M #W3_OU_]>CR[G_GNG_?K_Z] %BBJS)<JA/GIP,_ZK_Z])"+F6%',\8+*#CR
MO_KT 6J*K^7<_P#/=/\ OU_]>CR[G_GNG_?K_P"O0!8HJOY=S_SW3_OU_P#7
MH\NY_P">Z?\ ?K_Z] %BBJI,\4L(>5'5VVD!,=B?7VJU0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%55,\LLNR5$5'V@%,]@?7WIWEW/_ #W3_OU_
M]>@"Q15?R[G_ )[I_P!^O_KT>7<_\]T_[]?_ %Z +%%5_+N?^>Z?]^O_ *]'
MEW/_ #W3_OU_]>@"Q15?R[G_ )[I_P!^O_KT>7<_\]T_[]?_ %Z +%%5_+N?
M^>Z?]^O_ *]'EW/_ #W3_OU_]>@"Q15?R[G_ )[I_P!^O_KT>7<_\]T_[]?_
M %Z +%%5_+N?^>Z?]^O_ *]'EW/_ #W3_OU_]>@"Q15?R[G_ )[I_P!^O_KT
M>7<_\]T_[]?_ %Z +%%5_+N?^>Z?]^O_ *]'EW/_ #W3_OU_]>@"Q15?R[G_
M )[I_P!^O_KT>7<_\]T_[]?_ %Z +%%5_+N?^>Z?]^O_ *]'EW/_ #W3_OU_
M]>@"Q15?R[G_ )[I_P!^O_KU&YNEGBC\^/#YY\KT_&@"Y15?R[G_ )[I_P!^
MO_KT>7<_\]T_[]?_ %Z +%%5_+N?^>Z?]^O_ *]'EW/_ #W3_OU_]>@"Q15?
MR[G_ )[I_P!^O_KTML\C&59&#%'VY QG@'^M $]%%% !1110 4444 %%%% !
M1110 4444 %5M1_Y!MU_UQ?^1JS5;4?^0;=?]<7_ )&@#EOA3_R(5K_UTD_]
M"-=E7&_"G_D0K7_KI)_Z$:[*@ HHHH **** ,/QM_P B5K'_ %ZO_*F^!O\
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MK0!8HHHH **** "BBB@ HHHH **** "BBB@ JMJ/_(-NO^N+_P C5FJVH_\
M(-NO^N+_ ,C0!RWPI_Y$*U_ZZ2?^A&NRKC?A3_R(5K_UTD_]"-=E0 4444 %
M%%% &'XV_P"1*UC_ *]7_E3? W_(D:1_U[+3O&W_ ")6L?\ 7J_\J9X%.?!&
MD8_Y]EH WZH:O=K86J7+PSS+'(I*01&1^XX4<]ZOU4U3(TZ8B<0$#/F$D <]
MR.0#TR.1F@#)_P"$SM?^@9K7_@NE_P */^$SM?\ H&:U_P""Z7_"HI-:N88"
M\:BWC6$,&F#R\@'"]><XX/7'N:F;6;R)7FE5?))95"Q$E<("&)S@C)/IQWH
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M(K!W4P#Y?E91TSG.X<]?2@"7_A,[7_H&:U_X+I?\*/\ A,[7_H&:U_X+I?\
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M#"W[UB6S\P.0>AXY^E %7_A,[7_H&:U_X+I?\*/^$SM?^@9K7_@NE_PKH:*
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M,Q@8K$KL#&0K'<5'!!QC/4'&*BEUB]%Y]GC,(D=F7RS$Q,8$B*"3GG*L6[4
M'_"9VO\ T#-:_P#!=+_A1_PF=K_T#-:_\%TO^%-FUJ]%S':J!YI9HW;R3CJR
MAUY_V02.G/6FQZ]<QV40++-.8T*GRS^\^0EC@?[0Q0!)_P )G:_] S6O_!=+
M_A1_PF=K_P! S6O_  72_P"%36&I7\NKFUN%AV*N20-I/R@[@,DXR2/PZU"^
MHW"2*R,QE'G-+&<D1C>%!('8 $X[X- !_P )G:_] S6O_!=+_A1_PF=K_P!
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M4X?_  ('^-=U10!PO_"2>./^A3A_\"!_C1_PDGCC_H4X?_ @?XUW5% '"_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
8% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
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M,XRN">1P.M)IOA[2M&G>6QMQ"[C9_K&8!>NU020HXZ#'2IH-$T^W%YY=LO\
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M38?">C01Q1QV?RQ026R9D<[8W^\O)Z'].U.?PUIH1?)M(O,CLVLH]Y+*(C_
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M_P#/2\_\ 9__ (BM&/6K.726U)#-]E52Q)A<-@'!^3&[]*SO^$XT7_GI>?\
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M_P#X#_\ UZ/^%Q^&O2__ / ?_P"O1_PN/PUZ7_\ X#__ %Z/^%Q^&O2__P#
M?_Z]'_"X_#7I?_\ @/\ _7H_X7'X:]+_ /\  ?\ ^O1_PN/PUZ7_ /X#_P#U
MZ/\ A<?AKTO_ /P'_P#KT?\ "X_#7I?_ /@/_P#7H_X7'X:]+_\ \!__ *]'
M_"X_#7I?_P#@/_\ 7H_X7'X:]+__ ,!__KT?\+C\->E__P" _P#]>C_A<?AK
MTO\ _P !_P#Z]'_"X_#7I?\ _@/_ /7H_P"%Q^&O2_\ _ ?_ .O1_P +C\->
ME_\ ^ __ ->C_A<?AKTO_P#P'_\ KT?\+C\->E__ . __P!>C_A<?AKTO_\
MP'_^O1_PN/PUZ7__ (#_ /UZ/^%Q^&O2_P#_  '_ /KT?\+C\->E_P#^ _\
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M /7H_P"%Q^&O2_\ _ ?_ .O1_P +C\->E_\ ^ __ ->C_A<?AKTO_P#P'_\
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MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBJ6M?\@._P#^O:3_ -!-<U\)O^2=Z?\
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MJE:>!-%L[NWN8X)GDMXGA3S9WD'EL""A#$_+@D 5+9^#-(L+BUF@AE$EHS&
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M6BBBBBBBBBBBBBBBBBBBBBBBBBBBBJ6M?\@._P#^O:3_ -!-<U\)O^2=Z?\
M63_T,UV5%%%%<U\1?^1 UC_KA_44?#K_ )$#1_\ KA_4UTM%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%(>E<H/!GGZCXEDO94>VUE8PBH#NB*KC/US@CZ5E:7\.[V
MQT>V674H6U.SU!KZ&?RV9&+* 5=<@\XZUMZ;X5<W6K7NM2P7-UJD2PRK#&5C
M2,+C:,DD]>IK+TCX>/%X:U/3M6OA<3WJ)"LZ+_JXHP/+&#Z'GWJ73O!$EJ+O
M?#HT3O:R6\<MK;.CL7&-S$L<#V'YT:;X)N[*?PJ[W4##1898Y< _O"PP-O\
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MZN@$D<D]W9,I!.XKOCRP^ASSVJQ<3W5O<W-M&\AM$OT1V=V^2,PAL;@"0I?
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MI#+>&:4.UQ=XCG;C[01&O0>P4CCKMS5G6]3_ +-M T2H]U*?+@5VVJ6]6/8
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MYEQG'MS3KR[CLK2>YE!*01M(X49. ,GC\*9<ZA#::=)>R;O*CB,Q 'S%0,G
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MTK$\5V-Q>7$@@MY9%:Q:/* ]3+&<9'? )_"BYL+F._O4MK=_L/FVSM"@PLB
M$.%]_NDCOC'>MM+RUM;7?Y;PP!'<DQ% JKU)XX]O6K4,RSP)*F=CJ&7(QP1F
ML6VE:^UM[NYCFC2W#1VL+0L#_MR$D8R<8 ST_P![BIJ.G3ZF]\MH;D>=921>
M9.I!C<D85,XP#@Y[<+6CIIG.IL46Z%H8 7^TDY$N>B@^V<XXZ8J3P]%)!I C
MFC:-_.F.UA@X,KD?F"#^-9]]!<0ZW>ZC%;RR&WB@=%1<F4#S Z+ZG!''KBJA
MTV_1[AO*D=Y;>W>< X\S][(TL8/'.UL?3%:DL0%U8WEI;2?9[<RH\2Q;""P
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M>.XMF2:.,QEED=V9_O @@[@,@_P#KV'T"9;+4($@W^;=VS(78%GCC$()8_\
M &^OXTZ;3+U/$XOEM/.@6Y:08=<@&!4R >^X$5'!HE[;R))(C&%XYE:"$H?*
M\R4O@;Q@C:0#C'W>XK1T/2WTVYO08R(F,*Q,S!F95B5>3]0:+J&XN]=A:>WE
M-E:D-$%VD22$??;YLX7)P,=>>PJK;Z5<0VVGV4L86"PG,QG+C#*N[;@=<\C/
M3&#[5KP7S76F)>06\AWQ^8D385FXR!R< G^M8L6E7<L"W,T3MJ NH[J3?M57
MQD>6O)P%4D#.,GGN:GD@U&(:A=VMN4N;V1%095C"@7&\C(!/4[<^GO4T>FVT
M>FVT)TR2=8<JHEV%P3U8DGJ3R3GO3]%EFMXHM-N]\EU# ))'ZJH+$*N[N0!C
M\,]ZJ:G::C>7:*(#Y4=[!*A1D"F-64DG/S;N&X'&,=:OZ-;3VL%S!<1D9N9I
M%;((=7=F&/P/.:H0Z1*=1L95CN8[2P#M'#+(I^8J5"J!V )Y8^@'>I]7M9=1
MM/+2RD6?:##(SKMB?@Y89YVGM@YQ5>\TFZ>'5+*.(-%J$H?SMX 0%55\CKD;
M<C&<YK2U'[89;?[-'NBRWF,FW>O'&-W&.N>]8RZ3>MX-@TJ2TW3!(]X+*5XE
M!*]?[H)]/Y5)J6C74_\ ;K0P@O=>0(3N +;0,_3!S6R;\)?Q6K02AY2^TX!&
MU0"6.#P,D#US52]TLWNO12RHQM1:21.5D*Y)9" <$$@@&F7FG,=1M9;"V\B:
M)D5IU(5&@'WD(')XS@8X.#FDB:33]>NWEB<K?RQ)"5P?NQG<3Z 8-6]2%V9H
M!;Q%XB&$C)MWJ>-N-W&T\YZGIQ7/6_A^]71+V&2V3[1)I$-K'EE)\Q1)E<_5
MEYZ5/>Z/>FQN[6.R2=Y[];E9BZC"^8K9.>=R@8'L!SVK6U1+R21$MX2T+1N&
M9"F\,<8'S<;3SG&3TXJGHFGWEA-:F>$X_LV"W<A@=CQ[MP//^UP1GH:-5M-1
MO9S&L!\M;F"2-D9 I175F+9^;<,-P.V/>HH-"E%OI\4MN@5;RZDN!D?<D$O/
MOG<O^14WA6.62QENKA@\DC^2K@Y#1Q912/KAF_X%5'6-,U74EV_9N5^TC"N@
MCPT4BIC^(DEESGO],U-?Z%<SR.(;>+R_L5O'L8@*YCEW%#[%>.F.:OV%M.?$
M-]>R6GV>*6WAC5BREG92^<@>FX"LS4--U:_EC9[?!C6Y4A701_-&RKM_B.25
MSGOVK2T*PN;)KLW$>WS##MY!SMA13^JFLJ^T?5=5*^;$(G^RS1."R>7N8H0H
MQ\Q4[2,GUZ4W5;:<ZS;WDEDMM$S6L .]2S,+A3C [ 9P?KTJ_:Z5=+%I]L\0
M0V;.7N-P/G95E^OS%@QSCD=ZS;C1M3GTR&S^Q &WTI[0L9%(>0F+&.>F$/)K
M5U+29KC4+^6.!6673#;1DD?>)8[?8<CVJC-H5Y)8:LAMU:6YLH(8\L,LRJ=P
M)^IJ>_TB]?Q!]LMT(MH_).Q"N6VK(#@$$97<I&<>QXI(M!>*[E>.W8Q/8S1C
MS2A8/)(6*X' !]N*2WT>=8FBO;:21)+*V0F.1=R21;B>2>H)!!Z<5>2RU"\\
M-W%I=R[+J59$63 !VDG:6V\9QC...M4K_2KJ_D65+00(H@C,.Y2'VS(Y/'&%
M"G'KD\"K?BD9TRV C64_;K;",<!OWJ\57&EW?]I2:@8?D-TLWV;<N2!%LW>F
M[/.,]NM12:3?P;KJSB:.^>9GC 9#&D;,"8WSU!P6^7D$\>\-W:SVEY:K+;"0
M/K+3QY9<.#$Y&/<8[XZ=:MVFEW=K?"^:#>IGGD^SJPS'OVX89XS\ISS_ ,M#
MU[UX_#]TBWFZ",F73I(8P&&%9I)&\L>P#*,].*DM=$N=[QWHF9))89E:)D^4
MHJ<,2-W!4]"<@]N:73M$N+==$$ENB_99IY)0"/EW[\'WR2*@MM"O8PPN8Y&A
MEAEA:.)HR5#2NW\0(PRLO0\;1QZ2P:%<P6R1I#\R:JMQN9P6,8P-Q/<XX]:6
M32KM+>X\NWF6\CNIYK6>)D./,)(R&/W3G# CMQZUI:G:W=SHL2A%:Z22"5T0
MX!*.K,%S]#C-9_\ 8]TPN'^S@/)JT5T/F&?+&S)S[ ,,54D\/7DFA/;2QS27
MD-K-%&VZ,1R,X()S@$[NIST/7/6KU_HTUQ?W?F++):75ND 6(Q@IC.1\PX'.
M<@]1TZ4Y=+NEC%IY>2+X7/VHL"=N_=]=V/D^G?M5S1K>XT_3(H9H6,AGE+!6
M!VJTC,">?0CWYK3[4M%%%%%%%%%%%%%%%%%%4M:_Y =__P!>TG_H)KFOA-_R
M3O3_ *R?^AFNRHHHHKFOB+_R(&L?]</ZBCX=?\B!H_\ UP_J:Z6BBBBBBBBB
MD(SUHQBEHHI,4M%%%%%%%)BEHI,9I:*****1E#J58 J1@@]#2(BQHJ(H55&
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M".N<@#AO2NAT30GTG5]8NS(C1W\L;QHH.8U5 N#Z]*S-?\)7]]J6I7.F7T$
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M!I+:E)]C25Y9%\B,LY9R_P K'E",D9':M.;PK%+K=U?&=_(O;46MU:E05E4
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M;R7<T5C-/IM@ZI=WBNH$98 \*>6 ##/I[U8L/%@U#7-0L(K0*MD&#.\ZJ[D
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M?4XKI5MXDNH;<7*Q"\B960G'+YPA!QD'IGO3T\=Q-I$5Z;*1G:_%@T44JO\
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MZFU72[;6=.FL;U-\$RX8 X/J"#V(/-8DG@B&:W5)M3OI)XYTGAGQ$K1,H(&
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MUC?Q3QB]OK=+JV2WN5A=0)@@PA8$'D#TQFMN\TR2XTV*TM[^YLVCV@30[=^
M,8.X$<_2LVW\,2:<EE#IM]+'"MVUW?2.Q,MVQ!ZGI@G&1Z "I=:\)VNM7Z7<
MES=6\OV=[63R& \R)N2IR#CGN,&F/X/LWDF<SS@RZ8-,.".(QGYNGWN?I[54
MO/A]8W<#1)>WUNLMFEG<"%U G1%PI;(/(]L9K3U+PW;:GHEMITDTR"U,;PRH
M1O5X_NMR"#TZ$8J?1M&BT6">.*::;SYFG=YF!8NV,G@#TJC8>#]/L-1U6[&^
M4ZGD2Q2$%$4Y+*H[ DDFFZ;X.M-.N89GNKR[^S1-!:I<2!EMXV !"X )X &3
MDXJO'X#LX=-M;2.]NPUDS&TG^0O"C#!C&5P5^H)]ZUO["M9= ?2+HO<V\D92
M5I,!GSU/  !^@XK/B\%VJQW8N;V]NYKBT:R$T[J6BA.?E7  []2"3@9K:T^S
M33]/MK2-F9+>)8E+=2%&!G\JDN8%NK6:!R0LJ%"1U (Q5?1]+BT71[33H'=X
MK6,1(SXW$ =\54_X1FR>YUB6??,FKJBW$3XV@*FW QSTK.;P):RV4EK/J%[*
MN4,);RP82C!E(P@W'('WLYJ<>#;4VZ1/=W4A74$U$R.REGE4 <\8P<=!715C
M>(/#-GXD^Q_;&D7[++YB["!N&,,A_P!DCK5.7P-I\MQK<S2W ?5XC%+AAB(,
M/FV#'&3@G.>14[^$K8WT-U'<W$;I9?89%4KB:/! W9'4$YXQ2:=X1M--N=*G
MBGG9M-M&M(@Q&&0XY;CK\HJR/#MJ=7U&_D+2'4($MYHFQLVJ".._.XU0M?!J
MV4#PVVK:A&GEB.''E9A4$< [/FX&/FSQFLR\\#/!<^'[;2I;B.WLY[B:>Z61
M1*K.I^;!&#ENP&,=JT!X#T^*SMH[>XN8;FW:1UNP5>1VD.7W;E*G)QVXQQ4H
M\'0PWD%Y::C?6UTD:Q32QLF;E0<@."N/7D =:OZ/H,6BSWS6T\S17<QG\ER"
ML;L<L5XSR?4FJ,_@NPN9M4:66X,.I,LDL(8!4E7&)%.,AOE'?'M5O2/#\6DW
M%Q=O<W%Y>W 59;BX(+%5^ZH    R>@KG]*\$//>7\VK2W*0MJTE[':K(IBE
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M*I:U_P @._\ ^O:3_P!!-<U\)O\ DG>G_63_ -#-=E11117-?$7_ )$#6/\
MKA_44?#K_D0-'_ZX?U-=+111111111111111111111111111111111111111
M11111111111111111111111111111111111111111111111115+6O^0'?_\
M7M)_Z":YKX3?\D[T_P"LG_H9KLJ****YKXB_\B!K'_7#^HH^'7_(@:/_ -</
MZFNEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHJEK7_(#O_P#KVD_]!-<U\)O^2=Z?
M]9/_ $,UV5%%%%<U\1?^1 UC_KA_44?#K_D0-'_ZX?U-=+11111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111115+6O\ D!W_ /U[2?\ H)KFOA-_R3O3_K)_Z&:[*BBBBN:^
M(O\ R(&L?]</ZBCX=?\ (@:/_P!</ZFNEHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHJEK7_(#O_\ KVD_]!-<U\)O^2=Z?]9/_0S7944445S7Q%_Y$#6/^N']11\.
MO^1 T?\ ZX?U-=+111111111111111111111111111111111111111111111
M11111111111111111111111111111111111111111115+6O^0'?_ /7M)_Z"
M:YKX3?\ ).]/^LG_ *&:[*BBBBN:^(O_ "(&L?\ 7#^HH^'7_(@:/_UP_J:Z
M6BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBJ6M?\@._P#^O:3_ -!-<U\)O^2=Z?\
M63_T,UV5%%%%<U\1?^1 UC_KA_44?#K_ )$#1_\ KA_4UTM%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%4M:_Y =__ ->TG_H)KFOA-_R3O3_K)_Z&:[*BBBBN:^(O
M_(@:Q_UP_J*/AU_R(&C_ /7#^IKI:*******************************
M*********************************************************I:U
M_P @._\ ^O:3_P!!-<U\)O\ DG>G_63_ -#-=E11117-?$7_ )$#6/\ KA_4
M4?#K_D0-'_ZX?U-=+1111111111111111111111111111111111111111111
M1111111111111111111111111111111111111111111115+6O^0'?_\ 7M)_
MZ":YKX3?\D[T_P"LG_H9KLJ****YKXB_\B!K'_7#^HH^'7_(@:/_ -</ZFNE
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHJEK7_(#O_P#KVD_]!-<U\)O^2=Z?]9/_
M $,UV5%%%%<U\1?^1 UC_KA_44?#K_D0-'_ZX?U-=+111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M11111111115+6O\ D!W_ /U[2?\ H)KFOA-_R3O3_K)_Z&:[*BBBBN:^(O\
MR(&L?]</ZBCX=?\ (@:/_P!</ZFNEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHJEK
M7_(#O_\ KVD_]!-<U\)O^2=Z?]9/_0S7944445S7Q%_Y$#6/^N']11\.O^1
MT?\ ZX?U-=+1111111111111111111111111111111111111111111111111
M1111111111111111111111111111111111111115+6O^0'?_ /7M)_Z":YKX
M3?\ ).]/^LG_ *&:[*BBBBN:^(O_ "(&L?\ 7#^HH^'7_(@:/_UP_J:Z6BBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBJ6M?\@._P#^O:3_ -!-<U\)O^2=Z?\ 63_T
M,UV5%%%%<U\1?^1 UC_KA_44?#K_ )$#1_\ KA_4UTM%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%4M:_Y =__ ->TG_H)KFOA-_R3O3_K)_Z&:[*BBBBN:^(O_(@:
MQ_UP_J*/AU_R(&C_ /7#^IKI:***********************************
M*****************************************************I:U_P @
M._\ ^O:3_P!!-<U\)O\ DG>G_63_ -#-=E11117-?$7_ )$#6/\ KA_44?#K
M_D0-'_ZX?U-=+11111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111115+6O^0'?_\ 7M)_Z":Y
MKX3?\D[T_P"LG_H9KLJ****YKXB_\B!K'_7#^HH^'7_(@:/_ -</ZFNEHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHJEK7_(#O_P#KVD_]!-<U\)O^2=Z?]9/_ $,U
MV5%%%%<U\1?^1 UC_KA_44?#K_D0-'_ZX?U-=+1111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M1111115+6O\ D!W_ /U[2?\ H)KFOA-_R3O3_K)_Z&:[*BBBBN:^(O\ R(&L
M?]</ZBCX=?\ (@:/_P!</ZFNEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHJEK7_(#
MO_\ KVD_]!-<U\)O^2=Z?]9/_0S7944445S7Q%_Y$#6/^N']11\.O^1 T?\
MZX?U-=+11111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111115+6O^0'?_ /7M)_Z":YKX3?\
M).]/^LG_ *&:[*BBBBN:^(O_ "(&L?\ 7#^HH^'7_(@:/_UP_J:Z6BBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBJ6M?\@._P#^O:3_ -!-<U\)O^2=Z?\ 63_T,UV5
M%%%%<U\1?^1 UC_KA_44?#K_ )$#1_\ KA_4UTM%%%%%%%%%%%%%%%%%%%%%
M%%%%)6!8>)Y-5ND.GZ7=S:>TIC^W;D5,@D$A2=Q7(ZXK2@UK3;FYFMH+^VEG
M@YEC252R?4 \5!'XGT2>*62'5K*188_-D*3J=B?WCSTJA9^,[/4X=.GT[9+!
M>3O"YDF6-X=JEONGDG S@<X.:TK3Q#I%\76TU.SG9(_-81S*Q"_WC@]*FAU>
MPN'@2&\@D:YC,L(5P3(@ZLOJ.1S3;76M-O8II;6_M9HX"1*Z2J1'C^\<\50T
MSQ3:ZMK]QIUF8YX8K9+@7,4@97W,5V\>FWUK1_M?3_[2_L_[;;_;=N[[/Y@\
MS'^[UJ.+7])GO?LD.I6CW.YE\E9E+Y7J,9SD50U'Q=96FJ6-A;R0W4]Q=BUE
M6.8;H"5)RPY_NXQ4VH^*M*TS6K/2[JZ1+JZSM4D87TW>F3P/4U<CUC3Y=0:P
MCO;=KQ!EH!("X_X#UJEK/B6#1-7TZTNPD<-VLK-</(%6(1J#SGKG.*MSZYIE
MK9PW=QJ%K';3$".5Y5".3Z'.#5F:[@M[5KF::..!5W-(S *!ZYZ8K,3Q%;W&
MH:?%9O;W%K>QRR+<)<+_  8^ZO5N^2.F.:FA\2:-<.R0:I9RNBNS!)E8@+]X
MG!Z"I++7-,U)W6PU"UN6C4,XBE5BH/0G!Z4D&O:5<VDUU!J-I);P'$LJS*5C
M^ISQ571?$D&N:IJ5M:A'AL_*VSI(&68.N[(QTQTJZVKZ>FHK8/>VXO6&1 9!
MO(_W>M,37]*DO19IJ-HUT79/)$R[]PZC&<Y%5]=\4Z7X=EM8]1N5B>YD"(I(
MX'=CGHH[GZ5!I_BVRN]7OM/N)(;::WNOLT2R3#=.=H;*CCU]ZT_[6L#J1T_[
M9!]M"[C;^8/,QZ[>M%YJUAI__'[>06_R&3]ZX7Y00">>V2!^(I@US3#-<PC4
M+4RVBEIT$HW1 =2P[4]=6L&,.V[@/G1&:/#CYXQ@EA[<CGWJ.#7M*N;5+F#4
M;62!Y/*61)5*E_[N?6DA\0:3<W$$$&I6DDUPF^&-)5+2+Z@=QP:E@U:PNKV:
MSM[RWEN8/];"D@+I]1UHGU>PM;V&SN+R".ZG_P!5"T@#O]!U-4+#Q-:3:7%>
M:A-:60EF>% UTCJQ#%1AAP3QT[5'I7B^PO/#UKJU_+#IT=R[(JSS #(8KC)Q
MGIFMY6#J&4@J1D$=#2T44444444444444444444444452UK_ ) =_P#]>TG_
M *":YKX3?\D[T_ZR?^AFNRHHHHKFOB+_ ,B!K'_7#^HH^'7_ "(&C_\ 7#^I
MKI:*************************9+&)8V1LX8$'!]:Y+0K'7-$TV'07L8YK
M6+="FH0W(4K&2<,4(SN /:L[2O"NJ0MHUM-:6MNFC)*#=12@F\W*5 QC(!SE
MMW>G:!X1OK"7PP9[6!/L-E<0WA5E/S/C;T^]WJ/3?"VKP:?X=M9K.-#I5W,9
M7652)$9'"N/J6 QUXI-)\&ZC:Q>'4DMX86M=/N;>Z=64X>0 +T^]SFH+#PCK
MLJ:?:W<$5FEII%QIWVB.<.=S!0K@#! X^M1)X#U6YTF]MI$D@G^P"TB:6[1X
MI,,K!0J("%^4\L<C/>N@\.:3J47BV_U6]TRWT^">RBA6.*97^92<YQ[?H!5:
MYT37;SQ1%<7,<36UOJ*W$4B2JJ^2%(QLQN+\\DGITJ"#PEJ$?V5C:PB5/$3W
M[,'7/D$GG/KR.*K6'A+6;2ZT2V?3[4Q:;J4EQ)?+,-\R-N.=N,YY&?H*Z7Q!
MI5W-XCT+5+.UCN%LWE6="X0[74 -D]=N,XK#L?">J1/IVGR6]NL5CJ+7QU,2
M R3J69MNW&0QW8.3C K6\5:7J%SX@T/4+&PAOH[#SVEBDE5,[E 7&>]<VO@7
M6+2STV=,O+#]I\RTM9T3RA*^[",ZE2 .#P/:NDE\.LOP^BT9[.2Z*1*OD?:@
M'4ALC$F ,KQCC'%9 \,Z_>'37U"6,2Q65[!)-N7,/F "/. -Q ') ZUC:1!-
MJFIV=I:6UB'M-"GM7:SN%E0L0JJ69>!D@X!YZYK67P3J#PVD"I%:?\4^VGRR
MHP^68E?3DC@\^YJDW@;5KBS<M!(MQ MNJQW%Y&\5RL3AMF$087@X+9/-=/X3
MTN_L];UV^OK&&R2_DA>***0/C:A!SCOFLFY\):H[W>GI! 8KG5!J U0R#S(U
M#*VW;C.X8V@YQ@TYO"5^=T@M8?./B0:@&WKN^SYZY]?:MKQCI5UJ,>F3V%O'
M<S6-]'<F%F">8H!! 8\#K6#J'A'4;D:PZ6L)ENM7M[N%BZY\M-F[GMT;BD'@
MW4(_$<C2?:9K:34OMZSQW4:*G.?F4H7) ^7@X(QTK>UG0Y=3\7:1>/!%+8V\
M$ZS;\'#-MV?*>O(/TK \/>"[[3M5LX[]9YH+-YF%P+J/RY X;/[O9ORV1D%O
MQJ.V\!ZK/I&K65W+'$RVPL-.DWYS )"_S8Z;OE4^PIA\&ZG<PM(]K.)7NK0R
M)<7D4@>*-B6.$50, X]2"16R=!OK7QJEWI-HEE8OM6Z<2H8YD5" %CQE'!(&
M0<8'O6=X;\&ZAI>L6(NQ</%8R2R)<BZC\M]^<_)LWY.1D%L9R<UJ:CH^I-XV
MMM1TRW\E28UN[EIE*31+DE3&1D,,\,".M8^G^%-8TP:3=&PMKM[4WD<EK),H
M $LA97!Y'3@CKBJ\'@G6;;2-%;8YGLH)X);:WN(U*[Y"P96=64C'!&,]*[SP
MYIQTGP]963!P8(@NUY/,*^V[ SCIT'2M.BBBBBBBBBBBBBBBBBBBBBBBBBJ6
MM?\ (#O_ /KVD_\ 037-?";_ ))WI_UD_P#0S7944445S?Q#4MX!U@*"3Y'8
M>XI/AU_R(&C_ /7#^IKI:**************************2BEI**,4448HH
MI:*2BBEJ.&WAMP1#%'&&.2$4#)]>*DI**6BDHQ11BBEI****6DI:********
M******************I:S_R [_\ Z]I/_037-?";_DGFG_63_P!#-=E11115
M;4K&+4]-N;*?=Y5Q&T3[3@X(P<5YIIL7CGP+!)IUIID.KZ?&Q,+JW*@G/ SG
M\,<>M6O^$U\=_P#0FG\VH_X37QW_ -":?S:C_A-?'?\ T)I_-J/^$U\=_P#0
MFG\VH_X37QW_ -":?S:C_A-?'?\ T)I_-J/^$U\=_P#0FG\VH_X37QW_ -":
M?S:C_A-?'?\ T)I_-J/^$U\=_P#0FG\VH_X37QW_ -":?S:C_A-?'?\ T)I_
M-J/^$U\=_P#0FG\VH_X37QW_ -":?S:C_A-?'?\ T)I_-J/^$U\=_P#0FG\V
MH_X37QW_ -":?S:C_A-?'?\ T)I_-J/^$U\=_P#0FG\VH_X37QW_ -":?S:C
M_A-?'?\ T)I_-J/^$U\=_P#0FG\VH_X37QW_ -":?S:C_A-?'?\ T)I_-J/^
M$U\=_P#0FG\VH_X37QW_ -":?S:C_A-?'?\ T)I_-J/^$U\=_P#0FG\VH_X3
M7QW_ -":?S:C_A-?'?\ T)I_-J/^$U\=_P#0FG\VH_X37QW_ -":?S:C_A-?
M'?\ T)I_-J/^$U\=_P#0FG\VH_X37QW_ -":?S:C_A-?'?\ T)I_-J/^$U\=
M_P#0FG\VH_X37QW_ -":?S:C_A-?'?\ T)I_-J/^$U\=_P#0FG\VH_X37QW_
M -":?S:C_A-?'?\ T)I_-J/^$U\=_P#0FG\VH_X37QW_ -":?S:C_A-?'?\
MT)I_-J/^$U\=_P#0FG\VH_X37QW_ -":?S:C_A-?'?\ T)I_-J/^$U\=_P#0
MFG\VH_X37QW_ -":?S:C_A-?'?\ T)I_-J/^$U\=_P#0FG\VH_X37QW_ -":
M?S:C_A-?'?\ T)I_-J/^$U\=_P#0FG\VH_X37QW_ -":?S:C_A-?'?\ T)I_
M-J/^$U\=_P#0FG\VH_X37QW_ -":?S:C_A-?'?\ T)I_-J/^$U\=_P#0FG\V
MH_X37QW_ -":?S:C_A-?'?\ T)I_-J/^$U\=_P#0FG\VH_X37QW_ -":?S:C
M_A-?'?\ T)I_-J/^$U\=_P#0FG\VH_X37QW_ -":?S:C_A-?'?\ T)I_-J/^
M$U\=_P#0FG\VH_X37QW_ -":?S:C_A-?'?\ T)I_-J/^$U\=_P#0FG\VH_X3
M7QW_ -":?S:C_A-?'?\ T)I_-J/^$U\=_P#0FG\VH_X37QW_ -":?S:C_A-?
M'?\ T)I_-J/^$U\=_P#0FG\VH_X37QW_ -":?S:C_A-?'?\ T)I_-J/^$U\=
M_P#0FG\VH_X37QW_ -":?S:C_A-?'?\ T)I_-J/^$U\=_P#0FG\VH_X37QW_
M -":?S:C_A-?'?\ T)I_-J/^$U\=_P#0FG\VH_X37QW_ -":?S:H+^_\?^*K
M%].70HM,AN/W<TSO@[3UZG('T!KN_#.A1^&_#]IIL3E_)7YF_O,3EC[#)-:U
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>pdex-20250630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aAps7xRiXgen8uEYHMsSaiL6bPtx5176Zkhvmh6bUkKTyEnamE3zCgM8MVWEa0N -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:pdex="http://pro-dex.com/20250630" elementFormDefault="qualified" targetNamespace="http://pro-dex.com/20250630">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://pro-dex.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="pdex-20250630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="pdex-20250630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="pdex-20250630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
    <element id="pdex_RickMember" name="RickMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="pdex_ReportedValueOfEquityAwardsMember" name="ReportedValueOfEquityAwardsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="pdex_EquityAwardAdjustmentsMember" name="EquityAwardAdjustmentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="pdex_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember" name="AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="pdex_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember" name="ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="pdex_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember" name="AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="pdex_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember" name="ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="pdex_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember" name="SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="pdex_TotalEquityAwardAdjustmentMember" name="TotalEquityAwardAdjustmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="pdex_AlishaCharltonMember" name="AlishaCharltonMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>pdex-20250630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="pdex-20250630.xsd#Cover" roleURI="http://pro-dex.com/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpDisclosureWithAdditionalMeasures" roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosureWithAdditionalMeasures" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpTable" roleURI="http://xbrl.sec.gov/ecd/role/PvpTable" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpAdjustmentsToCompensation" roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsToCompensation" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#TabularListsByExecutiveCategory" roleURI="http://xbrl.sec.gov/ecd/role/TabularListsByExecutiveCategory" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#TabularListMeasures" roleURI="http://xbrl.sec.gov/ecd/role/TabularListMeasures" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpMeasures" roleURI="http://xbrl.sec.gov/ecd/role/PvpMeasures" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpExecutiveCategoriesOnly" roleURI="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpAdjustmentsOnly" roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#IndividualsOnly" roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#AwardTypeOnly" roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#TradingArrangmentsOnly" roleURI="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ForgoneRecoveries" roleURI="http://xbrl.sec.gov/ecd/role/ForgoneRecoveries" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#OutstandingRecoveries" roleURI="http://xbrl.sec.gov/ecd/role/OutstandingRecoveries" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#AwardsCloseToMnpiDisc" roleURI="http://xbrl.sec.gov/ecd/role/AwardsCloseToMnpiDisc" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingArrangemenstByInd" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangementsByInd" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#Defaults" roleURI="http://xbrl.sec.gov/ecd/role/Defaults" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pro-dex.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_ReportedValueOfEquityAwardsMember" xlink:label="loc_pdexReportedValueOfEquityAwardsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_pdexReportedValueOfEquityAwardsMember" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_EquityAwardAdjustmentsMember" xlink:label="loc_pdexEquityAwardAdjustmentsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_pdexEquityAwardAdjustmentsMember" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember" xlink:label="loc_pdexAddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_pdexAddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember" xlink:label="loc_pdexChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_pdexChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember" xlink:label="loc_pdexAddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_pdexAddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember" xlink:label="loc_pdexChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_pdexChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember" xlink:label="loc_pdexSubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_pdexSubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember" xlink:type="arc" order="60" />
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_TotalEquityAwardAdjustmentMember" xlink:label="loc_pdexTotalEquityAwardAdjustmentMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_pdexTotalEquityAwardAdjustmentMember" xlink:type="arc" order="70" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_RickMember" xlink:label="loc_pdexRickMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_pdexRickMember" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_AlishaCharltonMember" xlink:label="loc_pdexAlishaCharltonMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_pdexAlishaCharltonMember" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>pdex-20250630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis" xlink:label="ecd_ExecutiveCategoryAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ExecutiveCategoryAxis" xlink:to="ecd_ExecutiveCategoryAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ExecutiveCategoryAxis_lbl" xml:lang="en-US">Executive Category [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoMember" xlink:label="ecd_PeoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoMember" xlink:to="ecd_PeoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoMember_lbl" xml:lang="en-US">PEO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis" xlink:label="ecd_IndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_IndividualAxis" xlink:to="ecd_IndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_IndividualAxis_lbl" xml:lang="en-US">Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_RickMember" xlink:label="pdex_RickMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pdex_RickMember" xlink:to="pdex_RickMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pdex_RickMember_lbl" xml:lang="en-US">Rick [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis" xlink:label="ecd_AdjToCompAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAxis" xlink:to="ecd_AdjToCompAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAxis_lbl" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_ReportedValueOfEquityAwardsMember" xlink:label="pdex_ReportedValueOfEquityAwardsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pdex_ReportedValueOfEquityAwardsMember" xlink:to="pdex_ReportedValueOfEquityAwardsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pdex_ReportedValueOfEquityAwardsMember_lbl" xml:lang="en-US">Reported Value Of Equity Awards [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_EquityAwardAdjustmentsMember" xlink:label="pdex_EquityAwardAdjustmentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pdex_EquityAwardAdjustmentsMember" xlink:to="pdex_EquityAwardAdjustmentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pdex_EquityAwardAdjustmentsMember_lbl" xml:lang="en-US">Equity Award Adjustments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember" xlink:label="pdex_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pdex_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember" xlink:to="pdex_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pdex_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember_lbl" xml:lang="en-US">Add: fair value of awards granted during FY at end of year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember" xlink:label="pdex_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pdex_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember" xlink:to="pdex_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pdex_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember_lbl" xml:lang="en-US">Change in fair value of awards granted in any PY unvested at end of FY [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember" xlink:label="pdex_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pdex_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember" xlink:to="pdex_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pdex_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember_lbl" xml:lang="en-US">Add for awards granted and vested in the same FY the fair value as of vesting date [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember" xlink:label="pdex_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pdex_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember" xlink:to="pdex_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pdex_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember_lbl" xml:lang="en-US">Change in fair value as of vesting date of any awards from a PY vested in CY [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember" xlink:label="pdex_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pdex_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember" xlink:to="pdex_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pdex_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember_lbl" xml:lang="en-US">Subtract: Awards granted in any PY fail to meet vesting conditions during the year; value at end of PY [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_TotalEquityAwardAdjustmentMember" xlink:label="pdex_TotalEquityAwardAdjustmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pdex_TotalEquityAwardAdjustmentMember" xlink:to="pdex_TotalEquityAwardAdjustmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pdex_TotalEquityAwardAdjustmentMember_lbl" xml:lang="en-US">Total Equity Award Adjustments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember" xlink:label="ecd_NonPeoNeoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoMember" xlink:to="ecd_NonPeoNeoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoMember_lbl" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_AlishaCharltonMember" xlink:label="pdex_AlishaCharltonMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pdex_AlishaCharltonMember" xlink:to="pdex_AlishaCharltonMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pdex_AlishaCharltonMember_lbl" xml:lang="en-US">Alisha Charlton [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable" xlink:label="ecd_PvpTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTable" xlink:to="ecd_PvpTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTable_lbl" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock" xlink:label="ecd_PvpTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTableTextBlock" xlink:to="ecd_PvpTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTableTextBlock_lbl" xml:lang="en-US">Disclosure - Pay vs Performance Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName" xlink:label="ecd_CoSelectedMeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureName" xlink:to="ecd_CoSelectedMeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureName_lbl" xml:lang="en-US">Company Selected Measure Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="ecd_PeerGroupIssuersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupIssuersFnTextBlock" xlink:to="ecd_PeerGroupIssuersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupIssuersFnTextBlock_lbl" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="ecd_ChangedPeerGroupFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ChangedPeerGroupFnTextBlock" xlink:to="ecd_ChangedPeerGroupFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ChangedPeerGroupFnTextBlock_lbl" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt" xlink:label="ecd_PeoTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoTotalCompAmt" xlink:to="ecd_PeoTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoTotalCompAmt_lbl" xml:lang="en-US">PEO Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="ecd_PeoActuallyPaidCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoActuallyPaidCompAmt" xlink:to="ecd_PeoActuallyPaidCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoActuallyPaidCompAmt_lbl" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="ecd_AdjToPeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToPeoCompFnTextBlock" xlink:to="ecd_AdjToPeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToPeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xml:lang="en-US">CAP and TSR</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xml:lang="en-US">CAP and Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock" xlink:label="ecd_TabularListTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TabularListTableTextBlock" xlink:to="ecd_TabularListTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TabularListTableTextBlock_lbl" xml:lang="en-US">Tabular List, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt" xlink:label="ecd_TotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnAmt" xlink:to="ecd_TotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnAmt_lbl" xml:lang="en-US">Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt" xlink:label="ecd_CoSelectedMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureAmt" xlink:to="ecd_CoSelectedMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureAmt_lbl" xml:lang="en-US">Company Selected Measure Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt" xlink:label="ecd_OtherPerfMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OtherPerfMeasureAmt" xlink:to="ecd_OtherPerfMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OtherPerfMeasureAmt_lbl" xml:lang="en-US">Other Performance Measure, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt" xlink:label="ecd_AdjToCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAmt" xlink:to="ecd_AdjToCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAmt_lbl" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName" xlink:label="ecd_PeoName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoName" xlink:to="ecd_PeoName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoName_lbl" xml:lang="en-US">PEO Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName" xlink:label="ecd_MeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureName" xlink:to="ecd_MeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xml:lang="en-US">Non-GAAP Measure Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="ecd_Additional402vDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Additional402vDisclosureTextBlock" xlink:to="ecd_Additional402vDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Additional402vDisclosureTextBlock_lbl" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="ecd_PnsnBnftsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PnsnBnftsAdjFnTextBlock" xlink:to="ecd_PnsnBnftsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PnsnBnftsAdjFnTextBlock_lbl" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock" xlink:label="ecd_EqtyAwrdsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="ecd_EqtyAwrdsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EqtyAwrdsAdjFnTextBlock_lbl" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable" xlink:label="ecd_ErrCompRecoveryTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompRecoveryTable" xlink:to="ecd_ErrCompRecoveryTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompRecoveryTable_lbl" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis" xlink:label="ecd_RestatementDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDateAxis" xlink:to="ecd_RestatementDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDateAxis_lbl" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate" xlink:label="ecd_RestatementDeterminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDeterminationDate" xlink:to="ecd_RestatementDeterminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDeterminationDate_lbl" xml:lang="en-US">Restatement Determination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt" xlink:label="ecd_AggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompAmt" xlink:to="ecd_AggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompAmt_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="ecd_ErrCompAnalysisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompAnalysisTextBlock" xlink:to="ecd_ErrCompAnalysisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompAnalysisTextBlock_lbl" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="ecd_OutstandingAggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingAggtErrCompAmt" xlink:to="ecd_OutstandingAggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingAggtErrCompAmt_lbl" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName" xlink:label="ecd_ForgoneRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_ForgoneRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName" xlink:label="ecd_OutstandingRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_OutstandingRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="ecd_OutstandingRecoveryCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryCompAmt" xlink:to="ecd_OutstandingRecoveryCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryCompAmt_lbl" xml:lang="en-US">Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xml:lang="en-US">Restatement does not require Recovery</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems" xlink:label="ecd_AwardTmgDiscLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgDiscLineItems" xlink:to="ecd_AwardTmgDiscLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgDiscLineItems_lbl" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="ecd_AwardTmgMnpiDiscTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiDiscTextBlock" xlink:to="ecd_AwardTmgMnpiDiscTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiDiscTextBlock_lbl" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="ecd_AwardTmgMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMethodTextBlock" xlink:to="ecd_AwardTmgMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMethodTextBlock_lbl" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="ecd_AwardTmgPredtrmndFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgPredtrmndFlag" xlink:to="ecd_AwardTmgPredtrmndFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgPredtrmndFlag_lbl" xml:lang="en-US">Award Timing Predetermined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="ecd_MnpiDiscTimedForCompValFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MnpiDiscTimedForCompValFlag" xlink:to="ecd_MnpiDiscTimedForCompValFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MnpiDiscTimedForCompValFlag_lbl" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="ecd_AwardsCloseToMnpiDiscIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="ecd_AwardUndrlygSecuritiesAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardUndrlygSecuritiesAmt" xlink:to="ecd_AwardUndrlygSecuritiesAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardUndrlygSecuritiesAmt_lbl" xml:lang="en-US">Underlying Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice" xlink:label="ecd_AwardExrcPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardExrcPrice" xlink:to="ecd_AwardExrcPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardExrcPrice_lbl" xml:lang="en-US">Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue" xlink:label="ecd_AwardGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardGrantDateFairValue" xlink:to="ecd_AwardGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardGrantDateFairValue_lbl" xml:lang="en-US">Fair Value as of Grant Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="ecd_UndrlygSecurityMktPriceChngPct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_UndrlygSecurityMktPriceChngPct" xlink:to="ecd_UndrlygSecurityMktPriceChngPct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_UndrlygSecurityMktPriceChngPct_lbl" xml:lang="en-US">Underlying Security Market Price Change</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable" xlink:label="ecd_TradingArrByIndTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrByIndTable" xlink:to="ecd_TradingArrByIndTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrByIndTable_lbl" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis" xlink:label="ecd_TradingArrAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrAxis" xlink:to="ecd_TradingArrAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrAxis_lbl" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName" xlink:label="ecd_TrdArrIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_TrdArrIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle" xlink:label="ecd_TrdArrIndTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndTitle" xlink:to="ecd_TrdArrIndTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndTitle_lbl" xml:lang="en-US">Title</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate" xlink:label="ecd_TrdArrAdoptionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrAdoptionDate" xlink:to="ecd_TrdArrAdoptionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrAdoptionDate_lbl" xml:lang="en-US">Adoption Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate" xlink:label="ecd_TrdArrTerminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrTerminationDate" xlink:to="ecd_TrdArrTerminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrTerminationDate_lbl" xml:lang="en-US">Termination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate" xlink:label="ecd_TrdArrExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrExpirationDate" xlink:to="ecd_TrdArrExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrExpirationDate_lbl" xml:lang="en-US">Expiration Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration" xlink:label="ecd_TrdArrDuration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrDuration" xlink:to="ecd_TrdArrDuration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrDuration_lbl" xml:lang="en-US">Arrangement Duration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt" xlink:label="ecd_TrdArrSecuritiesAggAvailAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="ecd_TrdArrSecuritiesAggAvailAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrSecuritiesAggAvailAmt_lbl" xml:lang="en-US">Aggregate Available</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="ecd_InsiderTradingPoliciesProcLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingPoliciesProcLineItems" xlink:to="ecd_InsiderTradingPoliciesProcLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingPoliciesProcLineItems_lbl" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryIndName_2_lbl" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryIndName_2_lbl" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndName_2_lbl" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>pdex-20250630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="pdex-20250630.xsd#Cover" roleURI="http://pro-dex.com/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ErrCompDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#AwardTimingDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingArrangements" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingPoliciesProc" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" />
    <link:presentationLink xlink:type="extended" xlink:role="http://pro-dex.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:title="995410 - Disclosure - Pay vs Performance Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems" xlink:label="loc_ecdPayVsPerformanceDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable" xlink:label="loc_ecdPvpTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis" xlink:label="loc_ecdExecutiveCategoryAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdExecutiveCategoryAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllExecutiveCategoriesMember" xlink:label="loc_ecdAllExecutiveCategoriesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdExecutiveCategoryAxis" xlink:to="loc_ecdAllExecutiveCategoriesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoMember" xlink:label="loc_ecdPeoMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllExecutiveCategoriesMember" xlink:to="loc_ecdPeoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember" xlink:label="loc_ecdNonPeoNeoMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllExecutiveCategoriesMember" xlink:to="loc_ecdNonPeoNeoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_RickMember" xlink:label="loc_pdexRickMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_pdexRickMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_AlishaCharltonMember" xlink:label="loc_pdexAlishaCharltonMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_pdexAlishaCharltonMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis" xlink:label="loc_ecdAdjToCompAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdAdjToCompAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAdjToCompAxis" xlink:to="loc_ecdAllAdjToCompMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_ReportedValueOfEquityAwardsMember" xlink:label="loc_pdexReportedValueOfEquityAwardsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_pdexReportedValueOfEquityAwardsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_EquityAwardAdjustmentsMember" xlink:label="loc_pdexEquityAwardAdjustmentsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_pdexEquityAwardAdjustmentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember" xlink:label="loc_pdexAddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_pdexAddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember" xlink:label="loc_pdexChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_pdexChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember" xlink:label="loc_pdexAddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_pdexAddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember" xlink:label="loc_pdexChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_pdexChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember" xlink:label="loc_pdexSubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_pdexSubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pdex-20250630.xsd#pdex_TotalEquityAwardAdjustmentMember" xlink:label="loc_pdexTotalEquityAwardAdjustmentMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_pdexTotalEquityAwardAdjustmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock" xlink:label="loc_ecdPvpTableTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName" xlink:label="loc_ecdCoSelectedMeasureName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdCoSelectedMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="loc_ecdNamedExecutiveOfficersFnTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNamedExecutiveOfficersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="loc_ecdPeerGroupIssuersFnTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupIssuersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="loc_ecdChangedPeerGroupFnTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdChangedPeerGroupFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt" xlink:label="loc_ecdPeoTotalCompAmt" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="loc_ecdPeoActuallyPaidCompAmt" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoActuallyPaidCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="loc_ecdAdjToPeoCompFnTextBlock" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToPeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="loc_ecdNonPeoNeoAvgTotalCompAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNonPeoNeoAvgTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="loc_ecdAdjToNonPeoNeoCompFnTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:presentationArc order="2140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" />
      <link:presentationArc order="2150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" />
      <link:presentationArc order="2160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock" xlink:label="loc_ecdTabularListTableTextBlock" />
      <link:presentationArc order="2170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdTabularListTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt" xlink:label="loc_ecdTotalShareholderRtnAmt" />
      <link:presentationArc order="2180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="loc_ecdPeerGroupTotalShareholderRtnAmt" />
      <link:presentationArc order="2190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="2200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt" xlink:label="loc_ecdCoSelectedMeasureAmt" />
      <link:presentationArc order="2210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCoSelectedMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt" xlink:label="loc_ecdOtherPerfMeasureAmt" />
      <link:presentationArc order="2220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdOtherPerfMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt" xlink:label="loc_ecdAdjToCompAmt" />
      <link:presentationArc order="2230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName" xlink:label="loc_ecdPeoName" />
      <link:presentationArc order="2240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName" xlink:label="loc_ecdMeasureName" />
      <link:presentationArc order="2250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="loc_ecdNonGaapMeasureDescriptionTextBlock" />
      <link:presentationArc order="2260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdMeasureName" xlink:to="loc_ecdNonGaapMeasureDescriptionTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="loc_ecdAdditional402vDisclosureTextBlock" />
      <link:presentationArc order="2270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdAdditional402vDisclosureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="loc_ecdPnsnBnftsAdjFnTextBlock" />
      <link:presentationArc order="2280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPnsnBnftsAdjFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock" xlink:label="loc_ecdEqtyAwrdsAdjFnTextBlock" />
      <link:presentationArc order="2290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdEqtyAwrdsAdjFnTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:title="995440 - Disclosure - Recovery of Erroneously Awarded Compensation">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems" xlink:label="loc_ecdRecoveryOfErrCompDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable" xlink:label="loc_ecdErrCompRecoveryTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdErrCompRecoveryTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis" xlink:label="loc_ecdRestatementDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdRestatementDateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate" xlink:label="loc_ecdRestatementDeterminationDate" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdRestatementDeterminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt" xlink:label="loc_ecdAggtErrCompAmt" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="loc_ecdErrCompAnalysisTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdErrCompAnalysisTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="loc_ecdOutstandingAggtErrCompAmt" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdOutstandingAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="loc_ecdAggtErrCompNotYetDeterminedTextBlock" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdAggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName" xlink:label="loc_ecdForgoneRecoveryIndName" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName" xlink:label="loc_ecdOutstandingRecoveryIndName" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="loc_ecdOutstandingRecoveryCompAmt" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:title="995443 - Disclosure - Award Timing Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems" xlink:label="loc_ecdAwardTmgDiscLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="loc_ecdAwardTmgMnpiDiscTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiDiscTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="loc_ecdAwardTmgMethodTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="loc_ecdAwardTmgPredtrmndFlag" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgPredtrmndFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="loc_ecdAwardTmgMnpiCnsdrdFlag" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiCnsdrdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="loc_ecdMnpiDiscTimedForCompValFlag" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdMnpiDiscTimedForCompValFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="loc_ecdAwardsCloseToMnpiDiscIndName" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="loc_ecdAwardUndrlygSecuritiesAmt" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardUndrlygSecuritiesAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice" xlink:label="loc_ecdAwardExrcPrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardExrcPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue" xlink:label="loc_ecdAwardGrantDateFairValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="loc_ecdUndrlygSecurityMktPriceChngPct" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdUndrlygSecurityMktPriceChngPct" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="995445 - Disclosure - Insider Trading Arrangements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems" xlink:label="loc_ecdInsiderTradingArrLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable" xlink:label="loc_ecdTradingArrByIndTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTradingArrByIndTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis" xlink:label="loc_ecdTradingArrAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdTradingArrAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllTradingArrangementsMember" xlink:label="loc_ecdAllTradingArrangementsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrAxis" xlink:to="loc_ecdAllTradingArrangementsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="loc_ecdMtrlTermsOfTrdArrTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdMtrlTermsOfTrdArrTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName" xlink:label="loc_ecdTrdArrIndName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle" xlink:label="loc_ecdTrdArrIndTitle" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="loc_ecdRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="loc_ecdNonRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate" xlink:label="loc_ecdTrdArrAdoptionDate" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrAdoptionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="loc_ecdRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="loc_ecdNonRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate" xlink:label="loc_ecdTrdArrTerminationDate" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrTerminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate" xlink:label="loc_ecdTrdArrExpirationDate" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration" xlink:label="loc_ecdTrdArrDuration" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrDuration" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt" xlink:label="loc_ecdTrdArrSecuritiesAggAvailAmt" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrSecuritiesAggAvailAmt" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:title="995447 - Disclosure - Insider Trading Policies and Procedures">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="loc_ecdInsiderTradingPoliciesProcLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PRO-DEX, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000788920<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Disclosure - Pay vs Performance Disclosure</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_881_eecd--PvpTableTextBlock_ze253odgCMPf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Pay vs Performance Disclosure">
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt; text-align: center">&#160;</td><td style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td colspan="2" style="font-size: 11pt; text-align: center">&#160;</td><td style="font-size: 11pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td colspan="2" style="font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td colspan="2" style="font-size: 11pt; text-align: center">&#160;</td><td style="font-size: 11pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Year</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SCT for PEO<sup>(1)</sup></b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CAP for PEO<sup>(2)</sup></b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt; line-height: 110%"><b>SCT for Non-PEO NEO<sup>(3)</sup></b></span></td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt; line-height: 110%"><b>CAP for Non-PEO NEO<sup>(4)</sup></b></span></td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt; line-height: 110%"><b>Fixed $100 Investment Based on TSR<sup>(5)</sup></b></span></td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Net Income</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(in 000&#8217;s)<sup>(6)</sup></b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">(a)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">(b)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">(c)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">(d)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">(e)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">(f)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">(g)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 13%; text-align: center">2025</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eecd--PeoTotalCompAmt_c20240701__20250630_zwMt8KkZJDUf" style="width: 12%; text-align: right" title="Summary Compensation Table Total for PEO">652,951</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eecd--PeoActuallyPaidCompAmt_c20240701__20250630_zmg2KSXtQog1" style="width: 12%; text-align: right" title="Compensation Actually Paid to PEO">1,948,805</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eecd--NonPeoNeoAvgTotalCompAmt_c20240701__20250630_z4xpL4y1mZW7" style="width: 11%; text-align: right" title="Average Summary Compensation Table Total for Non-PEO Named Executive Officers">357,825</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20240701__20250630_zYIGFuynhJrc" style="width: 11%; text-align: right" title="Average Compensation Actually Paid to Non-PEO Named Executive Officers">773,236</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eecd--TotalShareholderRtnAmt_pp2p0_c20240701__20250630_zN1OPEnZUxFg" style="width: 11%; text-align: right" title="Total Shareholder Return Amount">271.22</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--NetIncomeLoss_pn3n3_c20240701__20250630_zOD2AyQ3VmWg" style="width: 11%; text-align: right" title="Net Income">8,978</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eecd--PeoTotalCompAmt_c20230701__20240630_z1UGiiLBvQoj" style="text-align: right" title="Summary Compensation Table Total for PEO">441,303</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eecd--PeoActuallyPaidCompAmt_c20230701__20240630_znuBrc9DECOh" style="text-align: right" title="Compensation Actually Paid to PEO">397,475</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eecd--NonPeoNeoAvgTotalCompAmt_c20230701__20240630_z176qpMTP4z9" style="text-align: right" title="Average Summary Compensation Table Total for Non-PEO Named Executive Officers">320,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230701__20240630_z2Os5pA6i2E3" style="text-align: right" title="Average Compensation Actually Paid to Non-PEO Named Executive Officers">328,349</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eecd--TotalShareholderRtnAmt_pp2p0_c20230701__20240630_zS42dq0lUIsb" style="text-align: right" title="Total Shareholder Return Amount">122.06</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--NetIncomeLoss_pn3n3_c20230701__20240630_zAHHVAMuNmAb" style="text-align: right" title="Net Income">2,127</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eecd--PeoTotalCompAmt_c20220701__20230630_z6H1gmeCvDE" style="text-align: right" title="Summary Compensation Table Total for PEO">418,605</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eecd--PeoActuallyPaidCompAmt_c20220701__20230630_zOjvKe8HK2I7" style="text-align: right" title="Compensation Actually Paid to PEO">632,137</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eecd--NonPeoNeoAvgTotalCompAmt_c20220701__20230630_z66lvtcVFD4d" style="text-align: right" title="Average Summary Compensation Table Total for Non-PEO Named Executive Officers">297,613</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220701__20230630_zsC3ZhgwTopf" style="text-align: right" title="Average Compensation Actually Paid to Non-PEO Named Executive Officers">424,446</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eecd--TotalShareholderRtnAmt_pp2p0_c20220701__20230630_zzaOxUMWNJN4" style="text-align: right" title="Total Shareholder Return Amount">118.71</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20230630_zT4mABQcwgP7" style="text-align: right" title="Net Income">7,074</td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote [Text Block]</a></td>
<td class="text"><p id="xdx_840_eecd--NamedExecutiveOfficersFnTextBlock_dU_zcaiXkienLz3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-size: 10pt">The dollar amounts reported in column (b) are the amounts of total compensation
reported for <span id="xdx_90C_eecd--PeoName_c20240701__20250630_zAN8gjvi5Y98"><span id="xdx_904_eecd--PeoName_c20230701__20240630_zxilWoxAXaNk"><span id="xdx_901_eecd--PeoName_c20220701__20230630_zkUBKoB3upPf">Rick</span></span></span>, our Chief Executive Officer, for each corresponding year in the &#8220;Total&#8221; column of the SCT. Refer to &#8220;Executive
Compensation &#8211; Summary Compensation Table.&#8221;</span></td></tr></table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="nump">$ 652,951<span></span>
</td>
<td class="nump">$ 441,303<span></span>
</td>
<td class="nump">$ 418,605<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="nump">$ 1,948,805<span></span>
</td>
<td class="nump">397,475<span></span>
</td>
<td class="nump">632,137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote [Text Block]</a></td>
<td class="text"><p id="xdx_84B_eecd--AdjToPeoCompFnTextBlock_dU_zolMlgYU6bwl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-size: 10pt">The dollar amounts reported in column (c) represent the amount of CAP to
Rick, as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual amount of compensation
earned by or paid to Rick during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following
adjustments were made to Rick&#8217;s total compensation as reported in the SCT for each year to determine the CAP:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Year</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt"></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SCT Total for PEO</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SCT Reported Equity Award Value for</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PEO</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Equity Award</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Adjustments</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>for PEO<span style="font-family: Times New Roman, Times, Serif"><sup>(A)</sup></span></b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CAP to</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PEO</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 19%; text-align: center">2025</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eecd--PeoTotalCompAmt_c20240701__20250630_zpRSp3cQXMYi" style="width: 17%; text-align: right">652,951</td><td style="width: 1%; text-align: left"></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_zTw5jM2Vw0c4" style="width: 17%; text-align: right">(47,630</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--EquityAwardAdjustmentsMember_zTiQ8JbIWwm9" style="width: 17%; text-align: right">1,343,484</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eecd--PeoActuallyPaidCompAmt_c20240701__20250630_zzefrWkVfYui" style="width: 17%; text-align: right">1,948,805</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eecd--PeoTotalCompAmt_c20230701__20240630_zUYzdqHPDcy2" style="text-align: right">441,303</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eecd--AdjToCompAmt_d0_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_zHklvaBdenjc" style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--EquityAwardAdjustmentsMember_zNlUVtT4AAN2" style="text-align: right">(43,828</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eecd--PeoActuallyPaidCompAmt_c20230701__20240630_zp2ZFoXZ8itk" style="text-align: right">397,475</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eecd--PeoTotalCompAmt_c20220701__20230630_zSE6qoVo3he1" style="text-align: right">418,605</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eecd--AdjToCompAmt_d0_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_zvZSPwn63Oe1" style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--EquityAwardAdjustmentsMember_zFPxrxplvvx6" style="text-align: right">213,532</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eecd--PeoActuallyPaidCompAmt_c20220701__20230630_zyHHj8bRySOk" style="text-align: right">632,137</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 10pt">(A)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-size: 10pt">Represents the year-over-year change in the fair value of equity
awards to Rick as summarized below:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Year</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Add: fair value of awards granted during FY at end of year</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Change in fair value of awards granted in any PY unvested at end of FY</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Add for awards granted and vested in the same FY the fair value as of vesting date</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Change in fair value as of vesting date of any awards from a PY vested in CY</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Subtract: Awards granted in any PY fail to meet vesting conditions during the year; value at end of PY</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Total Equity Award Adjustments</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 13%; text-align: center">2025</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember_zClFSVskUwu7" style="width: 12%; text-align: right">43,640</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember_zWFURhYOa1Xh" style="width: 12%; text-align: right">1,394,524</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eecd--AdjToCompAmt_d0_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember_z0mrZSSwXjV2" style="width: 11%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember_zgbGR4z40JO7" style="width: 11%; text-align: right">(6,300</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember_zuoRFfcLC2nk" style="width: 11%; text-align: right">(88,380</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--TotalEquityAwardAdjustmentMember_zYPy6nv3d353" style="width: 11%; text-align: right">1,343,484</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eecd--AdjToCompAmt_d0_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember_zl1lYr0pZoZa" style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember_z2vHmvd5EAob" style="text-align: right">42,122</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eecd--AdjToCompAmt_d0_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember_z7PrM2ho2Xo4" style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eecd--AdjToCompAmt_d0_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember_zd2I33lU6xYl" style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember_z5A6I3LdqDP3" style="text-align: right">(85,950</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--TotalEquityAwardAdjustmentMember_z2eKOjwS8Cl9" style="text-align: right">(43,828</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eecd--AdjToCompAmt_d0_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember_zj5bnUFLYmFf" style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember_z7upVd4a8axg" style="text-align: right">288,017</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_d0_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember_zBbwBLA45Tkf" style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember_zYCHsPDgjQwh" style="text-align: right">140,840</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember_zSojkcSVIGU7" style="text-align: right">(215,325</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--TotalEquityAwardAdjustmentMember_zYFEqZeSO3W2" style="text-align: right">213,532</td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="nump">$ 357,825<span></span>
</td>
<td class="nump">320,500<span></span>
</td>
<td class="nump">297,613<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="nump">$ 773,236<span></span>
</td>
<td class="nump">328,349<span></span>
</td>
<td class="nump">424,446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</a></td>
<td class="text"><p id="xdx_84A_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zktdUgWMofm1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">(3)</span></td><td style="text-align: justify"><span style="font-size: 10pt">The dollar amounts reported in column (d) of the PvP table represent the
amounts reported for Alisha, who is the Company&#8217;s only Non-PEO NEOs in the &#8220;Total&#8221; column of the SCT in each applicable
year. </span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">(4)</span></td><td style="text-align: justify"><span style="font-size: 10pt">The dollar amounts reported in column (e) represent the amount of CAP to
Alisha, as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual amount of compensation
earned by or paid to Alisha during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following
adjustments were made to Alisha&#8217;s total compensation as reported in the SCT for each year to determine the CAP:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td colspan="2" style="font-size: 8pt; text-align: center">&#160;</td><td style="font-size: 8pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Year</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SCT for Alisha Charlton</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SCT Reported Equity Award Value for</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Alisha Charlton</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Equity Award</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Adjustments</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>for Alisha </b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Charlton<span style="font-family: Times New Roman, Times, Serif"><sup>(A)</sup></span></b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Compensation </b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Actually</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Paid to </b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Alisha Charlton</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 19%; text-align: center">2025</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eecd--NonPeoNeoAvgTotalCompAmt_c20240701__20250630_z7FG8h1L9MQ4" style="width: 17%; text-align: right">357,825</td><td style="width: 1%; text-align: left"></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$&#160;</td><td id="xdx_986_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_zrsDXu00CPXh" style="width: 17%; text-align: right">(47,630</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--EquityAwardAdjustmentsMember_zbAW8QviX7E2" style="width: 17%; text-align: right">463,041</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20240701__20250630_zCeAvIA0ACy2" style="width: 17%; text-align: right">773,236</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eecd--NonPeoNeoAvgTotalCompAmt_c20230701__20240630_zoxojl9KaX2f" style="text-align: right">320,500</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: left">$&#160;</td><td id="xdx_98B_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_zF7qpWmHjm8l" style="text-align: right">(20,070</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--EquityAwardAdjustmentsMember_zjejMypa3lck" style="text-align: right">27,919</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230701__20240630_zxbyk2Xi9Irf" style="text-align: right">328,349</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eecd--NonPeoNeoAvgTotalCompAmt_c20220701__20230630_zM80TEHQ22L3" style="text-align: right">297,613</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eecd--AdjToCompAmt_d0_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_zDPZWrdlsbmh" style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--EquityAwardAdjustmentsMember_zsCNqaqWGcnb" style="text-align: right">126,833</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220701__20230630_zq2Y9Nopn9Xh" style="text-align: right">424,446</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-size: 10pt">(A)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-size: 10pt">Represents the year-over-year change in the fair value of Alisha&#8217;s
equity awards as summarized below:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Year</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Add: fair value of awards granted during FY at end of year</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Change in fair value of awards granted in any PY unvested at end of FY</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Add for awards granted and vested in the same FY the fair value as of vesting date</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Change in fair value as of vesting date of any awards from a PY vested in CY</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Subtract: Awards granted in any PY fail to meet vesting conditions during the year; value at end of PY</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Total Equity Award Adjustments</b></p></td><td style="padding-bottom: 1pt; font-size: 8pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 13%; text-align: center">2025</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember_zIrHLIVMiiP1" style="width: 12%; text-align: right">43,640</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember_zLqb5hXxSehl" style="width: 12%; text-align: right">451,867</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eecd--AdjToCompAmt_d0_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember_zhpmCIqB6IYa" style="width: 11%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember_zj87kFcV1D99" style="width: 11%; text-align: right">(6,688</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember_zkQi4zwUOOL9" style="width: 11%; text-align: right">(25,778</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--TotalEquityAwardAdjustmentMember_zNqPPjGGo9sg" style="width: 11%; text-align: right">463,041</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember_zlFJxgqFd596" style="text-align: right">39,280</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember_z1TXHyJ01dUg" style="text-align: right">13,708</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eecd--AdjToCompAmt_d0_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember_zIw5REBYHfib" style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_d0_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember_zn8LVY2hrUPh" style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember_zqTBVY0DUw7k" style="text-align: right">(25,069</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--TotalEquityAwardAdjustmentMember_zObPM8wpGlMk" style="text-align: right">27,919</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eecd--AdjToCompAmt_d0_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember_zME93pInFV92" style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember_zO48jcKhvGPk" style="text-align: right">92,897</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_d0_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember_z2HzoBHj22Va" style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember_zOz5NLguxGA8" style="text-align: right">88,184</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember_zeT9raLZWJSb" style="text-align: right">(54,248</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--TotalEquityAwardAdjustmentMember_zYdtV9a0gCjc" style="text-align: right">126,833</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">(5)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Cumulative total shareholder return (&#8220;TSR&#8221;) assumes $100 is
invested in Pro-Dex, Inc. common stock as of July 1, 2022. The TSR represents the cumulative value of the $100 investment as of the end
of each fiscal year presented (each, a measurement period). Pursuant to SEC rules, TSR is calculated by dividing the sum of the cumulative
amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between the Company&#8217;s share price
at the end and the beginning of the measurement period by the Company&#8217;s share price at the beginning of the measurement period.
However, as the Company does not pay dividends, TSR in this proxy statement is calculated by dividing the difference between the Company&#8217;s
share price at the end and the beginning of the measurement periods by the Company&#8217;s share price at the beginning of the measurement
period. </span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">(6)</span></td><td style="text-align: justify"><span style="font-size: 10pt">The dollar amounts reported represent the amount of net income reflected
in the Company&#8217;s audited financial statements for the applicable year.</span></td></tr></table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">CAP and TSR</a></td>
<td class="text"><p id="xdx_84E_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_zEcOxd3Ukh3f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><i><span style="text-decoration: underline">CAP and TSR</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As demonstrated by the
following graph, the amount of CAP for 2023, 2024 and 2025 and the CAP is generally aligned with our TSR over the three years presented
in the table. The alignment of CAP with our TSR over the period presented is because a significant portion of the CAP is comprised of
equity awards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 10pt"><i><img alt="" src="image_001.jpg" style="height: 337px; width: 577px"/></i></span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">CAP and Net Income</a></td>
<td class="text"><p id="xdx_847_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zEgAWXTq5DEh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">CAP and Net Income</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As demonstrated by the following graph, the amount
of CAP for 2023, 2024 and 2025 and is generally aligned with our net income over the three years presented in the table. However, as noted
above, a significant portion of the CAP is comprised of equity awards, and therefore this may not always be the case.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_001.gif" style="height: 319px; width: 570px"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="nump">$ 271.22<span></span>
</td>
<td class="nump">122.06<span></span>
</td>
<td class="nump">118.71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="nump">$ 8,978,000<span></span>
</td>
<td class="nump">$ 2,127,000<span></span>
</td>
<td class="nump">$ 7,074,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="text">Rick<span></span>
</td>
<td class="text">Rick<span></span>
</td>
<td class="text">Rick<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Rick [Member] | Reported Value Of Equity Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="num">$ (47,630)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Rick [Member] | Equity Award Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">1,343,484<span></span>
</td>
<td class="num">(43,828)<span></span>
</td>
<td class="nump">213,532<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Rick [Member] | Add: fair value of awards granted during FY at end of year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">43,640<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Rick [Member] | Change in fair value of awards granted in any PY unvested at end of FY [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">1,394,524<span></span>
</td>
<td class="nump">42,122<span></span>
</td>
<td class="nump">288,017<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Rick [Member] | Add for awards granted and vested in the same FY the fair value as of vesting date [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Rick [Member] | Change in fair value as of vesting date of any awards from a PY vested in CY [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="num">(6,300)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">140,840<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Rick [Member] | Subtract: Awards granted in any PY fail to meet vesting conditions during the year; value at end of PY [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="num">(88,380)<span></span>
</td>
<td class="num">(85,950)<span></span>
</td>
<td class="num">(215,325)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Rick [Member] | Total Equity Award Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">1,343,484<span></span>
</td>
<td class="num">(43,828)<span></span>
</td>
<td class="nump">213,532<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Alisha Charlton [Member] | Reported Value Of Equity Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="num">(47,630)<span></span>
</td>
<td class="num">(20,070)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Alisha Charlton [Member] | Equity Award Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">463,041<span></span>
</td>
<td class="nump">27,919<span></span>
</td>
<td class="nump">126,833<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Alisha Charlton [Member] | Add: fair value of awards granted during FY at end of year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">43,640<span></span>
</td>
<td class="nump">39,280<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Alisha Charlton [Member] | Change in fair value of awards granted in any PY unvested at end of FY [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">451,867<span></span>
</td>
<td class="nump">13,708<span></span>
</td>
<td class="nump">92,897<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Alisha Charlton [Member] | Add for awards granted and vested in the same FY the fair value as of vesting date [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Alisha Charlton [Member] | Change in fair value as of vesting date of any awards from a PY vested in CY [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="num">(6,688)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">88,184<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Alisha Charlton [Member] | Subtract: Awards granted in any PY fail to meet vesting conditions during the year; value at end of PY [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="num">(25,778)<span></span>
</td>
<td class="num">(25,069)<span></span>
</td>
<td class="num">(54,248)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Alisha Charlton [Member] | Total Equity Award Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">$ 463,041<span></span>
</td>
<td class="nump">$ 27,919<span></span>
</td>
<td class="nump">$ 126,833<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=pdex_RickMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=pdex_RickMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=pdex_ReportedValueOfEquityAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=pdex_ReportedValueOfEquityAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=pdex_EquityAwardAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=pdex_EquityAwardAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=pdex_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=pdex_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=pdex_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=pdex_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=pdex_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=pdex_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=pdex_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=pdex_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=pdex_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=pdex_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=pdex_TotalEquityAwardAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=pdex_TotalEquityAwardAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=pdex_AlishaCharltonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=pdex_AlishaCharltonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Award Timing Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgDiscLineItems', window );"><strong>Award Timing Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiDiscTextBlock', window );">Award Timing MNPI Disclosure [Text Block]</a></td>
<td class="text"><b>Equity Award Timing Policies and Procedures</b><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">In accordance with Item 402(x)
of Regulation S-K, we are providing information regarding our policies and procedures related to the granting of certain equity awards
in relation to the disclosure of material nonpublic information (&#8220;MNPI&#8221;). <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_902_eecd--AwardTmgMethodTextBlock_c20240701__20250630_zdKfyT7OxJ1e">We <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_90A_eecd--MnpiDiscTimedForCompValFlag_dbF_c20240701__20250630_zYUCdsJ02dNl">do not</span> have a formal policy, program, or plan
that requires us to award equity or equity-based compensation. Our Policy on Insider Trading prohibits directors, officers, and employees
from trading in our securities while in possession of or on the basis of MNPI</span>. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_90C_eecd--AwardTmgHowMnpiCnsdrdTextBlock_c20240701__20250630_zhMA9YjzH045">We have <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_904_eecd--AwardTmgMnpiCnsdrdFlag_dbF_c20240701__20250630_zSM96kySZlm7">not timed</span>, and do not plan to time, the disclosure
of MNPI for the purpose of affecting the value of executive compensation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the year ended June 30,
2025, no equity awards were granted to our named executive officers within four business days prior to, or one business day following,
the filing or furnishing of a periodic or current report by us that disclosed MNPI.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMethodTextBlock', window );">Award Timing Method [Text Block]</a></td>
<td class="text">We <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_90A_eecd--MnpiDiscTimedForCompValFlag_dbF_c20240701__20250630_zYUCdsJ02dNl">do not</span> have a formal policy, program, or plan
that requires us to award equity or equity-based compensation. Our Policy on Insider Trading prohibits directors, officers, and employees
from trading in our securities while in possession of or on the basis of MNPI<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiCnsdrdFlag', window );">Award Timing MNPI Considered [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock', window );">Award Timing, How MNPI Considered [Text Block]</a></td>
<td class="text">We have <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_904_eecd--AwardTmgMnpiCnsdrdFlag_dbF_c20240701__20250630_zSM96kySZlm7">not timed</span>, and do not plan to time, the disclosure
of MNPI for the purpose of affecting the value of executive compensation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MnpiDiscTimedForCompValFlag', window );">MNPI Disclosure Timed for Compensation Value [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgDiscLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgDiscLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgHowMnpiCnsdrdTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMethodTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMethodTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiCnsdrdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiCnsdrdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiDiscTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiDiscTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MnpiDiscTimedForCompValFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MnpiDiscTimedForCompValFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>51</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>12</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="pdex_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pro-dex.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="pdex_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="pdex_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995443 - Disclosure - Award Timing Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure</Role>
      <ShortName>Award Timing Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="pdex_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>pdex-20250630.xsd</File>
    <File>pdex-20250630_def.xml</File>
    <File>pdex-20250630_lab.xml</File>
    <File>pdex-20250630_pre.xml</File>
    <File doctype="DEF 14A" isProxy="true" isUsgaap="true" original="pdex_def14a.htm">pdex_def14a.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image_001.gif</File>
    <File>image_001.jpg</File>
    <File>image_002.jpg</File>
    <File>image_003.jpg</File>
    <File>logo.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://fasb.org/us-gaap/2025</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="90">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>21
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "pdex_def14a.htm": {
   "nsprefix": "pdex",
   "nsuri": "http://pro-dex.com/20250630",
   "dts": {
    "schema": {
     "local": [
      "pdex-20250630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "pdex-20250630_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "pdex-20250630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "pdex-20250630_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "pdex_def14a.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 3,
   "axisCustom": 0,
   "memberStandard": 2,
   "memberCustom": 10,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "contextCount": 51,
   "entityCount": 1,
   "segmentCount": 12,
   "elementCount": 106,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2025": 90,
    "http://xbrl.sec.gov/dei/2025": 4,
    "http://fasb.org/us-gaap/2025": 3
   },
   "report": {
    "R1": {
     "role": "http://pro-dex.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "pdex_def14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "pdex_def14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "pdex_def14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "pdex_def14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
     "longName": "995443 - Disclosure - Award Timing Disclosure",
     "shortName": "Award Timing Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "3",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "pdex_def14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "pdex_def14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "pdex_def14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "pdex_def14a.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "pdex_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://pro-dex.com/20250630",
     "localname": "AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Add: fair value of awards granted during FY at end of year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "pdex_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://pro-dex.com/20250630",
     "localname": "AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Add for awards granted and vested in the same FY the fair value as of vesting date [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r53",
      "r63",
      "r73",
      "r98"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r56",
      "r66",
      "r76",
      "r101"
     ]
    },
    "pdex_AlishaCharltonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://pro-dex.com/20250630",
     "localname": "AlishaCharltonMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Alisha Charlton [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r87"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r94"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r57",
      "r67",
      "r77",
      "r94",
      "r102",
      "r106",
      "r114"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "auth_ref": [
      "r112"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://pro-dex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://pro-dex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "pdex_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://pro-dex.com/20250630",
     "localname": "ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in fair value as of vesting date of any awards from a PY vested in CY [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "pdex_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://pro-dex.com/20250630",
     "localname": "ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in fair value of awards granted in any PY unvested at end of FY [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CAP and Net Income"
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CAP and TSR"
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://pro-dex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://pro-dex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://pro-dex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://pro-dex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "pdex_EquityAwardAdjustmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://pro-dex.com/20250630",
     "localname": "EquityAwardAdjustmentsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Award Adjustments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r53",
      "r63",
      "r73",
      "r98"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r50",
      "r60",
      "r70",
      "r95"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r57",
      "r67",
      "r77",
      "r102"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r57",
      "r67",
      "r77",
      "r102"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r57",
      "r67",
      "r77",
      "r102"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r57",
      "r67",
      "r77",
      "r102"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r57",
      "r67",
      "r77",
      "r102"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r57",
      "r67",
      "r77",
      "r94",
      "r102",
      "r106",
      "r114"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "auth_ref": [
      "r112"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r49",
      "r118"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r49",
      "r118"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r49",
      "r118"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name"
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r119"
     ]
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r55",
      "r65",
      "r75",
      "r100"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r58",
      "r68",
      "r78",
      "r103"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r58",
      "r68",
      "r78",
      "r103"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "auth_ref": [
      "r81"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure - Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "auth_ref": [
      "r50",
      "r60",
      "r70",
      "r95"
     ]
    },
    "pdex_ReportedValueOfEquityAwardsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://pro-dex.com/20250630",
     "localname": "ReportedValueOfEquityAwardsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reported Value Of Equity Awards [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r51",
      "r61",
      "r71",
      "r96"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r52",
      "r62",
      "r72",
      "r97"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r59",
      "r69",
      "r79",
      "r104"
     ]
    },
    "pdex_RickMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://pro-dex.com/20250630",
     "localname": "RickMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rick [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r54",
      "r64",
      "r74",
      "r99"
     ]
    },
    "pdex_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://pro-dex.com/20250630",
     "localname": "SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subtract: Awards granted in any PY fail to meet vesting conditions during the year; value at end of PY [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "pdex_TotalEquityAwardAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://pro-dex.com/20250630",
     "localname": "TotalEquityAwardAdjustmentMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Equity Award Adjustments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title"
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r119": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>22
<FILENAME>0001079973-25-001567-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001079973-25-001567-xbrl.zip
M4$L#!!0    ( +. 1ULKA>D;F"H  )4K   -    :6UA9V5?,# Q+F=I9KU7
M]5>4C]/%CX*D(L+2W2VL='>#U-(-"RP(THW2W;ET=Y<TTK5T=W<H""HASQ<\
M[]_PSMGSG#-G9N[<>^?YX5D9.6E>/A/^_T2>N2%Q4#X0J=M#G=U,'"WX*92L
MS1SMG1Y3"A4HU-K, HGRYL4SI,=@>7H\380@_5^ D9"@2$AP)"0$$A+PE('!
M2& H$AB.!$8@@8&G(A2,!(4B0>%(4 02%'CJA8.1X% D.!P)CD"" T^C"# 2
M HJ$@",A$$@(X!$)"0 C 5 D (X$()  X GX"?H1ZW'XL1MXVO,44# 8#@8C
MP&#@:>UC!H6"H7 P% && D\L'HMP*!@.!\,18#CP1.JQ%P$%(^!@! *, !XY
M/HZ" 2@8@(,!!!@ GB@_:7@D_<CRD1;PI.!ITR/T(];C,/ DZ"E_##@4BH!"
M@2=]CVL?,S@<"D= X<"3W$<6CT4$'(I 0!' H_I'4H^]4  .!1!0 '@RX\FL
MQ^E'.Q[U T_>/$EZ!'LD_<@2>++J:?$C]B/T(Q;PY-Q3^3%_# 0<#CP9^:CO
M<>UCAD# $<"CKX]R'UD\%N$  @X 3S8_707ZU/MD-/#D^I-WT*?1)SN IR,\
M*80^(3V1!IYN\L0#^@3\! T\G>BI&_JTYRF QXL]&OFH[W'M8X8  .#?VP#\
MNS?P[Z+ OYL!_ZX"_/,=^.<L\,\[X)\[P#_]P#^%P#\-P#^6P#\>P+]-P#\L
MX%\W\"]_]M_S__\?*H!4VXBS",L1\W^)!<(=JC$6#\2BI-/GO<CM#<5G-BU8
MC,T7CR"C=7TAYV@F%\4@DZ8/OZ162&*5:HV$ORD:@_-8'%>$U1^,QPI^SD(0
M-C!,YDOX$"DQ716J%2BG-Y&$5I;-E6O7P]9&&LL7JHU[PTD5FBJ6ZJUFR@Q&
MFRI7OG[:&<E4P&<>;'7_>;PV^K5ZH^O+<PPR07?*K=[0M\R&B.;:G<$(=O$L
MQ9:ZO=%4L V=C7O]P42.1 294NM)]W2)>KGA6&OCRGB5V6B64IOK_DR3T\GZ
M6-MOO<7.  QR97V>\^VA!&8CWW2FGP>3^0J_F3U:KT\6ZR.0JSK:?G^?C D
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M:0<!Q8Z(81AAQU/=(%/FQ5)[Q-.7HA*Z.,PWD<[04R_+^)+ID @8QQI_2*@
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M\5I3:0E3.(P[OZC 9J1,5E*[D998_4H@'U,SU"HRQK42G)\)4Q60NS@K4PL
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MM2OZ:EL%M*=ZOJO*O;>'M:<.V9-CV]-TM5A7VM-*MI"PV]-ILIC1W-&;M_@
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M43B/""<O'\_/2D!$%RZ0DI#2DI'1\ER#7N/Y+U]G]0 E$4@53P(,N@[@48+
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M5Z>HU925!\ZGE@?V*7/8)5UFI;-*VL4</8W7_E+Z19%GLLM:<XLHJM!8,HH
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MVM6:]-+*[RQ748^,K9%WYV,^*L2, 39C83LBI!'B9$=LN2G=X\YNAAYF+&=
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MM/(T._Z:M^,U2K?;XGH4>C4:RDM+H:@#[=E^SOSX1_%.C=NH>;9X9QFEF1]
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MWISCRM(9L-Q*U_ZR@?B*.6#@>/PSF,XJ,CYXJ2H<<@;(V9P*@L]-H332]+<
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M&EQ%C7@OIN.[DCQEGU+G8JD_J86UKPT:E:PDA\27=\K$"B&HM;Z?QKF'^;Y
M1+J72:2_ H&_9)9(]QTJLH[+?88<BYE,]E2*O;DX&UI\GJ2\RT+(XBL+K<2
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M2['^KIC>E;BIJM]/*!V__%8CM%!W 7U4<3JR_B#!_WK6_TGL!# $CG[MN7G
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MN:L_49#@"W'_BE9,\4392B\9TM6!=YEW!C6"9QU>*%U_'.+D">K=N>1N>KC
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M5L<L)0&4YGAID26\(N(HJ/:G6! N\/A?U/&X3HOGMSNN6'6UK&Y)<B[N6MX
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M,1HGOP+T_H=!1TOS JJ%7#@17RR<R97#L/,I;W2X(HERJ=ZJ< <1Y"--V*B
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MYD(6)*<:/(5H[!K?!,IV+^(9FDSQ#L5@O6P?EDDG(+RE2+IYMLY?3C;%G'?
M.D7]15D\)6H:V,GQF)=6<R"MBRN;G6,NO95.MM$4[A5RROE.X,#I9#&((SQ8
MM+=TUUZ-!)2G[Z'D'QTD)OB--XUZ50K7Q9C&X8N+/EQ#.,)/7W]?K639Y *O
M7X;*'\HHYM)5^N0(A8/SFD"Y9+G,O&J#\7$TR=^^\4_]UN<7O:\\MUK"TD?<
MS:0U:3HS=@U.2'F93W@##&TSBU#'S3X63* -[)&5)G!P%OGLA6M8EM\6H$;,
M[)IP7,'?FHYZ8A(DBE-#**!!OAZX*=89''_N6OYH2:?NX;DNY+GXW$S/E]J:
ME,09, F&4R0B'9 U(1799YM)]*3UD?/-+P9Q$D@F*M"$:PAEZJHC6(&^I+X!
M;KN!>8Q=PS'>R)TSDS2I )4!"9,#+/G+/U<CG!N\I+8&:V&VD$:>D@@#[&QC
M%1)F50X#*KMR00'J:A=DF@2).(@R<KBD44E.(G],]MD&J4E@WXBE-&;\Y3?8
MD=* ?_44?N\-Z+8UIY7CLW.W+T.PGL(H$0WBT/Z0V'V02+Y1M4,'02TN%4K(
M #]HJ%GQJ4DGO7QEQV6?FD]&]Q+M3 PL<9P5)S3ZI>X?K>#,KGGU.1)!C)[B
M!+HI_$\U'F'<R^Q>Q?@7]F,%%4YIAQ$'CZBV7M:,TX.Q#=%V,=^ <M2HO0XX
M ><N8C'UUOP:D29=TE3N2E4C9XA8)YFQ']\,*D;=ECZN"CQ+;8Q(4_#D["C0
MJPT;]MNDNP@/:X;.DTUXMC%];;3@>M(L^&8Y4'#S:Q#[SEQM+;?.=I9A!O/0
M>K;8.B/"7L)XF3VYH/^/<HZ3M)^I>..U, <)E2GWBS6XH.A'YCGE]CQ\R10_
MXY# O;K,Z;(2'FZ&YS^3*:6CPS^'7><^DOD^[[P^_$?4>-=C-6[>5&&9I]*+
MD:%)7<ZAH3/8 L\^L_A1S'"3K@AC.]YTC,YIU.>_;Z?E5_[%<N+&<%(8PU4T
ME1QQA:X\T:P12]:%4<JE+]=AM1FW?C&7^Y^_S?;_%ER_OX:YEMNTS*U$/D<M
MZ&^&V^%@.NV0E84;%655F&]UI"X8XZSHPT9[EV2=L[-Y)'3LFH\\20CL[$)N
MEQ8*VKT=).G_TK7JS%09,\';'<R'"-R6_VR&\G^0C=/M\5$A':$F9S.)33@6
MAVAMX'5\(R);E0V<E?SJ3)[19ZF&,5E,1E#>=\UCJW)^LC<=1Z"B8VIKUZ_0
M@1Y-PDY-_)T/(/$)U6OEM%'V;X1-YD>!LWA0@K_9]==HW9,KFPZDO6AM]^B7
MV1<RMDS68!@)X O@!AE)GS\=MA#%2KU/UO*JF1 ]J4>-3!$)@KTXTR4*#*G]
M"Y\WL\[-6=-1,S&,"0<EHM<T;!L9=_')T?K9>'2Q,H)Y)3PDI6)&<;#W$"7:
M\=T7NI%35V& )#D[6=]H(H[2UC+T^PWXEKMY@ L*L]W2OZ\Q"3ZIR=-2,&S-
MLYRVWJL,U]RA2Z.!UNYD5="%W*C:,ZLRPPL8=]"BYGOHDD!)W!AQ\S]@U+BS
M]Y7'O;.UJS</8K9/)!?5^2-#[A-%K'GYY0,-0B(G0=B.-?F)^U1@?Q!=?5-'
MC$)S%$3ONZB95APQ4TK2I;UJO@HCRCJ9KK <>HGUWN#VG,XG"^)(FD+EC#:(
MH[Q_ZVW9JL?DH'CMA^2"#)4?2Z3HO+\7F/!+B61;Y?;P4^!Z[7]Y\#_:49-%
MB*:"PL0^WPCPQ!SGLVY()IZ-^2$-_UFNY4AJHP:WI1%"P%GIJ_TKJ=H>;%\T
M1AHZ>W_Q%NI)<Y2/4$3A^3KUR,_+\0@)R>)K62T(J]IKP)[0RB L$4Z_ 97Y
MN#Z=%MY)RKG,H8Q]SDW2 8ZU'Q(^SL ;GH6[*]1HG1PD.5"V!Q6-=J@V[)TL
M%X1HI!_4KF$C[G]M.H\O@5V,_ZA[!=O1B+!\P9 8!AB?JC?M@,]K#HDUKU D
MS98["XS;'3,#[K9ZREI]C-C4LC\Z<XV^@^>4-&: &!LAM(THOW8!Y@9>@5H9
M1K91%O';2":7Q:EP'ZH:^C0AM'+,Q9C.2P+5]YV$%30<OR7YVE?"4OU3OC10
MG0#X@Y:EHG>+WYUX&&I.L17'?X"#WH.Q ]'G#Q.,+DJ%CJRM&>+H+']+Y?:P
M4B/D&[1( 5P2<Z<L[KGRE_IN(4)QP9AXTW!18O1@<O;C]..4N=8J)'UMK'17
M2AI'IF:?,S&*D8^U&]ZO;FRW/:DH9Z8#^UJ(SBGO9,B"Z [$B5.;0VBZYJ\[
M,M=&S>0T^SD@[I3OI:X/J,F:*>T_B;2O4VJ_'"*WF:&*GK43?WL#C@K0*IG>
MK3[)6QUP<@UN:)^&PFVUBG+=VY56V20#NKJHV;K:>P\@:!O'#4HLM NPG34X
MZ?1I<C+V'A]#=_F0[HGX!?;NP%V!=.CYAR\.AS=<!25[B>3G>B  < H<#N*K
M8,)LJ:X<X23O7/6HLT;'A99JDUPIQKGKS!F'VY5[J.PIR27F@#=WG^G!/BD"
MU0)B3:?VM3\_7V3(B4Y_LQ+1)^Y"Y]U.T]<P$C)EG]C'U!2G=IXZNT?G./O'
M5(N&I;(L;3^3!I3BDEC0HN&PZP0(O'Y*G9BHD4<*V=9,F%XQU%32+!8O\#UA
M>746)U[0$IZS25J1'HV?P_UB#+?>\:J;LEIFY!.5HN[\-)+M<'[@,"..XP9Y
M Z#-@ ,,AH2TE*G>BB%O1CGS;*,BIU^AK)IR.@+D<+3J Y+:*:%LAE63F1W)
M5F-;[\VQ.!%W<Q1/ZM=M_Q#I:&GL=H8Q 0,ZA#1J@>L71CY_Z15B!7?+JPV&
M;)LPX1!>&&631,$9^!>\-"?'C1._TB2J?B: @-P[-,_[L)5<KP-*,Z<[=)O&
MQ"]UQ<EQ96Q)'@?H?(VF!_X+ &;]/4%6?VF7M*/OI &,L&2,DGZ;KVM62S[6
M3";^K)%J3FIJEH"*OA8N !GV.IF&KNS=W$P218:OXX;'DDY!@@<C"MX )XSA
MHO:>=IGF]CCTQ69K,NJ\]@3P\5@!+ %1]CA[A\HD[NO?79F._XV]MPZJXUL3
M11LV%MS#QH-[<'>"0W!W=W<(L(% <'>'X![<@@1W=_>@"1[\<L[<.S4SY];,
MK]Y]]>96O?/'5[77JNYO?2ZK5_<..8R6-%"0R9'U&0(AS0GQ2]TM-2'+0G="
MD.[FM#C:DM,_-(5I:3" 8Z\0!_#@JS1(8F3BQ^]]QCX*](RH(!</=]])N2+J
M-,G%7><B&.O\]!N/HPAR:?8P8U#[-!7=>3*3?*QN&HD7>*9F[A[Y6*%(:&@1
MM81#M%[NPY$80>BG&^Q< 7*JA[P ?VZ FU(#K7:-+/%:OY^<;[@OF34_==X.
M[F37 T_R[XEO.*(*,&IB/NN6&-'%^__*O"Y>TK567J-;E?C6C\HCRA7M==@]
MSG>5UR ;RD#=G(7^E+4PNEQ@AEB."5^RZD\7UA QN&-\,[+/Y)$+OPLB8;GA
M$3I@!Q;2_U@3FTARO:$P,?6G,Q=?=AGW4\H.*9S^]=Z^"I^^'D&9,JY+UWG3
MR"_WR\26<E4Q0_(A61E=^R^25!&Z,B2CF 709<5W2>5T!0Y&M1W0^PX..IW=
M6,.'P*]7N6_LS.?(ZQK"C/D^2!'MA09&U>^:Q$N(7O[Z,]MX6JKS-2KR;)H-
MN7B#2I19P? M#,D+H"9??G1Q>%J+T#[0+Y,D^#DHI^0@^EK[!5!I1Y='A>;E
MW&#!"3EA_=WQ!>79!]"LRU&QVM*!Y"&2LYB24P0U.W*3[I0^'KV1^$J<QUYB
M[D\_;MDM5XH78QU3BO)KOO![RW?\'V*$$,D.UMR\;EC3M7C>R(![E;=:WU/,
M1TSE3_$?[P91FO8'E 6-A5#KH<SG?3]T.U[T9EN7TN(BW-4ZLD5BS'QG.7/
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MX6^K4#ESY.SO5:K>N[X &VP#B93S2O5[X0'9\'Z9V=[&$ ;!;] U>O')YC0
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MGUFK*GO.I6"I'$<H,]@PW=V2@=%V"QY"C+Z_G5LY/S<5^\CEIVR+Z>73OI'
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M-GW ]IB@YHC[*]*!6PBV_77*:,_H\&'#*+),JW*\ASF2";%Q' $^8(/()M,
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M&B]+WDMV)S(\L&]!L1GUO?NX3TPHXGE*(-YJ4LHX>7N-,ET<#UIM_2UX_+3
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M.)\$18HJ7B<B=#=NQVPB92I\Q_$@Z*I/<]95R:-$DJX/0PQ?8C<>02U.![1
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MCVL=)()9CC:YU-9Z+#C5ZEAFG4RV1$;Q$A8YW[*U;[0Q<W]3WG)X:K"^%:>
M;3BH92CURJ==)_Q7&;#X3>UEN,G!U"^.YJ1LI9TKU?.4A[[DS02A 150J\YE
MHHMYLIB[B?J6T6[%!7KY4LC5@ 7@H*PZI$E0'4K.1F36IM8+.W'R(&KX-A\@
M>6$\R[$"C3=298_?]H=/") _(UH0.] &^/N;$+1SG@P^;;-0$"4D$%?J&LJ
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M[V ]?H@M&4!//YW1)_!R;]_X6#QQMLE('_1D'%@N((F?G>MYB<?R\]A"&M/
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MJ$/0?!-?J'$TS2C&XU6B61>&L3RGI:7_P5RSW+>^NGNRXDL3/1Z&EOK>7<7
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M0I+")A1"1QZFL3("N^R-SP'4?^OHT/_^&O%VXZDY63)@I+ H9I;5YS6.F<H
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MGF4RO</%",W HKBA $S3+GQ</YN_O[Y/RWB>Z7K:8"6+#0$7<AYU?@7]"M&
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MG4<9:^A50^B#(Q@[J='L]2;>+4(]GIY4]3B'Z07M4!/3I9X:I':[4GEL.UZ
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M/[*;,@%FK-$[ [Z4I-.?MEA0?=)&6PAZZKVKP_S[MC[1A2E6#:N+90"OX*P
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M1Q!VOQCA4Z1IE Q,(3Y?E\C*H8;--5&K&X1>?>VDVE1SW51W(A%UXK$W$7^
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M6AC7@.@TG[O4%/5LM,J& 4U;ILAEUIJDPQEM"7KH:8OF*F)P#*0JW<P0MX*
M55>W+2U,/WJ8/&O1OZIQ9N%;:FB?9%FS/4I$%]:Z.Z3A-2I!D*$C1V5+!NS0
M/9K/LGW[8,Q? 7IFKX#)*%WS()O<L]5F^\HOW=8VMK96)T(\+*>4+U]$",U#
M*JG.QNN*#SDD=E9D<S(D/PFMRH@!LN0U+KCF0:NLLQ29*KZPC=P_AV43&/8O
M=1 RWIVRL,1V1:Y=;Z3DNE7IS-@<*:N:QRA&)IE,FWVJ,TH1;X^FTCU?6@K?
MH>R<R3[CAGAZ"C7D1I3A>Y6U^K*YAF'C;ET-2!SKJ1=LD+C=9>E/7SVF\5I?
M'6*WJ##!+60T,W:3V+D?2V9MDJCT\G@ ,].!UC0MTR]_["[Z30 VBYBBE"7P
M";_4B_P@(Z<8%AQZEI*4=LD./8\%B]GT7>5I,7B'[T$MX\U&5M,*4S:D9+4C
M[_'2:7BP[HD4!%'(/ J<<5:+SG4^9]@8(7*GW80FZ1BNZGKZTP?XG._N;!+L
MZW0(_JJZ3M-!Y-Q;;^'6@':MR:@A&1P0/Q$PCP9_G^?2\=;I(10 M3AY./T"
M3_90E]$A$_?PC:_F41&'_XGIF[_!(_U0,VMC+3C&,\2F!VS]VK8:;@P;[V '
M$)RU$#0OI\X*)6_^R&S%Y#,/6Z>-C[_KBDJZN>S\+LS+H&+ //^^ DFV[$,F
M3_"4S"@F _UCN,.XS$0V3L:&GH[2[)-0_I"SU8>V$+UPNM'8-GIF=J6;QE&H
MP<&'N8R!:"X@BEOT'T4=S]8HUIXM&6(S+D>6%11V.R@A2VL5S5DKVN9)YS"@
M3<=2P;("\=PYIX\.0\:P&"WC!'SX^-EX8[%4GIOLQZE4!-/6&M!64RK[NAJZ
M!" RX;J4$#Z4Q4F(^YGR$U[RXM.ONGP6]H&@Y:/BMD9Y^#MUR&G4=00+BH%>
M&_QX?6LP[T[2Y!H>6S.! %GLBM@!@YYMKS#EI$W%YLQ.8VWMQ6C\ ::6X#D\
ML-?DW; ?VR4I9%6</ D[3DM+2_R=?HA0G_"_].<2L,$%S%L;4P42N7JO.__3
M]I[6PW=.X1EEWO3-.W7G>PWN,;ABWN*K!!E:YY;H6__UYMA<4Y/_RIF5227,
M]_FI"R- 0$@J:[26/@BYV>%D8(<J-<=XK8)6/EDA?I7/?WI1L@&5 R/3?)5,
MP6:&#';_';<X=JOV*^#QT\MUY[S'LU"+6MYZ!5<5A+$Q<#1!.<JH!:VWK!@?
MAJ2I5#T3=M+JY/C$., \?I4V2/#WJMAV-7D.BL)(@"@.,"N0,P(Y0BL[6(DZ
MC\VO_N1%D3RJ%)%7ES1+X7-[[EY#ZKLTDN#,R*2]T2Z.)#Y:VH03,+LMM$4R
MX:<'DX:3N;H5HD851O-1(6FACD3[-K9"X0*NRZ60)+"2V<'H9_S.UL8"'H6S
MAHS"41-_&WPK-B:'Y2$*R9#2TAIR&'^9HCL5N:F3S<PQ<S%<KV*YT6"Z6@0!
MQ70TQ-)&8>A)9HF->JQ\C6CJ)+I=TX_K@3;(Z=#2!)05^K:H"]QYQ?K??444
M_73&E\:1H/P QP,>/V?;J!H:'DP\).-PIA9Z)S^->=U<9 M%0%U^V"6?RPIX
MXGW!/[M8&*,0'&,<HTW."-=\GIW@A8%)U>F$VVML=%A6L!R8L+OLK>/OXT"+
MW$/#/U^MX@XQ>SCB;Y9\-&$E<OH0JOAME\A#^:"%JZ.*D+IG6=*8JFQI_)QU
ML'M;NE3D+-AB4ZZN6M:8I+V@JR62*2J![H5&2/-A)\MQG83F8E<Q<V,EWUM4
MDG8TI-3[9^<*Y8P*7G?+YX*%BT*@N^T-.,1])5/BUDAF0L@2],12N QJ<%'^
MN*H7']3@')<D7<V6:"<&CT.<B3E-4]?0D&@>!SR16*Q;%N#[[F34N_7,KQKO
MIB.;>JK<E+DT;BV'*U 0%Z:AAD_L\L3 J "_S^WC+FWJFOFN$423L>4<^@J
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MC)01-%E#>YK=:CSG5%=&;]B?UB-*,F'_V"V8<*NQ37Y"VGY(($PZ1!/EEG"
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M$C1BT]#(6HJ<XNJPJG6E&^UQM:\(>I"XF^62#6J8(22JP-4,G  3PVU-(-<
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MYJG6:Y'=I")KN6330B!PPR*A("K1D2'Y**R-E F"C(VLA*696"05D*_(3,I
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MT*S^H&)*9Q:FELP$G]^I@Q_=C,6K\-7J-N7,16(-:X.^4$@G-$1=NT4JYUK
MWQGQ[V)5@7M]Y2@P#>^5-(#[)PZ+GJE/66>LL2&6NRY,WP+@BH<5>$25'6T
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MBT?>JEX6$T.PJ?9V4D^OPZK2>'EWGUQB&E5:_?;ZAA1<@?NRGUB'K,]')BK
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M:;IY<.0\8ZZN-T:,P@Y6+ :!_#$8_JU5:,ZFPT8HA]+(*[?>C05 S0#PH04
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M+Q!'BW]?R^V1\CR"O,"0LXL?@$9KPT9[\6!8WE"\<FS([NH!8TI1RF9_Y]I
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MK_L@5?79_^FHBZM 5I?H?7\ #4ZRUZ3FBX/N#VQ!X0CM7_B+=G\;9[XX;/5
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M_":%G9W<]/C]^#%*P]*709GPJI0PN5)^1G*_V2V$M5IR[? 0 Y,S7\<975^
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M%6N$H,P7-DBS@+S4M]AY7A;0-UF8B%PH0S6H)X8=JLDE[AI45O'/S)T1RQR
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MWWD[?$$7+<W%FCQ@/, N5'AJ!LOYX>',(S<1,WG.%8<:&T@U=GO_B-3V\'J
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M:__;JQ&2]OZIHC<&G71.EST&OH=O>MY[5P1'4W+[4[1EYCC'[LJ'5 GV3;*
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M;3_Y3:@I0^-!1H\J#)E]8:0L\ZFW\[D)RX&29.#^W7:5P$%?CN;*I%#Z&\O
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M^7#<^L1JN\VBN;?U<\"5!+S' Q!$>$C?X^5R&)+4 "MB) H<]@-<'#*3+<4
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MF#)JSPFU $'XX\R'4^"5<;'AH45.UA[;ZH_$-E3A9#2D-1SZCA>I^A,?K9_
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ME[M2>%Z/O@*?0463(L3'(D' "1.WN*@N613J+'V4XEX!.0WC7X1K/W'CI3[
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MKN]=;U';G&L?_?L^XQY1@DRZV/*'D3, -@ ;2I>$R<FNA:$J7!:<IZ 93(R
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M#$\"RGU$>38W_-BFO-32-[(2!5QD;^94!$#LU]4 :ADB] ",<A?W5]$T&4V
M+5P3,.;5!.XCH3-=0A?!.R282=5[$2*7,2L(%(1.F$IFGX]$DDTQ?!%6:+D,
M9;X/BNU"M,T&&Y!A 1YQ;,07&1%&+5<T;62:6:E :)BR+F$+NO43X:7"IC.8
M91+8,]6BFT@4& 46&HDB)VB-0L(PO OK49):-L12+X%#77< 15'R"Y1_5D:*
MX)FG\J80;M,AB5_<@BHB)':L1@ K=$"GCZU$8#:2 #.?]!Q1IP8%>XH#DT/1
M0S89M74)=PKERV))H> P(-DZ(<G= =W[HEAI8M4;^M1^"^1[09W4^):<?<(
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M074"J;$622?IC9/,.X,\U/[)T$.4I6\#J-*E#E=8C+D0IY"3"6I/2<-0]]*
MWD6:%]9&,LWY@<Y]LE+2Q*4F/"7#E!("3S!" POPU!Z<*UW>,IPAH<@4)_V
MZ1@E)E'#2SQ,;ACD^E@*;)2N1YRD1'<<B:[-:VJPAE6;X;[=ZF-OW^2B5*,F
M:TC0H.#(<YA187^.'7!Z;0G[U!31$=9G".NOX'T87A!'>/Z))5OA5YI7#A(2
M[_X,55Q_"CK@8)@SKO:CSMCW5">QR>>9=E<;>TG8,ST_P@B*45H1DTS?(@1=
M3@@L&<:#&Y3>?P5^.AG.I1G!4T(2G0V3>RIEX62RE%36YMV 1]3B#T.BQ3-*
M%BI&*L\:\$G\R$KMK 4,3W"!U)TJT5,R7D0''-M6498YPVUJT1;\.)NN#QR>
MXH-0TCM!J0B!T:/*#*.<?&",\?D<![*P_I734Q]A@7_QB@2,K6(Q<RLTQ419
M+&0#;"&AQ+Q$>I9BFH%] >(0,=HE_C#!:BWUZ(@*_UO$9Z4:?P%ZBQ\"#5/9
M,]W5(W7YUT(%)QY9/QQ7"3:N#%U( P"4)H[J'NC:,M^I"-ZF>I;1G1$@?&71
M!_R9?JD?-7X?:-7TB0+XG93.LXX5[4)) RF)QNKO.G"1L%06QL<UV9@"(X:6
M8ZM"<B1 T<R"B=.=%H=Z'(JD UTQ21BNIK@HI]DP#E#?H-7I0J^D>"0(DC"P
M<)MR3FER\-/Z-<JZ^P6.E=IK=:R\+1TK><?*(F+SWW<^8!@Q]T)QJ2TC'F@&
M/:V.5Z 8$N/6_5[*@!.;B2A!E0_R24W\F5"?XHF,Y=KYYXWX,1YLY]<",))@
M]_%MSA6'82PM#F/2*6,L=0?5+RY.03UB#.F"%L*%BH>04O:XD4PS7\("'^@,
MF( >Y Y M5=%,:6A#,+?%!$538T\?77^@T_CYD 9KV\4BFK"RT4*OZ(XS&=(
M142E1ENRYB[*8)K 9BHT!BQUHM0.,8FW^,8 *Q++XL663#*35@PM0BPQ0VCJ
MNFZG04G0QJP ,WGT%@WS:2,)T>BI>!G*P63X.E(G8<=Z#3T@\H&/3@5I2\37
M!-HJ.IY*_>Q:& :G/&'%4=\'O!V18ZT34:*=]!Z@6\&C5G^T69D@CIR9;/<D
MF<ON\ZYT[,@_7'Z-%9^UP+0$I,E14@J[)GPGN& DP\ Y"5MW:O:<L VEAX)6
MP='<@<HXGI+FD5(*L19H)WNA"6<"J;SB!*F[I#%ENKXL.!B2ITJ!4(0A(@@S
M3"VS2V$A=LBN29-KIAI?[[R@\S9#'TY/=23WB3X];5@ZF-)IDUL 4RY]48.A
MQ[D&<UPW7H)H$>+!(%R4V6<Y:0<T:EJF^SD$J25ELV,R.]Z;19O#%""#4H#L
M3";5CO"5AEH1QU2R06W5RS0244@E"EH(@0G]WBCW%#PF8RE4Y 1ZG7P#$W*#
M4&*97)Z0MJ36J_A2X3X<00:R$H2L9B$$#>R8.'1%'7NL&E_D87)DL($U0.82
M&B)K$-$^'PD!3TKJ^(?KY>0>*BL4[D9)"H;DZT]<16+)122T<,1/S=.3+]]%
MWM+)^5G[\\G%NF<M75$0+,:#>SX3F?88&2XDA[XS!.03]_,\\NDZ65;&4MN^
MM)K'K4O$"=:^NOQZ=/7ULK7FR'&>9JA1E2J0'2RA'W#97YZ*SPHE-=NN>$H]
MWXIDL]34=%SI-+5"N_K86@P-]6"E.E/4X@D]D.DW>JQ_&NDD;H(IY;7T:?4&
M:.'0_XF!Y.02IO'C(3I-R>ZIA<&8ADQ*4$D(8C]2ZLFY*O5]9QV3(I<#??+"
MRX[K+DZAF-A$NF+\F?9%$['X64@7GYB#80@17592)U5J S7:(H\L[O\Z=FP1
MV>)KEZ[)N(R"<$<B)D/P$$-"(QNG@VYU$;Z :$3/.^%/_0Y/YC25>QU3-&0F
M"\>-.N3OD,%"*C<X#;1)).L*^R2B!M"WBS*ODZ"R]![B)H556_6>%A9R6@C
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MYFYA(W./H=$:&'\W<#KH;NZ@%4:VNNCUU V(:BJ",0<M0AG;QG@Z!1^QU%L
MK"4M;XD)++T6Q(U@9.)D 3>#+AHCTVE3"47ESW:3"/M,^:OUT4\>Z?FMOU;/
M[T'I^7W&ENM/(Q8=G9]>M,[:9,3!JFVMOUI'7Z].OF$)MT\G1R 847V:=2SD
M-L4'CZ5ZN]P&MAH^R2J>UZHUR>V)_C'1!91:@Z(>0]&):(&00>@J2@N%"ZG=
MD3E7E%G(>BHZOH>UNFY%4@M5]H:]Z-T^E/\AU:LTO<705)N>/UGNDI%6PG&E
M17 G>>ADHYV08(X#BTP*_$9T=%?>*<TS+3I@DWZ7^J8KK!DE)<F2V:1H@F('
M#HFS3/,U)Z'6TH,UP#H]@90ZA1:99M/D7$'"$)YUHHM(3(!S"JX^2%-9&1I+
M>,G2G+)S*5;>#L.8A^FHB37!ZJ+50):(]D9".C$TL5@8CS*K4,/B@*E;GY3@
M1%M.1<^!;VMAL&0603?"'(,8"JVB $1<?([$<.7] W&+AR($.UW<JY%UM/2-
M/ *F&3"I!4W&BH]GURI<Y*Y0:@[9IO-&[(FD9)TWR$2N%!-4\_A-1W]'^&P
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M]=TZ,.L58 N-!UW(2P (Z$W[*T"-R!3&A-GG$-BJ]Q?8%#&JJ*>GB)Q85G6
MC"N3"G^*4%$9\DLI?R+"!J]7(TF*47DOELQ=C7RJD$UBO+S258:@&,GOL7_5
M=DEKIX?^)31X4RO;[(Y4Y@0% %G=;A#+;I\RX$<LQ:# GDX<B=2_S'>XS+W*
MK(WLLL=M9)_6;FC[>, VQ$(F;Z.QU$R-I\2O^ANF(9ALIB'+C"053"EEQ2CH
MF)KU XL^:/"N+.)#)W-]C;'ID>Q"Q*BY,=6;QM.2F54B)::9EJQI8SXA?76D
M501C5_[0Z1K[M;<F>^]D@P:W9)).QCFZ[7P0^&:%83P0F5 BMA;CZV1*3A*M
M9CE!NC)1RESD4,E5=BTO:98F07+F1S+>KE9CF]0R=NLC!6_KZWBC<F/3&[RM
MNJ,FV;HR)2U)%&F*2GJ7HN +[/"3'PS@\+?^2 ( T\ Z(QM8A\A/K;(Q:486
MF:?$+7F\HBXXY9W![((@8"R/ZM;)[( $!>3Z)B1L)>O]<ZN^!D3Q1,5GM-"^
M:05H=UYK =I:M:Q ^S05:)_RKMEYU%V31-AD>*NZ=62Q0I7]E,17+S5';F((
MK8XU>:S*KN.^V1<3XVE5".TD4_?!!$?3_8WD\[_9>/";]=W[OSJ++\JA]R;M
M9U+B!P7UZ"%>V1AN\H@B.\]E7DQ50V!9VS7,(GY$M/J+C-B^AUMZ<H3RK)-*
M0J8[P?8'5A3RE#NO&<[L(JX^9HB?M2@]5"V=^EG@(P*G5@8&CYQZ4GS!(P_D
MZ6(J9BWT! N>4<MEB<]\X,2#D/ZBY1:QH%6"Z4HM9@4/^ C(D8ZVB5)+<M+E
MV:[!V>Y6:W^P4ROJ8MMF<<I'\%3@=&*R1Y0GO2XG?8*9P5P*'2UI3GDUQ[L0
M(>AQA_EP@4C$]]/!+?Z8'B4:/4]@9''Z\@K%1HZYZUY&I%A]QZR^U.C"V@L.
MZWQK[KW8<%JSL?="L?V1,9TK'A9IKD=<9+T!"%9__G44LY=GB(D"<-PS<&\I
MT0]%9/\R BJ7',?X(-EDW4(9=\Q:X^WS+V-")/!SQ"SMKD(@8]VL'ZQ Z-1#
MXBD7$\:8$.=KBF2L ;17X 9=&6+<!25G!:[0FKF_NP)!U@\(I\R[#_&_%^W^
M%Q$OHF(SM>5N8G%2$?]$9<<INL@H*ONVD'71OXNL>#RY_.&>]IE@?M7$1J2$
ME6K>:J1#*H62T4P;R LP%9I8GJ&$W?*1IG#:<X_];GDQEE&#*P[+@#=,$1+:
MX=>69ZBBZE8XK=!=/K4M5?"P3+0L82YZA6(T8BQZFS)1ASDS]'G2*R49VF)#
MZ60V:&%8[)[ZSH98/)\UAX'CPFYH\3O4L1%F\41#/]6<" O\#H>^XT6BZ",-
M)!?#0^IC:$5;MTY27YT0Q,HCBQ956*'%)+%ZF=*"V3:?3Q4ZL][EI:N5AN,5
MEC*M5NKXU8PJHQ35M/<N9X2>\5)3-$.0+9A%3P0*B989V6QSB(5%_3AT1_!A
MM4$?RC;%[)AW^:## U9_2U&D.V_6MM+L\YR.ES3'M@+1?X#*^E+P/9U/">]%
MPIN8)O;9<B>VDJ"N7+(]'79\TQMF8(RTZ XGVP-3^+KJ+<!EFSMN_.0CK8N$
M: 4!$*:(;_BIM[V0G2OV6$N,F%1W%RTK\"J232!*-)@?#:9HH;,&_,PM-^J;
M#*\@RS6QHX?5<5P\&VKXY_00363LC:DU)\0>,X&X::GCA.@^+C#'2IN>I!U6
MDF8P ]7UPU)]I-/V*2^T=K,NU>=%D"*SV]K4<2Z41L6.#9)'6:$\.F;\F%,*
ME+!4<J#-$'NFRX'&F!PH1RDEP9?-]!XJ"<H,^*PD6)>I?TH2/ =E" 7!VFXI
M""[C<&3F8BF:K#LBE*+)@VKP._:O&W?VW8^#MV]_<-ZUM[8HP?1J<'WJ#9UC
M)^Q> 4 _ND 2/YR//[KH!*CN5VL_?J!OKKJW4_UQ_?%3\^KT^.KCUF]G1S_^
MN3KXZ^SS>?3EY\\>8*1KA:&88=CWHA^7O[G_?*_?W71WOHW^M]V,3EJ?=K[_
M]?O/DT^7P\Z?;OR_HX\MZZ^SOSN_'?QC__6[VVS^^/& M(J\Z.+<'7J^=Q8/
MX.LNW>JPJ4O>^W7C$U J[FFKNK]5K44^[FJKNK>U@^2D;O]F].O&D>]]!<8-
M= O/;3 >=JTAHEL0\PV"XB>K&XD'-I@'!_SK!H#S<"(TA3@G.  ]A%M ]G"!
M38,<V;/U GMVVG' 94^.S$:4%(89>.H<CZI[^0-I_K%_]'?S>_O\&Q>@D/M*
MY)#B3=;%MK+['JOZNPA!DK:E+THEZ.6W]C&_M1WGP&F<7O=.N_OWV=K.^-;J
M"]A:WO",?&Z"Z1F$4*O;]0.;S!(D.9Y$?,!VJ_7-NS?8'OB2VMO0/MI;?U"C
M=>QEDW9\U[N4B(YDZG(9ZA@T3#!(;^:'7(AN,GJGQU0?%'G)B21LP_$R&<W4
MZ0QPV/6I)SR\EG3Y Z0<QAV8-K,LU6OC].SB).DFP@0S3AA/M9YG/#SJ^W;*
M=HIXSC_V'[W1U?[YW>\UOB N\U N,843[!=R@NSVJ.MO'B1-"9*$:P#2V9_\
M #6+;Y;[R;6N?]B=3\6@^?[UR Y_K];M,_>902,PX=<-YRXZ[/B^RRVO9[EA
M'DQO=3!-V?+&!]O'UKCC;) N3)&%;XE97=E\S522G4F)^'!+&R2Z!8CI2!0Q
MM2,EA%?8[RMA;TOTAM/UM@H[!PJ[$(W= ,5//'1N!.PJ$/FS,%O?Z>!=;TM/
M![9Y3_NM8A]N==,;0DR4;\IVJR'OQH$3(?G>]AW1]W;HAR$V 1;]FE B%7($
M+,\A!1(); )4QNGM*$=OG_U;!/J1%]K!+++KGS8/OO_]S^?J;F-UR>Z@B.R*
M=TG41WB3A])N@3@D7IY.?>W3@[V?H_;_NH/]%T%]]>HD<27=[<8';$B->HP]
M <L$9@OR9*)WM%)\LK>&(;$UJ:LQC(.A:'G,+-%.498(2:J#I'VO,H0X827W
M$BA:>8&"_W/6/0GJN^>-WGT$BMUQ@6)G<0+%Y"B"N3>ZG]]H?>=_/UWM[O_S
M/X._"S::W\SNLC93)#*1=)0MN9+T,J.21R:66LE(*J+"$ DT:;-BCXJH%'1-
M0W'+P=9N\% G#AT/.[G:UBC$%M*(EKXIF"S/?)V:Z$Q#=%QS27H*6"\./"?L
M2UG*DO5>@%3A.^#F :>FL51;IC.B&P>O($D4L$8DB,J,\WQ"\"_)>CV[!,ON
MJRW!4BM+L"R\! LA\GD<A5C?"FE3U[:IL_PG46,,,_19*VWZMNJ]#A_1[U+7
MSJR.'T? *5, 97DJ1=( OT(V.:$@E;!?]0I:83YE>:H769MCKE3*XNRB!V6J
M/J3!16UGV6F^YV0KE23YV-CHI8)T!JCV'@RIPA3:A_;6FFJMG]AQZS] AN[P
M@'8U[W] ]>U45?V*A:3<$6;=/[HEVP/W\-4#42_H.B!0W6LC @7#_YC4<>R>
MJ+%(I'JBOF\/ WC.AON*)A<8LSKX4N+(ZDU>A"/+ZT\XJRM4K7:/.[FH?MK2
M0*79,I[V@%"B%9//\^\D8G]@)9&E-19; 9K_CY:XAE$H?S9A8/,_WTR\T!=Q
M9B4*3 -_(HH]-PZ,QWWTK('CC@ZG3[SQ(=_:FDS+)48]&T9)GL+O)=E?!$[W
MV= O*6WTLM#E):/(T DL7>IZZB,_MB+^,(GO<06E\A5A5J.@U /*Y>Q/*(;T
M=G6*(3UH Q.2Q5>LL-"$Q=?W*XVG!_ZD"MK5_>UJ;;M>55G>2ZA_,M6,^"#:
M>DS6^VQ3@3RG@^67])E[+:M3':%>61Y0QG!R]RFX_K+1<\(\\YJ>YNM&.=>+
M"3+=^\TG1/7BR^D9,+WQE)B^]V*Y;XG>+Q.]BZ20I:'WVY*1EYC^3)C>J#XA
M(]^M+HV1/QJ;B_*9EXH!0*S+XS$O58(N5/^6QG@7H-4]/^-=$DK4B^HJOW;T
M?'$*7BGVO@1AH+'\JV ME;KG9[XEHK](1']IZEW)QDOL?ADJW>**1XA_*_N3
MTMKSB%VO5S(HO,Q@_;DJQ>8S62:1/8PR(>^@H)Q)K3&!-/(Q)-GC5UU; 4#;
MD] BF?;//J<B(5BI1M:+BO48FZ1:S0T/9:^,*.GZ*[/-?*Z^=D(6.90G9]Q8
M 58F2HIGJ4[E73\(>#CT15Y(Y+->'&'.?P0#X"?863Y,Y^GV'7XC"J%@@G),
M75L'6+J :NFH%&=8AA_(UL/XG@K8-H88J4&EN>CC&ZY6C7_"2?[D$:-G"H>G
MK6'B:<!A)92^?=?EW,[,(=^WXT EF.Y51=*?,QAPVX$-N2-8".]R6ST1]0.>
MW_,T\&-%VEY@464QDW&'SJQ1_<5D^XU?<%V(>:8:@N"PA4"#Q[F='=+(5B$2
M=<<PP@' U*3*$; D=R32:ST*WY>YLF,X0=4E+,"OP/G)4S#^BU0GS$N$DZ;B
MT+!2M38?<-CQ+->@7*"*8$+OGZ1.WOIE\XS5Z<]$ZF2O_;JLW3_S7GUTEH\<
M<L&)/847=!*#UGCNMH&"8:ATHX=WGGN21BR+B?J>BHE9I'MXY/?<">L/C<B:
M6?-^0='^JS!//K%S7^NT?:^8PGL$_,WQ_OR*PV.B!Y7PM%# ZF&"A47W!$<X
M9&?)3?K5XU: UW*[;V&=F"L41SYCI9 SD#2^@4S [<<'&LY:+<4P9\7(!Y__
M_.=7(M-"D.E4"*[?5"&3%4&I?STV++Z>#8M?(DH^2?SLWMZZQ,_N3HB?;9AO
M5R5^=F+TZ82U[[T],!NUL89/3]+7<FT<V[5J$0(\AY6W9NZ,'^9\)UC:L5Z^
M'>LR-3; AOIH;J)Z)%CK1E8=09L2/!,%3A=K.87_/WMONM0XLJT-_SZZ"KT5
M^\2&"$%[8NKNT_$9,%7N9FIL:N@_';(M8U79DDNRH:BK_]:0F4K)DB=L8\ G
M3O0N0$,J<^7*-3X/'Y4/'5"OECGL^QX%L1"$B8,B=X[G!':W^V@T'-AO;@L!
M\\1=*<&B71,14D;?:_$K!$PSW)LOX9XQW3 <,J04<5S@Z(X2?Q#;&8=E^I[Q
MY[#[:.8)!66?WY;Q.80 BO$YA$++$RJX^'/T;)HE]6;]38&-$OB([U'WP6<Q
M:)8/DF#89AM,DAWZ!<?UD+G)]3P,9EW")<Q $P&V+"/&,^]>>Z.[K+"(7482
M;C\BNH\"T1M*VU.)F,G@EK2E,.2'6&0H&=GA5H.C)W"]A&,S&8Y-/.'2#EOV
M=_/$[KL#NRO-7PHU%G?W2R2>]/J5QA.7\M3Q.&9[;Q;'K+#!,4OBF*VU7%_;
MC^!X!N$P-*^C,_&E\,9,@[1=#B76+X&9H9ZJ54XD)XL!>A+.4YH W2B0R-77
M]]<2N%J'O@Z&78>PST)GP,AJ:'4H!._[;7,:!.\8[8N1CN<](/N!'Q-VW#X<
MX8,'Q_$R4%'!IA@,T1IB4PB-!@GMW594./J'BGR/H*S!;R%LRZX=#D3ZJ\T@
M>6A&A+L,]$2WP-3P/%AR4HE_L>7<.UV_#[-MFQXL9LN!%S/+8PS+54QP]N#%
MO!MR*4[*:BFDL98 <>[9WQ VEC.:=@M%@%E/$>"94J&A@.%TR$JD80][/21L
M.=''42>U(E]<.ZDK\'(C(4[XU=HDL#X2-BY> 5/QH( ^0Q.^@:R]+7=;GW;%
M$ 2'KH>\)-U1V-)()"M7:AZ(:9+SO5MNQC,SH?N8=V+0L3VV,+<P(X8 O+"
M8%>*UUWZW@Z\TKRL7(71_.-BP?_#S@$]9Q .]2Y&L1S!I11BPK$':PEOX"E'
M86X**8.=X'NPS 2\C#"KVDLD]Q)_%3T(IG/8'? ,RQG4AT6;':YJX^A#0U["
MS]DU3X>.1*]'<TA"^?; \!$):[A#X!1C3C!0PB+PC,631:H;151FUA$Y7Q<<
M86,ATCA(L*$EFW'[K!(3<84:MBZ4 0L_B[R@Q0F-V/20-1K?@VA=2HA<IBM
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MZ&]^RE,""CSEI<V4+VG*S]P?X+G_!SPDL^IA,I,:!XXI'871M]H-K\#><Z_
MJSTC+IT!%JWYO07 8TZL-W,],Y?+R7BDJ&?<7_1IL3KC>LJ-L65O;_1%RK0T
M-M.2-BW-S;2D34MK,RUIT^)LIB5M6MJ;:4F;EKNE3,M*BK/SQ0P@6$Q&K%M)
MLV*//90<N]>.7_<'=A>3LN7>()TR]N%B</C7MW_^/+UMOS,'[@#?."8O30^4
MOO=(=4LAO8Y:I'G.1'>JGJ&)#_'=U"F@6-*G%.>;]8:]EC]H.4VW9W??F>(?
M(25VAI[+#[^MG;[[8W^O8!WMY26;JQQ@5@7<&JQM.5K;LBA8N+;=UM@E[MT5
M_JI]'OSMW^75$L>65C[)Q$=ANGI1:YLRQ#F7>'_>)<Y;1Z5#ZS"W]X(66=(_
M7_H>3.(ES./]W>2=7/K1/R\]YGO_?#I0RUSF(HEQE2;1CE91B(RBC1&12'[1
M1)'(^J YA>)P7J$H[AU8AX67)!+E%)&@R=-V6*9D?*F^/QL^>IT_@^:(9(Q7
M!*L5B90/FD\RD@SDTTO&P4$1[(+]%R099T(R:#]1<U\'K"4GN!EX*!#]?J&?
M2Q>+R_S5=<7[Y_;'V9T2"]8&VF/,&V<P#$ TJ/CEZ>N=/LPYE[DPY3*CE0NF
MH9.RX(6#_&ZA\(+6&ZR[8;AS9]M]T ;.@"-IYWX8_MOWBEXQ?:FO3@OEQ[^+
M'WN?HJ6.XG!/6U4QFE]C@YES0:>UY':*:D6+R14]M(X.#A>WH$MNXM-<BM*J
MFN0B8:J,<16*2HA*+$3YV_>N>WY\_[?_=7Y78>'N09&%BL4K1:3FMAQ+I;Q5
MS!4G2M+R5RDWV>@?62QO>!PTCTXK)U>=.8S^91GZDQ9K?HONZ, J'4RVZ):_
M6/O3&.^C>^M@_WO_HGY=^GFT9.-]>0;[A,4MS6V4%0LY:P][B)]]<?=F,,-'
MUKAP%>[UR_MNH5)<EAF^=--[TAI/:Y&EK/&A52P=K<$:EZ<UJ$<6N%8JM+[G
MNK?5L#&S0;TL(WK2@DUK<8TQH?.%PFYNLLNT$FMFHFD\LFCE#Q\^EB^&E[UR
M8YQIO 1S>-+23&NYC#.&"U:^</#$I5ENK#W#&"ZN7GP*8XSA@A*;(HO-_H?\
M7<\YN3^MK)$M7% 254R5J+G-JU+^T-J?(H:Z_$4J3K:%1];JZNO]7\[AA[\*
MU8,ULH4G+-;>W.;2?A%V??&INWYEMO#HUMKOW@^:'\].2ZT7:PM/6MRY[:0"
M.#K[^77P2O,SV,(C:QR>%/_IW#W4_7[[Q=K"D]9X[K1DJ5"R2J5UL*@*T]K"
M(PO\T[[Z<7OQZ?+/R]+:V,*3%FQ:@VN<+9P_W#V8G%!>_LH=3&$+CRQ:O=0K
M'__=?+B[/EBQ+3QI:::U7,;9P@=6[J"T(%M8(7#$.EB7U\.[Z$;9_9S>*$NZ
M5*E2J4G//+UQMA\UQ99D0'+B??^V;O_]V;3=S]]<QSO_69P;+FGAJ-U3H MK
MS;13=81- FI*Q63*[1;V7"\.K!3_4V:5>Y[>R7U+:?7IJ0WSXQ]6'\4AT!OF
MP:D;]CQSJ[%-:"(1S#]#TY-ZUYON#74SFF7\:J6B<EJ=$@I2>N:J?'EX]_7>
MW?MR="@''SVAE/*$$0?_A]O]Y/\H?[8OOXT^(9_RA!&U^.WV^"__N#CL7[>5
MIIMU*\8V7_Y=W&7 5T_SY D1@_W"G,^=H'WWBZG/1>".I *<_+,05?U_+,;Y
MZKA.>]2@LTAVB%PA3@Q!V'("244 #9 M(* &I+ *D)G:27T7S(TVHH[X\GKU
M,B-F<U*[ #PAV]G8%2^)[;P$HECRRS4%NG?P[\\/?]<'3OEP<//17HY67/B1
ML:=+0;GUM>Z#*.#<9!\4QV)[95Q-QX/?O>C>?;G=;SQTGSX1.@[)6S\8"JL_
M&)K;$:>'S@+#.#=(^B) @T(Z)X;B=IM(10@9@PA#QH)9,:[E$]%R#(&6TWB4
M@#D*9E,#SK'[_2ZL%0H18>@@24QRK R218@P#/@$;YH QA7'WM+!HAZ< #EG
M6HX<C4)2&CU<<1)'$*5$#R>I2U*0\)R6,W""GNLY$LGFUW%J:ZD 0:M L5T9
M/,H;Q?K8#.ME#6N#_+%Y^2O&//GEY79"KP@M8X6 *K$\YP9(Y6F3>2.-.\'T
M0M0N@M$%IGCYW?.;-5P$00\MV_(7JQRY$<M_F0+?>1*73WEA7#YO7M;8NWY9
M*F$U/;Q'+[*']V"6'M[^3:U?;/[]^>*+.]+*<? L+;G[<U?=+Z(E-RUFMN@%
M*NJ1S7&K\R]=IB+-)_; N?.#Q_(/-Q1_@QF_(#X4\7/5:[GW;FMH=_FB)NAU
MO[>S@_&@V(71N^/7";N!+(6K-A]#S LG;O]9?]C[>E'X^)!KEJ:5F*ULD='G
M8)R\1-*"X_\W^FX>^;_:!\K?3/J4A-@=3"]V(7S<_[W;&:F].+!@U9[6/C2"
M>+ D&:RLKPQJ*Z49)DK\W+\/_VQ4/SWTCIZNL)8G?>,^(B%X<U=6YJUBJ6B5
M#B<7)JS/X;0W!PC!3Z<=?/KVL?UEN)@S:F'0 OM':P0M\*J;#<?55X]D[6^_
M_&Q]_W!]VGPL+*]>>D(^_6#N$MRY>P=_F7VJ$UM_PO'02N]=64LKY<.W[KU]
MW'*\K\WY9&#BT3 B $LR3 [R<4GZZ01^RPX[8X6(<G^%W]:@F+"496@\OQB-
M-S0NN[<?!_52N7PY5HL\Q;:=6X2FMRX.9J@6SS)KB]9A87)7_!A;]GG:F/N%
M?\[\S_\<NH-OS]V<?%!\WN;DM]*&-0Z^;*0TKU;9_^Y_](L=)_]L;54'\Q?Z
MS]M6M4@SX7B,F9"<[[4T$^[_J5T_>/O%JWEE8**.'Q& 99D)>R_:3,B,1SR_
M&(TW$\ZN?P0_^MW[^Q_[ZR9!,U@)<\=<"_FBM5><#(*T? F:PD08.0(>/WSX
M>MBX>:Q=+=]$F'02S!!_7$;/YN+IZJ>A^UM2E>U:\F2/+;@M9Q7<SL2@/?XE
M&HN]I';<0<9UIEIO=FSOSI'5H&W;#2(6;H<TB2&H[A6I?"BHZ^ =@C,T5AZZ
M+%+V;$K'38WHBRHOW QK,ZPW-JQ-1>WFY:_ZY1L*PQ=1<5MNM7Y-&'G"NKL+
M;.* %[U,9U],>X!,U'C)XV9Q7\+BGBA3?NP*8_><]VA>?P&'$NG,X%?14I]]
MV2STVB\T[&*JF$\L+'+#BP45[EQH]QS<R@G7SJ:60[P4MWK+'CB;15_[17].
M)3(J,*170(L($6P'?L^T4:=$ GBR427KO]RU86. D<-?N>D@[90 .>AB\*?G
M. ,E TV$5,!X8ZAW/Z.A\)N4&76F7&\$8?T%8?.:.5[#S6NQ9JN4IIH7TO;P
M,JG+UKBB&<RT,SA#12:7]>M[5J^GI#//OI0'%:]UU4;O66863[IGM8_AM]N'
MX<'3&;665^D\S\<E4E_S8\L6K?W2$RON5RJDN?454K;WJE[68E:]LO=X_>56
MN(IB3<^^2'']='9[T_ER9><_=]997)_VF0G!?4+]=_&H9.T57E+I_L&88I_G
M%U]40WX06\JRU_I(BUCUZAVG!L)U]@7^H5:^'%ZU/[(9>PH#E(*<ZP7_U&H/
MG[]^+(P(\LR<5<O5NXOXX+A('^:66$:T/K+\DO1P8M5 7WFB#@Q%J'S]1:[Y
MB=+%=XWW-Z6?I=R?5Z.F0X8(/TN/WM._-2&]^2=7.^];Q2GH8M:BA^]D?858
M1A/2CE98[&X=7N<,Q$J?J! "&XR@LM!49('@\_=:B?;0OSEK-\]/"MZWM1;M
M9<U 0N"?7MY_>&@5#U^(Q*]QYS1% %(K+J7D?KE^W/?NBZWB7G&=[8I)'Y(0
MP+D[&Y;0O?JJ6R#'U=H_?R_5?"&.;K[[)<CU__'_L=>M2^_I88W#TNNLR']^
M87MJJ*)P_Z%WW]JKE/W&NHG=(L,3AWOSLXA8^2F8C9<OA'MKK_06$W,XN XN
M"AV_\-DOK9M$+BG.L/^BE6-^K>5R$2&$5J%:+'9O]W]\Z:Z;1"X\:G#PHF4Q
M,Y;U_(*XO## 7GF_6CQO?3^]+HX3SV?ISE^1ZS]#UBS+]=^SCO;FX49>8&?_
M&IN9DUWZ@O/7U=>'VN%)]VCMI'!&/WZ&5-:2<"+>"DA!8:V;YN=SY+_N-;S;
ML_,OO;/VNG5!/]V1/UIF3NQ-M]8_U9$_&/8_MDKVH?WC;MW$;I&._-$,::U$
M>_[AH97+KP.?[SA$L><7Q,5Y\L>-A^/S<FFO_FTM->'B/?FCPHO6CN47I!WG
M<.._G'P(KT_OOO[]T%DW<5RT&W\T?RJJE+,.IZ@C?";;<#VD<7F^?,W_^JU9
M^UA]?WNP+"]J;B%=C2]_- ,,6(;W5<CO6<7"/$!Q"W3F,_/SSR^^4^3GSRK?
M_W%J5\5/<\+&+D\*9_/EC^;.^RP&S6D42F@<G^DA>(_?+KP_AZ6?S8]/9?&<
M!A=FT>2F1P<CY*:7OH=4MY,H3F.V1]8]1'3Z;="ZO?MTX;=[^55,T=LF/RVN
MGORTM2W)AJ_OKTV>_A@;JC%R-_;]EKMNV+$M\Z'CFRZC.J'TV-ZC(O_TO>ZC
M";*U<UVY,B\K5^%,O,=X,1&"1G2F!M.9CN,!?=OB4UJ]^#@3N7.EI*PI>RX/
M;WWX<WD\KXQ!5RCW);TC.EV='\WNL.7\\?O_V]DQSURGV_K5O+;OG-_@<=^'
M#BP?O'7?W-D15B88=M,VX([B^.$FGU7=B"UVE(8"F+5A.6>0O%[[0OEMOYGU
MQSX\O1S8#;?YFXF$]_S]ESY^<[ZHW_6+O W_E#2BI&#\_@M,4<ID!8[];:?A
M@,S!&_HTP[I:G&-VGC0;TPQ?_W2<$_QL,@^ET&QHI./9K@U$X&98+WU8&]"[
MS<LWN',;=)'5$DI'#K)YTK&#[L#W-@+RPFFE-^NYH9B>CF):2,KR7Z9D<4-H
MO2:2?:+':58@VH( 8@4,VB):]G+U[(:W.SMY>B2R02H15+Z_FTS@?7#V_K"3
M/S^Z^'MJ.N;L#&;6J^>C1SV:&]>IN'=@'4Z1S%XIDW<F"];^XKK2U0),E?OF
M72HWZ8(HL8+P]/,PESNY3L%Q6AF_=W(>9 5;V@?/QY=UM(""]Q?$]WWZ<F1T
M/-]6H_SI\.][]_-!912=:57\WW-(Y]1<7/G<_,S!^T4K5\J_(!BF2LJ11\NA
M<6IEGGPG3OF^6LZ53QX7( D31C#7 9C/S5VW?7!0!#MG?P.-,948[4]C.8WP
MP_H__*_=H[_LSX4Y*[5GLI;&,\3F<S, ^21LI4+.VIL"LBK=0)IQ\C-MH%1T
MDOG:^-; !CH[^-[_U/OPM7<XMOEY\7U]2[=[\KD9JJ2S2DUS%BSJ\U::9F*?
MK9^\C;=GOCI?+Q[[=K';G)."<G62-H,-,S>M<>' .LH?K4$E?FX&TV3D:/G1
M>/Q6^.P>58,%'"W3FB.33IBYJX*+A4.K6'KJHKR5]M[\-,;("!/MQ6&N7OGP
M=Z%P/A;/8$'&R'@NVGQN?CK@(_")\\7G924_6FBKX1J8(Z?7_WP*6MVPT5MM
M$]<*K)&7#;V2"HF]GF(VW@H)3RZ_V]\_O6]ZRT)$6YB$S6"%S!U_SA?VK</B
M'&KL6<V0D4/E>^'+T:7?]XX^SZDWYC%#)ITM<V/FEPHEJU2:'!.9M3EIPW.N
M.B+>.L]YO.S?8-IS26VVH3M??"WSIKYS\_(7\/)-<>F+J/K<<"=O9&C#G;Q9
MZ UW\F;1UT^);+B37ZM4;;B3-X*P><V&._G%<B>GTAFL9W7H?/C$U>##>?7C
MA>M>YT=J!5=%3CM'KN/)V,7Y_/S5I"^-6SF5*V8]A?BIN,?GWQM[G<\_:DZG
M^Y+$>8&8R/G\W+6UI;V\=;@_&1-Y?23[<*',RZO0T(O!4N[T>R?5[\?[U2_V
MB)BOBC%Q3JV]<)SE?'Z9.,MK+NOK*>B+P&?^>GCP[:SY,7]Z=#2MB*]%M]6"
MP9OS^:>7)>];^X>3Z4<VW5BS"?GR8)^__>V6?C[<7EV=ORS17PDD=#Z_ $CH
M/>O@X(7LB$P2L_7;$9.1I"^_7U]_??_>/PKO7I+=,A/*=#X_/[OHHOL47W5S
MVP()TM8S-M,]^_/'W?>SUM[1_KIWP"P@'C-W:7WQR"H<K@-'16IY_7H*Y%/C
M+/GZYP^/?^;RK=ME\4LM3#07&ELYF+MPNF@=Y.;A %RTD*;VH\Y-T/MR0B;5
MA[V;RO&7#VUWM=3FZQ,F.7S1'27C:-+63VX7$0'Q#L\_?BET@MOK934W+4_'
M/C7H<?2B9363[6?]!'5Y48SO]>./7W*GMP\'8_NWUP(J8#61B\(,*<?LR$5N
M?YZ&XU5P6:V?=$^.2%PUKB\.'_KONQ=KCS(P6Q2B,#\UZB*0!MY*4WOI1;54
MSQ>'N*@<%?MPN'\\6BW_V[/$(0HOF[4UL]9C_83QJ3&(J]+AU^9?G?OWU\M2
MW0L3RT7&( ISL[D>%:S#H]='>?UR8A"%#S_]XP]?"X6/]KI+[')B$(72BU:N
M"R0A?@D!B*N?>Y?G=\,?[\N'ZRZNBPY %.;.X1T>6OG#TAH(ZP+YVU]N$,*I
M'P7V^3^?_JR-C?HNGD%[?8,0,^39,H(0>^":E>;)92PP")&9_%T_Z9Z"8+LU
M^'ADY^Y.OC;77='.&(28/U^V$*"A5X5I\T)8?O<6R/)[,NP12>V](YAF02X#
MI^-W6TY@!LY@&'CFEN1KKMT(MN9MTP[#(<[E?V"R3#<T7-F*[GKF=>#OG#H_
M++/J-7>1NK;GXP#\YC?1B/KGL/MHYBT3MPTS^\*C(QIAQLYI1B-3G?#X>WXC
MO0XWA7@D_L7Q6@;\DSAPVVX(:\%4N.*Q,+@M_)MEVF;/L<,A4_>:?5A\O[6]
M:UX/@W!H(XVQ;]8J)V8P[*)PX-C<T(3'-7% 3"!,JDNV3<)4R#%$HS8B$F*Z
M&$874M<W7C;Z?HNGE/ISQ>4P(]%W6M0>CO>VW';;"8BXM>$,'AS'2V7?IH6$
M;W>;,)2!G"#UE(8#PNSAZ\3(1X>$WSGAR:9X\A1/VS4^^ \.[!)B@M:>:[9\
M$"1D<N[;C]%<B8G'CX/9[P?^CT<0(IA_>N;X!9ENBHR4#YEQBL(%S9$AYFC#
M;9ZI]?97Q&V>Q6;N.2!U'F@S1S*..RW#3=][]A!,1WA6V_5LK^FB6I62&^F
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MF!1PF.%E0PFZT&SZ08LF@1Y1A6UOEG*%K?MM%.8;YX[L ]_C*:WM_+7-_R)
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M4!M6,"0R\K8@XXYX-3!TMY7/;<OX$<XP3KT"%E*O0Q]L,+";'2X/2BNDPI*
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MC.U=LT) 6O$I0X1X;<1I(BOQK36<P:BK5<S!\6/7?L"E@2?T:5P1Q2#,@M_
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MX!4S4=A1IKP84G(W, (9_,-AT"(=S16^7C%GZB" S",$V2PCGI?X61796$(
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MZZS&EHO&DPK,RJ[_GD3_+ECN'6T</2$7;-%F1NT96(,V,YL#++IZ\"IG-F?
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M*_V^55[W7>EC% /0@*]2#;S!KS;B(S%,5=HO+\>FKDOKILP66[CS;1-?,QH
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MK-R;0WIB>9;+KOMAU^=L-$!"$_7:,C7\T&V4"7F"<EK@$"*E^5AVR_*+8:J
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M/"S^]_\ 4$L! A0#%     @ LX!'6RN%Z1N8*@  E2L   T
M ( !     &EM86=E7S P,2YG:6902P$"% ,4    " "S@$=;'&-8U!E*  "<
M9P  #0              @ '#*@  :6UA9V5?,# Q+FIP9U!+ 0(4 Q0    (
M +. 1UO1EWJ'GQ ! /Y% 0 -              "  0=U  !I;6%G95\P,#(N
M:G!G4$L! A0#%     @ LX!'6R:KKT 7LP  PN(   T              ( !
MT84! &EM86=E7S P,RYJ<&=02P$"% ,4    " "S@$=;%@X%':$>  "#'P
M"               @ $3.0( ;&]G;RYJ<&=02P$"% ,4    " "S@$=;@JC-
M8*@$  #A%@  $0              @ ':5P( <&1E>"TR,#(U,#8S,"YX<V10
M2P$"% ,4    " "S@$=;MEX)304%  #7)@  %0              @ &Q7 (
M<&1E>"TR,#(U,#8S,%]D968N>&UL4$L! A0#%     @ LX!'6][4DIJ#$@
M >T  !4              ( !Z6$" '!D97@M,C R-3 V,S!?;&%B+GAM;%!+
M 0(4 Q0    ( +. 1UM(M]EZD T   ZN   5              "  9]T @!P
M9&5X+3(P,C4P-C,P7W!R92YX;6Q02P$"% ,4    " "S@$=;L(%-!BH2 0">
M6@@ #P              @ %B@@( <&1E>%]D968Q-&$N:'1M4$L%!@     *
-  H 9P(  +F4 P    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>pdex_def14a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:pdex="http://pro-dex.com/20250630"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="pdex-20250630.xsd" xlink:type="simple"/>
    <context id="From2024-07-01to2025-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_ReportedValueOfEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_EquityAwardAdjustmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:EquityAwardAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_ReportedValueOfEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_EquityAwardAdjustmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:EquityAwardAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_ReportedValueOfEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_EquityAwardAdjustmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:EquityAwardAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_TotalEquityAwardAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:TotalEquityAwardAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_TotalEquityAwardAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:TotalEquityAwardAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_TotalEquityAwardAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:TotalEquityAwardAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:RickMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ReportedValueOfEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_EquityAwardAdjustmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:EquityAwardAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ReportedValueOfEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_EquityAwardAdjustmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:EquityAwardAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ReportedValueOfEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_EquityAwardAdjustmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:EquityAwardAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_TotalEquityAwardAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:TotalEquityAwardAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_TotalEquityAwardAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:TotalEquityAwardAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_TotalEquityAwardAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788920</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">pdex:TotalEquityAwardAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">pdex:AlishaCharltonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2024-07-01to2025-06-30" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="From2024-07-01to2025-06-30" id="Fact000004">0000788920</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2024-07-01to2025-06-30" id="xdx2ixbrl0010">DEF 14A</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="From2024-07-01to2025-06-30" id="Fact000011">PRO-DEX, INC.</dei:EntityRegistrantName>
    <ecd:AwardTmgMnpiDiscTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000016">&lt;b&gt;Equity Award Timing Policies and Procedures&lt;/b&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"&gt;In accordance with Item 402(x)
of Regulation S-K, we are providing information regarding our policies and procedures related to the granting of certain equity awards
in relation to the disclosure of material nonpublic information (&#x201c;MNPI&#x201d;). &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_902_eecd--AwardTmgMethodTextBlock_c20240701__20250630_zdKfyT7OxJ1e"&gt;We &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_90A_eecd--MnpiDiscTimedForCompValFlag_dbF_c20240701__20250630_zYUCdsJ02dNl"&gt;do not&lt;/span&gt; have a formal policy, program, or plan
that requires us to award equity or equity-based compensation. Our Policy on Insider Trading prohibits directors, officers, and employees
from trading in our securities while in possession of or on the basis of MNPI&lt;/span&gt;. &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_90C_eecd--AwardTmgHowMnpiCnsdrdTextBlock_c20240701__20250630_zhMA9YjzH045"&gt;We have &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_904_eecd--AwardTmgMnpiCnsdrdFlag_dbF_c20240701__20250630_zSM96kySZlm7"&gt;not timed&lt;/span&gt;, and do not plan to time, the disclosure
of MNPI for the purpose of affecting the value of executive compensation.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;In the year ended June 30,
2025, no equity awards were granted to our named executive officers within four business days prior to, or one business day following,
the filing or furnishing of a periodic or current report by us that disclosed MNPI.&lt;/p&gt;</ecd:AwardTmgMnpiDiscTextBlock>
    <ecd:AwardTmgMethodTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000017">We &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_90A_eecd--MnpiDiscTimedForCompValFlag_dbF_c20240701__20250630_zYUCdsJ02dNl"&gt;do not&lt;/span&gt; have a formal policy, program, or plan
that requires us to award equity or equity-based compensation. Our Policy on Insider Trading prohibits directors, officers, and employees
from trading in our securities while in possession of or on the basis of MNPI</ecd:AwardTmgMethodTextBlock>
    <ecd:MnpiDiscTimedForCompValFlag contextRef="From2024-07-01to2025-06-30" id="Fact000018">false</ecd:MnpiDiscTimedForCompValFlag>
    <ecd:AwardTmgHowMnpiCnsdrdTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000019">We have &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_904_eecd--AwardTmgMnpiCnsdrdFlag_dbF_c20240701__20250630_zSM96kySZlm7"&gt;not timed&lt;/span&gt;, and do not plan to time, the disclosure
of MNPI for the purpose of affecting the value of executive compensation.</ecd:AwardTmgHowMnpiCnsdrdTextBlock>
    <ecd:AwardTmgMnpiCnsdrdFlag contextRef="From2024-07-01to2025-06-30" id="Fact000020">false</ecd:AwardTmgMnpiCnsdrdFlag>
    <ecd:PvpTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000022">&lt;table cellpadding="0" cellspacing="0" id="xdx_881_eecd--PvpTableTextBlock_ze253odgCMPf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 11pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 8pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 8pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 11pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 8pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 11pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;SCT for PEO&lt;sup&gt;(1)&lt;/sup&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;CAP for PEO&lt;sup&gt;(2)&lt;/sup&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 8pt; line-height: 110%"&gt;&lt;b&gt;SCT for Non-PEO NEO&lt;sup&gt;(3)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 8pt; line-height: 110%"&gt;&lt;b&gt;CAP for Non-PEO NEO&lt;sup&gt;(4)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 8pt; line-height: 110%"&gt;&lt;b&gt;Fixed $100 Investment Based on TSR&lt;sup&gt;(5)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Net Income&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;(in 000&#x2019;s)&lt;sup&gt;(6)&lt;/sup&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;(a)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;(b)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;(c)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;(d)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;(e)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;(f)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"&gt;(g)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 13%; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eecd--PeoTotalCompAmt_c20240701__20250630_zwMt8KkZJDUf" style="width: 12%; text-align: right" title="Summary Compensation Table Total for PEO"&gt;652,951&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eecd--PeoActuallyPaidCompAmt_c20240701__20250630_zmg2KSXtQog1" style="width: 12%; text-align: right" title="Compensation Actually Paid to PEO"&gt;1,948,805&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eecd--NonPeoNeoAvgTotalCompAmt_c20240701__20250630_z4xpL4y1mZW7" style="width: 11%; text-align: right" title="Average Summary Compensation Table Total for Non-PEO Named Executive Officers"&gt;357,825&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20240701__20250630_zYIGFuynhJrc" style="width: 11%; text-align: right" title="Average Compensation Actually Paid to Non-PEO Named Executive Officers"&gt;773,236&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eecd--TotalShareholderRtnAmt_pp2p0_c20240701__20250630_zN1OPEnZUxFg" style="width: 11%; text-align: right" title="Total Shareholder Return Amount"&gt;271.22&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NetIncomeLoss_pn3n3_c20240701__20250630_zOD2AyQ3VmWg" style="width: 11%; text-align: right" title="Net Income"&gt;8,978&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;2024&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eecd--PeoTotalCompAmt_c20230701__20240630_z1UGiiLBvQoj" style="text-align: right" title="Summary Compensation Table Total for PEO"&gt;441,303&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eecd--PeoActuallyPaidCompAmt_c20230701__20240630_znuBrc9DECOh" style="text-align: right" title="Compensation Actually Paid to PEO"&gt;397,475&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eecd--NonPeoNeoAvgTotalCompAmt_c20230701__20240630_z176qpMTP4z9" style="text-align: right" title="Average Summary Compensation Table Total for Non-PEO Named Executive Officers"&gt;320,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230701__20240630_z2Os5pA6i2E3" style="text-align: right" title="Average Compensation Actually Paid to Non-PEO Named Executive Officers"&gt;328,349&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eecd--TotalShareholderRtnAmt_pp2p0_c20230701__20240630_zS42dq0lUIsb" style="text-align: right" title="Total Shareholder Return Amount"&gt;122.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NetIncomeLoss_pn3n3_c20230701__20240630_zAHHVAMuNmAb" style="text-align: right" title="Net Income"&gt;2,127&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;2023&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eecd--PeoTotalCompAmt_c20220701__20230630_z6H1gmeCvDE" style="text-align: right" title="Summary Compensation Table Total for PEO"&gt;418,605&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eecd--PeoActuallyPaidCompAmt_c20220701__20230630_zOjvKe8HK2I7" style="text-align: right" title="Compensation Actually Paid to PEO"&gt;632,137&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eecd--NonPeoNeoAvgTotalCompAmt_c20220701__20230630_z66lvtcVFD4d" style="text-align: right" title="Average Summary Compensation Table Total for Non-PEO Named Executive Officers"&gt;297,613&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220701__20230630_zsC3ZhgwTopf" style="text-align: right" title="Average Compensation Actually Paid to Non-PEO Named Executive Officers"&gt;424,446&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eecd--TotalShareholderRtnAmt_pp2p0_c20220701__20230630_zzaOxUMWNJN4" style="text-align: right" title="Total Shareholder Return Amount"&gt;118.71&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20230630_zT4mABQcwgP7" style="text-align: right" title="Net Income"&gt;7,074&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000024"
      unitRef="USD">652951</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000026"
      unitRef="USD">1948805</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000028"
      unitRef="USD">357825</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000030"
      unitRef="USD">773236</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2024-07-01to2025-06-30"
      decimals="2"
      id="Fact000032"
      unitRef="USD">271.22</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000034"
      unitRef="USD">8978000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000036"
      unitRef="USD">441303</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000038"
      unitRef="USD">397475</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000040"
      unitRef="USD">320500</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000042"
      unitRef="USD">328349</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2023-07-012024-06-30"
      decimals="2"
      id="Fact000044"
      unitRef="USD">122.06</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000046"
      unitRef="USD">2127000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000048"
      unitRef="USD">418605</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000050"
      unitRef="USD">632137</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000052"
      unitRef="USD">297613</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000054"
      unitRef="USD">424446</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2022-07-012023-06-30"
      decimals="2"
      id="Fact000056"
      unitRef="USD">118.71</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012023-06-30"
      decimals="-3"
      id="Fact000058"
      unitRef="USD">7074000</us-gaap:NetIncomeLoss>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000060">&lt;p id="xdx_840_eecd--NamedExecutiveOfficersFnTextBlock_dU_zcaiXkienLz3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;The dollar amounts reported in column (b) are the amounts of total compensation
reported for &lt;span id="xdx_90C_eecd--PeoName_c20240701__20250630_zAN8gjvi5Y98"&gt;&lt;span id="xdx_904_eecd--PeoName_c20230701__20240630_zxilWoxAXaNk"&gt;&lt;span id="xdx_901_eecd--PeoName_c20220701__20230630_zkUBKoB3upPf"&gt;Rick&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;, our Chief Executive Officer, for each corresponding year in the &#x201c;Total&#x201d; column of the SCT. Refer to &#x201c;Executive
Compensation &#x2013; Summary Compensation Table.&#x201d;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName contextRef="From2024-07-01to2025-06-30" id="Fact000061">Rick</ecd:PeoName>
    <ecd:PeoName contextRef="From2023-07-012024-06-30" id="Fact000062">Rick</ecd:PeoName>
    <ecd:PeoName contextRef="From2022-07-012023-06-30" id="Fact000063">Rick</ecd:PeoName>
    <ecd:AdjToPeoCompFnTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000065">&lt;p id="xdx_84B_eecd--AdjToPeoCompFnTextBlock_dU_zolMlgYU6bwl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;The dollar amounts reported in column (c) represent the amount of CAP to
Rick, as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual amount of compensation
earned by or paid to Rick during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following
adjustments were made to Rick&#x2019;s total compensation as reported in the SCT for each year to determine the CAP:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 8pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 8pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 8pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 8pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 8pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;SCT Total for PEO&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;SCT Reported Equity Award Value for&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;PEO&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Equity Award&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Adjustments&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;for PEO&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;sup&gt;(A)&lt;/sup&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;CAP to&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;PEO&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 19%; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eecd--PeoTotalCompAmt_c20240701__20250630_zpRSp3cQXMYi" style="width: 17%; text-align: right"&gt;652,951&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_zTw5jM2Vw0c4" style="width: 17%; text-align: right"&gt;(47,630&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--EquityAwardAdjustmentsMember_zTiQ8JbIWwm9" style="width: 17%; text-align: right"&gt;1,343,484&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eecd--PeoActuallyPaidCompAmt_c20240701__20250630_zzefrWkVfYui" style="width: 17%; text-align: right"&gt;1,948,805&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;2024&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eecd--PeoTotalCompAmt_c20230701__20240630_zUYzdqHPDcy2" style="text-align: right"&gt;441,303&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eecd--AdjToCompAmt_d0_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_zHklvaBdenjc" style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--EquityAwardAdjustmentsMember_zNlUVtT4AAN2" style="text-align: right"&gt;(43,828&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eecd--PeoActuallyPaidCompAmt_c20230701__20240630_zp2ZFoXZ8itk" style="text-align: right"&gt;397,475&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;2023&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eecd--PeoTotalCompAmt_c20220701__20230630_zSE6qoVo3he1" style="text-align: right"&gt;418,605&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eecd--AdjToCompAmt_d0_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_zvZSPwn63Oe1" style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--EquityAwardAdjustmentsMember_zFPxrxplvvx6" style="text-align: right"&gt;213,532&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eecd--PeoActuallyPaidCompAmt_c20220701__20230630_zyHHj8bRySOk" style="text-align: right"&gt;632,137&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(A)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Represents the year-over-year change in the fair value of equity
awards to Rick as summarized below:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 8pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 8pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 8pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 8pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 8pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 8pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 8pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Add: fair value of awards granted during FY at end of year&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Change in fair value of awards granted in any PY unvested at end of FY&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Add for awards granted and vested in the same FY the fair value as of vesting date&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Change in fair value as of vesting date of any awards from a PY vested in CY&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Subtract: Awards granted in any PY fail to meet vesting conditions during the year; value at end of PY&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Total Equity Award Adjustments&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 13%; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember_zClFSVskUwu7" style="width: 12%; text-align: right"&gt;43,640&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember_zWFURhYOa1Xh" style="width: 12%; text-align: right"&gt;1,394,524&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eecd--AdjToCompAmt_d0_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember_z0mrZSSwXjV2" style="width: 11%; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember_zgbGR4z40JO7" style="width: 11%; text-align: right"&gt;(6,300&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember_zuoRFfcLC2nk" style="width: 11%; text-align: right"&gt;(88,380&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--TotalEquityAwardAdjustmentMember_zYPy6nv3d353" style="width: 11%; text-align: right"&gt;1,343,484&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;2024&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eecd--AdjToCompAmt_d0_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember_zl1lYr0pZoZa" style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember_z2vHmvd5EAob" style="text-align: right"&gt;42,122&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eecd--AdjToCompAmt_d0_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember_z7PrM2ho2Xo4" style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eecd--AdjToCompAmt_d0_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember_zd2I33lU6xYl" style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember_z5A6I3LdqDP3" style="text-align: right"&gt;(85,950&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--TotalEquityAwardAdjustmentMember_z2eKOjwS8Cl9" style="text-align: right"&gt;(43,828&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;2023&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eecd--AdjToCompAmt_d0_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember_zj5bnUFLYmFf" style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember_z7upVd4a8axg" style="text-align: right"&gt;288,017&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eecd--AdjToCompAmt_d0_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember_zBbwBLA45Tkf" style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember_zYCHsPDgjQwh" style="text-align: right"&gt;140,840&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember_zSojkcSVIGU7" style="text-align: right"&gt;(215,325&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--IndividualAxis__custom--RickMember__ecd--AdjToCompAxis__custom--TotalEquityAwardAdjustmentMember_zYFEqZeSO3W2" style="text-align: right"&gt;213,532&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ecd:AdjToPeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000066"
      unitRef="USD">652951</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_ReportedValueOfEquityAwardsMember"
      decimals="0"
      id="Fact000067"
      unitRef="USD">-47630</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_EquityAwardAdjustmentsMember"
      decimals="0"
      id="Fact000068"
      unitRef="USD">1343484</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000069"
      unitRef="USD">1948805</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000070"
      unitRef="USD">441303</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_ReportedValueOfEquityAwardsMember"
      decimals="0"
      id="Fact000071"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_EquityAwardAdjustmentsMember"
      decimals="0"
      id="Fact000072"
      unitRef="USD">-43828</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000073"
      unitRef="USD">397475</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000074"
      unitRef="USD">418605</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_ReportedValueOfEquityAwardsMember"
      decimals="0"
      id="Fact000075"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_EquityAwardAdjustmentsMember"
      decimals="0"
      id="Fact000076"
      unitRef="USD">213532</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000077"
      unitRef="USD">632137</ecd:PeoActuallyPaidCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember"
      decimals="0"
      id="Fact000078"
      unitRef="USD">43640</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember"
      decimals="0"
      id="Fact000079"
      unitRef="USD">1394524</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember"
      decimals="0"
      id="Fact000080"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember"
      decimals="0"
      id="Fact000081"
      unitRef="USD">-6300</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember"
      decimals="0"
      id="Fact000082"
      unitRef="USD">-88380</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-07-012025-06-30_ecd_PeoMember_custom_RickMember_custom_TotalEquityAwardAdjustmentMember"
      decimals="0"
      id="Fact000083"
      unitRef="USD">1343484</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember"
      decimals="0"
      id="Fact000084"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember"
      decimals="0"
      id="Fact000085"
      unitRef="USD">42122</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember"
      decimals="0"
      id="Fact000086"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember"
      decimals="0"
      id="Fact000087"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember"
      decimals="0"
      id="Fact000088"
      unitRef="USD">-85950</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-07-012024-06-30_ecd_PeoMember_custom_RickMember_custom_TotalEquityAwardAdjustmentMember"
      decimals="0"
      id="Fact000089"
      unitRef="USD">-43828</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember"
      decimals="0"
      id="Fact000090"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember"
      decimals="0"
      id="Fact000091"
      unitRef="USD">288017</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember"
      decimals="0"
      id="Fact000092"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember"
      decimals="0"
      id="Fact000093"
      unitRef="USD">140840</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember"
      decimals="0"
      id="Fact000094"
      unitRef="USD">-215325</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-07-012023-06-30_ecd_PeoMember_custom_RickMember_custom_TotalEquityAwardAdjustmentMember"
      decimals="0"
      id="Fact000095"
      unitRef="USD">213532</ecd:AdjToCompAmt>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000097">&lt;p id="xdx_84A_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zktdUgWMofm1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;The dollar amounts reported in column (d) of the PvP table represent the
amounts reported for Alisha, who is the Company&#x2019;s only Non-PEO NEOs in the &#x201c;Total&#x201d; column of the SCT in each applicable
year. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;The dollar amounts reported in column (e) represent the amount of CAP to
Alisha, as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual amount of compensation
earned by or paid to Alisha during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following
adjustments were made to Alisha&#x2019;s total compensation as reported in the SCT for each year to determine the CAP:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 8pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 8pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 8pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 8pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 8pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;SCT for Alisha Charlton&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;SCT Reported Equity Award Value for&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Alisha Charlton&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Equity Award&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Adjustments&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;for Alisha &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Charlton&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;sup&gt;(A)&lt;/sup&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Compensation &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Actually&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Paid to &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Alisha Charlton&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 19%; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eecd--NonPeoNeoAvgTotalCompAmt_c20240701__20250630_z7FG8h1L9MQ4" style="width: 17%; text-align: right"&gt;357,825&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&#160;&lt;/td&gt;&lt;td id="xdx_986_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_zrsDXu00CPXh" style="width: 17%; text-align: right"&gt;(47,630&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--EquityAwardAdjustmentsMember_zbAW8QviX7E2" style="width: 17%; text-align: right"&gt;463,041&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20240701__20250630_zCeAvIA0ACy2" style="width: 17%; text-align: right"&gt;773,236&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;2024&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eecd--NonPeoNeoAvgTotalCompAmt_c20230701__20240630_zoxojl9KaX2f" style="text-align: right"&gt;320,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&#160;&lt;/td&gt;&lt;td id="xdx_98B_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_zF7qpWmHjm8l" style="text-align: right"&gt;(20,070&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--EquityAwardAdjustmentsMember_zjejMypa3lck" style="text-align: right"&gt;27,919&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230701__20240630_zxbyk2Xi9Irf" style="text-align: right"&gt;328,349&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;2023&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eecd--NonPeoNeoAvgTotalCompAmt_c20220701__20230630_zM80TEHQ22L3" style="text-align: right"&gt;297,613&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eecd--AdjToCompAmt_d0_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_zDPZWrdlsbmh" style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--EquityAwardAdjustmentsMember_zsCNqaqWGcnb" style="text-align: right"&gt;126,833&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220701__20230630_zq2Y9Nopn9Xh" style="text-align: right"&gt;424,446&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(A)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Represents the year-over-year change in the fair value of Alisha&#x2019;s
equity awards as summarized below:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Add: fair value of awards granted during FY at end of year&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Change in fair value of awards granted in any PY unvested at end of FY&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Add for awards granted and vested in the same FY the fair value as of vesting date&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Change in fair value as of vesting date of any awards from a PY vested in CY&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Subtract: Awards granted in any PY fail to meet vesting conditions during the year; value at end of PY&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: center"&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Total Equity Award Adjustments&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 13%; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember_zIrHLIVMiiP1" style="width: 12%; text-align: right"&gt;43,640&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember_zLqb5hXxSehl" style="width: 12%; text-align: right"&gt;451,867&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eecd--AdjToCompAmt_d0_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember_zhpmCIqB6IYa" style="width: 11%; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember_zj87kFcV1D99" style="width: 11%; text-align: right"&gt;(6,688&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember_zkQi4zwUOOL9" style="width: 11%; text-align: right"&gt;(25,778&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eecd--AdjToCompAmt_c20240701__20250630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--TotalEquityAwardAdjustmentMember_zNqPPjGGo9sg" style="width: 11%; text-align: right"&gt;463,041&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;2024&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember_zlFJxgqFd596" style="text-align: right"&gt;39,280&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember_z1TXHyJ01dUg" style="text-align: right"&gt;13,708&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eecd--AdjToCompAmt_d0_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember_zIw5REBYHfib" style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eecd--AdjToCompAmt_d0_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember_zn8LVY2hrUPh" style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember_zqTBVY0DUw7k" style="text-align: right"&gt;(25,069&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eecd--AdjToCompAmt_c20230701__20240630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--TotalEquityAwardAdjustmentMember_zObPM8wpGlMk" style="text-align: right"&gt;27,919&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;2023&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eecd--AdjToCompAmt_d0_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember_zME93pInFV92" style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember_zO48jcKhvGPk" style="text-align: right"&gt;92,897&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eecd--AdjToCompAmt_d0_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember_z2HzoBHj22Va" style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember_zOz5NLguxGA8" style="text-align: right"&gt;88,184&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember_zeT9raLZWJSb" style="text-align: right"&gt;(54,248&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eecd--AdjToCompAmt_c20220701__20230630__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--IndividualAxis__custom--AlishaCharltonMember__ecd--AdjToCompAxis__custom--TotalEquityAwardAdjustmentMember_zYdtV9a0gCjc" style="text-align: right"&gt;126,833&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Cumulative total shareholder return (&#x201c;TSR&#x201d;) assumes $100 is
invested in Pro-Dex, Inc. common stock as of July 1, 2022. The TSR represents the cumulative value of the $100 investment as of the end
of each fiscal year presented (each, a measurement period). Pursuant to SEC rules, TSR is calculated by dividing the sum of the cumulative
amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between the Company&#x2019;s share price
at the end and the beginning of the measurement period by the Company&#x2019;s share price at the beginning of the measurement period.
However, as the Company does not pay dividends, TSR in this proxy statement is calculated by dividing the difference between the Company&#x2019;s
share price at the end and the beginning of the measurement periods by the Company&#x2019;s share price at the beginning of the measurement
period. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;The dollar amounts reported represent the amount of net income reflected
in the Company&#x2019;s audited financial statements for the applicable year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000098"
      unitRef="USD">357825</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ReportedValueOfEquityAwardsMember"
      decimals="0"
      id="Fact000099"
      unitRef="USD">-47630</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_EquityAwardAdjustmentsMember"
      decimals="0"
      id="Fact000100"
      unitRef="USD">463041</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000101"
      unitRef="USD">773236</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000102"
      unitRef="USD">320500</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ReportedValueOfEquityAwardsMember"
      decimals="0"
      id="Fact000103"
      unitRef="USD">-20070</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_EquityAwardAdjustmentsMember"
      decimals="0"
      id="Fact000104"
      unitRef="USD">27919</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000105"
      unitRef="USD">328349</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000106"
      unitRef="USD">297613</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ReportedValueOfEquityAwardsMember"
      decimals="0"
      id="Fact000107"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_EquityAwardAdjustmentsMember"
      decimals="0"
      id="Fact000108"
      unitRef="USD">126833</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2022-07-012023-06-30"
      decimals="0"
      id="Fact000109"
      unitRef="USD">424446</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember"
      decimals="0"
      id="Fact000110"
      unitRef="USD">43640</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember"
      decimals="0"
      id="Fact000111"
      unitRef="USD">451867</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember"
      decimals="0"
      id="Fact000112"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember"
      decimals="0"
      id="Fact000113"
      unitRef="USD">-6688</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember"
      decimals="0"
      id="Fact000114"
      unitRef="USD">-25778</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-07-012025-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_TotalEquityAwardAdjustmentMember"
      decimals="0"
      id="Fact000115"
      unitRef="USD">463041</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember"
      decimals="0"
      id="Fact000116"
      unitRef="USD">39280</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember"
      decimals="0"
      id="Fact000117"
      unitRef="USD">13708</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember"
      decimals="0"
      id="Fact000118"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember"
      decimals="0"
      id="Fact000119"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember"
      decimals="0"
      id="Fact000120"
      unitRef="USD">-25069</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-07-012024-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_TotalEquityAwardAdjustmentMember"
      decimals="0"
      id="Fact000121"
      unitRef="USD">27919</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_AddFairValueOfAwardsGrantedDuringFYAtEndOfYearMember"
      decimals="0"
      id="Fact000122"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ChangeInFairValueOfAwardsGrantedInAnyPYUnvestedAtEndOfFYMember"
      decimals="0"
      id="Fact000123"
      unitRef="USD">92897</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_AddForAwardsGrantedAndVestedInTheSameFYTheFairValueAsOfVestingDateMember"
      decimals="0"
      id="Fact000124"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_ChangeInFairValueAsOfVestingDateOfAnyAwardsFromAPYVestedInCYMember"
      decimals="0"
      id="Fact000125"
      unitRef="USD">88184</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_SubtractAwardsGrantedInAnyPYFailToMeetVestingConditionsDuringTheYearValueAtEndOfPYMember"
      decimals="0"
      id="Fact000126"
      unitRef="USD">-54248</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-07-012023-06-30_ecd_NonPeoNeoMember_custom_AlishaCharltonMember_custom_TotalEquityAwardAdjustmentMember"
      decimals="0"
      id="Fact000127"
      unitRef="USD">126833</ecd:AdjToCompAmt>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000129">&lt;p id="xdx_84E_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_zEcOxd3Ukh3f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;CAP and TSR&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;As demonstrated by the
following graph, the amount of CAP for 2023, 2024 and 2025 and the CAP is generally aligned with our TSR over the three years presented
in the table. The alignment of CAP with our TSR over the period presented is because a significant portion of the CAP is comprised of
equity awards.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;i&gt;&lt;img alt="" src="image_001.jpg" style="height: 337px; width: 577px"/&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000131">&lt;p id="xdx_847_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zEgAWXTq5DEh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;CAP and Net Income&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As demonstrated by the following graph, the amount
of CAP for 2023, 2024 and 2025 and is generally aligned with our net income over the three years presented in the table. However, as noted
above, a significant portion of the CAP is comprised of equity awards, and therefore this may not always be the case.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;img alt="" src="image_001.gif" style="height: 319px; width: 570px"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="From2024-07-01to2025-06-30" id="Fact000132">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
